0 36 (addiction AND industry:Opioids) yfdk0378 Endo Documents endo Bingol, Demir public no restrictions Caulkins JC Nicosia N What economics can contribute to the addiction sciences Addiction 2010.pdf Bingol, Demir\Opaia Message Archives\Bingol,Demir_Export_0024.pst\Top of Personal Folders\Deleted Items\No Subject-76.EML In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Caulkins JC Nicosia N What economics can contribute to the addiction sciences Addiction 2010.pdf;What economics can contribute to the addiction sciences 2010 July 02 document 8 English ENDO-OPIOID_MDL-02100967 2025 July 31 zrxk0389 Endo Documents endo Kopecky, Ernest Privacy public no restrictions nida_science_of_addiction.pdf Kopecky, Ernest\My Documents\Endo Pharmaceuticals\Journal Articles Backup\Journal Articles\Abuse Liability In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Science of Addiction;Science of addiction buprenorhine suboxone subutex naloxone and other addiction medications NIDA 2012 April 05 document 35 English ENDO-OPIOID_MDL-03316930 yes 2025 September 25 hqnd0241 Mallinckrodt Litigation Documents mnk public no restrictions 2012 October 29 2019-07-16 Opioids emails\Silver, David\Silver, David all_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) List of addiction products- Addiction 06:56 PM Silver, David 2012 October 29 06:56 PM Re: List of addiction products- Addiction "Silver, David" <david.silver@covidien.com> 2012 October 29 Document Email 1 "Klug, Melissa A" <melissa.klug@covidien.com> Methadone MNKOIv002 MNKOI0003125165 2021 October 21 ftky0421 Endo Documents endo Kitlinski, Linda Privacy public no restrictions 2006 February 23 2006 February 23 FW: Two recent opioid articles on iatrogenic addiction & addiction terminology Kitlinski, Linda\Kitlinski,Linda_Export_0001.pst\Top of Personal Folders\Sent Items\Recovered Sent Items ENDO_FLAG-00434706 ENDO_FLAG-00434713 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: Two recent opioid articles on iatrogenic addiction & addiction terminology "Kitlinski, Linda" <kitlinski.linda@endo.com> 2006 February 23 email 1 "Aron, Carey" <aron.carey@endo.com> "Tormo, Vin" <tormo.vin@endo.com> "Thomson,Heather" <thomson.heather@endo.com> "Yuen,Frank" <yuen.frank@endo.com> "Jackson,Elizabeth" <jackson.elizabeth@endo.com> "Speiller,Marcia" <speiller.marcia@endo.com> "Brown,Bobbie-Sue" <brown.bobbiesue@endo.com> "Williams,Andrea" <williams.andrea@endo.com> English ENDO_FLAG-00434705 yes 2026 April 30 gqfd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Controlled Substance Registration Certificate for Addiction Research & Treatment, Inc. (dba BAART, Facet & Bay Area Addiction Research and Treatment Center, of San Francisco, California - DEA Registration Numbers : RA0240123 & ZA0240123 (Maintenance)) United States. Drug Enforcement Administration 2011 June 02 document 1 opioids MNKOIv002 MNKOI0003320118 2021 October 21 jmnw0246 Mallinckrodt Litigation Documents mnk public no restrictions 2012 February 22 Wessler emails 1 1 10 fwd_20/Wessler emails 1 1 10 fwd_20.pst/Top of Personal Folders/Archive MNKOI0004132996 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) michael.glatt@covidien.com has shared: DRUG ADDICTION: Doctors and Patients To Blame For Prescription Drug Addiction 01:52:12 PM Wessler, Michael 2012 February 22 01:52:12 PM FW: michael.glatt@covidien.com has shared: DRUG ADDICTION: Doctors and Patients To Blame For Prescription Drug Addiction FW: michael.glatt@covidien.com has shared: DRUG ADDICTION: Doctors and Patients To Blame For Prescription Drug Addiction "Glatt, Michael J" <michael.glatt@covidien.com> 2012 February 22 Document Email 1 "Wessler, Michael" <michael.wessler@covidien.com>, "Patterson, Mike E" <mike.patterson@covidien.com> "Kisinger, Connie" <connie.kisinger@covidien.com> opioids MNKOIv004 MNKOI0004132995 2021 October 21 fxdf0414 Endo Documents endo Quaranta, Lynn Privacy public no restrictions NRS-04 Pain Addiction or Both (Curtiss).pdf Quaranta, Lynn\MyDocs\quaranta.lynn\My Documents\Saturday (9.8.12) In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Microsoft PowerPoint - NRS-04 Pain Addiction or Both (Curtiss).pptx [Read-Only];NRS-04 Pain Addiction or Both (Curtiss).pdf cbrown 2012 September 08 document 22 English ENDO-OPIOID_MDL-00538843 yes 2026 February 26 xpnb0255 Mallinckrodt Litigation Documents mnk public no restrictions 2012 February 22 TX and PA custodians for opioids\Kisinger, Connie\Kisinger, Connie pre2014 all_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) michael.glatt@covidien.com has shared: DRUG ADDICTION: Doctors and Patients To Blame For Prescription Drug Addiction 02:05 PM Kisinger, Connie 2012 February 22 02:05 PM Fwd: michael.glatt@covidien.com has shared: DRUG ADDICTION: Doctors and Patients To Blame For Prescription Drug Addiction "Paranjothi, Krishnan" <krishnan.paranjothi@covidien.com> 2012 February 22 Document Email 1 "Kisinger, Connie" <connie.kisinger@covidien.com> opioids MNKOIv009 MNKOI0007330699 2021 October 21 qnld0271 Insys Litigation Documents insys Cromartie, Tiffany Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 RE: Addiction to WINNING is a HEALTHY addiction Myles A. Walsh 2013 May 13 email 4 Sayra Torberson Crystal Skelton Richard Simon Sales Team - SFO INSYS-MDL-004672878 yes 2023 January 19 mpld0271 Insys Litigation Documents insys Cromartie, Tiffany Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Torgny Andersson 2013 May 13 email 3 Richard Simon Sales Team - SFO INSYS-MDL-004673301 yes 2023 January 19 mypd0271 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Crystal Skelton 2013 May 13 email 3 Richard Simon AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Sales Team - SFO storberson@insysrx.com INSYS-MDL-004932617 yes 2023 January 19 nypd0271 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Kristiana M. Wright 2013 May 13 email 3 Richard Simon AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Alec Burlakoff Sales Team - SFO storberson@insysrx.com INSYS-MDL-004932621 yes 2023 January 19 qypd0271 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2013 May 14 2013 May 14 Re: Addiction to WINNING is a HEALTHY addiction Ty Rustin 2013 May 14 email 4 Richard Simon AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Alec Burlakoff Sales Team - SFO storberson@insysrx.com INSYS-MDL-004932635 yes 2023 January 19 lypd0271 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Torgny Andersson 2013 May 13 email 3 Richard Simon AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Sales Team - SFO storberson@insysrx.com INSYS-MDL-004932607 yes 2023 January 19 yypd0271 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Sayra Torberson 2013 May 13 email 4 Crystal Skelton AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Richard Simon Sales Team - SFO storberson@insysrx.com INSYS-MDL-004932627 yes 2023 January 19 pypd0271 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 RE: Addiction to WINNING is a HEALTHY addiction Myles A. Walsh 2013 May 13 email 4 Sayra Torberson Crystal Skelton AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Richard Simon Sales Team - SFO storberson@insysrx.com INSYS-MDL-004932631 yes 2023 January 19 qqbf0271 Insys Litigation Documents insys Torberson, Sayra Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Sayra Torberson 2013 May 13 email 3 Crystal Skelton Richard Simon Sales Team - SFO INSYS-MDL-005310213 yes 2023 January 19 zskw0276 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Addiction to WINNING is a HEALTHY addiction Richard Simon 2013 May 13 email 5 Sales Team - SFO AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Alec Burlakoff storberson@insysrx.com INSYS-MDL-010642160 yes 2023 February 23 ftkw0276 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Andrew McNaughton 2013 May 13 email 6 Richard Simon Sales Team - SFO AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Alec Burlakoff storberson@insysrx.com INSYS-MDL-010642174 yes 2023 February 23 srnb0276 Insys Litigation Documents insys Cromartie, Tiffany Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 RE: Addiction to WINNING is a HEALTHY addiction Tiffany Cromartie 2013 May 13 email 5 Richard Simon INSYS-MDL-004706456 yes 2023 February 23 zmyb0276 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Andrew McNaughton 2013 May 13 email 6 Richard Simon Sales Team - SFO AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Alec Burlakoff storberson@insysrx.com INSYS-MDL-004932611 yes 2023 February 23 mmnb0276 Insys Litigation Documents insys Cromartie, Tiffany public no restrictions 2013 May 13 2013 May 13 Addiction to WINNING is a HEALTHY addiction Richard Simon 2013 May 13 email 5 Sales Team - SFO Alec Burlakoff INSYS-MDL-004673365 yes 2023 February 23 tmyb0276 Insys Litigation Documents insys McNaughton, Andrew public no restrictions 2013 May 13 2013 May 13 Addiction to WINNING is a HEALTHY addiction Richard Simon 2013 May 13 email 5 Sales Team - SFO AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Alec Burlakoff storberson@insysrx.com INSYS-MDL-004932601 yes 2023 February 23 xfpb0276 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Andrew McNaughton 2013 May 13 email 6 Richard Simon Sales Team - SFO Alec Burlakoff INSYS-MDL-005034434 yes 2023 February 23 nsgk0273 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 FW: Addiction to WINNING is a HEALTHY addiction Alec Burlakoff 2013 May 13 email 4 Anna Bolet Sunrise Lee Joseph Rowan Jeff Pearlman Brian Richmond Darin Fila INSYS-MDL-010169515 yes 2023 February 23 qffp0273 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Jaimi Hooker 2013 May 13 email 3 Richard Simon INSYS-MDL-010642180 yes 2023 February 23 xgfp0273 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 RE: Addiction to WINNING is a HEALTHY addiction Myles A. Walsh 2013 May 13 email 4 Sayra Torberson Crystal Skelton AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Richard Simon Sales Team - SFO storberson@insysrx.com INSYS-MDL-010642204 yes 2023 February 23 jgfp0273 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2013 May 14 2013 May 14 Re: Addiction to WINNING is a HEALTHY addiction Ty Rustin 2013 May 14 email 4 Richard Simon AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Alec Burlakoff Sales Team - SFO storberson@insysrx.com INSYS-MDL-010642208 yes 2023 February 23 pffp0273 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Torgny Andersson 2013 May 13 email 3 Richard Simon AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Sales Team - SFO storberson@insysrx.com INSYS-MDL-010642170 yes 2023 February 23 ggfp0273 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Kristiana M. Wright 2013 May 13 email 3 Richard Simon AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Alec Burlakoff Sales Team - SFO storberson@insysrx.com INSYS-MDL-010642194 yes 2023 February 23 yyld0271 Insys Litigation Documents insys Cromartie, Tiffany Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Crystal Skelton 2013 May 13 email 3 Richard Simon Sales Team - SFO INSYS-MDL-004673079 yes 2023 January 19 fgfp0273 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Crystal Skelton 2013 May 13 email 3 Richard Simon AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Sales Team - SFO storberson@insysrx.com INSYS-MDL-010642190 yes 2023 February 23 hgfp0273 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Sayra Torberson 2013 May 13 email 4 Crystal Skelton AMcNaughton@insysrx.com cskelton@insysrx.com gbrannon@insysrx.com jhooker@insysrx.com kwright@insysrx.com mwalsh@insysrx.com rsimon@insysrx.com tandersson@insysrx.com tcromartie@insysrx.com trustin@insysrx.com Richard Simon Sales Team - SFO storberson@insysrx.com INSYS-MDL-010642200 yes 2023 February 23 xnld0271 Insys Litigation Documents insys Cromartie, Tiffany Confidential Personal Information public no restrictions 2013 May 14 2013 May 14 Re: Addiction to WINNING is a HEALTHY addiction Ty Rustin 2013 May 14 email 3 Richard Simon Sales Team - SFO Alec Burlakoff INSYS-MDL-004672757 yes 2023 January 19 kyld0271 Insys Litigation Documents insys Cromartie, Tiffany Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 Re: Addiction to WINNING is a HEALTHY addiction Kristiana M. Wright 2013 May 13 email 3 Richard Simon Sales Team - SFO Alec Burlakoff INSYS-MDL-004673027 yes 2023 January 19 yhhg0275 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 000000002FFBD581306B944388EAFE4E31E48C21C42D2000.MSG RE: Addiction to WINNING is a HEALTHY addiction Tiffany Cromartie 2013 May 13 email 4 Richard Simon [rsimon@insysrx.com] INSYS-MDL-013619253 yes 2023 February 23 xhhh0275 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 0000000052702B17AEB5FD48BE1324F24866AB49C4CD2300.MSG Re: Addiction to WINNING is a HEALTHY addiction Ty Rustin 2013 May 13 email 3 Richard Simon [rsimon@insysrx.com] Sales Team - SFO [salesteamsfo@insysrx.com] Alec Burlakoff [aburlakoff@insysrx.com] INSYS-MDL-013706419 yes 2023 February 23 khhh0275 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 0000000052702B17AEB5FD48BE1324F24866AB4984CE2300.MSG Re: Addiction to WINNING is a HEALTHY addiction Sayra Torberson 2013 May 13 email 3 Crystal Skelton [cskelton@insysrx.com] Richard Simon [rsimon@insysrx.com] Sales Team - SFO [salesteamsfo@insysrx.com] INSYS-MDL-013706431 yes 2023 February 23 pxhh0275 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 0000000052702B17AEB5FD48BE1324F24866AB49E4D02300.MSG Re: Addiction to WINNING is a HEALTHY addiction Kristiana M. Wright 2013 May 13 email 3 Richard Simon [rsimon@insysrx.com] Sales Team - SFO [salesteamsfo@insysrx.com] Alec Burlakoff [aburlakoff@insysrx.com] INSYS-MDL-013706672 yes 2023 February 23 qxhh0275 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 0000000052702B17AEB5FD48BE1324F24866AB4944D12300.MSG Re: Addiction to WINNING is a HEALTHY addiction Crystal Skelton 2013 May 13 email 3 Richard Simon [rsimon@insysrx.com] Sales Team - SFO [salesteamsfo@insysrx.com] INSYS-MDL-013706675 yes 2023 February 23 sxhh0275 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 0000000052702B17AEB5FD48BE1324F24866AB4904D22300.MSG Re: Addiction to WINNING is a HEALTHY addiction Torgny Andersson 2013 May 13 email 3 Richard Simon [rsimon@insysrx.com] Sales Team - SFO [salesteamsfo@insysrx.com] INSYS-MDL-013706688 yes 2023 February 23 rhmy0275 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 14 2013 May 14 000000001C21B10D1E410D448D2705DB1A103847A48D2100.MSG Fwd: Addiction to WINNING is a HEALTHY addiction Gigi Brannon 2013 May 14 email 3 Anna Bolet [abolet@insysrx.com] INSYS-MDL-014765810 yes 2023 February 23 flbv0424 Endo Documents endo Leigh, Teresa public no restrictions image002.gif Leigh, Teresa\Endo_eDiscovery\7.17.2018_Opioids\Leigh_Teresa\07.19.2018_Leigh_EndoArchive\Messages\07.19.2018_Leigh_EndoArchive.pst\Top of Outlook data file\Root Items\FW: oxycontin In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) OxyContin maker misled on addiction risks - Addictions - MSNBC.com 2007 May 11 html 5 English ENDO_OPIOID_OHAG-00117630 2026 April 30 glbv0424 Endo Documents endo Leigh, Teresa public no restrictions image004.jpg Leigh, Teresa\Endo_eDiscovery\7.17.2018_Opioids\Leigh_Teresa\07.19.2018_Leigh_EndoArchive\Messages\07.19.2018_Leigh_EndoArchive.pst\Top of Outlook data file\Root Items\FW: oxycontin In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) OxyContin maker misled on addiction risks - Addictions - MSNBC.com 2007 May 11 html 5 English ENDO_OPIOID_OHAG-00117635 2026 April 30 sjxj0422 Endo Documents endo Kitlinski, Linda Privacy public no restrictions 2004 March 04 RE Nicholson DRUGSAddiction reference.htm Kitlinski, Linda\My Documents\Opana\Kitlinski.Linda\My Documents\EN3202-03\Risk Management Initiatives In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Addiction reference;RE: Addiction reference adrienne wald [awald@hms- edu.com] 2004 March 04 html 2 Kitlinski, Linda English ENDO_FLAG-01039662 yes 2026 April 30 npwk0319 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2015 August 06 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0002.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement Focus on Chronic Pain and Addiction at Addiction Medicine State of the Art Conference [MARKETING] CSAM (External) <csam@csam-asam.org> 2015 August 06 email 2 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01047876 TEVA_MDL_A_01305342 yes 2024 August 29 smdf0320 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2016 May 24 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0002.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement Addressing Pain and Addiction at Essentials of Addiction Medicine [MARKETING] CSAM (External) <csam@csam-asam.org> 2016 May 24 email 3 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01191808 TEVA_MDL_A_01476842 2024 August 29 ntfl0389 Endo Documents endo Tormo, Vin public no restrictions Patient concerns about addiction with studies.doc Tormo, Vin\Tormo.Vin\My Documents\Sync My Documents\Patient info addiction concerns In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Patient concerns about addiction with studies.doc;Some people who are prescibed opioid medications are concerned about addiction Tormo.Vin 2001 May 07 document 3 English ENDO-OPIOID_MDL-03388173 2025 September 25 xmgl0393 Endo Documents endo Still, Daniel public no restrictions 2013 May 01 2013 May 01 Keyword: [opioids ]: American Society of Addiction Medicine Urges an End to Interference with Physician-Patient Decisions on Addiction ....msg Still_Daniel_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Keyword: [opioids ]: American Society of Addiction Medicine Urges an End to Interference with Physician-Patient Decisions on Addiction ... news-alerts@yahoo-inc.com 2013 May 01 email 1 Still, Daniel still.daniel@endo.com ENDO-OPIOID_MDL-07455664 2025 October 23 zzmn0393 Endo Documents endo Alvarez, Nancy Privacy public no restrictions 2006 September 05 Opana ER SRL - Drug Abuse and Addiction V1D4 - Comments from Marie 090506.htm Alvarez, Nancy\My Documents\Opana\Alvarez.Nancy\My Documents\Medical Science\PPD Medical Communications\Database\2005 PPD Transition\Opana ER In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Opana ER SRL - Drug Abuse and Addiction V1D4;RE: Opana ER SRL - Drug Abuse and Addiction V1D4 HI Nancy, Pinizzotto,Marie 2006 September 05 html 2 Alvarez, Nancy English ENDO-OPIOID_MDL-07562938 yes 2025 October 23 xhmn0393 Endo Documents endo Alvarez, Nancy Privacy public no restrictions 2006 October 03 PRE - Drug Abuse Misuse and Diversion V3D1 revised drug abuse and addiction letter.htm Alvarez, Nancy\My Documents\Opana\Alvarez.Nancy\My Documents\Medical Science\PPD Medical Communications\Database\2005 PPD Transition\DRAFT Opana ER In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: Drug Abuse Misuse and Diversion V3D1 **revised drug abuse and addiction letter**;Re: Opana ER SRL - Drug Abuse and Addiction V1D4 Eleni Allen [Eleni.Allen@durham.ppdi.com] 2006 October 03 email 7 Alvarez, Nancy Elizabeth Froom Robin Reap English ENDO-OPIOID_MDL-07561471 yes 2025 October 23 fznn0393 Endo Documents endo Alvarez, Nancy public no restrictions ADE_Addiction with Lidoderm UPDATED Oct 2003.doc Alvarez, Nancy\My Documents\Opana\Alvarez.Nancy\My Documents\Medical Science\PPD Medical Communications\Database\NAA File KAI Exchange\Lidoderm In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Lidoderm addiction response;This response concerns the issue of addiction caused by the use of LIDODERM® Gammaitoni.Arnold 2003 October 29 document 1 English ENDO-OPIOID_MDL-07564631 2025 October 23 jlpn0393 Endo Documents endo Alvarez, Nancy Privacy public no restrictions 2006 October 05 010807 Opana ER - FDA requirements re opiate misuse.htm Alvarez, Nancy\My Documents\Opana\Alvarez.Nancy\My Documents\Medical Science\PPD Medical Communications\Writing and Editoral Services\Questions\Out of Scope requests\2007\Jan 2007 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: Drug Abuse Misuse and Diversion V3D1 **revised drug abuse and addiction letter** Good point about the boxed warning....thanks.;Re: Opana ER SRL - Drug Abuse and Addiction V1D4 Alvarez, Nancy [Alvarez.Nancy@Endo.com] 2006 October 05 email 7 Eleni Allen Elizabeth Froom Robin Reap English ENDO-OPIOID_MDL-07567269 yes 2025 October 23 kfkm0393 Endo Documents endo Yuen, Frank Privacy public no restrictions 2006 February 23 2006 February 23 FW: Two recent opioid articles on iatrogenic addiction & addiction terminology.msg Yuen_Frank_Email.7z\ ENDO-OPIOID_MDL-07500198 ENDO-OPIOID_MDL-07500205 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: Two recent opioid articles on iatrogenic addiction & addiction terminology /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=KITLINSKI.LINDA 2006 February 23 email 1 Aron, Carey aron.carey@endo.com Tormo, Vin tormo.vin@endo.com Thomson,Heather thomson.heather@endo.com Yuen,Frank yuen.frank@endo.com Jackson,Elizabeth jackson.elizabeth@endo.com Speiller,Marcia speiller.marcia@endo.com Brown,Bobbie-Sue brown.bobbiesue@endo.com Williams,Andrea williams.andrea@endo.com ENDO-OPIOID_MDL-07500197 yes 2025 October 23 mkcn0235 Mallinckrodt Litigation Documents mnk public no restrictions 2012 October 29 /005/005-03-Email collection/Collier, Ginger/Collier emails 1 1 10 fwd_15/Collier emails 1 1 10 fwd_15.pst/Top of Personal Folders/Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) List of addiction products- Addiction 08:51:49 PM Collier, Ginger 2012 October 29 08:51:49 PM RE: List of addiction products- Addiction RE: List of addiction products- Addiction "Klug, Melissa A" <melissa.klug@covidien.com> 2012 October 29 Document Email 3 "Bullerdick, Jennifer M" <jennifer.bullerdick@covidien.com> "Collier, Ginger L" <ginger.collier@covidien.com> Methadone MNKOIv001 MNKOI0000524654 2021 October 21 smbn0235 Mallinckrodt Litigation Documents mnk public no restrictions 2012 October 29 /005/005-03-Email collection/Collier, Ginger/Collier emails 1 1 10 fwd_15/Collier emails 1 1 10 fwd_15.pst/Top of Personal Folders/Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) List of addiction products- Addiction 08:56:11 PM Collier, Ginger 2012 October 29 08:56:11 PM RE: List of addiction products- Addiction RE: List of addiction products- Addiction "Bullerdick, Jennifer M" <jennifer.bullerdick@covidien.com> 2012 October 29 Document Email 4 "Klug, Melissa A" <melissa.klug@covidien.com> "Collier, Ginger L" <ginger.collier@covidien.com> Methadone MNKOIv001 MNKOI0000522698 2021 October 21 ffbh0239 Mallinckrodt Litigation Documents mnk Network Share (Regulatory Affairs) public no restrictions 99-ACK-020414.pdf 20180829_Collection_Set2A\Target\N\Hazelwood01\Quality\Cots\INSIGHT\United States (US) produced document; Electronic File In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Letter from Kevin Healy (Director of Regulatory Affairs for Mallinckrodt Pharmaceuticals) to Bob A. Rappaport (Director of the Division of Anesthesia, Analgesia, and Addiction Products at the Center for Drug Evaluation and Research), re: IND 104,702; SN 0052, Protocol Amendment: New Protocol for Study MNKl5162014, General Correspondence: Request for Agency Comments and Advice (Attention: Dominic Chiapperino, Ph.D., Sr. Regulatory Project Manager) -- Letter from Kevin Healy (Director of Regulatory Affairs for Mallinckrodt Pharmaceuticals) to Bob A. Rappaport (Director of the Division of Anesthesia, Analgesia, and Addiction Products at the Center for Drug Evaluation and Research), re: IND 104,702; SN 0053, Protocol Amendment: New Protocol for Study MNK15181017, General Correspondence: Request for Agency Comments and Advice (Attention: Dominic Chiapperino, Ph.D., Sr. Regulatory Project Manager) Healy, Kevin D. Mallinckrodt Pharmaceuticals 2014 February 04; 2014 February 18 document 7 Hydrocodone Hydrocodone Bitartrate Oxycodone MNKOIv002 MNKOI0002252489 2021 October 21 yjyj0236 Mallinckrodt Litigation Documents mnk Synchrony public no restrictions FrontPsychiatry 4,Aug,72 RD Rotzell 8-8.pdf /011/011/011.L01/FILES FROM SYNCHRONY MEDICAL/Project Folders/Methadone Educational Slides/12-COV-0253/Module 2/1 References/_Old_References General/References From MNK produced document; Electronic File In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction is a reward deficit and stress surfeit disorder; Drug addiction can be defined by a three-stage cycle – binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation – that involves allostatic changes in the brain reward and stress systems. George F. Koob 2015 June 20 document 18 Buprenorphine Methadone Morphine MNKOIv001 MNKOI0000851052 2021 October 21 rzyc0426 Endo Documents endo Quaranta, Lynn public no restrictions Powerful New Painkillers Have Addiction Experts Worried | Healthland | TIME.com.pdf Quaranta, Lynn\Email\01.26.2018_GJS_EndoJournal_Quaranta_Extended\Messages\01.26.2018_GJS_EndoJournal_Quaranta_Extended_0001.pst\Top of Outlook data file\Root Items\2 articles from ASAM weekly In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Powerful New Painkillers Have Addiction Experts Worried | Healthland | TIME.com;Powerful New Painkillers Have Addiction Experts Worried | Healthland | TIME.com.pdf Frank Yuen 2012 January 11 document 3 English ENDO-OPIOID_MDL-00577436 yes 2026 May 28 mkjh0276 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 000000002BC2E72BDA1D754B91A4C5D5AC1E68B4241F3300.MSG Re: Addiction to WINNING is a HEALTHY addiction Andrew McNaughton 2013 May 13 email 5 Richard Simon [rsimon@insysrx.com] Sales Team - SFO [salesteamsfo@insysrx.com] Alec Burlakoff [aburlakoff@insysrx.com] INSYS-MDL-014669073 yes 2023 February 23 fpyg0276 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 0000000052702B17AEB5FD48BE1324F24866AB49A4D12300.MSG Re: Addiction to WINNING is a HEALTHY addiction Andrew McNaughton 2013 May 13 email 5 Richard Simon [rsimon@insysrx.com] Sales Team - SFO [salesteamsfo@insysrx.com] Alec Burlakoff [aburlakoff@insysrx.com] INSYS-MDL-013706683 yes 2023 February 23 lmjg0276 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 000000001C21B10D1E410D448D2705DB1A10384744AE2100.MSG FW: Addiction to WINNING is a HEALTHY addiction Alec Burlakoff 2013 May 13 email 6 Anna Bolet [abolet@insysrx.com] Sunrise Lee [slee@insysrx.com] Joseph Rowan [jrowan@insysrx.com] Jeff Pearlman [jpearlman@insysrx.com] Brian Richmond [brichmond@insysrx.com] Darin Fila [dfila@insysrx.com] INSYS-MDL-013397820 yes 2023 February 23 khwh0276 Insys Litigation Documents insys Richmond, Brian Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 000000005BD2BDE001E679489668750743A53813C4EE3C00.MSG FW: Addiction to WINNING is a HEALTHY addiction Alec Burlakoff 2013 May 13 email 5 Anna Bolet [abolet@insysrx.com] Sunrise Lee [slee@insysrx.com] Joseph Rowan [jrowan@insysrx.com] Jeff Pearlman [jpearlman@insysrx.com] Brian Richmond [brichmond@insysrx.com] Darin Fila [dfila@insysrx.com] INSYS-MDL-014366885 yes 2023 February 23 yryg0276 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 00000000FE5A6B9F8A75F444871B91786D780A2684632000.MSG FW: Addiction to WINNING is a HEALTHY addiction Alec Burlakoff 2013 May 13 email 5 Anna Bolet [abolet@insysrx.com] Sunrise Lee [slee@insysrx.com] Joseph Rowan [jrowan@insysrx.com] Jeff Pearlman [jpearlman@insysrx.com] brichmond@insysrx.com Darin Fila [dfila@insysrx.com] INSYS-MDL-013711965 yes 2023 February 23 nxpg0276 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 00000000DCB891710F45934BA60A13B078AE9149442C2100.MSG FW: Addiction to WINNING is a HEALTHY addiction Alec Burlakoff 2013 May 13 email 5 Anna Bolet [abolet@insysrx.com] Sunrise Lee [slee@insysrx.com] Joseph Rowan [jrowan@insysrx.com] Jeff Pearlman [jpearlman@insysrx.com] Brian Richmond [brichmond@insysrx.com] Darin Fila [dfila@insysrx.com] INSYS-MDL-013718760 yes 2023 February 23 msvh0276 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 000000002BC2E72BDA1D754B91A4C5D5AC1E68B4241F3300.MSG Re: Addiction to WINNING is a HEALTHY addiction Andrew McNaughton 2013 May 13 email 5 Richard Simon [rsimon@insysrx.com] Sales Team - SFO [salesteamsfo@insysrx.com] Alec Burlakoff [aburlakoff@insysrx.com] INSYS-MDL-013846491 yes 2023 February 23 lhkh0276 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 000000001C21B10D1E410D448D2705DB1A10384744AE2100.MSG FW: Addiction to WINNING is a HEALTHY addiction Alec Burlakoff 2013 May 13 email 5 Anna Bolet [abolet@insysrx.com] Sunrise Lee [slee@insysrx.com] Joseph Rowan [jrowan@insysrx.com] Jeff Pearlman [jpearlman@insysrx.com] Brian Richmond [brichmond@insysrx.com] Darin Fila [dfila@insysrx.com] INSYS-MDL-014766118 yes 2023 February 23 ynyw0275 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 14 2013 May 14 000000001C21B10D1E410D448D2705DB1A103847A48D2100.MSG Fwd: Addiction to WINNING is a HEALTHY addiction Gigi Brannon 2013 May 14 email 3 Anna Bolet [abolet@insysrx.com] INSYS-MDL-013397503 yes 2023 February 23 xpmg0275 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 14 2013 May 14 00000000C36F0BBB06063645B7C444F0209D9D6E44AD2000.MSG Fwd: Addiction to WINNING is a HEALTHY addiction Gigi Brannon 2013 May 14 email 3 Anna Bolet [abolet@insysrx.com] INSYS-MDL-013650863 yes 2023 February 23 sghh0275 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 0000000052702B17AEB5FD48BE1324F24866AB4944C82300.MSG RE: Addiction to WINNING is a HEALTHY addiction Myles A. Walsh 2013 May 13 email 3 Sayra Torberson [storberson@insysrx.com] Crystal Skelton [cskelton@insysrx.com] Richard Simon [rsimon@insysrx.com] Sales Team - SFO [salesteamsfo@insysrx.com] INSYS-MDL-013706349 yes 2023 February 23 zxhh0275 Insys Litigation Documents insys INSYS Therapeutics Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 0000000052702B17AEB5FD48BE1324F24866AB4944D22300.MSG Addiction to WINNING is a HEALTHY addiction Richard Simon 2013 May 13 email 4 Sales Team - SFO [salesteamsfo@insysrx.com] Alec Burlakoff [aburlakoff@insysrx.com] INSYS-MDL-013706696 yes 2023 February 23 kqhf0276 Insys Litigation Documents insys Richmond, Brian Confidential Personal Information public no restrictions 2013 May 13 2013 May 13 000000005BD2BDE001E679489668750743A53813C4EE3C00.MSG FW: Addiction to WINNING is a HEALTHY addiction Alec Burlakoff 2013 May 13 email 5 Anna Bolet [abolet@insysrx.com] Sunrise Lee [slee@insysrx.com] Joseph Rowan [jrowan@insysrx.com] Jeff Pearlman [jpearlman@insysrx.com] Brian Richmond [brichmond@insysrx.com] Darin Fila [dfila@insysrx.com] INSYS-MDL-012225031 yes 2023 February 23 kzxd0388 Endo Documents endo Quaranta, Lynn public no restrictions Can Pain Treatment Survive Our Addiction to Law_ - Reason Magazine.pdf Quaranta, Lynn\MyDocs\quaranta.lynn\My Documents\CPE Exam Materials In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Can Pain Treatment Survive Our Addiction to Law? - Reason Magazine;Can Pain Treatment Survive Our Addiction to Law_ - Reason Magazine.pdf 2010 June 17 document 3 English ENDO-OPIOID_MDL-00528151 2025 September 25 qqhh0390 Endo Documents endo Tormo, Vin public no restrictions Patient concerns about addiction with studies.doc Tormo, Vin\MyDocs\tormo.vin\My Documents\Sync My Documents\Patient info addiction concerns In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Patient concerns about addiction with studies.doc;Some people who are prescibed opioid medications are concerned about addiction Tormo.Vin 2001 May 07 document 3 English ENDO-OPIOID_MDL-04869718 2025 September 25 ygfx0391 Endo Documents endo Shusterman, Neil public no restrictions 04 - View from and Addiction Treatment Specialist_C4.pptx Shusterman, Neil\MyDocs\shusterman.neil\Documents\Projects\Opana CRF\Ad Comm 2017\HCPJs\Dr Shawn Ryan_ Example of slides for Mock2.msg\EXTERNAL: My presentation from today with the minor changes as I presented it In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) 04 - View from and Addiction Treatment Specialist_C4.pptx;The Impact of Reformulated OPANA ER from the Perspective of an Addiction Medicine Clinician 3D General User 2017 March 01 presentation 10 ENDO-OPIOID_MDL-01629008 2025 September 25 ztmf0402 Endo Documents endo Brown, Bobbie Sue Privacy public no restrictions 2014 September 12 2014 September 12 EXTERNAL: American Academy of Addiction Psychiatry Receives $3 Million Grant to Address Opioid Addiction.msg \Brown_Bobbie-Sue_Email_0001.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) EXTERNAL: American Academy of Addiction Psychiatry Receives $3 Million Grant to Address Opioid Addiction justina@aaap.org 2014 September 12 email 2 Brown, Bobbie-Sue brown.bobbiesue@endo.com ENDO_SF-00105887 yes 2025 November 20 hslg0402 Endo Documents endo Brown, Bobbie Sue Privacy public no restrictions 2006 February 23 2006 February 23 FW: Two recent opioid articles on iatrogenic addiction & addiction terminology.msg \Brown_Bobbie-Sue_MyDocs.7z\My Documents\Outlook Files\ ENDO_SF-00150770 ENDO_SF-00150777 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: Two recent opioid articles on iatrogenic addiction & addiction terminology /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=KITLINSKI.LINDA 2006 February 23 email 1 Aron, Carey /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=ARON.CAREY Tormo, Vin /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=TORMO.VINCENTE Thomson,Heather /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=THOMSON.HEATHER Yuen,Frank /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=YUEN.FRANK Jackson,Elizabeth /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=JACKSON.ELIZABETH Speiller,Marcia /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=SPEILLER.MARCIA Brown,Bobbie-Sue /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=BROWN.BOBBIESUE Williams,Andrea /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=WILLIAMS.ANDREA ENDO_SF-00150769 yes 2025 November 20 mnyc0426 Endo Documents endo Quaranta, Lynn public no restrictions Can Pain Treatment Survive Our Addiction to Law_ - Reason Magazine.pdf Quaranta, Lynn\Email\01.26.2018_GJS_EndoJournal_Quaranta_Extended\Messages\01.26.2018_GJS_EndoJournal_Quaranta_Extended_0001.pst\Top of Outlook data file\Root Items\CPE In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Can Pain Treatment Survive Our Addiction to Law? - Reason Magazine;Can Pain Treatment Survive Our Addiction to Law_ - Reason Magazine.pdf 2010 June 17 document 3 English ENDO-OPIOID_MDL-00574212 2026 May 28 qpcc0426 Endo Documents endo Camper, Steve Privacy public no restrictions Rapid-Onset Opioids Recognizing and Preventing Abuse, Addiction, and Diversion.htm Camper, Steve\MyDocs\camper.steve\Documents\My World\Journal Articles - Data\Pain Management In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Rapid-Onset Opioids Recognizing and Preventing Abuse, Addiction, and Diversion.htm;Rapid-Onset Opioids: Recognizing and Preventing Abuse, Addiction, and Diversion 2006 August 10 html 15 English ENDO-OPIOID_MDL-00364744 yes 2026 May 28 kglc0426 Endo Documents endo Quaranta, Lynn Privacy public no restrictions Bailey Review Crossroads of Pain and Addiction Pain Medicine 2010.pdf Quaranta, Lynn\MyDocs\quaranta.lynn\My Documents\OPIOID INFORMATION\ABUSE & ADDICTION In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Bailey Review Crossroads of Pain and Addiction Pain Medicine 2010.pdf;Crossroads of Pain and Addiction 2011 May 31 document 16 English ENDO-OPIOID_MDL-00532550 yes 2026 May 28 pfmj0426 Endo Documents endo Vitanza, Kristin public no restrictions New Addiction on Campus.doc Vitanza, Kristen\vitanza\Vitanza,Kristin_Export_0010.pst\Top of Personal Folders\Inbox\2009 Emails\2008 Emails\OPANA Brand 2008\Saatchi 2008\WSJ: New Addiction on Campus: Raiding the Medicine Cabinet In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) New Addiction on Campus.doc;New Addiction on Campus: KKirvin 2008 March 25 document 2 English ENDO-OPIOID_MDL-01490484 2026 May 28 ntmh0427 Endo Documents endo Journal public no restrictions Opioid addiction in chronic pain.pdf Journal\Opana Master Case Export\Opana Master Case Export 3_0566.pst\Top of Outlook data file\Root Items\EXTERNAL: Opioid addiction in chronic pain patients In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Classification and identification of opioid addiction in chronic pain patients;Opioid addiction in chronic pain.pdf "Jette Højsted Per Rotbøll Nielsen Sally Kendall Guldstrand Liv Frich Per Sjøgren" 2014 January 07 document 1 English ENDO-OPIOID_MDL-03494310 2026 May 28 rkpg0426 Endo Documents endo Chapman, Tara public no restrictions Group Health Study 3B Memo - Index Date versus AA Onset Date.pdf Chapman, Tara\Email\01.26.2018_GJS_EndoJournal_Chapman\Messages\01.26.2018_GJS_EndoJournal_Chapman_0001.pst\Top of Outlook data file\Root Items\EXTERNAL: *For OSW Review by 12pm ET on 8\25* Portabiltiy Assessment FDA Slides In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Comparing Study 3B Index Date to Onset Date of Opioid Abuse/Addiction;Observational Study 3B: An Observational Study to Develop Computable Algorithms for Identifying Opioid Abuse and Addiction Based on Administrative Claims Data Group Health Research Institute 2016 May 19 document 1 English ENDO-OPIOID_MDL-01233675 2026 May 28 rgxm0426 Endo Documents endo Chapman, Tara public no restrictions OPC OSW Study 3B Memo - Index Date Versus AA Onset Date 08-25-2016.pdf Chapman, Tara\Email\01.26.2018_GJS_EndoJournal_Chapman\Messages\01.26.2018_GJS_EndoJournal_Chapman_0001.pst\Top of Outlook data file\Root Items\EXTERNAL: FW: OPC OSW Materials in preparation for August 30th TCon with FDA to discuss Studies 3A\3B\1B In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Comparing Study 3B Index Date to Onset Date of Opioid Abuse/Addiction;Observational Study 3B: An Observational Study to Develop Computable Algorithms for Identifying Opioid Abuse and Addiction Based on Administrative Claims Data Group Health Research Institute 2016 August 25 document 1 English ENDO-OPIOID_MDL-01802954 2026 May 28 kxjc0427 Endo Documents endo Camper, Steve Privacy public no restrictions Rapid-Onset Opioids Recognizing and Preventing Abuse, Addiction, and Diversion.htm Camper, Steve\My Documents\Opana\camper.steve\My Documents\My World\Journal Articles - Data\Pain Management In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Rapid-Onset Opioids Recognizing and Preventing Abuse, Addiction, and Diversion.htm;Rapid-Onset Opioids: Recognizing and Preventing Abuse, Addiction, and Diversion 2006 August 10 html 15 English ENDO-OPIOID_MDL-02472986 yes 2026 May 28 xggx0426 Endo Documents endo Collins, Mark public no restrictions REMS Definitions for Abuse Misuse Addiction 19Feb14.pptx Collins, Mark\06.20.2018_Opioids\Endo_Journal\06.20.2018_Collins_EndoJournal\06.20.2018_Collins_EndoJournal_0009.pst\Top of Outlook data file\Root Items\EXTERNAL: PMR OSW Agenda and materials for tomorrow's teleconference In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FDA Approved Definitions for Abuse, Misuse, & Addiction used in the ER/LA Opioid Analgesics REMS;REMS Definitions for Abuse Misuse Addiction 19Feb14.pptx Kline, Ann 2014 February 24 presentation 1 English ENDO-OPIOID_MDL-01322252 2026 May 28 ymhv0247 Mallinckrodt Litigation Documents mnk public no restrictions 2016 February 02 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_10\Spaulding emails 1 1 14 to 5 9 18_10.pst\Top of Personal Folders\Archive MNKOI0004261155 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) [RxNews] ASAM addiction is not a moral failing, but rather a medical condition that must be treated.” 12:09 AM Spaulding, Eileen 2016 February 02 12:09 AM [RxNews] ASAM addiction is not a moral failing, but rather a medical condition that must be treated.” Coolidge <coolidge@dakota2k.net> 2016 February 02 Document Email 2 NADDI <rxnews@listserve.com> Buprenorphine Hydrocodone Methadone Oxycodone MNKOIv004 MNKOI0004261153 2021 October 21 ktkv0247 Mallinckrodt Litigation Documents mnk public no restrictions 2015 July 01 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_12\Spaulding emails 1 1 14 to 5 9 18_12.pst\Top of Personal Folders\Archive MNKOI0004262205 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) [RxNews] Buprenorphine waiver program increases access to opioid addiction treatment 03:46 PM Spaulding, Eileen 2015 July 01 03:46 PM [RxNews] Buprenorphine waiver program increases access to opioid addiction treatment MudriAssociates--- via RxNews <rxnews@listserve.com> 2015 July 01 Document Email 2 rxnews@listserve.com Buprenorphine MNKOIv004 MNKOI0004262203 2021 October 21 jkbc0247 Mallinckrodt Litigation Documents mnk public no restrictions 2016 April 04 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_9\Spaulding emails 1 1 14 to 5 9 18_9.pst\Top of Personal Folders\Archive MNKOI0004268721 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) [RxNews] Few Doctors sign up to treat opioid addiction 06:57 PM Spaulding, Eileen 2016 April 04 06:58 PM [RxNews] Few Doctors sign up to treat opioid addiction MudriAssociates--- via RxNews <rxnews@listserve.com> 2016 April 04 Document Email 4 rxnews@listserve.com Buprenorphine Hydrocodone Methadone Oxycodone MNKOIv004 MNKOI0004268717 2021 October 21 xxxc0247 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 29 Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive MNKOI0004273660 MNKOI0004273661 MNKOI0004273716 MNKOI0004273717 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Genrics Addiction/Abuse Approved Customer Modules 10:26 PM Jackson, Catherine 2014 August 29 10:26 PM FW: Genrics Addiction/Abuse Approved Customer Modules "Hasse, Debra C" <debra.hasse@mallinckrodt.com> 2014 August 29 Document Email 1 "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> opioids MNKOIv004 MNKOI0004273659 2021 October 21 lhcc0247 Mallinckrodt Litigation Documents mnk public no restrictions 2016 May 11 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_9\Spaulding emails 1 1 14 to 5 9 18_9.pst\Top of Personal Folders\Archive MNKOI0004268992 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) [RxNews] Treating Pain Without Feeding Addiction at ‘Ground Zero’ for Opioids 08:33 PM Spaulding, Eileen 2016 May 11 UCSF 08:33 PM [RxNews] Treating Pain Without Feeding Addiction at ‘Ground Zero’ for Opioids Arthur Thexton XXXXXXXXX@hotmail.com> 2016 May 11 Document Email 7 rxnews naddi <rxnews@listserve.com> Fentanyl Hydrocodone Oxycodone MNKOIv004 MNKOI0004268985 yes 2021 October 21 nhcc0247 Mallinckrodt Litigation Documents mnk public no restrictions 2016 May 11 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_9\Spaulding emails 1 1 14 to 5 9 18_9.pst\Top of Personal Folders\Archive MNKOI0004268994 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) CNN Anderson Cooper Town Hall tonight @ 9 Prescription Addiction 08:39 PM Spaulding, Eileen 2016 May 11 08:39 PM [RxNews] CNN Anderson Cooper Town Hall tonight @ 9 Prescription Addiction Fred Brason II <fbrason@projectlazarus.org> 2016 May 11 Document Email 1 rxnews@listserve.com opioids MNKOIv004 MNKOI0004268993 2021 October 21 ypkl0247 Mallinckrodt Litigation Documents mnk public no restrictions 2014 March 10 Williams, Jane\Williams, Jane emails all_4.pst\Top of Personal Folders\Archive MNKOI0004368867 MNKOI0004368868 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) FY14 Q1 Addiction Treatment SICP 05:01 PM Williams, Jane 2014 March 10 05:01 PM FY14 Q1 Addiction Treatment SICP "Dillon-Eckhard, Karen S" <karen.dillon-eckhard@mallinckrodt.com> 2014 March 10 Document Email 1 "Williams, Jane L" <jane.williams@mallinckrodt.com> "Brueggeman, Patrick S" <patrick.brueggeman@mallinckrodt.com> opioids MNKOIv004 MNKOI0004368866 2021 October 21 xpml0247 Mallinckrodt Litigation Documents mnk public no restrictions 2013 May 06 Williams, Jane\Williams, Jane emails all_7.pst\Top of Personal Folders\Archive MNKOI0004369893 MNKOI0004369894 MNKOI0004369895 MNKOI0004369896 MNKOI0004369897 MNKOI0004369898 MNKOI0004369899 MNKOI0004369900 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction treatment clinics 04:29 PM Williams, Jane 2013 May 06 04:29 PM Fwd: Addiction treatment clinics "Williams, Jane L" <jane.williams@covidien.com> 2013 May 06 Document Email 2 "Alexander, Dan" <daniel.alexander@covidien.com> opioids MNKOIv004 MNKOI0004369891 2021 October 21 trjl0247 Mallinckrodt Litigation Documents mnk public no restrictions 2014 June 19 Williams, Jane\Williams, Jane emails all_3.pst\Top of Personal Folders\Archive MNKOI0004368496 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Price History Tool 10:04 PM Williams, Jane 2014 June 19 10:04 PM Addiction Treatment Price History Tool "Kayich, Natalie (Tretter)" <natalie.kayich@mallinckrodt.com> 2014 June 19 Document Email 1 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> opioids MNKOIv004 MNKOI0004368495 2021 October 21 yzjl0247 Mallinckrodt Litigation Documents mnk public no restrictions 2014 July 21 Williams, Jane\Williams, Jane emails all_3.pst\Top of Personal Folders\Archive MNKOI0004368558 MNKOI0004368559 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) FY14 Q3 YTD Addiction Treatment SICP 03:30 PM Williams, Jane 2014 July 21 03:30 PM FY14 Q3 YTD Addiction Treatment SICP "Dillon-Eckhard, Karen S" <karen.dillon-eckhard@mallinckrodt.com> 2014 July 21 Document Email 1 "Williams, Jane L" <jane.williams@mallinckrodt.com> "Brueggeman, Patrick S" <patrick.brueggeman@mallinckrodt.com> "Mindak, Barb J" <barb.mindak@mallinckrodt.com> "McCune, Ellen" <ellen.mccune@mallinckrodt.com> opioids MNKOIv004 MNKOI0004368557 2021 October 21 tzjl0247 Mallinckrodt Litigation Documents mnk public no restrictions 2014 July 24 Williams, Jane\Williams, Jane emails all_3.pst\Top of Personal Folders\Archive MNKOI0004368565 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) FY14 Q3 YTD Addiction Treatment SICP 03:50 PM Williams, Jane 2014 July 24 03:50 PM FW: FY14 Q3 YTD Addiction Treatment SICP "Williams, Jane L" <jane.williams@mallinckrodt.com> 2014 July 24 Document Email 2 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> opioids MNKOIv004 MNKOI0004368563 2021 October 21 fgll0247 Mallinckrodt Litigation Documents mnk public no restrictions 2014 April 22 Williams, Jane\Williams, Jane emails all_4.pst\Top of Personal Folders\Archive MNKOI0004369020 MNKOI0004369021 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) FY14 Q2 YTD Addiction Treatment SICP 05:03 PM Williams, Jane 2014 April 22 05:03 PM FW: FY14 Q2 YTD Addiction Treatment SICP "Williams, Jane L" <jane.williams@mallinckrodt.com> 2014 April 22 Document Email 2 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> opioids MNKOIv004 MNKOI0004369018 2021 October 21 sfkl0247 Mallinckrodt Litigation Documents mnk public no restrictions 2014 July 29 Williams, Jane\Williams, Jane emails all_3.pst\Top of Personal Folders\Archive MNKOI0004368591 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Pricing Tool 04:01 PM Williams, Jane 2014 July 29 04:02 PM Addiction Treatment Pricing Tool "Kayich, Natalie (Tretter)" <natalie.kayich@mallinckrodt.com> 2014 July 29 Document Email 1 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> opioids MNKOIv004 MNKOI0004368590 2021 October 21 pxpb0247 Mallinckrodt Litigation Documents mnk public no restrictions 2016 July 06 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_8\Spaulding emails 1 1 14 to 5 9 18_8.pst\Top of Personal Folders\Archive MNKOI0004268125 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) [RxNews] Office based addiction treatment numbers expanded 05:01 PM Spaulding, Eileen 2016 July 06 05:01 PM [RxNews] Office based addiction treatment numbers expanded MudriAssociates--- via RxNews <rxnews@listserve.com> 2016 July 06 Document Email 4 rxnews@listserve.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv004 MNKOI0004268121 2021 October 21 hpkj0247 Mallinckrodt Litigation Documents mnk public no restrictions 2013 November 22 Naten, Derek\Naten, Derek pre 2015_5.pst\Top of Personal Folders\Archive MNKOI0004352134 MNKOI0004352136 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) IL Association for Medication Assisted Addiction Treatment 05:09 PM Naten, Derek 2013 November 22 05:09 PM Fwd: IL Association for Medication Assisted Addiction Treatment "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2013 November 22 Document Email 2 "Bullerdick, Jennifer M" <jennifer.bullerdick@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> "Naten, Derek" <derek.naten@mallinckrodt.com> "Burton, J Craig" <craig.burton@mallinckrodt.com> "Sigel, Tom J" <tom.sigel@mallinckrodt.com> Methadone MNKOIv004 MNKOI0004352132 2021 October 21 mrnx0247 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 24 Long, Erika\Long, Erika all_8.pst\Top of Personal Folders\Archive MNKOI0004337348 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry 03:14 PM Long, Erika 2016 June 24 03:15 PM FW: NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry Elizabeth Murray <emurray@tdyllc.com> 2016 June 24 Document Email 2 Charlotte Ivancic <civancic@tdyllc.com> Rai Downs <rdowns@tdyllc.com> Jennifer Young <jyoung@tdyllc.com> Michelle Easton <measton@tdyllc.com> opioids MNKOIv004 MNKOI0004337346 2021 October 21 yrnx0247 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 24 Long, Erika\Long, Erika all_8.pst\Top of Personal Folders\Archive MNKOI0004337351 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry 03:32 PM Long, Erika 2016 June 24 03:32 PM FW: NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry "Long, Erika" <erika.long@mallinckrodt.com> 2016 June 24 Document Email 2 "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> "Sciarra, Rhonda" <rhonda.sciarra@mallinckrodt.com> opioids MNKOIv004 MNKOI0004337349 2021 October 21 qrnx0247 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 24 Long, Erika\Long, Erika all_8.pst\Top of Personal Folders\Archive MNKOI0004337354 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Attorney Clinet Priveldge: NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry 04:14 PM Long, Erika 2016 June 24 04:14 PM Attorney Clinet Priveldge: NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry "Long, Erika" <erika.long@mallinckrodt.com> 2016 June 24 Document Email 2 desmond.hogan@hoganlovells.com elizabeth.jose@hoganlovells.com opioids MNKOIv004 MNKOI0004337352 2021 October 21 spdj0247 Mallinckrodt Litigation Documents mnk public no restrictions 2017 October 20 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_2.pst\Top of Personal Folders\Archive MNKOI0004346166 MNKOI0004346168 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Attorney General Laxalt Launches “Nevada’s Prescription for Addiction” Opioid Initiative with Unanimous Bipartisan Approval from the Legislature 08:55 PM Naten, Derek 2017 October 20 08:55 PM Fwd: Attorney General Laxalt Launches “Nevada’s Prescription for Addiction” Opioid Initiative with Unanimous Bipartisan Approval from the Legislature Jenny Reese <jenny@carraranv.com> 2017 October 20 Document Email 3 Derek Naten <derek.naten@mallinckrodt.com> Rocky Finseth <rocky@carraranv.com> opioids MNKOIv004 MNKOI0004346163 2021 October 21 yylx0247 Mallinckrodt Litigation Documents mnk public no restrictions 2017 September 20 Long, Erika\Long, Erika all_2.pst\Top of Personal Folders\Archive MNKOI0004333236 MNKOI0004333237 MNKOI0004333238 MNKOI0004333239 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Update: President’s Commission on Combating Drug Addiction and the Opioid Crisis ADC Sign-on Letter 12:47 PM Long, Erika 2017 September 20 UCSF 12:47 PM Fwd: Update: President’s Commission on Combating Drug Addiction and the Opioid Crisis ADC Sign-on Letter "Naten, Derek" <derek.naten@mallinckrodt.com> 2017 September 20 Document Email 5 "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> "Martello, Kendra" <kendra.martello@mallinckrodt.com> "Long, Erika" <erika.long@mallinckrodt.com> opioids MNKOIv004 MNKOI0004333231 yes 2021 October 21 ttjx0247 Mallinckrodt Litigation Documents mnk public no restrictions 2017 November 01 Long, Erika\Long, Erika all_1.pst\Top of Personal Folders\Archive MNKOI0004332012 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Information for Wednesday's Final Meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis - November 1, 2017 01:49 PM Long, Erika 2017 November 01 01:49 PM FW: Information for Wednesday's Final Meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis - November 1, 2017 "Naten, Derek" <derek.naten@mallinckrodt.com> 2017 November 01 Document Email 2 "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> "Long, Erika" <erika.long@mallinckrodt.com> "Martello, Kendra" <kendra.martello@mallinckrodt.com> opioids MNKOIv004 MNKOI0004332010 2021 October 21 hjmx0247 Mallinckrodt Litigation Documents mnk public no restrictions 2017 March 29 Long, Erika\Long, Erika all_4.pst\Top of Personal Folders\Archive MNKOI0004333779 MNKOI0004333783 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Draft Executive Order Establishing a Commission on Combatting Drug Addiction 11:26 PM Long, Erika 2017 March 29 11:26 PM Draft Executive Order Establishing a Commission on Combatting Drug Addiction Jennifer Young <jyoung@tdyllc.com> 2017 March 29 Document Email 1 Rai Downs <rdowns@tdyllc.com> Charlotte Ivancic <civancic@tdyllc.com> Elizabeth Murray <emurray@tdyllc.com> Linda Tarplin <ltarplin@tdyllc.com> Michelle Easton <measton@tdyllc.com> Pamela Smith <psmith@tdyllc.com> Emma Boone <eboone@tdyllc.com> opioids MNKOIv004 MNKOI0004333778 2021 October 21 tyxj0247 Mallinckrodt Litigation Documents mnk public no restrictions 2014 June 17 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive MNKOI0004350677 MNKOI0004350678 MNKOI0004350679 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Treating Addiction - Criminal Justice Population 09:26 PM Naten, Derek 2014 June 17 09:26 PM Fwd: Treating Addiction - Criminal Justice Population "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2014 June 17 Document Email 1 "Naten, Derek" <derek.naten@mallinckrodt.com> opioids MNKOIv004 MNKOI0004350676 2021 October 21 rsyx0247 Mallinckrodt Litigation Documents mnk public no restrictions 2016 May 24 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_10.pst\Top of Personal Folders\Archive MNKOI0004338837 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) PA Task Force: Co-Sponsorship Memos/Opioid Addiction--Senate Democratic Package 01:26 PM Naten, Derek 2016 May 24 01:26 PM PA Task Force: Co-Sponsorship Memos/Opioid Addiction--Senate Democratic Package "Baker, Sonya" <sbaker@phrma.org> 2016 May 24 Document Email 3 mmarks@celgene.com alan.must@pharma.com mark.o'rourke@astellas.com panorton@amgen.com dird@novonordisk.com adam.taliaferro@bms.com steve.kermisch@takeda.com anne.berry@astrazeneca.com "Watkins, Marissa" <mwatkins@phrma.org> tony.severoni@sunovion.com clayton.wright@mpi.com jessica.dipaolo@jgadvocacy.com neely.frye@novartis.com domenick.argento@merck.com paul.miller@astellas.com donna.huang@astrazeneca.com loredana.cromarty@allergan.com kevin.fuller@bayer.com jennifer.bland@merck.com tpiper@pabio.org pla@lundbeck.com riley@thebravogroup.com bravacos@thebravogroup.com wendy.lazarus@pfizer.com "VanderVeer, Priscilla" <pvanderveer@phrma.org> gregg.taylor@klgates.com chris@pennsylvaniabio.org judy.jenkins@otsuka-us.com kathryn.lavriha@sanofi.com dapp@thebravogroup.com timothy.x.sullivan@gsk.com karla.white@cslbehring.com jcohen6@its.jnj.com ctucker@pabio.org elizabeth.brewer@sanofi.com peter.gleason@klgates.com jim.m.campolongo@gsk.com lyden_timothy@lilly.com andrew.sandusky@abbvie.com "Wood, Nicole" <npalyawood@phrma.org> derek.naten@mallinckrodt.com steven.gardner@bms.com brian.rosen@pharma.com john.gibson@biogen.com "Garofalo, Ryan" <rgarofalo@phrma.org> jane.weirich@boehringer-ingelheim.com "Groves, Paula" <pgroves@phrma.org> opioids MNKOIv004 MNKOI0004338834 2021 October 21 gjbj0247 Mallinckrodt Litigation Documents mnk public no restrictions 2015 August 27 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_15.pst\Top of Personal Folders\Archive MNKOI0004342141 MNKOI0004342142 MNKOI0004342143 MNKOI0004342152 MNKOI0004342153 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Illinois Governor's veto of MAT funding for addiction treatment 07:56 PM Naten, Derek 2015 August 27 07:56 PM RE: Illinois Governor's veto of MAT funding for addiction treatment "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2015 August 27 Document Email 2 Paul Samuels <psamuels@lac.org> "Naten, Derek" <derek.naten@mallinckrodt.com> Dan Belnap <dbelnap@lac.org> Mark Parrino <9fec3c40-4c93-479c-95d2-82ae22208916@exch080.serverpod.net> opioids MNKOIv004 MNKOI0004342139 2021 October 21 mjbj0247 Mallinckrodt Litigation Documents mnk public no restrictions 2015 August 27 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_15.pst\Top of Personal Folders\Archive MNKOI0004342156 MNKOI0004342157 MNKOI0004342158 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Illinois Governor's veto of MAT funding for addiction treatment 09:11 PM Naten, Derek 2015 August 27 09:11 PM RE: Illinois Governor's veto of MAT funding for addiction treatment "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2015 August 27 Document Email 2 Paul Samuels <psamuels@lac.org> "Naten, Derek" <derek.naten@mallinckrodt.com> Dan Belnap <dbelnap@lac.org> Mark Parrino <9fec3c40-4c93-479c-95d2-82ae22208916@exch080.serverpod.net> opioids MNKOIv004 MNKOI0004342154 2021 October 21 rxdj0247 Mallinckrodt Litigation Documents mnk public no restrictions 2015 January 20 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_19.pst\Top of Personal Folders\Archive MNKOI0004345844 MNKOI0004345845 MNKOI0004345846 MNKOI0004345847 MNKOI0004345848 MNKOI0004345849 MNKOI0004345850 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) USA Today Centerfold Medication Adherence and Addiction Campaign 09:48 PM Naten, Derek 2015 January 20 09:48 PM Fwd: USA Today Centerfold Medication Adherence and Addiction Campaign "Naten, Derek" <derek.naten@mallinckrodt.com> 2015 January 20 Document Email 4 "Kevin Walker (kwalker@PENNQUARTERPARTNERS.COM)" <kwalker@pennquarterpartners.com> opioids MNKOIv004 MNKOI0004345840 2021 October 21 szkv0247 Mallinckrodt Litigation Documents mnk public no restrictions 2015 July 08 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_12\Spaulding emails 1 1 14 to 5 9 18_12.pst\Top of Personal Folders\Archive MNKOI0004262233 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) [RxNews] Rx drug epidemic linked to heroin addiction 06:42 PM Spaulding, Eileen 2015 July 08 06:42 PM [RxNews] Rx drug epidemic linked to heroin addiction MudriAssociates--- via RxNews <rxnews@listserve.com> 2015 July 08 Document Email 4 rxnews@listserve.com opioids MNKOIv004 MNKOI0004262229 2021 October 21 qklv0247 Mallinckrodt Litigation Documents mnk public no restrictions 2015 July 23 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_12\Spaulding emails 1 1 14 to 5 9 18_12.pst\Top of Personal Folders\Archive MNKOI0004262332 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) [RxNews] They became billionaires by America's addiction to Oxy's 03:11 PM Spaulding, Eileen 2015 July 23 03:14 PM [RxNews] They became billionaires by America's addiction to Oxy's MudriAssociates--- via RxNews <rxnews@listserve.com> 2015 July 23 Document Email 2 rxnews@listserve.com Oxycodone MNKOIv004 MNKOI0004262330 2021 October 21 nkcg0247 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 18 Decker, John\Decker, John all_14.pst\Top of Personal Folders\Archive MNKOI0004306474 MNKOI0004306475 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) TAXONOMY- FW: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) February 2014 newsletters 12:26 AM Decker, John 2014 February 18 12:26 AM Re: TAXONOMY- FW: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) February 2014 newsletters "Decker, John F" <john.decker@mallinckrodt.com> 2014 February 18 Document Email 4 "Peppin, John F" <john.peppin@mallinckrodt.com> opioids MNKOIv004 MNKOI0004306470 2021 October 21 qkcg0247 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 18 Decker, John\Decker, John all_14.pst\Top of Personal Folders\Archive MNKOI0004306480 MNKOI0004306481 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) TAXONOMY- FW: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) February 2014 newsletters 12:28 AM Decker, John 2014 February 18 12:28 AM Re: TAXONOMY- FW: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) February 2014 newsletters "Decker, John F" <john.decker@mallinckrodt.com> 2014 February 18 Document Email 4 "Peppin, John F" <john.peppin@mallinckrodt.com> opioids MNKOIv004 MNKOI0004306476 2021 October 21 mfdc0247 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 20 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_9\Spaulding emails 1 1 14 to 5 9 18_9.pst\Top of Personal Folders\Archive MNKOI0004269269 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) [RxNews] New implant drug could ease opiate addiction 03:24 PM Spaulding, Eileen 2016 June 20 UCSF 03:24 PM [RxNews] New implant drug could ease opiate addiction MudriAssociates--- via RxNews <rxnews@listserve.com> 2016 June 20 Document Email 5 rxnews@listserve.com XXXXXXXXXXX@aol.com Buprenorphine MNKOIv004 MNKOI0004269264 yes 2021 October 21 ffxc0247 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 14 Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive MNKOI0004273400 MNKOI0004273407 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) AMCP - Pain Management Abuse and Addiction Forum - 9/9/2014 04:06 PM Jackson, Catherine 2014 August 14 04:06 PM Fwd: AMCP - Pain Management Abuse and Addiction Forum - 9/9/2014 "Corson, Maureen E" <maureen.corson@mallinckrodt.com> 2014 August 14 Document Email 2 "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> Sonya C. Martin <smartin@tmacmail.com> "Anderson, Jan" <jan.anderson@mallinckrodt.com> opioids MNKOIv004 MNKOI0004273398 2021 October 21 pqhc0247 Mallinckrodt Litigation Documents mnk public no restrictions 2014 July 16 Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive MNKOI0004273241 MNKOI0004273247 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Urgent: September AMCP Pain Management Forum - Abuse Addiction Forum 02:25 PM Jackson, Catherine 2014 July 16 02:25 PM FW: Urgent: September AMCP Pain Management Forum - Abuse Addiction Forum "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> 2014 July 16 Document Email 4 "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> opioids MNKOIv004 MNKOI0004273237 2021 October 21 mjcl0259 Insys Litigation Documents insys Rowan, Joe Confidential Personal Information public no restrictions 2015 August 04 2015 August 04 Fwd: Dr. Taylor's - Managing Patients with Chronic Pain and Opioid Addiction Crystal Skelton 2015 August 04 email 2 Mark Hein Rick Kadile Darin Fila Joseph Rowan INSYS-MDL-004083678 yes 2022 December 08 hmgb0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 December 08 2015 December 08 Stop your addiction..to drinking? Guillermo Richards 2015 December 08 email 1 Michael Babich INSYS-MDL-003922011 2022 December 08 kqyb0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 24 2015 November 24 Alcohol-Addiction- Alternatives -Get Prepared- for the Holiday Season Temptations Alcohol Rehab 2015 November 24 email 1 Michael Babich INSYS-MDL-003927902 2022 December 08 gjbc0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 16 2015 November 16 Overcome your. addiction in vacation rehab Dora Hernandez 2015 November 16 email 2 Michael Babich INSYS-MDL-003929549 2022 December 08 szcc0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 11 2015 November 11 Rid your addiction now.!! Robert Parker 2015 November 11 email 2 Michael Babich INSYS-MDL-003930706 2022 December 08 mzjc0259 Insys Litigation Documents insys Babich, Mike Confidential Personal Information public no restrictions 2015 October 29 2015 October 29 End your addiction in our rehab facility Start Over 2015 October 29 email 2 Michael Babich INSYS-MDL-003935594 yes 2022 December 08 klpc0259 Insys Litigation Documents insys Babich, Mike Confidential Personal Information public no restrictions 2015 October 23 2015 October 23 Stop your addiction in a rehab center near you Rehab Near You 2015 October 23 email 2 Michael Babich INSYS-MDL-003939388 yes 2022 December 08 hgwd0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 June 30 2016 June 30 Get Help for Alcohol Addiction Alcohol Rehab Centers 2016 June 30 email 2 Michael Babich INSYS-MDL-003942070 2022 December 08 rhwd0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 March 16 2016 March 16 Imagine Your Life Addiction Free. Find Help Inside Elisa 2016 March 16 email 2 Michael Babich INSYS-MDL-003942128 2022 December 08 fgkd0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 February 20 2016 February 20 Personalized Addiction Treatment Drug Rehabilitation 2016 February 20 email 2 Michael Babich INSYS-MDL-003947418 2022 December 08 xrld0259 Insys Litigation Documents insys Babich, Mike Confidential Personal Information public no restrictions 2016 June 03 2016 June 03 Get Help for Alcohol Addiction Professional Alcohol Treatment 2016 June 03 email 2 Michael Babich INSYS-MDL-003948823 yes 2022 December 08 mhnd0259 Insys Litigation Documents insys Babich, Mike Confidential Personal Information public no restrictions 2016 May 17 2016 May 17 Do you or a loved one need help with alcohol addiction? Professional Alcohol Rehab Facilities 2016 May 17 email 2 Michael Babich INSYS-MDL-003949707 yes 2022 December 08 kgcb0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 January 02 2016 January 02 Alcohol--Addiction & Detox--centers -- Connect with Leading-Professionals... Alcoholism Help 2016 January 02 email 1 Michael Babich INSYS-MDL-003918610 2022 December 08 xhcb0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 January 14 2016 January 14 Beat Your- Addiction. with Treatment_Today Josephine 2016 January 14 email 2 Michael Babich INSYS-MDL-003918646 2022 December 08 xygb0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 December 15 2015 December 15 Rid your-addiction now! Search-Here. / Gloria Wood 2015 December 15 email 2 Michael Babich INSYS-MDL-003922103 2022 December 08 mrgb0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 December 16 2015 December 16 Beat Your Addiction. with Treatment Today../ Emilio 2015 December 16 email 2 Michael Babich INSYS-MDL-003922318 2022 December 08 fjkb0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 December 03 2015 December 03 Rid your addiction now. Search for rehab centers here, Anne Howard 2015 December 03 email 1 Michael Babich INSYS-MDL-003925018 2022 December 08 gxbc0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 20 2015 November 20 Rid your-addiction now- Gregory Sanders 2015 November 20 email 1 Michael Babich INSYS-MDL-003929517 2022 December 08 nqbc0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 26 2015 November 26 Alcohol--Addiction & Detox--centers -- Connect with Leading-Professionals... Alcoholism Help 2015 November 26 email 1 Michael Babich INSYS-MDL-003929865 2022 December 08 zzdc0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 07 2015 November 07 Don't let drug addiction control your life Drug and Alcohol Treatment 2015 November 07 email 1 Michael Babich INSYS-MDL-003931366 2022 December 08 hkfc0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 07 2015 November 07 Alcohol--addiction & Detox--Centers - Connect with Leading-Professionals.. Drug and Alcohol Treatment 2015 November 07 email 1 Michael Babich INSYS-MDL-003932490 2022 December 08 prfc0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 08 2015 November 08 Alcohol--addiction & Detox--Centers - Connect with Leading-Professionals.. Alcoholism Help 2015 November 08 email 1 Michael Babich INSYS-MDL-003932750 2022 December 08 pyjc0259 Insys Litigation Documents insys Babich, Mike Confidential Personal Information public no restrictions 2015 November 03 2015 November 03 Are you in need of treatment for addiction? Recovery now 2015 November 03 email 2 Michael Babich INSYS-MDL-003935362 yes 2022 December 08 phnc0259 Insys Litigation Documents insys Babich, Mike Confidential Personal Information public no restrictions 2015 October 22 2015 October 22 Recover what your addiction has taken away from you Recover Life 2015 October 22 email 2 Michael Babich INSYS-MDL-003937813 yes 2022 December 08 ypyc0259 Insys Litigation Documents insys Babich, Mike Confidential Personal Information public no restrictions 2015 October 23 2015 October 23 Let us help you stop your addiction to drinking Rehab Relief 2015 October 23 email 2 Michael Babich INSYS-MDL-003938873 yes 2022 December 08 hmdd0259 Insys Litigation Documents insys Babich, Mike Confidential Personal Information public no restrictions 2016 August 02 2016 August 02 Consider the Advantages of Drug or Alcohol Addiction Programs Alcohol Treatment 2016 August 02 email 2 Michael Babich INSYS-MDL-003941658 yes 2022 December 08 nffd0259 Insys Litigation Documents insys Babich, Mike Confidential Personal Information public no restrictions 2016 March 01 2016 March 01 Drug and Alcohol Addiction Help (Teen or Adult) Substance Abuse Recovery 2016 March 01 email 1 Michael Babich INSYS-MDL-003942960 yes 2022 December 08 zzwd0259 Insys Litigation Documents insys Babich, Mike Confidential Personal Information public no restrictions 2016 March 03 2016 March 03 Help,Your...Loved-One,With...Addiction. Intervention Help 2016 March 03 email 2 Michael Babich INSYS-MDL-003942932 yes 2022 December 08 qmjd0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 February 25 2016 February 25 Find Drug and Alcohol Addiction Help (Teen or Adult) Substance Abuse Recovery 2016 February 25 email 1 Michael Babich INSYS-MDL-003946931 2022 December 08 htmd0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 October 14 2016 October 14 Local Treatment Centers - Alcohol Addiction Help..., mbabich@insysrx.com Rehab Center -- for Alcohol 2016 October 14 email 1 Michael Babich INSYS-MDL-003949536 2022 December 08 qqxw0260 Insys Litigation Documents insys Torres, Stephanie Confidential Personal Information public no restrictions 2016 September 06 2016 September 06 Insys Exhibit request, Pain Addiction Law 2016, Chapel Hill NC Sugata Mazumdar 2016 September 06 email 1 Stephanie Torres INSYS-MDL-004256920 yes 2022 December 08 jygw0260 Insys Litigation Documents insys Torres, Stephanie Confidential Personal Information public no restrictions 2016 September 14 2016 September 14 Re: Pain Addiction and the Law - Oct. 1, 2016 Sugata Mazumdar 2016 September 14 email 2 INSYS Exhibits Stephanie Torres INSYS-MDL-004255634 yes 2022 December 08 qyjg0258 Insys Litigation Documents insys Michelle, Breitenbach Confidential Personal Information public no restrictions 2016 May 17 2016 May 17 Do you or a loved one need help with alcohol addiction? Professional Alcohol Rehab Facilities 2016 May 17 email 2 Michelle Breitenbach INSYS-MDL-003673854 yes 2022 December 08 mfxv0258 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 February 04 2016 February 04 Rid your addiction now. Search for rehab centers here, Signe 2016 February 04 email 1 Michael Babich mbabich@INSYSTHERAPEUTICS.mail.onmicrosoft.com INSYS-MDL-003571557 2022 December 08 ymxk0260 Insys Litigation Documents insys Torres, Stephanie Confidential Personal Information public no restrictions 2016 September 06 2016 September 06 Re: Insys Exhibit request, Pain Addiction Law 2016, Chapel Hill NC storres@insysrx.com 2016 September 06 email 1 Sugata Mazumdar INSYS-MDL-004307097 yes 2022 December 08 zkfd0262 Insys Litigation Documents insys Hollandsworth, Desiree Confidential Personal Information public no restrictions 2014 April 15 2014 April 15 FW: Pain Addiction and the Law with Duke and UNC Anna Marzahl 2014 April 15 email 2 Desiree Hollandsworth INSYS-MDL-006060887 yes 2022 December 08 fxcb0262 Insys Litigation Documents insys Knox, Joshua public no restrictions 2015 August 24 2015 August 24 Heroin and Prescription Opioid Addiction: CDC Report and Administration Response PAINWeek Daily Dose 2015 August 24 email 2 Joshua Knox INSYS-MDL-004856942 2022 December 08 lscv0261 Insys Litigation Documents insys Clancy/Couturier, Lindsay public no restrictions 2015 August 24 2015 August 24 Heroin and Prescription Opioid Addiction: CDC Report and Administration Response PAINWeek Daily Dose 2015 August 24 email 2 Lindsay Couturier INSYS-MDL-004358272 2022 December 08 mscv0261 Insys Litigation Documents insys Clancy/Couturier, Lindsay public no restrictions 2015 August 24 2015 August 24 Heroin and Prescription Opioid Addiction: CDC Report and Administration Response PAINWeek Daily Dose 2015 August 24 email 2 Lindsay Couturier INSYS-MDL-004358274 2022 December 08 ntyh0260 Insys Litigation Documents insys Torres, Stephanie Confidential Personal Information public no restrictions 2016 September 06 2016 September 06 Re: Insys Exhibit request, Pain Addiction Law 2016, Chapel Hill NC Stephanie Torres 2016 September 06 email 1 Sugata Mazumdar INSYS-MDL-004287729 yes 2022 December 08 fzyh0260 Insys Litigation Documents insys Torres, Stephanie public no restrictions 2016 September 06 2016 September 06 Re: UNC Pain, Addiction and the Law 2016 Stephanie Torres 2016 September 06 email 1 Sugata Mazumdar INSYS-MDL-004287761 2022 December 08 jgky0261 Insys Litigation Documents insys Gandara, Alexandra Confidential Personal Information public no restrictions 2015 October 14 2015 October 14 Risk Assessment Tools for Addiction | Pain Management Specialist in San Diego & La Jolla Nancy Sajben 2015 October 14 email 1 agandara@insysrx.com INSYS-MDL-004789657 yes 2022 December 08 lykb0261 Insys Litigation Documents insys Clancy/Couturier, Lindsay Confidential Personal Information public no restrictions 2014 March 03 2014 March 03 FW: Pain Addiction and the Law with Duke and UNC Lindsay Couturier 2014 March 03 email 2 Anna Marzahl INSYS-MDL-004404518 yes 2022 December 08 hgmb0261 Insys Litigation Documents insys Clancy/Couturier, Lindsay Confidential Personal Information public no restrictions 2014 January 23 2014 January 23 Fw: Pain ADDICTION AND THE LAW- MAY 2-4, 2014 Maury Rice 2014 January 23 email 1 Desiree Hollandsworth Anna Marzahl Lindsay Couturier INSYS-MDL-004407569 yes 2022 December 08 qgmh0257 gae72k00 Florida Walgreens Litigation Documents flapharm public no restrictions 2018-CA-001438 The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction Kolodny, Andrew 2015 January 12 document 21 Originally published in the Annual Review of Public Health (Volume 36 - 2015). Downloaded from the ARPH website on March 10, 2022.; Keywords : prescription drug abuse, heroin, overdose deaths, chronic pain, opioid, addiction. Abstract : Public health authorities have described, with growing alarm, an unprecedented increase in morbidity and mortality associated with use of opioid pain relievers (OPRs). Efforts to address the opioid crisis have focused mainly on reducing nonmedical OPR use. Too often overlooked, however, is the need for preventing and treating opioid addiction, which occurs in both medical and nonmedical OPR users. Overprescribing of OPRs has led to a sharp increase in the prevalence of opioid addiction, which in turn has been associated with a rise in overdose deaths and heroin use. A multifaceted public health approach that utilizes primary, secondary, and tertiary opioid addiction prevention strategies is required to effectively reduce opioid-related morbidity and mortality. We describe the scope of this public health crisis, its historical context, contributing factors, and lines of evidence indicating the role of addiction in exacerbating morbidity and mortality, and we provide a framework for interventions to address the epidemic of opioid addiction. PX-FL-06325 No 2022 October 13 fmky0257 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 20 2015 November 20 Recover - what your addiction has taken away- from you-! Robert Sanchez 2015 November 20 email 1 Michael Babich mbabich@INSYSTHERAPEUTICS.mail.onmicrosoft.com INSYS-MDL-003546561 2022 December 08 yzmy0257 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 26 2015 November 26 Alcohol--Addiction & Detox--centers -- Connect with Leading-Professionals... Alcoholism Help 2015 November 26 email 1 Michael Babich mbabich@INSYSTHERAPEUTICS.mail.onmicrosoft.com INSYS-MDL-003548292 2022 December 08 lfdp0257 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 December 08 2015 December 08 Stop your addiction..to drinking? Guillermo Richards 2015 December 08 email 1 Michael Babich mbabich@INSYSTHERAPEUTICS.mail.onmicrosoft.com INSYS-MDL-003552621 2022 December 08 hjhp0257 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 December 16 2015 December 16 Beat Your Addiction. with Treatment Today../ Emilio 2015 December 16 email 2 Michael Babich mbabich@INSYSTHERAPEUTICS.mail.onmicrosoft.com INSYS-MDL-003556512 2022 December 08 ksxy0257 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 16 2015 November 16 Overcome your. addiction in vacation rehab Dora Hernandez 2015 November 16 email 2 Michael Babich mbabich@INSYSTHERAPEUTICS.mail.onmicrosoft.com INSYS-MDL-003545370 2022 December 08 ztdj0259 Insys Litigation Documents insys Rowan, Joe public no restrictions 2016 April 18 2016 April 18 Addiction, Empathy and Opioid Alternatives Andrew Byars 2016 April 18 email 1 Sales OHI Joseph Rowan Jeffrey Del Carmen INSYS-MDL-004052099 2022 December 08 txxk0260 Insys Litigation Documents insys Torres, Stephanie Confidential Personal Information public no restrictions 2016 September 06 2016 September 06 Re: UNC Pain, Addiction and the Law 2016 storres@insysrx.com 2016 September 06 email 2 Sugata Mazumdar INSYS-MDL-004306994 yes 2022 December 08 syxk0260 Insys Litigation Documents insys Torres, Stephanie public no restrictions 2016 September 06 2016 September 06 Re: UNC Pain, Addiction and the Law 2016 storres@insysrx.com 2016 September 06 email 1 Sugata Mazumdar INSYS-MDL-004307175 2022 December 08 ssyh0260 Insys Litigation Documents insys Torres, Stephanie Confidential Personal Information public no restrictions 2016 September 06 2016 September 06 Re: UNC Pain, Addiction and the Law 2016 Stephanie Torres 2016 September 06 email 2 Sugata Mazumdar INSYS-MDL-004287695 yes 2022 December 08 rlwh0264 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2012 October 23 2012 October 23 Actiq writers that are addiction specialists Andrew McNaughton 2012 October 23 email 1 Darin Fila Brian Hoff Brianna Smith Brook Spangler Colt Woods Erika Gutzeit Myles A. Walsh Sara Sadraie Sayra Torberson ssadraie@insysrx.com INSYS-MDL-006760863 yes 2022 December 08 ptlm0269 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2012 October 23 2012 October 23 Actiq writers that are addiction specialists Andrew McNaughton 2012 October 23 email 1 Darin Fila Brian Hoff Brianna Smith Brook Spangler Colt Woods Erika Gutzeit Myles A. Walsh Sara Sadraie Sayra Torberson ssadraie@insysrx.com INSYS-MDL-004918433 yes 2023 January 19 ztlm0269 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2012 October 23 2012 October 23 Re: Actiq writers that are addiction specialists Brian Hoff 2012 October 23 email 1 Andrew McNaughton INSYS-MDL-004918442 yes 2023 January 19 nxbn0269 Insys Litigation Documents insys McNaughton, Andrew Confidential Personal Information public no restrictions 2012 October 23 2012 October 23 Actiq writers that are addiction specialists Andrew McNaughton 2012 October 23 email 1 Darin Fila Myles A. Walsh Brianna Smith Brian Hoff Erika Gutzeit Sara Sadraie Sayra Torberson Brook Smets Colt Woods INSYS-MDL-005035959 yes 2023 January 19 zrnk0267 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2016 January 28 2016 January 28 Upcoming Webinar - Confronting and Reducing Opioid Addiction Academy of Managed Care Pharmacy 2016 January 28 email 2 Mike Gurry mgurry@INSYSTHERAPEUTICS.mail.onmicrosoft.com INSYS-MDL-008233285 yes 2022 December 08 yqmp0265 Insys Litigation Documents insys public no restrictions 2015 December 08 2015 December 08 Stop your addiction..to drinking? Melody Osborne 2015 December 08 email 1 John Kapoor jkapoor@INSYSTHERAPEUTICS.mail.onmicrosoft.com INSYS-MDL-007629403 2022 December 08 lxkv0266 Insys Litigation Documents insys public no restrictions 2014 May 16 2014 May 16 Automatic reply: Alcohol Addiction - Pipeline Review, H1 2014 Dion Reimer 2014 May 16 email 1 Global Markets Direct INSYS-MDL-007663735 2022 December 08 hxkj0267 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2014 July 28 2014 July 28 UPDATED WITH AGENDA: Insys_Synchrony Medical: 2014-2015 Scientific Communication/Tactical Publication Planning for SUBSYS & Pain/Addiction Pipeline Nicole Forman 2014 July 28 email 1 Neha Parikh Giovanni DeCastro Willene Brondum Mark Hein Matthew Napoletano Mike Gurry Vikram Malhotra Colleen Hedge (chedge@synchronymed.com) Shawn Boyle (sboyle@synchronymed.com) Mary Beth Moncrief Board Room - SPECTRUM Desiree Hollandsworth Nicole Durst Rod Hughes Steven Jensen INSYS-MDL-008216418 yes 2022 December 08 tsxg0265 Insys Litigation Documents insys public no restrictions 2014 July 11 2014 July 11 Accepted: HOLD THE DATE: Insys_Synchrony Medical: 2014-2015 Scientific Communication/Tactical Publication Planning for SUBSYS & Pain/Addiction Pipeline Mike Gurry 2014 July 11 email 1 Nicole Forman INSYS-MDL-007428530 2022 December 08 lxfh0265 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2014 July 11 2014 July 11 UPDATED WITH AGENDA: Insys_Synchrony Medical: 2014-2015 Scientific Communication/Tactical Publication Planning for SUBSYS & Pain/Addiction Pipeline Nicole Forman 2014 July 11 email 1 Matthew Napoletano Mary Beth Moncrief Mark Hein Willene Brondum Giovanni DeCastro Colleen Hedge (chedge@synchronymed.com) Mike Gurry Vikram Malhotra Neha Parikh Shawn Boyle (sboyle@synchronymed.com) Steven Jensen Nicole Durst Rod Hughes Desiree Hollandsworth INSYS-MDL-007439050 yes 2022 December 08 hgcp0266 Insys Litigation Documents insys public no restrictions 2016 February 24 2016 February 24 [RxNews] How buprenorphine, changed opioid addiction treatment - RxNews 2016 February 24 email 1 NADDI dreimer@insysrx.com INSYS-MDL-008084411 2022 December 08 hyyy0266 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2016 February 02 2016 February 02 [RxNews] ASAM addiction is not a moral failing, but rather a medical condition that must be treated.” RxNews 2016 February 02 email 2 NADDI dreimer@insysrx.com INSYS-MDL-008080100 yes 2022 December 08 zyvp0266 Insys Litigation Documents insys public no restrictions 1970 January 01 2016 February 14 [RxNews] a vaccine for addiction in the works note the graphs on death from Rx vs heroin CDC RxNews 1970 January 01 email 1 NADDI dreimer@insysrx.com INSYS-MDL-008082775 2022 December 08 thnw0266 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2015 September 01 2015 September 01 [RxNews] 6 month addiction product RxNews 2015 September 01 email 1 rxnews@listserve.com dreimer@insysrx.com INSYS-MDL-007841414 yes 2022 December 08 xxnw0266 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2015 September 01 2015 September 01 FW: [RxNews] 6 month addiction product Dion Reimer 2015 September 01 email 1 Jennifer Menes jmenes@insysrx.com INSYS-MDL-007841440 yes 2022 December 08 fpxm0264 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2016 March 23 2016 March 23 Stop Your Addiction with-Treatment in Your Area Addiction_Help 2016 March 23 email 2 John Kapoor INSYS-MDL-006931345 yes 2022 December 08 xpxm0264 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2016 March 23 2016 March 23 Rid your-addiction now Born Again From Addicts 2016 March 23 email 2 John Kapoor INSYS-MDL-006931351 yes 2022 December 08 mgjm0264 Insys Litigation Documents insys public no restrictions 2016 March 22 2016 March 22 Stop Your Addiction with-Treatment-in Your Area Rehab Can Help 2016 March 22 email 1 John Kapoor INSYS-MDL-006931683 2022 December 08 tgjm0264 Insys Litigation Documents insys public no restrictions 2016 March 22 2016 March 22 Stop Your Addiction with-Treatment-in Your Area Rehab Helps 2016 March 22 email 1 John Kapoor INSYS-MDL-006931696 2022 December 08 txjm0264 Insys Litigation Documents insys public no restrictions 2016 March 27 2016 March 27 End Your-Addiction with Treatment Today.. Alcohol Stop Addiction.. 2016 March 27 email 2 John Kapoor INSYS-MDL-006931839 2022 December 08 sljm0264 Insys Litigation Documents insys public no restrictions 2016 March 23 2016 March 23 Are you in need of treatment for Addiction? Sober With Rehab 2016 March 23 email 2 John Kapoor INSYS-MDL-006931985 2022 December 08 jmlm0264 Insys Litigation Documents insys public no restrictions 2016 March 16 2016 March 16 Imagine Your Life Addiction Free. Find Help Inside Theodore George 2016 March 16 email 2 John Kapoor INSYS-MDL-006934344 2022 December 08 fnnm0264 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2016 January 13 2016 January 13 Sponsorship Opportunity - New York Academy of Sciences Conference on Addiction May 18-20, 2016 Erick Tatro 2016 January 13 email 2 John Kapoor INSYS-MDL-006936538 yes 2022 December 08 fzcn0264 Insys Litigation Documents insys public no restrictions 2016 May 10 2016 May 10 Stop Your Addiction with-Treatment in Your Area Addicts help 2016 May 10 email 2 John Kapoor INSYS-MDL-006942480 2022 December 08 gqhn0264 Insys Litigation Documents insys public no restrictions 2016 May 24 2016 May 24 Accepted: Meeting with Dr. Rappaport to discuss pain and addiction projects John Kapoor 2016 May 24 email 1 Stephen Sherman INSYS-MDL-006947996 2022 December 08 mnpv0266 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2015 May 15 2015 May 15 [RxNews] Court approves lawsuits by patients with addiction RxNews 2015 May 15 email 1 rxnews@listserve.com dreimer@insysrx.com INSYS-MDL-007676901 yes 2022 December 08 mkjj0267 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2014 May 16 2014 May 16 Alcohol Addiction - Pipeline Review, H1 2014 Global Markets Direct 2014 May 16 email 2 Mike Gurry INSYS-MDL-008215345 yes 2022 December 08 ykvx0267 Insys Litigation Documents insys public no restrictions 2014 July 11 2014 July 11 Accepted: HOLD THE DATE: Insys_Synchrony Medical: 2014-2015 Scientific Communication/Tactical Publication Planning for SUBSYS & Pain/Addiction Pipeline Mike Gurry 2014 July 11 email 1 INSYS-MDL-008188353 2022 December 08 nkvx0267 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2014 July 11 2014 July 11 HOLD THE DATE: Insys_Synchrony Medical: 2014-2015 Scientific Communication/Tactical Publication Planning for SUBSYS & Pain/Addiction Pipeline Nicole Forman 2014 July 11 email 1 Neha Parikh Giovanni DeCastro Willene Brondum Mark Hein Matthew Napoletano Mike Gurry Vikram Malhotra Colleen Hedge (chedge@synchronymed.com) Shawn Boyle (sboyle@synchronymed.com) Mary Beth Moncrief Board Room - SPECTRUM INSYS-MDL-008188351 yes 2022 December 08 hnfy0266 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2015 July 23 2015 July 23 [RxNews] They became billionaires by America's addiction to Oxy's RxNews 2015 July 23 email 2 rxnews@listserve.com dreimer@insysrx.com INSYS-MDL-008067736 yes 2022 December 08 jqhp0267 Insys Litigation Documents insys public no restrictions 2016 June 20 2016 June 20 Probuphine Implant / Op Addiction Bradford Yeater 2016 June 20 email 1 Xun Yu INSYS-MDL-008288318 2022 December 08 rxky0257 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 20 2015 November 20 Alcohol Addiction support - how-to - avoid Relapse-During This - holiday - Season Private Alcohol Rehabs 2015 November 20 email 1 Michael Babich mbabich@INSYSTHERAPEUTICS.mail.onmicrosoft.com INSYS-MDL-003546334 2022 December 08 hmky0257 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 20 2015 November 20 Rid your-addiction now- Gregory Sanders 2015 November 20 email 1 Michael Babich mbabich@INSYSTHERAPEUTICS.mail.onmicrosoft.com INSYS-MDL-003546564 2022 December 08 klbc0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2015 November 20 2015 November 20 Recover - what your addiction has taken away- from you-! Robert Sanchez 2015 November 20 email 1 Michael Babich INSYS-MDL-003929631 2022 December 08 yqln0258 Insys Litigation Documents insys Sue, Beisler Confidential Personal Information public no restrictions 2016 August 19 2016 August 19 No one should have to struggle with addiction-alone - Take a look at these alcohol-rehab programs. Alcohol Rehab 2016 August 19 email 2 Susan Beisler INSYS-MDL-003879609 yes 2022 December 08 khbv0258 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 January 14 2016 January 14 Beat Your- Addiction. with Treatment_Today Josephine 2016 January 14 email 2 Michael Babich mbabich@INSYSTHERAPEUTICS.mail.onmicrosoft.com INSYS-MDL-003565846 2022 December 08 nxlv0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 March 23 2016 March 23 Rid your addiction now Rehab For You 2016 March 23 email 2 Michael Babich INSYS-MDL-003912719 2022 December 08 zzmv0259 Insys Litigation Documents insys Babich, Mike Confidential Personal Information public no restrictions 2016 March 23 2016 March 23 End Your Addiction-with Treatment Today Help.u.Need. 2016 March 23 email 2 Michael Babich INSYS-MDL-003914100 yes 2022 December 08 fgmv0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 March 27 2016 March 27 Ditch Your Addiction-with Treatment Today.. Alcohol Stop Addiction.. 2016 March 27 email 2 Michael Babich INSYS-MDL-003913372 2022 December 08 hkmv0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 March 22 2016 March 22 Beat Your- Addiction. with Treatment_Today Rehab Helps 2016 March 22 email 1 Michael Babich INSYS-MDL-003913565 2022 December 08 tqyv0259 Insys Litigation Documents insys Babich, Mike public no restrictions 2016 February 04 2016 February 04 Rid your addiction now. Search for rehab centers here, Signe 2016 February 04 email 1 Michael Babich INSYS-MDL-003915614 2022 December 08 mzww0260 Insys Litigation Documents insys Torres, Stephanie Confidential Personal Information public no restrictions 2016 September 14 2016 September 14 RE: Pain Addiction and the Law - Oct. 1, 2016 INSYS Exhibits 2016 September 14 email 2 Sugata Mazumdar INSYS Exhibits Stephanie Torres INSYS-MDL-004254622 yes 2022 December 08 tghw0260 Insys Litigation Documents insys Torres, Stephanie Confidential Personal Information public no restrictions 2016 September 13 2016 September 13 Pain Addiction and the Law - Oct. 1, 2016 INSYS Exhibits 2016 September 13 email 1 Stephanie Torres INSYS Exhibits Sugata Mazumdar INSYS-MDL-004255983 yes 2022 December 08 qtdp0267 Insys Litigation Documents insys public no restrictions 2016 July 12 2016 July 12 Managed Care / Opioid Addiction Bradford Yeater 2016 July 12 email 1 Xun Yu INSYS-MDL-008284657 2022 December 08 fmxc0262 Insys Litigation Documents insys Hollandsworth, Desiree Confidential Personal Information public no restrictions 2016 May 13 2016 May 13 RE: CBD Opioid Addiction Status Update Robert Brown 2016 May 13 email 2 Meghan MacMillan Jin Yu Santosh Vetticaden Desiree Hollandsworth INSYS-MDL-005590269 yes 2022 December 08 kswy0263 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2015 May 19 2015 May 19 You can do it: Smoking addiction lessens after 10 days. New Quit Programs 2015 May 19 email 2 Jeff Pearlman jpearlman@insysrx.com INS-NY-00825003 yes 2022 December 08 hpmm0264 Insys Litigation Documents insys public no restrictions 2016 January 14 2016 January 14 End Your Addiction with Treatment Today Kala 2016 January 14 email 2 John Kapoor INSYS-MDL-006935786 2022 December 08 tfnm0264 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2016 January 29 2016 January 29 Sponsorship Opportunity - Conference on Addictions - NYC - May 18-20, 2016 Erick Tatro 2016 January 29 email 2 John Kapoor INSYS-MDL-006936167 yes 2022 December 08 tpym0264 Insys Litigation Documents insys public no restrictions 2015 December 15 2015 December 15 Overcome your-addiction in vacation..rehab.. Donald Reed 2015 December 15 email 2 John Kapoor INSYS-MDL-006937459 2022 December 08 jzym0264 Insys Litigation Documents insys public no restrictions 2015 December 08 2015 December 08 Stop your addiction..to drinking? Melody Osborne 2015 December 08 email 1 John Kapoor INSYS-MDL-006937730 2022 December 08 pndn0264 Insys Litigation Documents insys public no restrictions 2016 May 24 2016 May 24 Meeting with Dr. Rappaport to discuss pain and addiction projects Stephen Sherman 2016 May 24 email 2 John Kapoor Ramesh Acharya Santosh Vetticaden Venkat Goskonda INSYS-MDL-006943187 2022 December 08 mzdn0264 Insys Litigation Documents insys public no restrictions 2016 May 20 2016 May 20 Need help with Your Alcohol Addiction? Search For Help Here Addiction Help 2016 May 20 email 2 John Kapoor INSYS-MDL-006943625 2022 December 08 pphn0264 Insys Litigation Documents insys public no restrictions 2016 May 24 2016 May 24 Accepted: Meeting with Dr. Rappaport to discuss pain and addiction projects John Kapoor 2016 May 24 email 1 Stephen Sherman INSYS-MDL-006947977 2022 December 08 ghxn0264 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2016 February 01 2016 February 01 FW: Sponsorship Opportunity - Conference on Addictions - NYC - May 18-20, 2016 John Kapoor 2016 February 01 email 2 svetticaden@insysrx.com INSYS-MDL-006948993 yes 2022 December 08 ypxn0264 Insys Litigation Documents insys public no restrictions 2016 May 24 2016 May 24 Meeting with Dr. Rappaport to discuss pain and addiction projects Stephen Sherman 2016 May 24 email 1 Stephen Sherman John Kapoor Ramesh Acharya Santosh Vetticaden Venkat Goskonda INSYS-MDL-006949410 2022 December 08 tnkb0265 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2015 September 01 2015 September 01 FW: [RxNews] 6 month addiction product Dion Reimer 2015 September 01 email 1 Jennifer Menes INSYS-MDL-007023006 yes 2022 December 08 yzhb0266 Insys Litigation Documents insys public no restrictions 2016 January 15 2016 January 15 [RxNews] treating addiction story RxNews 2016 January 15 email 1 NADDI dreimer@insysrx.com INSYS-MDL-007696988 2022 December 08 mqkb0266 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2015 November 04 2015 November 04 [RxNews] Massachusetts clinic is treating opiate addiction with medical marijuana: RxNews 2015 November 04 email 1 rxnews@listserve.com dreimer@insysrx.com INSYS-MDL-007704674 yes 2022 December 08 tskb0266 Insys Litigation Documents insys Confidential Personal Information public no restrictions 2015 November 05 2015 November 05 [RxNews] Chris Christie Makes Emotional Plea To Rethink Drug Addiction Treatment RxNews 2015 November 05 email 1 rxnews@listserve.com dreimer@insysrx.com INSYS-MDL-007705055 yes 2022 December 08 pnnx0287 jah84l00 NY Opioid Litigation Documents nypp public no restrictions NY v. Purdue Pharma -- OCRed PDFs\Admitted Exhibits\P-DEMO-008.pdf In Re Opioid Litigation; Index No.: 400000/2017 Dark Paradise : A History of Opiate Addiction in America (written by David T. Courtwright) - Cover N/A image 1 N/A N/A Cataloger-supplied title.; A color photograph of the cover of a softcover book, laying on a flat surface. P-DEMO-008_00001 P-DEMO-008 No 2024 January 25 fynx0287 pah84l00 NY Opioid Litigation Documents nypp public no restrictions NY v. Purdue Pharma -- OCRed PDFs\Admitted Exhibits\P-DEMO-297.pdf In Re Opioid Litigation; Index No.: 400000/2017 Dark Paradise : Opiate Addiction in America before 1940 (written by David T. Courtwright) N/A image 1 N/A N/A Cataloger-supplied title.; A color photograph of the cover of a book. P-DEMO-297_00001 P-DEMO-297 No 2024 January 25 zzyx0279 Insys Litigation Documents insys Cecil, Darin Confidential Personal Information public no restrictions 2014 April 22 2014 April 22 00000000E5F9EECC8242A94CAB584F37CA88B95564F32000.MSG Playbook for Pain, Addiction, and the Law Anna Marzahl 2014 April 22 email 1 Darin Cecil [dcecil@insysrx.com] Carrie Dove [cdove@insysrx.com] Jacquilyn Weiner [jweiner@insysrx.com] INSYS-MDL-015600544 yes 2023 March 23 yfgm0278 Insys Litigation Documents insys Hein, Mark Confidential Personal Information public no restrictions 2014 September 04 2014 September 04 000000006E07F18E01D5864D8E634CD21DB50DE204822100.MSG Fears of addiction keep cancer patients from getting pain relief | Reuters John Kapoor 2014 September 04 email 1 Michael Babich [mbabich@insysrx.com] Nicole Forman [nforman@insysrx.com] Christopher Homrich [chomrich@insysrx.com] Steven Jensen [sjensen@insysrx.com] Vikram Malhotra [vmalhotra@insysrx.com] Brian Pipko [bpipko@insysrx.com] Mark Hein [mhein@insysrx.com] Robin Wachsman [rwachsman@insysrx.com] INSYS-MDL-012678153 yes 2023 March 23 lgwv0281 Insys Litigation Documents insys Richmond, Brian Confidential Personal Information public no restrictions 2014 April 16 2014 April 16 000000005BD2BDE001E679489668750743A53813E4993900.MSG Re: SORRY IT'S A LONG ONE....Addiction, Pain and the Law, Stanley and stuff Darin Cecil 2014 April 16 email 2 Desiree Hollandsworth [dhollandsworth@insysrx.com] Joseph Rowan [jrowan@insysrx.com] Brian Richmond [brichmond@insysrx.com] Matthew Napoletano [mnapoletano@insysrx.com] Meghan MacMillan [mmacmillan@insysrx.com] INSYS-MDL-012196499 yes 2023 April 20 ygwv0281 Insys Litigation Documents insys Richmond, Brian Confidential Personal Information public no restrictions 2014 April 16 2014 April 16 000000005BD2BDE001E679489668750743A53813E49D3900.MSG SORRY IT'S A LONG ONE....Addiction, Pain and the Law, Stanley and stuff Desiree Hollandsworth 2014 April 16 email 2 Darin Cecil [dcecil@insysrx.com] Joseph Rowan [jrowan@insysrx.com] Brian Richmond [brichmond@insysrx.com] Matthew Napoletano [mnapoletano@insysrx.com] Meghan MacMillan [mmacmillan@insysrx.com] INSYS-MDL-012196568 yes 2023 April 20 hqlv0281 Insys Litigation Documents insys Hein, Mark Confidential Personal Information public no restrictions 2014 July 28 2014 July 28 00000000F3DEBC513341B444AED87A0C1B481418E4F42000.MSG UPDATED WITH AGENDA: Insys_Synchrony Medical: 2014-2015 Scientific Communication/Tactical Publication Planning for SUBSYS & Pain/Addiction Pipeline Nicole Forman 2014 July 28 email 2 Neha Parikh [nparikh@insysrx.com] Giovanni DeCastro [gdecastro@insysrx.com] Willene Brondum [wbrondum@insysrx.com] Mark Hein [mhein@insysrx.com] Matthew Napoletano [mnapoletano@insysrx.com] Mike Gurry [mgurry@insysrx.com] Vikram Malhotra [vmalhotra@insysrx.com] Colleen Hedge (chedge@synchronymed.com) [chedge@synchronymed.com] Shawn Boyle (sboyle@synchronymed.com) [sboyle@synchronymed.com] Mary Beth Moncrief [mmoncrief@synchronymed.com] Steven Jensen [sjensen@insysrx.com] Desiree Hollandsworth [dhollandsworth@insysrx.com] Nicole Durst [ndurst@insysrx.com] Rod Hughes [rhughes@synchronygroup.com] INSYS-MDL-012595938 yes 2023 April 20 ryfv0281 Insys Litigation Documents insys Richmond, Brian Confidential Personal Information public no restrictions 2014 April 16 2014 April 16 000000005BD2BDE001E679489668750743A5381344154000.MSG RE: SORRY IT'S A LONG ONE....Addiction, Pain and the Law, Stanley and stuff Brian Richmond 2014 April 16 email 2 Desiree Hollandsworth [dhollandsworth@insysrx.com] INSYS-MDL-012239728 yes 2023 April 20 fsgv0281 Insys Litigation Documents insys Richmond, Brian Confidential Personal Information public no restrictions 2014 April 16 2014 April 16 000000003A529C1E9B5838419E1BF553F420F0CC04B13400.MSG Re: SORRY IT'S A LONG ONE....Addiction, Pain and the Law, Stanley and stuff Darin Cecil 2014 April 16 email 2 Desiree Hollandsworth [dhollandsworth@insysrx.com] Joseph Rowan [jrowan@insysrx.com] Brian Richmond [brichmond@insysrx.com] Matthew Napoletano [mnapoletano@insysrx.com] Meghan MacMillan [mmacmillan@insysrx.com] INSYS-MDL-012315064 yes 2023 April 20 fnlh0257 hud72k00 Ohio Pharmacy Litigation Documents ohiopharm public no restrictions N.D.Ohio_1 17-md-02804-DAP_4104_36.pdf 1:17-md-2804; Case Track Three Lake County ADAMHS Board : County Hub Program to Combat Opioid Addiction - Report, December 2019 Lake County (Ohio). Alcohol, Drug Addiction, and Mental Health Services Board Fraser, Kimberly 2019 December document 18 Other identifiers : ADAMHS0000004896, Doc #: 4104-36. CVS-MDL-04963 2022 October 13 fzcp0256 McKinsey Documents mck Tingley, Christen public no restrictions MR-01857 - General Risks of Addiction, Abuse and Misuse Tear Pad.pdf Adobe Portable Document Format MR-01857 - General Risks of Addiction, Abuse and Misuse Tear Pad.pdf 2017 March 28; 2017 December 11 Document 1 opioids MCK-MAAG-1025643 2022 June 06 pkkd0320 Teva and Allergan Documents teva Marchione, Carol public no restrictions 2013 August 01 Marchione, Carol\Opioids - Civil Cases-MDL\Archive\CarolMarchione_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement Neurotech Insights Alert: Addiction [MARKETING] NeuroInsights <newsletter@neuroinsights.com> 2013 August 01 email 4 Carol Marchione <carol.marchione@tevapharm.com> TGOS_VA4_MDL_01168014 TEVA_MDL_A_01450655 2024 August 29 yqwk0319 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2015 August 24 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0002.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement Heroin and Prescription Opioid Addiction: CDC Report and Administration Response [MARKETING] PAINWeek Daily Dose (External) <noreply-alert@painweek.org> 2015 August 24 email 1 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01047912 TEVA_MDL_A_01305378 2024 August 29 yrwk0319 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2015 September 28 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0002.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement Addiction Medicine: Bringing Primary Care Up to Speed [MARKETING] PAINWeek Daily Dose (External) <noreply-alert@painweek.org> 2015 September 28 email 1 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01047947 TEVA_MDL_A_01305413 2024 August 29 prwk0319 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2015 September 28 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0002.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement Addiction Medicine: Bringing Primary Care Up to Speed [MARKETING] PAINWeek Daily Dose (External) <noreply-alert@painweek.org> 2015 September 28 email 1 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01047948 TEVA_MDL_A_01305414 2024 August 29 ppbc0325 Teva and Allergan Documents teva Morreale, Michael public no restrictions 2005 December 02 Morreale, Michael\MichaelMorreale_Export_0001.pst\Top of Personal Folders\Inbox\Brown, Chris Teva and Allergan Global Opioid Settlement Agreement Free Addiction Medicine CME Chris Brown <"/o=teva/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=cbrown"> 2005 December 02 email 1 "Finerty, Laura" <lfinerty@cephalon.com> "VanDyke, Darren" <dvandyke@cephalon.com> "Whiting, Steven" <swhiting@cephalon.com> "Musick, Amy" <amusick@cephalon.com> Brandon Owens <"/o=teva/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=bowens"> xxxxxxxxxxxxx@att.net Jason Schwarz <xxxxxxxxxxxxx@comcast.net> xxxxxxxxxxx@yahoo.com Michael Morreale <"/o=teva/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=mmorreal"> "Potenza, Daniel" <dpotenza@cephalon.com> Brian Crawford <brian.crawford@alkermes.com> "Carnohan, William" <wcarnoha@cephalon.com> "Salzman, Nadene" <nsalzman@cephalon.com> "Pezzullo, AnnMary" <apezzull@cephalon.com> "Keck, Gregory" <gkeck@cephalon.com> "Pezzullo, AnnMary" <apezzull@cephalon.com> Mara Define <"/o=teva/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=mdefine"> TGOS_VA4_MDL_01502610 TEVA_MDL_A_01868082 yes 2024 September 26 jnwc0325 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2012 May 08 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement ASAM Weekly -- News in Addiction Medicine: May 8, 2012 ASAM Weekly <asamweekly@multibriefs.com> 2012 May 08 email 11 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01504471 TEVA_MDL_A_01869992 yes 2024 September 26 sswc0325 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2012 June 05 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement ASAM Weekly -- News in Addiction Medicine: June 5, 2012 ASAM Weekly <asamweekly@multibriefs.com> 2012 June 05 email 10 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01505074 TEVA_MDL_A_01870595 2024 September 26 gffc0325 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2012 June 12 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement ASAM Weekly -- News in Addiction Medicine: June 12, 2012 ASAM Weekly <asamweekly@multibriefs.com> 2012 June 12 email 10 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01505352 TEVA_MDL_A_01870919 yes 2024 September 26 rlfc0325 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2012 July 17 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement ASAM Weekly -- News in Addiction Medicine: July 17, 2012 ASAM Weekly <asamweekly@multibriefs.com> 2012 July 17 email 9 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01506105 TEVA_MDL_A_01871720 yes 2024 September 26 kmfc0325 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2012 July 24 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement ASAM Weekly -- News in Addiction Medicine: July 24, 2012 ASAM Weekly <asamweekly@multibriefs.com> 2012 July 24 email 10 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01506134 TEVA_MDL_A_01871749 yes 2024 September 26 znfc0325 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2012 July 31 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement ASAM Weekly -- News in Addiction Medicine: July 24, 2012 ASAM Weekly <asamweekly@multibriefs.com> 2012 July 31 email 10 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01506634 TEVA_MDL_A_01872249 yes 2024 September 26 msgc0325 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2012 November 27 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement ASAM Weekly -- News in Addiction Medicine: Nov. 27, 2012 ASAM Weekly <asamweekly@multibriefs.com> 2012 November 27 email 9 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01509131 TEVA_MDL_A_01874858 yes 2024 September 26 qzxc0325 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2013 March 21 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement RE: "Like minded physicians" Addiction is a problem of biology "Troncale MD, Joseph A" <jtroncale2@lghealth.org> 2013 March 21 email 5 xxxxxxx@comcast.net Kenneth Thompson MD <kthompson@caron.org> psam-members@list.pamedsoc.org TGOS_VA4_MDL_01518898 TEVA_MDL_A_01884958 yes 2024 September 26 lfjc0325 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2013 March 26 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement Addiction Expert: Care Needed in Implementing New Buprenorphine Prescribing Rules ASAM Weekly <asamweekly@multibriefs.com> 2013 March 26 email 11 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01519178 TEVA_MDL_A_01885238 yes 2024 September 26 zskc0325 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2013 August 15 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement Don't Miss Five Special Addresses that Define the State of the Art in Addiction Medicine [MARKETING] American Society of Addiction Medicine <education@asam.org> 2013 August 15 email 3 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01526425 TEVA_MDL_A_01893540 yes 2024 September 26 xmkc0325 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2013 July 10 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement Register for the State of the Art Course-Learn What's New in Addiction Medicine [MARKETING] American Society of Addiction Medicine <email@asam.org> 2013 July 10 email 2 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01523613 TEVA_MDL_A_01890539 yes 2024 September 26 gqkc0325 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2013 July 26 Narayana, Arvind\Opioids - Civil Cases-MDL\Archive\ArvindNarayana_Export_0001.pst\Top of Outlook data file\Inbox Teva and Allergan Global Opioid Settlement Agreement Explore Emerging Problems and Advances in Addiction Medicine [MARKETING] American Society of Addiction Medicine <education@asam.org> 2013 July 26 email 2 Arvind Narayana <arvind.narayana@tevapharm.com> TGOS_VA4_MDL_01525430 TEVA_MDL_A_01892537 2024 September 26 lnym0341 Teva and Allergan Documents teva Martin, Greg;Meyer, Chris;Morreale, Michael public no restrictions 2005 December 07 Martin, Greg\Teva Opioids-Civil MDL-20181015.zip\Zantaz_MARTIN_GREGORYS__GMARTIN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Field Sales New Hires - Addiction Medicine "Hoopes, Jane" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=jhoopes"> 2005 December 07 email 3 626 (Sales Training) <626@cephalon.com> 628 (Sales Operations) <628@cephalon.com> "Adam Winterhof @ Promotech" <awinterhof@promotechdirect.com> annex@promotechdirect.com Anthony Maris/RxHope <amaris@rxhope.com> ARI Fleet <cephalon@arifleet.com> "Beltrante, Anita" <abeltran@cephalon.com> "Buffa, Shannon" <sbuffa@cephalon.com> "Camponelli, Paul" <pcampone@cephalon.com> Carrie Pickard Promotech <cpickard@promotechdirect.com> "Corrado, Joan" <jcorrado@cephalon.com> "Daniele, Pina" <pdaniele@cephalon.com> "David, Annette" <adavid@cephalon.com> "DeRogatis, Robin" <rderogat@cephalon.com> "Duncan, Deborah" <dduncan@cephalon.com> Employee Information Form <employeeinformationform@cephalon.com> "Grasso, Theresa" <tgrasso@cephalon.com> Greg Langhart - Promotech <glanghart@promotechdirect.com> "Haak, Christopher" <chaak@cephalon.com> "Hoopes, Jane" <jhoopes@cephalon.com> Jason Ferber - Promotech <"jferber@promotechdirect.com."> "Jennifer Simpson @ medicaled" <jennifer@medicaled.com> "Kim Coia @ Priority Air Express" <kim.coia@priorityairexpress.com> Lisa Cristofich <lcristofich@worldtravelinc.com> "Llagas, Heidi" <hllagas@cephalon.com> "Loyle, Richard" <rloyle@cephalon.com> Maria Thomas / Covance <maria.thomas@covance.com> "McConaghy, Lynn" <lmcconag@cephalon.com> "McMaster, Donna" <dmcmaste@cephalon.com> MediCom <csb@medicaled.com> "Nelson, Danielle" <dnelson@cephalon.com> Promotech <ceph@promotechdirect.com> "Scarani, Karen" <kscarani@cephalon.com> "Smith, Michael G" <mgsmith@cephalon.com> "Stevens, Danielle" <dhall@cephalon.com> "T Harvey @ Promotech" <tharvey@promotechdirect.com> "Tigue, Philip" <ptigue@cephalon.com> Tom Costello <tcostello@ribbons-express.com> "Vandenberg, Patricia" <pvandenb@cephalon.com> World Travel / Kristen Hill <knapiorski@worldtravelinc.com> "Pezzullo, AnnMary" <apezzull@cephalon.com> "Haygood, Joe" <jhaygood@cephalon.com> "Morreale, Michael" <mmorreal@cephalon.com> "File, Jeff" <jfile@cephalon.com> "Sullivan, Glenn" <gsulliva@cephalon.com> "Stanley, Scott" <sstanley@cephalon.com> "Buchholtz, Christopher" <cbuchhol@cephalon.com> "Barnes, Ryan" <rbarnes@cephalon.com> "Carnohan, William" <wcarnoha@cephalon.com> TGOS_VA4_MDL_07156236 TEVA_MDL_A_08926827 yes 2024 December 19 knym0341 Teva and Allergan Documents teva Martin, Greg;Meyer, Chris public no restrictions 2005 December 06 Martin, Greg\Teva Opioids-Civil MDL-20181015.zip\Zantaz_MARTIN_GREGORYS__GMARTIN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Addiction Alignment Index Analysis "Shanfelt, Nancy" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=nshanfel"> 2005 December 06 email 1 "Martin, Gregory S." <gmartin@cephalon.com> "Meyer, Chris" <cmeyer@cephalon.com> TGOS_VA4_MDL_07156234 TEVA_MDL_A_08926825 yes 2024 December 19 lzmn0341 Teva and Allergan Documents teva Meyer, Chris public no restrictions 2018 May 17 Meyer, Chris\Opioids Chicago Search Request Update - 20180625.zip\Opioids Search Update 20180620 - Chris Meyer.pst\Top of Personal Folders\Recoverable Items\Deletions\{Recoverable Items} Teva and Allergan Global Opioid Settlement Agreement FDA grants approval to first non-opioid treatment to manage opioid addiction withdrawal symptoms, Allergan sued for trying to stop U.S. retailers from selling generic forms of dry-eye disease drug Restasis, and more in the PharmaLive Daily Advantage [M... Daily Advantage (External) <dailyadvantage@pharmalive.com> 2018 May 17 email 2 Chris Meyer <chris.meyer@tevapharm.com> TGOS_VA4_MDL_07170095 TEVA_MDL_A_08941396 2024 December 19 kqvp0341 Teva and Allergan Documents teva Reilly, Jim public no restrictions 2018 February 24 Reilly, Jim\Opioids Chicago Search Request Update - 20180625.zip\Opioids Update Search 20180619 - Jim Reilly.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement CNS Cluster Addiction Drug Development Pipeline Review, 2017 [MARKETING] Rachel Thompson (External) <rachel.thompson@researchandmarkets.org> 2018 February 24 email 2 Jim Reilly <jim.reilly@tevapharm.com> TGOS_VA4_MDL_07188183 TEVA_MDL_A_08960888 2024 December 19 gkkb0342 Teva and Allergan Documents teva King, James, Jr. public no restrictions King, James, Jr\Zantaz-JamesKingJr-01012004-07272017.pst\Top of Personal Folders\Inbox\FW: VIVITROL & LIVE outside the bottle News - September 14, 2007 Teva and Allergan Global Opioid Settlement Agreement Business Wire (Addiction) 9.13.07.doc 2007 September 14 document 2 TGOS_VA4_MDL_05521202 TEVA_MDL_A_06913130 yes 2024 December 19 mjhh0341 Teva and Allergan Documents teva Amanda, Wilhelm public no restrictions 2008 April 02 Amanda, Wilhelm\Teva Opioids-Civil MDL-20181015.zip\Zantaz_MISHIZEN_AMANDA_AMISHIZE_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement ESP: Emerging Solutions in Pain: Chronic Pain, Opioid Misuse, Opioid Abuse, Opioid Addiction-New User Details User Registration <info@emergingsolutionsinpain.com> 2008 April 02 email 1 "Mishizen, Amanda" <amishizen@cephalon.com> TGOS_VA4_MDL_07069970 TEVA_MDL_A_08835917 2024 December 19 kryx0341 Teva and Allergan Documents teva Bearer, Deborah public no restrictions 2006 April 04 Bearer, Deborah\Teva Opioids-Civil MDL-20181015.zip\Zantaz_BEARER_DEBORAH_DBEARER_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement RE: Addiction Medicine Articles "Bearer, Deborah" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=dbearer"> 2006 April 04 email 3 "Shilling, Douglas" <dshillin@cephalon.com> TGOS_VA4_MDL_07085742 TEVA_MDL_A_08852463 yes 2024 December 19 sfpx0341 Teva and Allergan Documents teva Bearer, Deborah;Morreale, Michael public no restrictions Bearer, Deborah\Teva Opioids-Civil MDL-20181015.zip\Zantaz_BEARER_DEBORAH_DBEARER_Export_0001.pst\Top of Outlook data file\Vivitrol Media Coverage June 28, 2006 (NOT FOR PROMOTION)\VIVITROL News June 28, 2006.msg\VIVITROL News June 28, 2006 Teva and Allergan Global Opioid Settlement Agreement An Anti-Addiction Pill NY Times Magazine 6 25 06.pdf 2006 June 28 document 7 TGOS_VA4_MDL_07085959 TEVA_MDL_A_08852681 2024 December 19 zhfj0341 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions 2016 October 03 Caminiti, Joseph\Opioids Chicago Search Request Update - 20180625.zip\Opioids Update Search 20180619 - Joseph Caminiti.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement Feature: Opioid Addiction Epidemic, Biosimilars Dominate New Federal, State Bills, Laws [MARKETING] AIS's Health Business Daily (External) <hbd@aishealth.com> 2016 October 03 email 3 Joseph Caminiti <joseph.caminiti@tevapharm.com> TGOS_VA4_MDL_07090773 TEVA_MDL_A_08857856 2024 December 19 qngj0341 Teva and Allergan Documents teva Dewildt, Charles public no restrictions 2008 March 07 Dewildt, Charles\CharlesDewildt_Export_0001.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement RE: Abuse/Addiction/Diversion program update "Hennecke, David" <dhenneck@cephalon.com> 2008 March 07 email 1 Charles DeWildt <charles.dewildt@tevapharm.com> TGOS_VA4_MDL_07091864 TEVA_MDL_A_08859020 2024 December 19 kkpj0341 Teva and Allergan Documents teva Dewildt, Charles public no restrictions 2007 August 07 Dewildt, Charles\Teva Opioids-Civil MDL-20181015.zip\Zantaz_DEWILDT_CHARLES_CDEWILDT_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Abuse/Addiction/Diversion CSPs "Tatum, Chandler" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=ctatum"> 2007 August 07 email 9 "Hemenway, Michael" <mhemenwa@cephalon.com> "Kramin, Matthew" <mkramin@cephalon.com> "Morrison, Jacqueline" <jmorriso@cephalon.com> "Nikolaus, Matthew" <mnikolau@cephalon.com> "Rutkowski, Courtney" <crutkows@cephalon.com> "Tocco, Philip" <ptocco@cephalon.com> "DeWildt, Charles" <cdewildt@cephalon.com> "Hennecke, David" <dhenneck@cephalon.com> TGOS_VA4_MDL_07107381 TEVA_MDL_A_08874744 2024 December 19 hsgv0342 Teva and Allergan Documents teva Williams, Paula public no restrictions 2008 April 04 Williams, Paula\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Paula Williams_1.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement FW: abuse, addiction, and diversion slide deck "Castagno, Paula" <pcastagn@cephalon.com> 2008 April 04 email 2 "Hollandsworth, Desiree" <dhollandsworth@theselvagroup.com> "Dicaprio, Krista" <kdicaprio@theselvagroup.com> "Custodero, Ann" <acustodero@theselvagroup.com> TGOS_VA4_MDL_05493315 TEVA_MDL_A_06877708 yes 2024 December 19 ysgv0342 Teva and Allergan Documents teva Terifay, Terrance;Williams, Paula public no restrictions 2008 April 02 Williams, Paula\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Paula Williams_1.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement FW: abuse, addiction, and diversion slide deck "Castagno, Paula" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=pcastagn"> 2008 April 02 email 2 "Terifay, Terrence" <tterifay@cephalon.com> TGOS_VA4_MDL_05493379 TEVA_MDL_A_06877772 yes 2024 December 19 zsgv0342 Teva and Allergan Documents teva Williams, Paula public no restrictions 2008 April 08 Williams, Paula\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Paula Williams_1.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement FW: abuse, addiction, and diversion slide deck "Castagno, Paula" <pcastagn@cephalon.com> 2008 April 08 email 2 "McGurk, Mary Lou" <mmcgurk@cephalon.com> TGOS_VA4_MDL_05493440 TEVA_MDL_A_06877833 yes 2024 December 19 xkkb0342 Teva and Allergan Documents teva King, James, Jr. public no restrictions King, James, Jr\Zantaz-JamesKingJr-01012004-07272017.pst\Top of Personal Folders\Inbox\FW: VIVITROL & LIVE outside the bottle News - September 14, 2007 Teva and Allergan Global Opioid Settlement Agreement Join Together Online (Addiction) 9.13.07.doc 2007 September 14 document 1 TGOS_VA4_MDL_05521206 TEVA_MDL_A_06913134 2024 December 19 tffk0340 Teva and Allergan Documents teva Larijani, Susan;Marchione, Carol public no restrictions 2005 April 06 Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani_1.pst\Top of Personal Folders Teva and Allergan Global Opioid Settlement Agreement Glamour Magazine (May 2005) Reports on Prescription Drug Addiction "Beckhardt, Stacey" <sbeckhar@cephalon.com> 2005 April 06 email 1 "Bader, Robert" <rbader@cephalon.com> "Beckhardt, Stacey" <sbeckhar@cephalon.com> "Bender, Jeannine" <jbender@cephalon.com> "Berg, Edward" <eberg@cephalon.com> "Castagno, Paula" <pcastagn@cephalon.com> "Gant, Colleen" <cgant@cephalon.com> "Hoey, Edward" <ehoey@cephalon.com> "Larijani, Susan" <slarijan@cephalon.com> "Marchione, Carol" <cmarchio@cephalon.com> "McCreery, Joanne" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=jmccreer"> "McGhee, Kay" <kmcghee@cephalon.com> "McKinley, Jay" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=jmckinle"> "Messina, John" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=jmessina"> "Mutisya, Elizabeth" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=emutisya"> "Patel, Mina" <mpatel@cephalon.com> "Pyfer, Andy" <apyfer@cephalon.com> "Pyfer, Christine" <cpyfer@cephalon.com> "Richardson, Michael" <mrichardson@cephalon.com> "Robinson, Dean" <drobinso@cephalon.com> "Simmons, Betsy" <bsimmons@cephalon.com> "Terifay, Terrence" <tterifay@cephalon.com> "Vadiei, Kiumars" <kvadiei@cephalon.com> "Williams, Sheryl" <swilliam@cephalon.com> "Grupp, Robert" <rgrupp@cephalon.com> "Brookes, Lynne" <lbrookes@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> TGOS_VA4_MDL_06555246 TEVA_MDL_A_08238109 2024 December 19 hhxf0341 Teva and Allergan Documents teva Day, Matthew public no restrictions 2018 May 29 Day, Matthew\Opioids Chicago Search Request Update - 20180625.zip\Opioids Update Search 20180620 - Matthew Day.pst\Top of Personal Folders\Deleted Items Teva and Allergan Global Opioid Settlement Agreement Recalled oral contraceptive packaged at Sharp Packaging Solutions, says Allergan / Avara to buy Novartis site, signs supply deal / Braeburn resubmits opioid addiction candidate to US FDA / Catalent-made Lucemyra wins US FDA approval for opioid withdraw... in-PharmaTechnologist (External) <newsletter@in-pharmatechnologist.com> 2018 May 29 email 3 Matthew Day <matthew.day@tevapharm.com> TGOS_VA4_MDL_06969454 TEVA_MDL_A_08714792 2024 December 19 zkpf0341 Teva and Allergan Documents teva Day, Matthew public no restrictions 2017 May 31 Day, Matthew\Opioids Chicago Search Request Update - 20180625.zip\Opioids Update Search 20180620 - Matthew Day.pst\Top of Personal Folders\Sent Items Teva and Allergan Global Opioid Settlement Agreement RE: Pittsburgh Addiction Specialist? Matthew Day <"/o=teva/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=mday"> 2017 May 31 email 2 Dalton Tomlinson <dalton.tomlinson@tevapharm.com> TGOS_VA4_MDL_06991410 TEVA_MDL_A_08739948 yes 2024 December 19 ryhw0341 Teva and Allergan Documents teva Day, Matthew;Miller, Wendy public no restrictions 2011 November 14 Day, Matthew\Zantaz-MatthewDay-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement News Articles about Opioid Addiction & Abuse "Newdeck, Michelle" <mnewdeck@cephalon.com> 2011 November 14 email 1 "Day, Matthew" <mday@cephalon.com> "Jacobs, John C." <jcjacobs@cephalon.com> "Miller, Wendy" <wmiller@cephalon.com> TGOS_VA4_MDL_06953806 TEVA_MDL_A_08698321 yes 2024 December 19 mpwg0341 Teva and Allergan Documents teva Day, Matthew public no restrictions 2017 January 25 Day, Matthew\Opioids Chicago Search Request Update - 20180625.zip\Opioids Update Search 20180620 - Matthew Day.pst\Top of Personal Folders\Inbox\TEVA\Protfolio\VANTRELA\GH Teva and Allergan Global Opioid Settlement Agreement Hogan Announces New Measures to Address Opioid Addiction "Culbertson, Kallie (CHI-GOL)" <kculbertson@golin.com> 2017 January 25 email 3 Rob Falb <rob.falb@tevapharm.com> Robert Kincaid <robert.kincaid@tevapharm.com> Jerry Moore <jerry.moore@tevapharm.com> Matthew Day <matthew.day@tevapharm.com> Liza Tresser <liza.tresser@tevapharm.com> Shannen Kelly <shannen.kelly05@tevapharm.com> Doris Saltkill <doris.saltkill@tevapharm.com> GOL WW TEVA <teva@golinharris.com> TGOS_VA4_MDL_07011122 TEVA_MDL_A_08762867 2024 December 19 fzpf0341 Teva and Allergan Documents teva Day, Matthew public no restrictions 2017 March 30 Day, Matthew\Opioids Chicago Search Request Update - 20180625.zip\Opioids Update Search 20180620 - Matthew Day.pst\Top of Personal Folders\Sent Items Teva and Allergan Global Opioid Settlement Agreement RE: President’s Commission on Combatting Drug Addiction and the Opioid Crisis Matthew Day <"/o=teva/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=mday"> 2017 March 30 email 1 Rob Falb <rob.falb@tevapharm.com> Jeffrey Dierks <jeffrey.dierks@tevapharm.com> Shannon Dzubin <shannon.dzubin@tevapharm.com> Debra Barrett <debra.barrett@tevapharm.com> TGOS_VA4_MDL_06992585 TEVA_MDL_A_08741364 yes 2024 December 19 xfcd0341 Teva and Allergan Documents teva Day, Matthew public no restrictions 2016 May 13 Day, Matthew\Opioids Chicago Search Request Update - 20180625.zip\Opioids Update Search 20180620 - Matthew Day.pst\Top of Personal Folders\Sent Items Teva and Allergan Global Opioid Settlement Agreement Re: Opp for painmatters: Remnant Placement in Heroin Addiction Campaign: ONDCP Director Botticelli, Vivek Murthy, Sylvia Burwell, speak out matthew.day@tevapharm.com 2016 May 13 email 2 Dalton Tomlinson <dalton.tomlinson@tevapharm.com> TGOS_VA4_MDL_06913511 TEVA_MDL_A_08655129 yes 2024 December 19 rmhd0341 Teva and Allergan Documents teva Day, Matthew public no restrictions 2018 May 17 Day, Matthew\Opioids Chicago Search Request Update - 20180625.zip\Opioids Update Search 20180620 - Matthew Day.pst\Top of Personal Folders\Recoverable Items\Deletions\{Recoverable Items} Teva and Allergan Global Opioid Settlement Agreement FDA grants approval to first non-opioid treatment to manage opioid addiction withdrawal symptoms, Allergan sued for trying to stop U.S. retailers from selling generic forms of dry-eye disease drug Restasis, and more in the PharmaLive Daily Advantage [M... Daily Advantage (External) <dailyadvantage@pharmalive.com> 2018 May 17 email 2 Matthew Day <matthew.day@tevapharm.com> TGOS_VA4_MDL_06930411 TEVA_MDL_A_08672324 2024 December 19 xsyw0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2010 October 21 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0003.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Neurobiology of Addiction revised slide deck "Barrett, Andrew" <abarrett@cephalon.com> 2010 October 21 email 1 "Narayana, Arvind" <anarayan@cephalon.com> TGOS_VA4_MDL_05630227 TEVA_MDL_A_07034259 yes 2024 December 19 nhvf0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2010 December 03 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0003.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement World Market for Addiction Disorders, 2009-2016, The Future Therapies fo r Substance Dependence and Impulse Control Amy Cole <amy.cole@researchandmarkets.org> 2010 December 03 email 4 "Narayana, Arvind" <anarayan@cephalon.com> TGOS_VA4_MDL_05631089 TEVA_MDL_A_07035122 yes 2024 December 19 lmlc0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2007 March 08 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement National Study: Treat Addiction to Rx Pain Medications NADDI RxNews <rxnews@naddi.org> 2007 March 08 email 2 rxnews-list@naddi.org TGOS_VA4_MDL_05593808 TEVA_MDL_A_06997217 yes 2024 December 19 rtlc0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2007 March 28 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Oxy is the gateway drug to heroin addiction south of Boston NADDI RxNews <rxnews@naddi.org> 2007 March 28 email 2 rxnews-list@naddi.org TGOS_VA4_MDL_05594149 TEVA_MDL_A_06997561 yes 2024 December 19 mmbg0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2012 April 10 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0004.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement ASAM Weekly -- News in Addiction Medicine: April 10, 2012 ASAM Weekly <asamweekly@multibriefs.com> 2012 April 10 email 6 "Narayana, Arvind" <anarayan@cephalon.com> TGOS_VA4_MDL_05653992 TEVA_MDL_A_07058217 yes 2024 December 19 krbg0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2012 April 20 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0004.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Med-Sci Conference Takes on the Hot Topics in Addiction Medicine ASAM <asam@xmr3.com> 2012 April 20 email 2 "Narayana, Arvind" <anarayan@cephalon.com> TGOS_VA4_MDL_05654232 TEVA_MDL_A_07058459 2024 December 19 yqbg0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2012 April 17 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0004.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement ASAM Weekly -- News in Addiction Medicine: April 17, 2012 ASAM Weekly <asamweekly@multibriefs.com> 2012 April 17 email 10 "Narayana, Arvind" <anarayan@cephalon.com> TGOS_VA4_MDL_05654193 TEVA_MDL_A_07058420 yes 2024 December 19 tzxg0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2011 November 23 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0004.pst\Top of Outlook data file\[No Subject]\.msg\RE: Actiq addiction\RE_ Actiq addiction.msg Teva and Allergan Global Opioid Settlement Agreement RE: Actiq addiction "Kaper, Robert" <rkaper@cephalon.com> 2011 November 23 email 1 Vissers Eugene <evissers@cephalon.com> "Narayana, Arvind" <anarayan@cephalon.com> TGOS_VA4_MDL_05658743 TEVA_MDL_A_07063340 2024 December 19 gtyc0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2007 August 13 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement RE: Myspace page educating people about Rx Drug addiction NADDI RxNews <rxnews@naddi.org> 2007 August 13 email 5 rxnews-list@naddi.org TGOS_VA4_MDL_05596980 TEVA_MDL_A_07000394 yes 2024 December 19 kzyc0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2007 August 15 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement RE: Myspace page educating people about Rx Drug addiction NADDI RxNews <rxnews@naddi.org> 2007 August 15 email 7 rxnews-list@naddi.org TGOS_VA4_MDL_05597028 TEVA_MDL_A_07000442 yes 2024 December 19 mhgd0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2008 July 02 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Updated: Med Svcs Pain/Addictions Team (PAT) Update Meeting "Altman, Charles" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=caltman"> 2008 July 02 calendar 1 "Larijani, Susan" <slarijan@cephalon.com> "Narayana, Arvind" <anarayan@cephalon.com> "Sehgal, Arpana" <asehgal@cephalon.com> "Bonhomme, Andrea" <abonhomm@cephalon.com> "Panning, Deborah" <dpanning@cephalon.com> "Dayno, Jeffrey" <jdayno@cephalon.com> "Altman, Charles" <caltman@cephalon.com> TGOS_VA4_MDL_05605066 TEVA_MDL_A_07008896 2024 December 19 prnd0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2009 April 09 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0002.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement FW: Neurobiology of Addiction deck "Narayana, Arvind" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=anarayan"> 2009 April 09 email 1 Arvind Narayana <xxxxxxxxxxx@comcast.net> TGOS_VA4_MDL_05611131 TEVA_MDL_A_07015121 yes 2024 December 19 nznd0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2009 April 16 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0002.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement FW: Neurobiology of Addiction deck "Narayana, Arvind" <anarayan@cephalon.com> 2009 April 16 email 2 "Altman, Charles" <caltman@cephalon.com> TGOS_VA4_MDL_05611262 TEVA_MDL_A_07015253 yes 2024 December 19 mznd0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2009 April 16 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0002.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement FW: Neurobiology of Addiction deck "Narayana, Arvind" <anarayan@cephalon.com> 2009 April 16 email 2 "Barrett, Andrew" <abarrett@cephalon.com> "Giordano, Connie" <cgiordan@cephalon.com> TGOS_VA4_MDL_05611258 TEVA_MDL_A_07015249 yes 2024 December 19 rjbg0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2012 April 03 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0004.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement ASAM Weekly -- News in Addiction Medicine: April 3, 2012 ASAM Weekly <asamweekly@multibriefs.com> 2012 April 03 email 10 "Narayana, Arvind" <anarayan@cephalon.com> TGOS_VA4_MDL_05653713 TEVA_MDL_A_07057935 yes 2024 December 19 hklw0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2010 July 22 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0003.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Neurobiology of Addiction deck "Barrett, Andrew" <abarrett@cephalon.com> 2010 July 22 email 1 "Narayana, Arvind" <anarayan@cephalon.com> TGOS_VA4_MDL_05625831 TEVA_MDL_A_07029854 yes 2024 December 19 kgpw0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2010 November 01 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0003.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement RE: Neurobiology of Addiction revised slide deck "Barrett, Andrew" <abarrett@cephalon.com> 2010 November 01 email 2 "Narayana, Arvind" <anarayan@cephalon.com> TGOS_VA4_MDL_05630442 TEVA_MDL_A_07034475 yes 2024 December 19 zjpw0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2010 November 01 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0003.pst\Top of Outlook data file\updates\RE_ Neurobiology of Addiction revised slide deck.msg Teva and Allergan Global Opioid Settlement Agreement RE: Neurobiology of Addiction revised slide deck "Narayana, Arvind" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=anarayan"> 2010 November 01 email 1 "Barrett, Andrew" <abarrett@cephalon.com> TGOS_VA4_MDL_05630550 TEVA_MDL_A_07034583 yes 2024 December 19 gyym0341 Teva and Allergan Documents teva Martin, Greg;Meyer, Chris public no restrictions 2005 December 12 Martin, Greg\Teva Opioids-Civil MDL-20181015.zip\Zantaz_MARTIN_GREGORYS__GMARTIN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Field Sales New Hires - Addiction Medicine and CNS "Hoopes, Jane" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=jhoopes"> 2005 December 12 email 2 626 (Sales Training) <626@cephalon.com> 628 (Sales Operations) <628@cephalon.com> "Adam Winterhof @ Promotech" <awinterhof@promotechdirect.com> annex@promotechdirect.com Anthony Maris/RxHope <amaris@rxhope.com> ARI Fleet <cephalon@arifleet.com> "Beltrante, Anita" <abeltran@cephalon.com> "Buffa, Shannon" <sbuffa@cephalon.com> "Camponelli, Paul" <pcampone@cephalon.com> Carrie Pickard Promotech <cpickard@promotechdirect.com> "Corrado, Joan" <jcorrado@cephalon.com> "Daniele, Pina" <pdaniele@cephalon.com> "David, Annette" <adavid@cephalon.com> "DeRogatis, Robin" <rderogat@cephalon.com> "Duncan, Deborah" <dduncan@cephalon.com> Employee Information Form <employeeinformationform@cephalon.com> "Grasso, Theresa" <tgrasso@cephalon.com> Greg Langhart - Promotech <glanghart@promotechdirect.com> "Haak, Christopher" <chaak@cephalon.com> "Hoopes, Jane" <jhoopes@cephalon.com> Jason Ferber - Promotech <"jferber@promotechdirect.com."> "Jennifer Simpson @ medicaled" <jennifer@medicaled.com> "Kim Coia @ Priority Air Express" <kim.coia@priorityairexpress.com> Lisa Cristofich <lcristofich@worldtravelinc.com> "Llagas, Heidi" <hllagas@cephalon.com> "Loyle, Richard" <rloyle@cephalon.com> Maria Thomas / Covance <maria.thomas@covance.com> "McConaghy, Lynn" <lmcconag@cephalon.com> "McMaster, Donna" <dmcmaste@cephalon.com> MediCom <csb@medicaled.com> "Nelson, Danielle" <dnelson@cephalon.com> Promotech <ceph@promotechdirect.com> "Scarani, Karen" <kscarani@cephalon.com> "Smith, Michael G" <mgsmith@cephalon.com> "Stevens, Danielle" <dhall@cephalon.com> "T Harvey @ Promotech" <tharvey@promotechdirect.com> "Tigue, Philip" <ptigue@cephalon.com> Tom Costello <tcostello@ribbons-express.com> "Vandenberg, Patricia" <pvandenb@cephalon.com> World Travel / Kristen Hill <knapiorski@worldtravelinc.com> "Pezzullo, AnnMary" <apezzull@cephalon.com> "Carnohan, William" <wcarnoha@cephalon.com> "Ruivo, Ruth" <rruivo@cephalon.com> "Shimokawa, David" <dshimoka@cephalon.com> "Griggs, Cornelius" <cgriggs@cephalon.com> "Clark, Tom" <tclark@cephalon.com> TGOS_VA4_MDL_07156261 TEVA_MDL_A_08926852 yes 2024 December 19 tqgm0341 Teva and Allergan Documents teva Larijani, Susan public no restrictions Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani_2.pst\Top of Personal Folders\[No Subject]\.msg\Updated FENTORA SRL's\Updated FENTORA SRL's.msg\Updated FENTORA SRL's Teva and Allergan Global Opioid Settlement Agreement FENT012-Potential for Misuse Abuse Addiction and Overdose.pdf 2018 March 25 document 6 TGOS_VA4_MDL_07150196 TEVA_MDL_A_08920369 yes 2024 December 19 tnpk0341 Teva and Allergan Documents teva Bearer, Deborah;Larijani, Susan;Martin, Greg;Meyer, Chris public no restrictions 2007 July 03 Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani_1.pst\Top of Personal Folders Teva and Allergan Global Opioid Settlement Agreement Alcohol & Addiction News - July 3, 2007 "Boyce, Karen" <kboyce@cephalon.com> 2007 July 03 email 3 "Altman, Charles" <caltman@cephalon.com> "Bader, Robert" <rbader@cephalon.com> "Barnes, Ryan" <rbarnes@cephalon.com> "Bearer, Deborah" <dbearer@cephalon.com> "Bellucci, Robert" <rbellucc@cephalon.com> "Bittenbender, Fritz" <fbittenb@cephalon.com> "Boyce, Karen" <kboyce@cephalon.com> "Bradway, Randy" <rbradway@cephalon.com> "Brookes, Lynne" <lbrookes@cephalon.com> "Brooks, Jacqueline" <jbrooks@cephalon.com> "Brown, Charles" <cgbrown@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Carnohan, William" <wcarnoha@cephalon.com> "Connelly, Jennifer" <jconnell@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "DeChristopher, Robin" <rdechris@cephalon.com> "Del Ricci, Francine" <fdelricc@cephalon.com> "Duarte, Joseph" <jduarte@cephalon.com> "Emerson, Robert" <remerson@cephalon.com> "Ferry, Shawn" <sferry@cephalon.com> "Fiorelli, Kenneth" <kfiorell@cephalon.com> "Grupp, Robert" <rgrupp@cephalon.com> "Kelly, Andy" <alkelly@cephalon.com> "Gilliland, Kevin" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=kgillila"> "Kim, Stuart" <skim@cephalon.com> "Larijani, Susan" <slarijan@cephalon.com> "Madden, Denise" <dmadden@cephalon.com> "Marczely, Joseph" <jmarczel@cephalon.com> Mark Kruger (DPM) <mkruger@dpmadvert.com> "Martin, Gregory S." <gmartin@cephalon.com> "McGaurn, Susan" <smcgaurn@cephalon.com> "McGuinness, Sue" <smcguinn@cephalon.com> "McKibbon, Howard" <hmckibbo@cephalon.com> "McKinley, Jay" <jmckinle@cephalon.com> "Meyer, Chris" <cmeyer@cephalon.com> "Mulholland, Michael" <mmulholl@cephalon.com> "Myers, Jeff M" <jmmyers@cephalon.com> "Neale, Douglas" <dneale@cephalon.com> "Pomento, Brian" <bpomento@cephalon.com> "Pyfer, Christine" <cpyfer@cephalon.com> "Riley, Joyce P." <jpriley@cephalon.com> "Riotto, Mark" <mriotto@cephalon.com> "Rydell, Jeffrey" <jrydell@cephalon.com> "Scott, Dan" <dscott@cephalon.com> "Shanfelt, Nancy" <nshanfel@cephalon.com> "Summers, Martin" <msummers@cephalon.com> "Tiller, Jane" <jtiller@cephalon.com> "Urban, Robert" <rurban@cephalon.com> "White, Andres" <awhite@cephalon.com> "Yeh, Helen" <hyeh@cephalon.com> TGOS_VA4_MDL_07128744 TEVA_MDL_A_08897804 2024 December 19 xypk0341 Teva and Allergan Documents teva Bearer, Deborah;Larijani, Susan;Martin, Greg;Meyer, Chris public no restrictions Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani_1.pst\Top of Personal Folders\Alcohol & Addiction News - July 3, 2007 Teva and Allergan Global Opioid Settlement Agreement ArriveNet Editorials (Addiction) 7.2.07.doc 2007 July 03 document 1 TGOS_VA4_MDL_07128755 TEVA_MDL_A_08897815 2024 December 19 zsph0341 Teva and Allergan Documents teva Amanda, Wilhelm public no restrictions 2012 February 08 Amanda, Wilhelm\Teva Opioids-Civil MDL-20181015.zip\Zantaz_MISHIZEN_AMANDA_AMISHIZE_Export_0001.pst\Top of Outlook data file\[No Subject]\.msg\Advances in Pain and Addiction\Advances in Pain and Addiction.msg Teva and Allergan Global Opioid Settlement Agreement Advances in Pain and Addiction IAPCD <info@iapcd.org> 2012 February 08 email 2 "Mishizen, Amanda" <amishize@cephalon.com> TGOS_VA4_MDL_07075286 TEVA_MDL_A_08841302 yes 2024 December 19 tsph0341 Teva and Allergan Documents teva Amanda, Wilhelm public no restrictions 2012 February 08 Amanda, Wilhelm\Teva Opioids-Civil MDL-20181015.zip\Zantaz_MISHIZEN_AMANDA_AMISHIZE_Export_0001.pst\Top of Outlook data file\[No Subject]\.msg Teva and Allergan Global Opioid Settlement Agreement Advances in Pain and Addiction IAPCD <info@iapcd.org> 2012 February 08 email 1 "Mishizen, Amanda" <amishize@cephalon.com> TGOS_VA4_MDL_07075285 TEVA_MDL_A_08841301 2024 December 19 xhvj0341 Teva and Allergan Documents teva Bearer, Deborah;Morreale, Michael public no restrictions 2007 March 06 Bearer, Deborah\Teva Opioids-Civil MDL-20181015.zip\Zantaz_BEARER_DEBORAH_DBEARER_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Cephalon Sponsors FAVOR/CADCA HBO Addiction Efforts/VIVITROL Media Coverage "Boyce, Karen" <kboyce@cephalon.com> 2007 March 06 email 3 Sales ADM <salesadm@cephalon.com> MSL-Addiction <msl-addiction@cephalon.com> MSL-CNS <msl-cns@cephalon.com> Sales Healthcare Systems & Reimbursement <saleshealthcaresystems&reimbursement@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Ferry, Shawn" <sferry@cephalon.com> "Neale, Douglas" <dneale@cephalon.com> "White, Andres" <awhite@cephalon.com> "Pyfer, Christine" <cpyfer@cephalon.com> "McKibbon, Howard" <hmckibbo@cephalon.com> "Kim, Stuart" <skim@cephalon.com> "Pomento, Brian" <bpomento@cephalon.com> "Leap, Danielle" <dleap@cephalon.com> "Williams, Sheryl" <swilliam@cephalon.com> Patricia D. Allman <pallman@dap-llc.com> Elizabeth Hutter <ehutter@biosector2.com> TGOS_VA4_MDL_07086795 TEVA_MDL_A_08853522 yes 2024 December 19 ngwj0341 Teva and Allergan Documents teva Caminiti, Joseph;Larijani, Susan;Martin, Greg;Meyer, Chris;Warner, Jamie public no restrictions 2006 August 22 Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement Alcohol and Addiction News (August 22, 2006) "Boyce, Karen" <kboyce@cephalon.com> 2006 August 22 email 1 "@CEP-11981" <cep-11981@cephalon.com> "Bader, Robert" <rbader@cephalon.com> "Barnes, Ryan" <rbarnes@cephalon.com> "Bellucci, Robert" <rbellucc@cephalon.com> "Bradway, Randy" <rbradway@cephalon.com> "Brookes, Lynne" <lbrookes@cephalon.com> "Brooks, Jacqueline" <jbrooks@cephalon.com> "Brown, Charles" <cgbrown@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Carnohan, William" <wcarnoha@cephalon.com> "Clements, Sean" <sclement@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "Define, Mara" <mdefine@cephalon.com> "Del Ricci, Francine" <fdelricc@cephalon.com> "Emerson, Robert" <remerson@cephalon.com> "Ferry, Shawn" <sferry@cephalon.com> "Fiorelli, Kenneth" <kfiorell@cephalon.com> "Guiton, Christopher" <cguiton@cephalon.com> "Hughes, Rod" <rhughes@cephalon.com> "Kelly, Andy" <alkelly@cephalon.com> "Gilliland, Kevin" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=kgillila"> "Larijani, Susan" <slarijan@cephalon.com> "Marczely, Joseph" <jmarczel@cephalon.com> "Martin, Gregory S." <gmartin@cephalon.com> "McGaurn, Susan" <smcgaurn@cephalon.com> "McKibbon, Howard" <hmckibbo@cephalon.com> "McKinley, Jay" <jmckinle@cephalon.com> "Meyer, Chris" <cmeyer@cephalon.com> "Mulholland, Michael" <mmulholl@cephalon.com> "Mutisya, Elizabeth" <emutisya@cephalon.com> "Neale, Douglas" <dneale@cephalon.com> "Powers, Joe M." <jmpowers@cephalon.com> "Pyfer, Christine" <cpyfer@cephalon.com> "Radhakrishnan, Maha" <mradhakr@cephalon.com> "Riotto, Mark" <mriotto@cephalon.com> "Savage, Virginia" <vsavage@cephalon.com> "Scott, Dan" <dscott@cephalon.com> "Shah Bell, Bhaval" <bshah@cephalon.com> "Shanfelt, Nancy" <nshanfel@cephalon.com> "Sikirica, Mirko" <msikiric@cephalon.com> "Solomon, Mark" <msolomon@cephalon.com> "Stevens, Charles" <cstevens@cephalon.com> "Tiller, Jane" <jtiller@cephalon.com> "Urban, Robert" <rurban@cephalon.com> "Vadiei, Kiumars" <kvadiei@cephalon.com> "Wang, Ed" <ewang@cephalon.com> "Warner, Jamie" <jwarner@cephalon.com> "White, Andres" <awhite@cephalon.com> "Yeh, Helen" <hyeh@cephalon.com> TGOS_VA4_MDL_07089787 TEVA_MDL_A_08856791 2024 December 19 ptcd0341 Teva and Allergan Documents teva Day, Matthew public no restrictions 2017 October 19 Day, Matthew\Opioids Chicago Search Request Update - 20180625.zip\Opioids Update Search 20180620 - Matthew Day.pst\Top of Personal Folders\Inbox\TEVA\Protfolio\Fasinumab\ Pain Care\Research Teva and Allergan Global Opioid Settlement Agreement RE: inThought Alert: FDA Expedites Review of Pear's Digital Therapeutic for Opioid Addiction Dalton Tomlinson <dalton.tomlinson@tevapharm.com> 2017 October 19 email 2 Matthew Day <matthew.day@tevapharm.com> TGOS_VA4_MDL_06914393 TEVA_MDL_A_08656113 yes 2024 December 19 slwj0341 Teva and Allergan Documents teva Caminiti, Joseph;Larijani, Susan public no restrictions 2007 January 05 Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement American Academy of Addiction Psychiatry "McGaurn, Susan" <smcgaurn@cephalon.com> 2007 January 05 email 1 elliot.ehrich@alkermes.com "Altman, Charles" <caltman@cephalon.com> david.gastfriend@alkermes.com "Ferry, Shawn" <sferry@cephalon.com> "White, Andres" <awhite@cephalon.com> "McKibbon, Howard" <hmckibbo@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Tiller, Jane" <jtiller@cephalon.com> "Vadiei, Kiumars" <kvadiei@cephalon.com> "Larijani, Susan" <slarijan@cephalon.com> "Connolly, Kevin" <kconnoll@cephalon.com> robert.forman@alkermes.com ken.andrews@alkermes.com TGOS_VA4_MDL_07090191 TEVA_MDL_A_08857247 2024 December 19 nlwj0341 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox\Vivitrol Media Coverage June 28, 2006 (NOT FOR PROMOTION)\VIVITROL News June 28, 2006 Teva and Allergan Global Opioid Settlement Agreement An Anti-Addiction Pill NY Times Magazine 6 25 06.pdf 2006 June 28 document 7 TGOS_VA4_MDL_07090168 TEVA_MDL_A_08857224 2024 December 19 xhgk0341 Teva and Allergan Documents teva Larijani, Susan public no restrictions 2014 April 01 Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement Treating Opioid Addiction in Your Community - CME Survey MedPage Today <meeting.roundup@medpagetoday.com> 2014 April 01 email 1 Susan Larijani <susan.larijani@tevapharm.com> TGOS_VA4_MDL_07117152 TEVA_MDL_A_08885270 yes 2024 December 19 fyly0342 Teva and Allergan Documents teva Napoletano, M public no restrictions Loosefiles\Napoletano, M\LR-DSP-0198\MNapoletano1\MNapoletano4.pst\Personal Folders Teva and Allergan Global Opioid Settlement Agreement FENT012- Potential for drug abuse, addiction and diversion with the use of FENTORA.pdf kdisabat document 4 TGOS_VA4_MDL_05831121 TEVA_MDL_A_07366755 2024 December 19 xfnv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file\articles Teva and Allergan Global Opioid Settlement Agreement Heit-addiction tolerance.TIF 2008 March 07 image 16 TGOS_VA4_MDL_05935704 TEVA_MDL_A_07487743 2024 December 19 ppmc0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0004.pst\Top of Outlook data file\FW: Cephalonia Genetic Project Teva and Allergan Global Opioid Settlement Agreement Genetics of Opioid Addiction 04_09_Version 2 Amend 20Apr09.doc 2011 October 24 document 15 TGOS_VA4_MDL_06079575 TEVA_MDL_A_07665448 yes 2024 December 19 glgd0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0004.pst\Top of Outlook data file\[No Subject]\.msg\Updated FENTORA SRL's\Updated FENTORA SRL's.msg\Updated FENTORA SRL's Teva and Allergan Global Opioid Settlement Agreement FENT012-Potential for Misuse Abuse Addiction and Overdose.pdf 2018 February 18 document 6 TGOS_VA4_MDL_06164787 TEVA_MDL_A_07763650 yes 2024 December 19 yngv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file\FW: Pain Management Primary Care Study Teva and Allergan Global Opioid Settlement Agreement Opioid Addiction - Chronic Pain - Industry FINAL.pdf 2006 November 07 document 19 TGOS_VA4_MDL_05873995 TEVA_MDL_A_07421952 yes 2024 December 19 lqgv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file\FW: Pain Management Primary Care Study Teva and Allergan Global Opioid Settlement Agreement Opioid Addiction - Chronic Pain - Industry FINAL.pdf 2007 January 11 document 19 TGOS_VA4_MDL_05874230 TEVA_MDL_A_07422222 yes 2024 December 19 xkjv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file\FW: abuse\addiction screening in persistent pain management patients Teva and Allergan Global Opioid Settlement Agreement Heit-addiction tolerance.TIF 2007 June 13 image 16 TGOS_VA4_MDL_05904703 TEVA_MDL_A_07453496 2024 December 19 yxkv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2007 August 28 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Addiction to opiates proliferates in Maine NADDI RxNews <rxnews@naddi.org> 2007 August 28 email 4 rxnews-list@naddi.org TGOS_VA4_MDL_05917979 TEVA_MDL_A_07466850 yes 2024 December 19 rkpv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2008 August 13 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Re: Additional Thoughts on Genetics of Opioid Addiction Proposal for Funding "Tollen, Lindsay" <ltollen@cephalon.com> 2008 August 13 email 2 "Dayno, Jeffrey" <jdayno@cephalon.com> "Altman, Charles" <caltman@cephalon.com> "Narayana, Arvind" <anarayan@cephalon.com> TGOS_VA4_MDL_05943499 TEVA_MDL_A_07497814 yes 2024 December 19 snjv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file\FW: Addiction screening in pain patients deck Teva and Allergan Global Opioid Settlement Agreement Addiction screening deck changes.doc 2007 June 25 document 3 TGOS_VA4_MDL_05905178 TEVA_MDL_A_07454012 2024 December 19 plnv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2008 April 02 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement FW: abuse, addiction, and diversion slide deck "Narayana, Arvind" <anarayan@cephalon.com> 2008 April 02 email 2 "Dayno, Jeffrey" <jdayno@cephalon.com> TGOS_VA4_MDL_05937688 TEVA_MDL_A_07489729 2024 December 19 gsnv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2008 May 05 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement RE: Csp abuse and addiction slides "Narayana, Arvind" <anarayan@cephalon.com> 2008 May 05 email 1 "Levin, Penny" <plevin@cephalon.com> "Messina, John" <jmessina@cephalon.com> TGOS_VA4_MDL_05939989 TEVA_MDL_A_07492155 2024 December 19 jgyv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file\FW: investigator initiated study Teva and Allergan Global Opioid Settlement Agreement Genetics of Opioid Addiction 3 6 08 FINAL.doc 2008 May 28 document 17 TGOS_VA4_MDL_05940216 TEVA_MDL_A_07492384 yes 2024 December 19 hkyv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2008 June 18 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement FW: recent review article on abuse and addiction "Narayana, Arvind" <anarayan@cephalon.com> 2008 June 18 email 1 "Levin, Penny" <plevin@cephalon.com> TGOS_VA4_MDL_05940809 TEVA_MDL_A_07494944 2024 December 19 fmyv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file\ISS Core Team Review Teva and Allergan Global Opioid Settlement Agreement Katz - Genetics of Opioid Addiction 3 6 08 FINAL 28May08.doc 2008 June 26 document 17 TGOS_VA4_MDL_05941053 TEVA_MDL_A_07495283 yes 2024 December 19 qkpv0343 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2008 August 13 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement FW: Additional Thoughts on Genetics of Opioid Addiction Proposal for Funding "Narayana, Arvind" <anarayan@cephalon.com> 2008 August 13 email 1 "Tollen, Lindsay" <ltollen@cephalon.com> TGOS_VA4_MDL_05943498 TEVA_MDL_A_07497813 yes 2024 December 19 yhly0342 Teva and Allergan Documents teva Napoletano, M public no restrictions Loosefiles\Napoletano, M\LR-DSP-0198\MNapoletano1\MNapoletano4.pst\Personal Folders Teva and Allergan Global Opioid Settlement Agreement FENT012- Potential for drug abuse, addiction and diversion with the use of FENTORA.pdf kdisabat document 4 TGOS_VA4_MDL_05830705 TEVA_MDL_A_07366338 2024 December 19 rtbp0342 Teva and Allergan Documents teva Napoletano, M public no restrictions 2007 July 15 Loosefiles\Napoletano, M\LR-DSP-0198\MNapoletano2\MNapoletano7.pst\Personal Folders Teva and Allergan Global Opioid Settlement Agreement BENENTT - Opioid Chapter in Addiction Text Daniel Bennett, MD, DABPM <dbennett@denverpain.com> 2007 July 15 email 1 Napoletano, Matthew <mnapolet@cephalon.com> TGOS_VA4_MDL_05839060 TEVA_MDL_A_07376854 yes 2024 December 19 thvc0342 Teva and Allergan Documents teva Megaffin, Scott public no restrictions 2009 June 01 Megaffin, Scott\Opioids - Civil Cases-MDL\Archive\Zantaz_MEGAFFIN_SCOTT_SMEGAFFI_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement FW: Citizen Petition was submitted by the National Center on Addiction and Substance Abuse at Columbia University regarding REMS programs and opioid drugs "Del Ricci, Francine" <fdelricc@cephalon.com> 2009 June 01 email 2 "Schmider, Juergen" <jschmide@cephalon.com> "Megaffin, Scott" <smegaffi@cephalon.com> "Kaper, Robert" <rkaper@cephalon.com> TGOS_VA4_MDL_05532136 TEVA_MDL_A_06928455 yes 2024 December 19 zrwc0342 Teva and Allergan Documents teva Morreale, Michael public no restrictions 2005 November 08 Morreale, Michael\Opioids - Civil Cases-MDL\Archive\MichaelMorreale_Export_0001.pst\Top of Outlook data file\Inbox\Brown, Chris Teva and Allergan Global Opioid Settlement Agreement RE: Addiction Treatment Centers Chris Brown <"/o=teva/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=cbrown"> 2005 November 08 email 1 Shawn Ferry <shawn.ferry@tevapharm.com> "Potenza, Daniel" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=dpotenza"> Michael Morreale <michael.morreale@tevapharm.com> Joe Haygood <joseph.haygood@tevapharm.com> "Keck, Gregory" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=gkeck"> "Salzman, Nadene" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=nsalzman"> TGOS_VA4_MDL_05545746 TEVA_MDL_A_06948640 yes 2024 December 19 xsyc0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2007 August 13 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Myspace page educating people about Rx Drug addiction NADDI RxNews <rxnews@naddi.org> 2007 August 13 email 2 rxnews-list@naddi.org TGOS_VA4_MDL_05596955 TEVA_MDL_A_07000369 yes 2024 December 19 ptyc0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2007 August 14 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Re: Myspace page educating people about Rx Drug addiction NADDI RxNews <rxnews@naddi.org> 2007 August 14 email 7 rxnews-list@naddi.org TGOS_VA4_MDL_05597005 TEVA_MDL_A_07000419 yes 2024 December 19 szyc0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2007 August 15 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Re: Myspace page educating people about Rx Drug addiction NADDI RxNews <rxnews@naddi.org> 2007 August 15 email 12 rxnews-list@naddi.org TGOS_VA4_MDL_05597053 TEVA_MDL_A_07000467 yes 2024 December 19 kpgd0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2008 July 21 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Updated: Med Svcs Pain/Addictions Team (PAT) Update Meeting "Altman, Charles" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=caltman"> 2008 July 21 calendar 1 "Altman, Charles" <caltman@cephalon.com> "Larijani, Susan" <slarijan@cephalon.com> "Narayana, Arvind" <anarayan@cephalon.com> "Sehgal, Arpana" <asehgal@cephalon.com> "Bonhomme, Andrea" <abonhomm@cephalon.com> "Panning, Deborah" <dpanning@cephalon.com> "Dayno, Jeffrey" <jdayno@cephalon.com> TGOS_VA4_MDL_05605342 TEVA_MDL_A_07009172 2024 December 19 sxvw0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2009 July 30 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0002.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Re: [RxNews] Rapid detox for Rx Drug Addiction "Thomas F. Jan, DO" <xxxx@optonline.net> 2009 July 30 email 4 xxxxxxxxxxxxxxx@aol.com rxnews@listserve.com TGOS_VA4_MDL_05613092 TEVA_MDL_A_07017096 yes 2024 December 19 hjvw0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2009 July 30 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0002.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Re: [RxNews] Rapid detox for Rx Drug Addiction xxxx@optonline.net 2009 July 30 email 3 "Brian Fingerson@KYPRN" <kyprn@insightbb.com> rxnews@listserve.com xxxxxxxxxxxxxxx@aol.com TGOS_VA4_MDL_05613102 TEVA_MDL_A_07017108 yes 2024 December 19 xpyf0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2011 November 29 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0004.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement RE: Actiq addiction Vissers Eugene <"/o=cephalon/ou=uk01 administrative group/cn=recipients/cn=evissers"> 2011 November 29 email 2 "Narayana, Arvind" <anarayan@cephalon.com> "Kaper, Robert" <rkaper@cephalon.com> TGOS_VA4_MDL_05650104 TEVA_MDL_A_07054312 yes 2024 December 19 zyyf0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2011 November 28 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0004.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement RE: Actiq addiction "Narayana, Arvind" <anarayan@cephalon.com> 2011 November 28 email 2 Vissers Eugene <evissers@cephalon.com> "Kaper, Robert" <rkaper@cephalon.com> TGOS_VA4_MDL_05650069 TEVA_MDL_A_07054277 yes 2024 December 19 szxg0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2011 November 23 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0004.pst\Top of Outlook data file\[No Subject]\.msg Teva and Allergan Global Opioid Settlement Agreement RE: Actiq addiction "Kaper, Robert" <rkaper@cephalon.com> 2011 November 23 email 1 Vissers Eugene <evissers@cephalon.com> "Narayana, Arvind" <anarayan@cephalon.com> TGOS_VA4_MDL_05658742 TEVA_MDL_A_07063339 2024 December 19 htjc0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2007 January 18 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement FW: Annals of Internal Medicine (1/16/07) - Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction "Narayana, Arvind" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=anarayan"> 2007 January 18 email 1 Richard Brook <xxxxxxx@earthlink.net> TGOS_VA4_MDL_05593278 TEVA_MDL_A_06996674 yes 2024 December 19 gygk0342 Teva and Allergan Documents teva Wilhelm, Amanda public no restrictions Wilhelm, Amanda\Opioids - Civil Cases-MDL\Archive\AmandaWilhelm_Export_0001.pst\Top of Outlook data file\Calendar\Global Armodafinil IRC Meeting- Start time needed to be rescheduled Teva and Allergan Global Opioid Settlement Agreement Amy Neuman NIH Nuvigil Addiction Proposal.pdf 2013 January 03 document 2 TGOS_VA4_MDL_05735997 TEVA_MDL_A_07163012 2024 December 19 zhyk0342 Teva and Allergan Documents teva Williams, Paula public no restrictions Williams, Paula\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Paula Williams_1.pst\Top of Personal Folders\FINAL AAD DECK Teva and Allergan Global Opioid Settlement Agreement Heit-addiction tolerance-annotated.TIF 2008 May 27 image 16 TGOS_VA4_MDL_05752651 TEVA_MDL_A_07181973 2024 December 19 stfk0342 Teva and Allergan Documents teva Wilhelm, Amanda public no restrictions Wilhelm, Amanda\Opioids - Civil Cases-MDL\Archive\AmandaWilhelm_Export_0001.pst\Top of Outlook data file\Inbox\ISS\Grants\Global Armodafinil IRC Meeting- Start time needed to be rescheduled Teva and Allergan Global Opioid Settlement Agreement Amy Neuman NIH Nuvigil Addiction Proposal.pdf 2013 January 17 document 2 TGOS_VA4_MDL_05735074 TEVA_MDL_A_07160747 2024 December 19 klkd0342 Teva and Allergan Documents teva Narayana, Arvind public no restrictions 2008 December 22 Narayana, Arvind\Teva-Opioids.zip\Teva-Opioids\Zantaz_NARAYANA_ARVIND_ANARAYAN_Export_0002.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement The Global Anti-Addiction Market, 2008-2023 Mehfuz Hussain - Visiongain Ltd. <mehfuz.hussain@vg-sales.com> 2008 December 22 email 13 "Latchinian, Lilian" <llatchinian@cephalon.com> TGOS_VA4_MDL_05608061 TEVA_MDL_A_07011944 yes 2024 December 19 ntpd0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions 2006 September 25 Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement NEWS CLIPS: Chemical and Engineering News cover story on addiction; other items "Grupp, Robert" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=rgrupp"> 2006 September 25 email 17 "Baldino, Frank" <fbaldino@cephalon.com> "Buchi, Kevin" <kbuchi@cephalon.com> "Grebow, Peter" <pgrebow@cephalon.com> "Osborn, John" <josborn@cephalon.com> "Roche, Robert" <rroche@cephalon.com> "Russell, Lesley" <lrussell@cephalon.com> "Savini, Carl" <casavini828@cephalon.com> "Vaught, Jeffry" <jvaught@cephalon.com> "Antonacci, Jenifer" <jantonac@cephalon.com> ARAGUES Alain <aaragues@cephalon.fr> "Barndt, Natalie" <nbarndt@cephalon.com> "Barr, Mike" <mbarr@cephalon.com> "Beckhardt, Stacey" <sbeckhar@cephalon.com> "Bittenbender, Fritz" <fbittenb@cephalon.com> "Boyce, Karen" <kboyce@cephalon.com> "Bradway, Randy" <rbradway@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Clements, Sean" <sclement@cephalon.com> "Connolly, Kevin" <kconnoll@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "Dawson, John" <jdawson@cephalon.com> DE-LA-SALLE Marie-Dominique <mdde-la-salle@cephalon.fr> "DeRogatis, Robin" <rderogat@cephalon.com> "Grout, Eileen" <egrout@cephalon.com> "Jooste, LeRoux" <ljooste@cephalon.com> "Limongelli, John" <jlimonge@cephalon.com> "Marczely, Joseph" <jmarczel@cephalon.com> "McCue, Lisa" <lisa.mccue@cimalabs.com> "Merritt, Chip" <cmerritt@cephalon.com> "Mulholland, Michael" <mmulholl@cephalon.com> "Myers, Jeff M" <jmmyers@cephalon.com> "Rauch, Carolyn" <crauch@cephalon.com> "Reeves, Martin" <mreeves@cephalon.com> "Reinhart, Charles" <creinhar@cephalon.com> "Turi, Joseph" <jturi@cephalon.com> "Urban, Robert" <rurban@cephalon.com> "Williams, Michael" <mwilliam@cephalon.com> "Williams, Sheryl" <swilliam@cephalon.com> TGOS_VA4_MDL_09111572 TEVA_MDL_A_11135333 2025 February 27 kfcw0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions 2006 December 22 Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement Alcohol & Addiction News -- December 22, 2006 "Boyce, Karen" <kboyce@cephalon.com> 2006 December 22 email 2 "Bader, Robert" <rbader@cephalon.com> "Barnes, Ryan" <rbarnes@cephalon.com> "Bearer, Deborah" <dbearer@cephalon.com> "Bellucci, Robert" <rbellucc@cephalon.com> "Bittenbender, Fritz" <fbittenb@cephalon.com> "Bradway, Randy" <rbradway@cephalon.com> "Brookes, Lynne" <lbrookes@cephalon.com> "Brooks, Jacqueline" <jbrooks@cephalon.com> "Brown, Charles" <cgbrown@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Carnohan, William" <wcarnoha@cephalon.com> "Clements, Sean" <sclement@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "Del Ricci, Francine" <fdelricc@cephalon.com> "Duarte, Joseph" <jduarte@cephalon.com> "Emerson, Robert" <remerson@cephalon.com> "Ferry, Shawn" <sferry@cephalon.com> "Fiorelli, Kenneth" <kfiorell@cephalon.com> "Grupp, Robert" <rgrupp@cephalon.com> "Kelly, Andy" <alkelly@cephalon.com> "Gilliland, Kevin" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=kgillila"> "Kim, Stuart" <skim@cephalon.com> "Larijani, Susan" <slarijan@cephalon.com> "Marczely, Joseph" <jmarczel@cephalon.com> Mark Kruger (DPM) <mkruger@dpmadvert.com> "Martin, Gregory S." <gmartin@cephalon.com> "McGaurn, Susan" <smcgaurn@cephalon.com> "McGuinness, Sue" <smcguinn@cephalon.com> "McKibbon, Howard" <hmckibbo@cephalon.com> "McKinley, Jay" <jmckinle@cephalon.com> "Meyer, Chris" <cmeyer@cephalon.com> "Mulholland, Michael" <mmulholl@cephalon.com> "Myers, Jeff M" <jmmyers@cephalon.com> "Neale, Douglas" <dneale@cephalon.com> "Pyfer, Christine" <cpyfer@cephalon.com> "Riotto, Mark" <mriotto@cephalon.com> "Rydell, Jeffrey" <jrydell@cephalon.com> "Schobel, Virginia" <vschobel@cephalon.com> "Scott, Dan" <dscott@cephalon.com> "Shanfelt, Nancy" <nshanfel@cephalon.com> "Solomon, Mark" <msolomon@cephalon.com> "Tiller, Jane" <jtiller@cephalon.com> "Urban, Robert" <rurban@cephalon.com> "Vadiei, Kiumars" <kvadiei@cephalon.com> "White, Andres" <awhite@cephalon.com> "Yeh, Helen" <hyeh@cephalon.com> TGOS_VA4_MDL_09114684 TEVA_MDL_A_11138984 2025 February 27 tzdw0350 Teva and Allergan Documents teva Caminiti, Joseph;Warner, Jamie public no restrictions Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox\Materials for Executive S&OP Meeting 081507 Teva and Allergan Global Opioid Settlement Agreement Executive S&OP Addiction Franchise Aug 2007.ppt 2007 August 14 presentation 11 TGOS_VA4_MDL_09116526 TEVA_MDL_A_11141165 2025 February 27 mqdw0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox\VIVITROL News September 17 Teva and Allergan Global Opioid Settlement Agreement New York Times (Addiction) 9.14.07.doc 2007 September 17 document 2 TGOS_VA4_MDL_09116321 TEVA_MDL_A_11140892 2025 February 27 yqdw0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox\VIVITROL News September 17 Teva and Allergan Global Opioid Settlement Agreement SAMHSA News Release (Addiction) 9.14.07.doc 2007 September 17 document 2 TGOS_VA4_MDL_09116325 TEVA_MDL_A_11140896 yes 2025 February 27 fxww0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox\Alcohol & Addiction News - December 6, 2006 Teva and Allergan Global Opioid Settlement Agreement 24-7 Press Release (Addiction) 12.6.06.doc 2006 December 07 document 3 TGOS_VA4_MDL_09116659 TEVA_MDL_A_11141305 2025 February 27 nqdw0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox\VIVITROL News September 17 Teva and Allergan Global Opioid Settlement Agreement American Digital Networks (Addiction) 9.14.07.doc 2007 September 17 document 2 TGOS_VA4_MDL_09116323 TEVA_MDL_A_11140894 2025 February 27 pqdw0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox\VIVITROL News September 17 Teva and Allergan Global Opioid Settlement Agreement PR Newswire (Addiction) 9.17.07.doc 2007 September 17 document 2 TGOS_VA4_MDL_09116327 TEVA_MDL_A_11140898 2025 February 27 nqww0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox\Alcohol & Addiction News - January 2, 2007 Teva and Allergan Global Opioid Settlement Agreement New York Times (Addiction) 1.2.07.doc 2007 January 04 document 3 TGOS_VA4_MDL_09117241 TEVA_MDL_A_11141962 2025 February 27 jfgw0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions 2006 December 28 Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement FW: Alcohol & Addiction News - December 27, 2006 "Boyce, Karen" <kboyce@cephalon.com> 2006 December 28 email 2 "Bader, Robert" <rbader@cephalon.com> "Barnes, Ryan" <rbarnes@cephalon.com> "Bearer, Deborah" <dbearer@cephalon.com> "Bellucci, Robert" <rbellucc@cephalon.com> "Bittenbender, Fritz" <fbittenb@cephalon.com> "Bradway, Randy" <rbradway@cephalon.com> "Brookes, Lynne" <lbrookes@cephalon.com> "Brooks, Jacqueline" <jbrooks@cephalon.com> "Brown, Charles" <cgbrown@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Carnohan, William" <wcarnoha@cephalon.com> "Clements, Sean" <sclement@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "Del Ricci, Francine" <fdelricc@cephalon.com> "Duarte, Joseph" <jduarte@cephalon.com> "Emerson, Robert" <remerson@cephalon.com> "Ferry, Shawn" <sferry@cephalon.com> "Fiorelli, Kenneth" <kfiorell@cephalon.com> "Grupp, Robert" <rgrupp@cephalon.com> "Kelly, Andy" <alkelly@cephalon.com> "Gilliland, Kevin" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=kgillila"> "Kim, Stuart" <skim@cephalon.com> "Larijani, Susan" <slarijan@cephalon.com> "Marczely, Joseph" <jmarczel@cephalon.com> Mark Kruger (DPM) <mkruger@dpmadvert.com> "Martin, Gregory S." <gmartin@cephalon.com> "McGaurn, Susan" <smcgaurn@cephalon.com> "McGuinness, Sue" <smcguinn@cephalon.com> "McKibbon, Howard" <hmckibbo@cephalon.com> "McKinley, Jay" <jmckinle@cephalon.com> "Meyer, Chris" <cmeyer@cephalon.com> "Mulholland, Michael" <mmulholl@cephalon.com> "Myers, Jeff M" <jmmyers@cephalon.com> "Neale, Douglas" <dneale@cephalon.com> "Pyfer, Christine" <cpyfer@cephalon.com> "Riotto, Mark" <mriotto@cephalon.com> "Rydell, Jeffrey" <jrydell@cephalon.com> "Schobel, Virginia" <vschobel@cephalon.com> "Scott, Dan" <dscott@cephalon.com> "Shanfelt, Nancy" <nshanfel@cephalon.com> "Solomon, Mark" <msolomon@cephalon.com> "Tiller, Jane" <jtiller@cephalon.com> "Urban, Robert" <rurban@cephalon.com> "Vadiei, Kiumars" <kvadiei@cephalon.com> "White, Andres" <awhite@cephalon.com> "Yeh, Helen" <hyeh@cephalon.com> TGOS_VA4_MDL_09118457 TEVA_MDL_A_11143277 yes 2025 February 27 nfjx0350 Teva and Allergan Documents teva Larijani, Susan public no restrictions Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani.pst\Top of Personal Folders\Inbox\PROV DOCs #2\PROV DOCs Approved 2003 to 2004.zip\PROV DOCs Approved 2004 Teva and Allergan Global Opioid Settlement Agreement PROV004-Abuse Potential (Withdrawal Dependence) and Use in Addiction Approved 4-28-2004.pdf 2014 June 20 document 7 TGOS_VA4_MDL_09194030 TEVA_MDL_A_11231559 2025 February 27 tgvj0350 Teva and Allergan Documents teva Larijani, Susan public no restrictions Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani.pst\Top of Personal Folders\Inbox\FW: COPAXONE and PROVIGIL SRLs\PROVIGIL SRLS.zip\PROVIGIL SRLS Teva and Allergan Global Opioid Settlement Agreement PROV166 - Use in Addiction or Dependence.PDF 2013 November 13 document 7 TGOS_VA4_MDL_09227747 TEVA_MDL_A_11268159 yes 2025 February 27 rlhf0350 Teva and Allergan Documents teva Dewildt, Charles public no restrictions 2016 January 28 Dewildt, Charles\Opioids Chicago Search Request Update - 20180625.zip\Opioids Update Search 20180619 - Charles DeWildt.pst\Top of Personal Folders\Sent Items Teva and Allergan Global Opioid Settlement Agreement FW: Upcoming Webinar - Confronting and Reducing Opioid Addiction [MARKETING] Charles DeWildt <"/o=teva/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=cdewildt"> 2016 January 28 email 2 Deborah Bearer <deborah.bearer@tevapharm.com> Kevin Lindsay <kevin.lindsay@tevapharm.com> John Zabroske <john.zabroske@tevapharm.com> Ken Orr <ken.orr@tevapharm.com> David Barrasso <david.barrasso@tevapharm.com> TGOS_VA4_MDL_09146424 TEVA_MDL_A_11175106 yes 2025 February 27 fgwy0350 Teva and Allergan Documents teva Larijani, Susan public no restrictions 2006 October 10 Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani_2.pst\Top of Personal Folders Teva and Allergan Global Opioid Settlement Agreement RE: Pain Management/Addiction Medicine/Neurology Update Meeting Minutes "Abou-Gharbia, Shereen" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=sabougha"> 2006 October 10 email 2 "Larijani, Susan" <slarijan@cephalon.com> TGOS_VA4_MDL_09325486 TEVA_MDL_A_11380743 yes 2025 February 27 gthx0350 Teva and Allergan Documents teva Larijani, Susan public no restrictions Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani.pst\Top of Personal Folders\Inbox\PROV DOCs #3\PROV DOCs Approved 2005 to 2006.zip\PROV DOCs Approved 2006 Teva and Allergan Global Opioid Settlement Agreement PROV004-Abuse Potential (Withdrawal Dependence) and Use in Addiction Approved 7-7-2006.pdf 2014 June 20 document 7 TGOS_VA4_MDL_09192864 TEVA_MDL_A_11229817 yes 2025 February 27 nyxx0350 Teva and Allergan Documents teva Larijani, Susan public no restrictions Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani.pst\Top of Personal Folders\Inbox\PROV DOCs #2\PROV DOCs Approved 2003 to 2004.zip\PROV DOCs Approved 2003 Teva and Allergan Global Opioid Settlement Agreement PROV004-Abuse Potential (Withdrawal Dependence) and Use in Addiction Approved 9-24-2003.pdf 2014 June 20 document 6 TGOS_VA4_MDL_09193576 TEVA_MDL_A_11231105 2025 February 27 khcc0351 Teva and Allergan Documents teva Martin, Greg public no restrictions 2005 September 15 Martin, Greg\Teva Opioids-Civil MDL-20181015.zip\Zantaz_MARTIN_GREGORYS__GMARTIN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement FW: Addiction Market Monthly Prescriber Data "Schurr, Kent" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=kschurr"> 2005 September 15 email 6 "Johansen, Rick #PHX" <rick.johansen@ndchealth.com> "Brownell, Bart # PHX" <bart.brownell@ndchealth.com> "Martin, Gregory S." <gmartin@cephalon.com> TGOS_VA4_MDL_09375211 TEVA_MDL_A_11443417 yes 2025 February 27 rnwg0351 Teva and Allergan Documents teva Warner, Jamie public no restrictions Warner, Jamie\Zantaz-JamieWarner-01012004-07272017.pst\Top of Personal Folders\Inbox\Updated Materials and Agenda for Executive S&OP Meeting Today Teva and Allergan Global Opioid Settlement Agreement Executive S&OP Addiction Franchise Sep 2007.ppt 2007 September 20 presentation 11 TGOS_VA4_MDL_09528118 TEVA_MDL_A_11614783 2025 February 27 sllv0351 Teva and Allergan Documents teva Larijani, Susan;Martin, Greg;Meyer, Chris public no restrictions 2006 August 04 Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani_2.pst\Top of Personal Folders Teva and Allergan Global Opioid Settlement Agreement Alcohol and Addiction News (August 4, 2006) "Boyce, Karen" <kboyce@cephalon.com> 2006 August 04 email 2 "@CEP-11981" <cep-11981@cephalon.com> "Bader, Robert" <rbader@cephalon.com> "Barnes, Ryan" <rbarnes@cephalon.com> "Bellucci, Robert" <rbellucc@cephalon.com> "Bradway, Randy" <rbradway@cephalon.com> "Brookes, Lynne" <lbrookes@cephalon.com> "Brooks, Jacqueline" <jbrooks@cephalon.com> "Brown, Charles" <cgbrown@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Carnohan, William" <wcarnoha@cephalon.com> "Clements, Sean" <sclement@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "Define, Mara" <mdefine@cephalon.com> "Del Ricci, Francine" <fdelricc@cephalon.com> "Emerson, Robert" <remerson@cephalon.com> "Ferry, Shawn" <sferry@cephalon.com> "Fiorelli, Kenneth" <kfiorell@cephalon.com> "Guiton, Christopher" <cguiton@cephalon.com> "Hughes, Rod" <rhughes@cephalon.com> "Kelly, Andy" <alkelly@cephalon.com> "Gilliland, Kevin" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=kgillila"> "Larijani, Susan" <slarijan@cephalon.com> "Marczely, Joseph" <jmarczel@cephalon.com> "Martin, Gregory S." <gmartin@cephalon.com> "McGaurn, Susan" <smcgaurn@cephalon.com> "McKibbon, Howard" <hmckibbo@cephalon.com> "McKinley, Jay" <jmckinle@cephalon.com> "Meyer, Chris" <cmeyer@cephalon.com> "Mulholland, Michael" <mmulholl@cephalon.com> "Mutisya, Elizabeth" <emutisya@cephalon.com> "Neale, Douglas" <dneale@cephalon.com> "Powers, Joe M." <jmpowers@cephalon.com> "Pyfer, Christine" <cpyfer@cephalon.com> "Radhakrishnan, Maha" <mradhakr@cephalon.com> "Riotto, Mark" <mriotto@cephalon.com> "Savage, Virginia" <vsavage@cephalon.com> "Scott, Dan" <dscott@cephalon.com> "Shah Bell, Bhaval" <bshah@cephalon.com> "Shanfelt, Nancy" <nshanfel@cephalon.com> "Sikirica, Mirko" <msikiric@cephalon.com> "Solomon, Mark" <msolomon@cephalon.com> "Stevens, Charles" <cstevens@cephalon.com> "Tiller, Jane" <jtiller@cephalon.com> "Urban, Robert" <rurban@cephalon.com> "Vadiei, Kiumars" <kvadiei@cephalon.com> "Wang, Ed" <ewang@cephalon.com> "Warner, Jamie" <jwarner@cephalon.com> "White, Andres" <awhite@cephalon.com> "Yeh, Helen" <hyeh@cephalon.com> TGOS_VA4_MDL_09343145 TEVA_MDL_A_11399136 2025 February 27 zmdg0351 Teva and Allergan Documents teva Warner, Jamie public no restrictions Warner, Jamie\Zantaz-JamieWarner-01012004-07272017.pst\Top of Personal Folders\Inbox\Materials and Agenda for Executive S&OP Meeting 092007 Teva and Allergan Global Opioid Settlement Agreement Executive S&OP Addiction Franchise Sep 2007.ppt 2007 September 19 presentation 11 TGOS_VA4_MDL_09526568 TEVA_MDL_A_11612662 2025 February 27 rfwg0351 Teva and Allergan Documents teva Warner, Jamie public no restrictions 2010 October 13 Warner, Jamie\Zantaz-JamieWarner-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement Oct. 13: FDA approves Vivitrol to combat opioid addictions DIA Daily <diadaily@dia.custombriefings.com> 2010 October 13 email 7 "Warner, Jamie" <jwarner@cephalon.com> TGOS_VA4_MDL_09527504 TEVA_MDL_A_11614063 2025 February 27 xmcc0351 Teva and Allergan Documents teva Dewildt, Charles;Martin, Greg;Meyer, Chris public no restrictions 2006 February 01 Martin, Greg\Teva Opioids-Civil MDL-20181015.zip\Zantaz_MARTIN_GREGORYS__GMARTIN_Export_0001.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Addiction Medicine Area Maps "Shanfelt, Nancy" <nshanfel@cephalon.com> 2006 February 01 email 1 Sales CNS Directors <salescnsdirectors@cephalon.com> "Datin, Joseph" <jdatin@cephalon.com> "DeWildt, Charles" <cdewildt@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "Martin, Gregory S." <gmartin@cephalon.com> "Meyer, Chris" <cmeyer@cephalon.com> TGOS_VA4_MDL_09375506 TEVA_MDL_A_11443864 yes 2025 February 27 mqww0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions 2007 January 04 Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement Alcohol & Addiction News - January 2, 2007 "Boyce, Karen" <kboyce@cephalon.com> 2007 January 04 email 2 "Bader, Robert" <rbader@cephalon.com> "Barnes, Ryan" <rbarnes@cephalon.com> "Bearer, Deborah" <dbearer@cephalon.com> "Bellucci, Robert" <rbellucc@cephalon.com> "Bittenbender, Fritz" <fbittenb@cephalon.com> "Bradway, Randy" <rbradway@cephalon.com> "Brookes, Lynne" <lbrookes@cephalon.com> "Brooks, Jacqueline" <jbrooks@cephalon.com> "Brown, Charles" <cgbrown@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Carnohan, William" <wcarnoha@cephalon.com> "Clements, Sean" <sclement@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "Del Ricci, Francine" <fdelricc@cephalon.com> "Duarte, Joseph" <jduarte@cephalon.com> "Emerson, Robert" <remerson@cephalon.com> "Ferry, Shawn" <sferry@cephalon.com> "Fiorelli, Kenneth" <kfiorell@cephalon.com> "Grupp, Robert" <rgrupp@cephalon.com> "Kelly, Andy" <alkelly@cephalon.com> "Gilliland, Kevin" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=kgillila"> "Kim, Stuart" <skim@cephalon.com> "Larijani, Susan" <slarijan@cephalon.com> "Marczely, Joseph" <jmarczel@cephalon.com> Mark Kruger (DPM) <mkruger@dpmadvert.com> "Martin, Gregory S." <gmartin@cephalon.com> "McGaurn, Susan" <smcgaurn@cephalon.com> "McGuinness, Sue" <smcguinn@cephalon.com> "McKibbon, Howard" <hmckibbo@cephalon.com> "McKinley, Jay" <jmckinle@cephalon.com> "Meyer, Chris" <cmeyer@cephalon.com> "Mulholland, Michael" <mmulholl@cephalon.com> "Myers, Jeff M" <jmmyers@cephalon.com> "Neale, Douglas" <dneale@cephalon.com> "Pyfer, Christine" <cpyfer@cephalon.com> "Riotto, Mark" <mriotto@cephalon.com> "Rydell, Jeffrey" <jrydell@cephalon.com> "Schobel, Virginia" <vschobel@cephalon.com> "Scott, Dan" <dscott@cephalon.com> "Shanfelt, Nancy" <nshanfel@cephalon.com> "Solomon, Mark" <msolomon@cephalon.com> "Tiller, Jane" <jtiller@cephalon.com> "Urban, Robert" <rurban@cephalon.com> "Vadiei, Kiumars" <kvadiei@cephalon.com> "White, Andres" <awhite@cephalon.com> "Yeh, Helen" <hyeh@cephalon.com> TGOS_VA4_MDL_09117239 TEVA_MDL_A_11141960 yes 2025 February 27 lsfw0350 Teva and Allergan Documents teva Caminiti, Joseph;Warner, Jamie public no restrictions 2006 March 07 Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement Alcohol/Addiction Related News 3.7.06 "Boyce, Karen" <kboyce@cephalon.com> 2006 March 07 email 3 "Bader, Robert" <rbader@cephalon.com> "Bellucci, Robert" <rbellucc@cephalon.com> "Bradway, Randy" <rbradway@cephalon.com> "Brookes, Lynne" <lbrookes@cephalon.com> "Brooks, Jacqueline" <jbrooks@cephalon.com> "Brown, Charles" <cgbrown@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "Define, Mara" <mdefine@cephalon.com> "Del Ricci, Francine" <fdelricc@cephalon.com> "Emerson, Robert" <remerson@cephalon.com> "Ferry, Shawn" <sferry@cephalon.com> "Fiorelli, Kenneth" <kfiorell@cephalon.com> "Guiton, Christopher" <cguiton@cephalon.com> "Hsu, Melissa" <mhsu@cephalon.com> "Hughes, Rod" <rhughes@cephalon.com> "Kelly, Andy" <alkelly@cephalon.com> "Gilliland, Kevin" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=kgillila"> "Larijani, Susan" <slarijan@cephalon.com> "Martin, Gregory S." <gmartin@cephalon.com> "McGaurn, Susan" <smcgaurn@cephalon.com> "McKinley, Jay" <jmckinle@cephalon.com> "Meyer, Chris" <cmeyer@cephalon.com> "Mulholland, Michael" <mmulholl@cephalon.com> "Mutisya, Elizabeth" <emutisya@cephalon.com> "Neale, Douglas" <dneale@cephalon.com> "Powers, Joe M." <jmpowers@cephalon.com> "Radhakrishnan, Maha" <mradhakr@cephalon.com> "Riotto, Mark" <mriotto@cephalon.com> "Savage, Virginia" <vsavage@cephalon.com> "Scott, Dan" <dscott@cephalon.com> "Shah, Bhaval" <bshah@cephalon.com> "Shanfelt, Nancy" <nshanfel@cephalon.com> "Solomon, Mark" <msolomon@cephalon.com> "Stevens, Charles" <cstevens@cephalon.com> "Urban, Robert" <rurban@cephalon.com> "Vadiei, Kiumars" <kvadiei@cephalon.com> "Wang, Ed" <ewang@cephalon.com> "Warner, Jamie" <jwarner@cephalon.com> "White, Andres" <awhite@cephalon.com> TGOS_VA4_MDL_09118264 TEVA_MDL_A_11143052 2025 February 27 nsfw0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions 2007 June 25 Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement Alcohol & Addiction News - 6/22-6/25 "Boyce, Karen" <kboyce@cephalon.com> 2007 June 25 email 2 "Altman, Charles" <caltman@cephalon.com> "Bader, Robert" <rbader@cephalon.com> "Barnes, Ryan" <rbarnes@cephalon.com> "Bearer, Deborah" <dbearer@cephalon.com> "Bellucci, Robert" <rbellucc@cephalon.com> "Bittenbender, Fritz" <fbittenb@cephalon.com> "Boyce, Karen" <kboyce@cephalon.com> "Bradway, Randy" <rbradway@cephalon.com> "Brookes, Lynne" <lbrookes@cephalon.com> "Brooks, Jacqueline" <jbrooks@cephalon.com> "Brown, Charles" <cgbrown@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Carnohan, William" <wcarnoha@cephalon.com> "Connelly, Jennifer" <jconnell@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "DeChristopher, Robin" <rdechris@cephalon.com> "Del Ricci, Francine" <fdelricc@cephalon.com> "Duarte, Joseph" <jduarte@cephalon.com> "Emerson, Robert" <remerson@cephalon.com> "Ferry, Shawn" <sferry@cephalon.com> "Fiorelli, Kenneth" <kfiorell@cephalon.com> "Grupp, Robert" <rgrupp@cephalon.com> "Kelly, Andy" <alkelly@cephalon.com> "Gilliland, Kevin" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=kgillila"> "Kim, Stuart" <skim@cephalon.com> "Larijani, Susan" <slarijan@cephalon.com> "Madden, Denise" <dmadden@cephalon.com> "Marczely, Joseph" <jmarczel@cephalon.com> Mark Kruger (DPM) <mkruger@dpmadvert.com> "Martin, Gregory S." <gmartin@cephalon.com> "McGaurn, Susan" <smcgaurn@cephalon.com> "McGuinness, Sue" <smcguinn@cephalon.com> "McKibbon, Howard" <hmckibbo@cephalon.com> "McKinley, Jay" <jmckinle@cephalon.com> "Meyer, Chris" <cmeyer@cephalon.com> "Mulholland, Michael" <mmulholl@cephalon.com> "Myers, Jeff M" <jmmyers@cephalon.com> "Neale, Douglas" <dneale@cephalon.com> "Pomento, Brian" <bpomento@cephalon.com> "Pyfer, Christine" <cpyfer@cephalon.com> "Riley, Joyce P." <jpriley@cephalon.com> "Riotto, Mark" <mriotto@cephalon.com> "Rydell, Jeffrey" <jrydell@cephalon.com> "Scott, Dan" <dscott@cephalon.com> "Shanfelt, Nancy" <nshanfel@cephalon.com> "Summers, Martin" <msummers@cephalon.com> "Tiller, Jane" <jtiller@cephalon.com> "Urban, Robert" <rurban@cephalon.com> "White, Andres" <awhite@cephalon.com> "Yeh, Helen" <hyeh@cephalon.com> TGOS_VA4_MDL_09118277 TEVA_MDL_A_11143065 2025 February 27 nxfw0350 Teva and Allergan Documents teva Caminiti, Joseph;Larijani, Susan;Martin, Greg;Meyer, Chris;Warner, Jamie public no restrictions 2006 November 06 Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement Alcohol & Addiction News - November 6, 2006 "Boyce, Karen" <kboyce@cephalon.com> 2006 November 06 email 2 "Bader, Robert" <rbader@cephalon.com> "Barnes, Ryan" <rbarnes@cephalon.com> "Bellucci, Robert" <rbellucc@cephalon.com> "Bradway, Randy" <rbradway@cephalon.com> "Brookes, Lynne" <lbrookes@cephalon.com> "Brooks, Jacqueline" <jbrooks@cephalon.com> "Brown, Charles" <cgbrown@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Carnohan, William" <wcarnoha@cephalon.com> "Clements, Sean" <sclement@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "Del Ricci, Francine" <fdelricc@cephalon.com> "Emerson, Robert" <remerson@cephalon.com> "Ferry, Shawn" <sferry@cephalon.com> "Fiorelli, Kenneth" <kfiorell@cephalon.com> "Kelly, Andy" <alkelly@cephalon.com> "Gilliland, Kevin" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=kgillila"> "Kim, Stuart" <skim@cephalon.com> "Larijani, Susan" <slarijan@cephalon.com> "Marczely, Joseph" <jmarczel@cephalon.com> Mark Kruger (DPM) <mkruger@dpmadvert.com> "Martin, Gregory S." <gmartin@cephalon.com> "McGaurn, Susan" <smcgaurn@cephalon.com> "McGuinness, Sue" <smcguinn@cephalon.com> "McKibbon, Howard" <hmckibbo@cephalon.com> "McKinley, Jay" <jmckinle@cephalon.com> "Meyer, Chris" <cmeyer@cephalon.com> "Mulholland, Michael" <mmulholl@cephalon.com> "Neale, Douglas" <dneale@cephalon.com> "Pyfer, Christine" <cpyfer@cephalon.com> "Riotto, Mark" <mriotto@cephalon.com> "Savage, Virginia" <vsavage@cephalon.com> "Scott, Dan" <dscott@cephalon.com> "Shanfelt, Nancy" <nshanfel@cephalon.com> "Solomon, Mark" <msolomon@cephalon.com> "Tiller, Jane" <jtiller@cephalon.com> "Urban, Robert" <rurban@cephalon.com> "Vadiei, Kiumars" <kvadiei@cephalon.com> "Warner, Jamie" <jwarner@cephalon.com> "White, Andres" <awhite@cephalon.com> "Yeh, Helen" <hyeh@cephalon.com> TGOS_VA4_MDL_09117734 TEVA_MDL_A_11142513 yes 2025 February 27 krgw0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions 2014 July 31 Caminiti, Joseph\Opioids Chicago Search Request Update - 20180625.zip\Opioids Update Search 20180619 - Joseph Caminiti.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement New in the Addiction Market From Kaleo Pharmaceuticals - Evzio promotion Christine Alongi (External) <alongi@dtwresearch.com> 2014 July 31 email 3 Christine Alongi <alongi@dtwresearch.com> TGOS_VA4_MDL_09119158 TEVA_MDL_A_11144198 2025 February 27 tkcw0350 Teva and Allergan Documents teva Caminiti, Joseph;Warner, Jamie public no restrictions Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox\RE: Materials for Executive S&OP Meeting 072307 Teva and Allergan Global Opioid Settlement Agreement Executive S&OP Addiction Franchise July 2007.ppt 2007 July 20 presentation 11 TGOS_VA4_MDL_09115004 TEVA_MDL_A_11139346 2025 February 27 hspd0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions 2006 September 25 Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement NEWS CLIPS: Chemical and Engineering News cover story on addiction; other items "Grupp, Robert" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=rgrupp"> 2006 September 25 email 17 "Baldino, Frank" <fbaldino@cephalon.com> "Buchi, Kevin" <kbuchi@cephalon.com> "Grebow, Peter" <pgrebow@cephalon.com> "Osborn, John" <josborn@cephalon.com> "Roche, Robert" <rroche@cephalon.com> "Russell, Lesley" <lrussell@cephalon.com> "Savini, Carl" <casavini828@cephalon.com> "Vaught, Jeffry" <jvaught@cephalon.com> "Coletta, Mary Lou" <mcoletta@cephalon.com> "Corrado, Joan" <jcorrado@cephalon.com> "Courtemanche, Diane" <dcourtem@cephalon.com> "Diebold, Jeanette R." <jrdiebol@cephalon.com> "Geis, Mary Lou" <mgeis@cephalon.com> "Schall, Patricia" <pschall@cephalon.com> Andria Arena <andria.arena@nyc.bm.com> Bev Wrightstone <bwrightstone@cephalon.com> Lisa Burns <lburns@burnsmc.com> Michael Szumera <michael_szynera@nyc.bm.com> Nancy Goldstein <nancy_goldstein@nyc.bm.com> Pete Judice <peter_judice@nyc.bm.com> "Antonacci, Jenifer" <jantonac@cephalon.com> "Barndt, Natalie" <nbarndt@cephalon.com> "Barr, Mike" <mbarr@cephalon.com> "Beckhardt, Stacey" <sbeckhar@cephalon.com> "Bittenbender, Fritz" <fbittenb@cephalon.com> "Boyce, Karen" <kboyce@cephalon.com> "Bradway, Randy" <rbradway@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Clements, Sean" <sclement@cephalon.com> "Connolly, Kevin" <kconnoll@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "Dawson, John" <jdawson@cephalon.com> "DeRogatis, Robin" <rderogat@cephalon.com> "Grout, Eileen" <egrout@cephalon.com> "Grupp, Robert" <rgrupp@cephalon.com> "Jooste, LeRoux" <ljooste@cephalon.com> "Limongelli, John" <jlimonge@cephalon.com> "Marczely, Joseph" <jmarczel@cephalon.com> "McCue, Lisa" <lisa.mccue@cimalabs.com> "Merritt, Chip" <cmerritt@cephalon.com> "Mulholland, Michael" <mmulholl@cephalon.com> "Myers, Jeff M" <jmmyers@cephalon.com> "Rauch, Carolyn" <crauch@cephalon.com> "Reeves, Martin" <mreeves@cephalon.com> "Reinhart, Charles" <creinhar@cephalon.com> "Turi, Joseph" <jturi@cephalon.com> "Urban, Robert" <rurban@cephalon.com> "Williams, Michael" <mwilliam@cephalon.com> "Williams, Sheryl" <swilliam@cephalon.com> ARAGUES Alain <aaragues@cephalon.fr> DE-LA-SALLE Marie-Dominique <mdde-la-salle@cephalon.fr> TGOS_VA4_MDL_09111518 TEVA_MDL_A_11135259 2025 February 27 nhww0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions 2006 December 07 Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement Alcohol & Addiction News - December 6, 2006 "Boyce, Karen" <kboyce@cephalon.com> 2006 December 07 email 2 "Bader, Robert" <rbader@cephalon.com> "Barnes, Ryan" <rbarnes@cephalon.com> "Bearer, Deborah" <dbearer@cephalon.com> "Bellucci, Robert" <rbellucc@cephalon.com> "Bittenbender, Fritz" <fbittenb@cephalon.com> "Bradway, Randy" <rbradway@cephalon.com> "Brookes, Lynne" <lbrookes@cephalon.com> "Brooks, Jacqueline" <jbrooks@cephalon.com> "Brown, Charles" <cgbrown@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> "Carnohan, William" <wcarnoha@cephalon.com> "Clements, Sean" <sclement@cephalon.com> "Craig, Roy" <rcraig@cephalon.com> "Del Ricci, Francine" <fdelricc@cephalon.com> "Duarte, Joseph" <jduarte@cephalon.com> "Emerson, Robert" <remerson@cephalon.com> "Ferry, Shawn" <sferry@cephalon.com> "Fiorelli, Kenneth" <kfiorell@cephalon.com> "Grupp, Robert" <rgrupp@cephalon.com> "Kelly, Andy" <alkelly@cephalon.com> "Gilliland, Kevin" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=kgillila"> "Kim, Stuart" <skim@cephalon.com> "Larijani, Susan" <slarijan@cephalon.com> "Marczely, Joseph" <jmarczel@cephalon.com> Mark Kruger (DPM) <mkruger@dpmadvert.com> "Martin, Gregory S." <gmartin@cephalon.com> "McGaurn, Susan" <smcgaurn@cephalon.com> "McGuinness, Sue" <smcguinn@cephalon.com> "McKibbon, Howard" <hmckibbo@cephalon.com> "McKinley, Jay" <jmckinle@cephalon.com> "Meyer, Chris" <cmeyer@cephalon.com> "Mulholland, Michael" <mmulholl@cephalon.com> "Myers, Jeff M" <jmmyers@cephalon.com> "Neale, Douglas" <dneale@cephalon.com> "Pyfer, Christine" <cpyfer@cephalon.com> "Riotto, Mark" <mriotto@cephalon.com> "Rydell, Jeffrey" <jrydell@cephalon.com> "Savage, Virginia" <vsavage@cephalon.com> "Scott, Dan" <dscott@cephalon.com> "Shanfelt, Nancy" <nshanfel@cephalon.com> "Solomon, Mark" <msolomon@cephalon.com> "Tiller, Jane" <jtiller@cephalon.com> "Urban, Robert" <rurban@cephalon.com> "Vadiei, Kiumars" <kvadiei@cephalon.com> "White, Andres" <awhite@cephalon.com> "Yeh, Helen" <hyeh@cephalon.com> TGOS_VA4_MDL_09116642 TEVA_MDL_A_11141288 2025 February 27 phww0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox\Alcohol & Addiction News - December 6, 2006 Teva and Allergan Global Opioid Settlement Agreement AScribe (Addiction) 12.6.06.doc 2006 December 07 document 4 TGOS_VA4_MDL_09116645 TEVA_MDL_A_11141291 yes 2025 February 27 lxgw0350 Teva and Allergan Documents teva Caminiti, Joseph;Warner, Jamie public no restrictions Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox\Materials for Executive S&OP Meeting 061807-Fentora II Teva and Allergan Global Opioid Settlement Agreement Executive S&OP Addiction Franchise June 2007.ppt 2007 June 15 presentation 11 TGOS_VA4_MDL_09118729 TEVA_MDL_A_11143670 2025 February 27 snyd0350 Teva and Allergan Documents teva Caminiti, Joseph public no restrictions 2007 August 10 Caminiti, Joseph\Zantaz-JosephCaminiti-01012004-07272017.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement FW: Please email Bob Roche the budget presentation for addiction "Ferry, Shawn" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=sferry"> 2007 August 10 email 1 "Roche, Robert" <rroche@cephalon.com> "Coletta, Mary Lou" <mcoletta@cephalon.com> "Caminiti, Joseph" <jcaminit@cephalon.com> TGOS_VA4_MDL_09110056 TEVA_MDL_A_11133408 yes 2025 February 27 fxlv0351 Teva and Allergan Documents teva Larijani, Susan public no restrictions Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani_2.pst\Top of Personal Folders\Pain Management\Addiction Medicine\Neurology September Minutes 2006 Teva and Allergan Global Opioid Settlement Agreement Pain Management Addiction Medicine September Minutes.doc 2006 September 13 document 2 TGOS_VA4_MDL_09342886 TEVA_MDL_A_11398877 2025 February 27 hlwh0350 Teva and Allergan Documents teva Dewildt, Charles public no restrictions 2008 March 10 Dewildt, Charles\Teva Opioids-Civil MDL-20181015.zip\Zantaz_DEWILDT_CHARLES_CDEWILDT_Export_0002.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement RE: Abuse/Addiction/Diversion program update "Amar, Allison" <aamar@cephalon.com> 2008 March 10 email 3 "DeWildt, Charles" <cdewildt@cephalon.com> TGOS_VA4_MDL_09159572 TEVA_MDL_A_11191269 yes 2025 February 27 jqxm0348 Teva and Allergan Documents teva Larijani, Susan public no restrictions 2006 September 12 Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani_2.pst\Top of Personal Folders Teva and Allergan Global Opioid Settlement Agreement Pain Management Addiction Medicine September Minutes "Beaulieu, Judith" <"/o=cephalon/ou=us01 administrative group/cn=recipients/cn=jbeaulie"> 2006 September 12 email 1 "Larijani, Susan" <slarijan@cephalon.com> TGOS_VA4_MDL_08247914 TEVA_MDL_A_10099071 2025 January 30 kqxm0348 Teva and Allergan Documents teva Larijani, Susan public no restrictions Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani_2.pst\Top of Personal Folders\Pain Management Addiction Medicine September Minutes Teva and Allergan Global Opioid Settlement Agreement Pain Management Addiction Medicine September Minutes.doc 2006 September 12 document 2 TGOS_VA4_MDL_08247915 TEVA_MDL_A_10099072 2025 January 30 pnph0350 Teva and Allergan Documents teva King, James, Jr public no restrictions 2010 October 13 King, James, Jr\Teva Opioids-Civil MDL-20181015.zip\Zantaz_KING_JAMESG__JGKING_Export_0002.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Oct. 13: FDA approves Vivitrol to combat opioid addictions DIA Daily <diadaily@dia.custombriefings.com> 2010 October 13 email 7 "King, James G." <jgking@cephalon.com> TGOS_VA4_MDL_09170784 TEVA_MDL_A_11203149 2025 February 27 qnph0350 Teva and Allergan Documents teva King, James, Jr public no restrictions 2010 October 13 King, James, Jr\Teva Opioids-Civil MDL-20181015.zip\Zantaz_KING_JAMESG__JGKING_Export_0002.pst\Top of Outlook data file Teva and Allergan Global Opioid Settlement Agreement Oct. 13: FDA Approves Vivitrol To Combat Opioid Addictions DIA Daily <diadaily@dia.custombriefings.com> 2010 October 13 email 5 "King, James G." <jgking@cephalon.com> TGOS_VA4_MDL_09170791 TEVA_MDL_A_11203156 2025 February 27 jxhn0351 Teva and Allergan Documents teva Larijani, Susan;Warner, Jamie public no restrictions 2016 March 22 Larijani, Susan\Opioids Chicago Search Request Update - 20180625.zip\Opioids Full Search 20180621 - Susan Larijani_2.pst\Top of Personal Folders\Inbox Teva and Allergan Global Opioid Settlement Agreement FDA Announces Enhanced Warnings for Immediate-Release Opioid Pain Medications Related to Risks of Misuse, Abuse, Addiction, Overdose and Death Penny Levin <penny.levin@tevapharm.com> 2016 March 22 email 1 Douglas Harnish <douglas.harnish@tevapharm.com> Susan Franks <susan.franks@tevapharm.com> James Ottinger <james.ottinger@tevapharm.com> Jennifer Pansch <jennifer.pansch@tevapharm.com> Brian Kilmartin <brian.kilmartin@tevapharm.com> Judith Zander <judith.zander@tevapharm.com> Tal Kleinfeld <tal.kleinfeld@teva.co.il> Richard Malamut <richard.malamut@tevapharm.com> Marcelo Bigal <marcelo.bigal@tevapharm.com> Michael Tillinger <michael.tillinger@tevapharm.com> Michael Fetell <michael.fetell@tevapharm.com> Jean-Pierre Fluckiger <jean-pierre.fluckiger@tevapharm.com> Nancy Bassilious <nancy.bassilious@tevapharm.com> Scott Tomsky <scott.tomsky@tevapharm.com> Jill Pastore <jill.pastore@tevapharm.com> Rich Leone <rich.leone@tevapharm.com> Cory Wohlbach <cory.wohlbach@tevapharm.com> Brian McCormick <brian.mccormick@tevapharm.com> Jason Daly <jason.daly01@tevapharm.com> Rob Falb <rob.falb@tevapharm.com> Jamie Warner <jamie.warner@tevapharm.com> James Ciciriello <james.ciciriello@tevapharm.com> Susan Larijani <susan.larijani@tevapharm.com> Yatindra Joshi <yatindra.joshi@tevapharm.com> Derek Moe <derek.moe@cimalabs.com> Terri Stewart <terri.stewart@tevapharm.com> Britt Vermeij <britt.vermeij@tevanederland.com> Victor Todd <victor@dgresearch.com> Ethan Lovell (External) <elovell@dgresearch.com> TGOS_VA4_MDL_09700106 TEVA_MDL_A_11815084 yes 2025 February 27 nmyx0363 Teva and Allergan Documents teva Leitch, Nathalie public no restrictions 2015 December 10 Teva and Allergan Global Opioid Settlement Agreement FW: Titan Pharmaceuticals and Braeburn Pharmaceuticals Announce Date of FDA Advisory Committee Review of Probuphine for Opioid Addiction Degady, Renata </O=MAIL/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=RENATA.DEGADY> 2015 December 10 email 2 Leitch, Nathalie </O=MAIL/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=NLeitc01483> TGOS_VA4_MDL_12070393 Acquired_Actavis_01357496 yes 2025 April 24 kjgg0230 kjf71j00 Oklahoma Opioid Litigation Documents okopioid public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] report health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 Duragesic: Information on Opioid Dependence, Tolerance and Addiction Document 4 Fentanyl s0760 2020 January 23 ljgg0230 ljf71j00 Oklahoma Opioid Litigation Documents okopioid public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] report health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 Duragesic: Information on Opioid Dependence, Tolerance and Addiction 2003 June 16 Document 4 Fentanyl s0760a 2020 January 23 knfg0230 acf71j00 Oklahoma Opioid Litigation Documents okopioid public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] chart; diagram; photograph health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 Oklahoma Kids and Adults don't go Far to Feed their Addiction Charlie, Price Woodward, Mark Oklahoma Bureau of Narcotics Mathes, Patty 2008 September 29 Image 22 Emily, Lang Hydrocodone Meperidine Methadone Morphine Oxycodone J0637 2020 January 23 mnfg0230 ccf71j00 Oklahoma Opioid Litigation Documents okopioid public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] report health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 Opioid Analgesic Therapy and Abuse/Addiction/Aberrant Drug-Related Behaviors Fishbain, David A Cole, Brandly Lewis, John Rosmoff, Hubert L Rosomoff, R Steele Miller School of Medicine University of Miami Miami VA Medical Center Rosomoff Comprehensive Pain Center, The Document 16 Butorphanol Fentanyl Hydrocodone Methadone Morphine Oxycodone Oxymorphone Propoxyphene Tramadol J0646 2020 January 23 npgg0230 fnf71j00 Oklahoma Opioid Litigation Documents okopioid public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] letter; report health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 The Drug Addiction and Opioid Crisis Christie, Chris Kennedy, Patrick J Madras, Bertha Bondi, Pam Cooper, Roy Baum, Richard J 2017 November 01 Document 138 Trump, Donald J Anhydrous Morphine Buprenorphine Buprenorphine/Naloxone Fentanyl Hydrocodone Hydromorphone Meperidine Methadone Morphine Oxycodone Oxycodone Naloxone Oxymorphone Tapentadol Tramadol s1574 2020 January 23 hqnh0230 bgo71j00 Oklahoma Opioid Litigation Documents okopioid {"type":"video","title":"Internet Archive","id":"drug_hqnh0230","url":"https://www.archive.org/details/drug_hqnh0230"} public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] video health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 Excerpt of Dr. Terrell Phillips presentation at OSMA CME - Pain Management: How to Avoid the Road to Addiction 2016 October 28 Video opioids Excerpt of Phillip's 2016 talk at the Oklahoma State Medical Association CME on Pain Management: "Everyone here knows how we got in this situation, they told us we were under prescribing, we need to prescribe more, it's the patients rights to have pain medicine so we all got on board, and, when someone said they were hurting we aid ok we are gonna give you something, now it's just the opposite, not everyone deserves pain medicine." s4744b 2020 February 27 qkgg0230 gkf71j00 Oklahoma Opioid Litigation Documents okopioid public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] article; publication health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 Addiction Rare in Patients Treated With Narcotics Boston University Medical Center Porter, Jane Jick, Hershel 2018 November 30 Document 1 Hydromorphone Meperidine Oxycodone s0901 2020 January 23 rfgg0230 fhf71j00 Oklahoma Opioid Litigation Documents okopioid public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] graph; publication; table; report health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 National Addictions Vigilance Intervention and Prevention Program - Surveillance Report for Nucynta Inflexxion, Inc 2011 December 06 Document Image 66 Ortho-McNeil Janssen Pharmaceuticals Buprenorphine Buprenorphine Hydrochloride Buprenorphine/Naloxone Hydrocodone Hydromorphone Morphine Oxycodone Oxymorphone Tapentadol Tramadol J1388 2020 January 23 lhhg0230 bsf71j00 Oklahoma Opioid Litigation Documents okopioid public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] transcript; legal health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 State Exhibit - Video Transcript of Dr. Terrell Phillips presenting at OSMA CME, October 28, 2016: Pain Management : How to Avoid the Road to Addiction 2016 October 28 Document 1 opioids s4743 2020 January 23 nfgg0230 bhf71j00 Oklahoma Opioid Litigation Documents okopioid public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] diagram; report; table health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 National Addictions Vigilance Intervention and Prevention Program 2011 September 02 Document Image 58 Buprenorphine Buprenorphine Hydrochloride Buprenorphine/Naloxone Fentanyl Hydrocodone Hydromorphone Oxycodone Oxymorphone Tapentadol Tramadol J1371 2020 January 23 zpnh0230 yfo71j00 Oklahoma Opioid Litigation Documents okopioid {"type":"video","title":"Internet Archive","id":"drug_zpnh0230","url":"https://www.archive.org/details/drug_zpnh0230"} public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] video health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 Excerpt of Dr. Terrell Phillips presentation at OSMA CME - Pain Management: How to Avoid the Road to Addiction 2016 October 28 Video opioids Excerpt of Phillip's 2016 talk at the Oklahoma State Medical Association CME on Pain Management s4744a 2020 February 27 spbf0232 wlj78j00 National Prescription Opiate Litigation Documents npo public no restrictions presentation IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION; Case No. 1:17-MD-2804 The History & Medical Basis of Methadone in the Treatment of Opioid Addiction Covidien Presentation 34 Methadone Morphine 38 2020 October 08 jqdf0232 vfk78j00 Kentucky Opioid Litigation Documents kyopioid public no restrictions [{"type":"plaintext","title":"anonymous"}] newsletter; exhibit Commonwealth of Kentucky v. Purdue Pharma LP, et al., No 07-CI-01303 Breaking the Chains of Addiction - Exhibit 5 for Purdue's Motion to Change Venue in Kentucky v Purdue Pharma LP, et al Rogers, Hal US Congress 2010 March 15 Document 3 Oxycodone Oxycontin CHKc42d8001ea0abd37b90ca6c0ea405e68.pdf 5 2020 October 08 ghhg0230 wrf71j00 Oklahoma Opioid Litigation Documents okopioid public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] table health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 Actions Taken to Address the Opioid Addiction Epidemic 2019 June 03 Image 16 Buprenorphine Fentanyl Methadone Oxycodone s4738 2020 January 23 jkpw0232 toi78j00 National Prescription Opiate Litigation Documents npo public no restrictions legal IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION; Case No. 1:17-MD-2804 [Addendum to Statement Regarding OxyContin Addiction] Document 12 Fentanyl Hydrocodone Morphine Oxycodone 17 2020 October 08 gqbf0232 amj78j00 National Prescription Opiate Litigation Documents npo public no restrictions presentation IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION; Case No. 1:17-MD-2804 Addiction Treatment Business Mallinckrodt Pharmaceuticals Presentation 16 Methadone Oxycodone 41 2020 October 08 kqbf0232 emj78j00 National Prescription Opiate Litigation Documents npo public no restrictions presentation IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION; Case No. 1:17-MD-2804 Understanding Addiction: The Great Brain Robbery Mallinckrodt Pharmaceuticals Presentation 32 Buprenorphine Methadone 37 2020 October 08 snmw0232 knh78j00 National Prescription Opiate Litigation Documents npo public no restrictions letter IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION; Case No. 1:17-MD-2804 Letter from Kenneth Mills to Scott S. Oslecki requesting for funding from the Alcohol, Drug Addiction and Mental Health Services Board of Cuyahoga County to provide Medication Assisted Treatment (MAT) to Cuyahoga County Corrections Center (CCCC) inmates diagnosed with an opiod substance use disorder (SUD), who are leaving the jail. Mills, Kenneth Director, Regional Corrections, Cuyahoga County 2018 May 23 Document 3 Oslecki, Scott S Chief Executive Officer, Alcohol, Drug Addiction and Mental Health Services Board of Cuyahoga County Buprenorphine 29 2020 October 08 sxff0232 yuk78j00 National Prescription Opiate Litigation Documents npo public no restrictions report; press release IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION; Case No. 1:17-MD-2804 Duragesic - Information on Opioid Dependence, Tolerance and Addiction Document 5 Fentanyl PSJ2 Exh 55 2020 November 05 tymw0232 boh78j00 National Prescription Opiate Litigation Documents npo public no restrictions memo IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION; Case No. 1:17-MD-2804 Memo to employees re opiod addiction and abuse. Barrett, George Cardinal Health 2017 Document 3 Cardinal Health Employees opioids 31 2020 October 08 prnj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 April 02 Collier, Ginger SUPP OCT 2018_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 04:31 AM Collier, Ginger 2010 April 02 04:31 AM My Alert: Addiction "market intelligence portal" 2010 April 02 Document Email 3 "collier, ginger l" Morphine Oxycodone MNKOIv002 MNKOI0002886359 2021 October 21 qgyj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 May 15 Collier, Ginger SUPP OCT 2018_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:32 AM Collier, Ginger 2010 May 15 03:32 AM My Alert: Addiction "market intelligence portal" 2010 May 15 Document Email 2 "collier, ginger l" Oxymorphone MNKOIv002 MNKOI0002886765 2021 October 21 rgpj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2009 August 19 Collier, Ginger SUPP OCT 2018_14.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) A New Service For Health Care Providers Who Prescribe Methadone To Treat Chronic Pain Or Opioid Addiction 01:30 PM Collier, Ginger 2009 August 19 01:30 PM RE: A New Service For Health Care Providers Who Prescribe Methadone To Treat Chronic Pain Or Opioid Addiction "myers, penny" 2009 August 19 Document Email 2 "haybron, elizabeth f" "lesnak, robert a" "collier, ginger l" Buprenorphine Methadone MNKOIv002 MNKOI0002888340 2021 October 21 yrwp0240 Mallinckrodt Litigation Documents mnk public no restrictions 2008 June 17 20181127_Emails\Rowley-Kilper, Tiffany\Rowley-Kilper, Tiffany all emails_15.pst\Top of Personal Folders\Archive MNKOI0003046859 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Catalog PDF 03:38 PM Rowley-Kilper, Tiffany 2008 June 17 03:38 PM Addiction Catalog PDF "ford, carol" 2008 June 17 Document Email 1 "rowley, tiffany l" opioids MNKOIv002 MNKOI0003046858 2021 October 21 lzxv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2017 September 28 ONeill, Hugh\ONeill, Hugh 1 1 15 to 12 31 17_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) ENDP,TEVA: New measures to fight opioid addiction 08:24 AM O’Neill, Hugh 2017 September 28 08:24 AM ENDP,TEVA: New measures to fight opioid addiction SA Breaking News Team <account@seekingalpha.com> 2017 September 28 Document Email 1 hugh.oneill@mallinckrodt.com opioids MNKOIv002 MNKOI0001868190 2021 October 21 slpl0240 Mallinckrodt Litigation Documents mnk public no restrictions 2008 October 27 Young, Jim SUPP OCT 2018 pre2014_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Avigen announced that it will now switch its focus to AV411, which is in development for neuropathic pain and opioid addiction and withdrawal 06:05 PM Young, Jim 2008 October 27 06:05 PM RE: Avigen announced that it will now switch its focus to AV411, which is in development for neuropathic pain and opioid addiction and withdrawal "berberich, dave" 2008 October 27 Document Email 3 "young, jim l" "giuliani, michael" "heasley, ralph a" Methadone Morphine MNKOIv002 MNKOI0002948383 2021 October 21 grvm0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 November 29 Spaulding, Eileen SUPP OCT 2018 pre2014_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Shipping history verification for PN0127212 Narcotic Addiction Rehab 07:37 PM Spaulding, Eileen 2010 November 29 07:37 PM RE: Shipping history verification for PN0127212 Narcotic Addiction Rehab "Corbett, James J." <james.j.corbett@usdoj.gov> 2010 November 29 Document Email 1 "spaulding, eileen l." Methadone MNKOIv002 MNKOI0002949752 2021 October 21 ngyc0240 Mallinckrodt Litigation Documents mnk public no restrictions 2017 July 27 20181017_Emails\Cardetti, Lisa All emails after 2013_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Confidential - Attain Med Addiction Treatment Opportunities 01:24 PM Cardetti, Lisa 2017 July 27 01:24 PM RE: Confidential - Attain Med Addiction Treatment Opportunities "Cardetti, Lisa M" <lisa.cardetti@mallinckrodt.com> 2017 July 27 Document Email 4 Lenny Rodriguez <lenny.rodriguez@attainmed.com> Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0002765649 2021 October 21 xjcd0240 Mallinckrodt Litigation Documents mnk public no restrictions 2014 September 19 20181017_Emails\Cardetti, Lisa All emails after 2013_11.pst\Top of Personal Folders\Archive MNKOI0002769497 MNKOI0002769500 MNKOI0002769503 MNKOI0002769506 MNKOI0002769509 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Business Reviews 07:51 PM Cardetti, Lisa 2014 September 19 07:51 PM Addiction Treatment Business Reviews "Saul, Christopher" <christopher.saul@mallinckrodt.com> 2014 September 19 Document Email 1 "Cardetti, Lisa M" <lisa.cardetti@mallinckrodt.com> "Prouhet, Linda A" <linda.prouhet@mallinckrodt.com> opioids MNKOIv002 MNKOI0002769496 2021 October 21 pkvm0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 November 29 Spaulding, Eileen SUPP OCT 2018 pre2014_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Shipping history verification for PN0127212 Narcotic Addiction Rehab 04:49 PM Spaulding, Eileen 2010 November 29 04:49 PM RE: Shipping history verification for PN0127212 Narcotic Addiction Rehab "spaulding, eileen l." 2010 November 29 Document Email 2 "White, Heather R." <heather.r.white@usdoj.gov> Methadone MNKOIv002 MNKOI0002949393 2021 October 21 ljdm0240 Mallinckrodt Litigation Documents mnk public no restrictions 2008 June 05 Spaulding, Eileen SUPP OCT 2018 pre2014_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) RUSH - Clinic Emergency Order: Addiction Research/ Aurora, CO 06:29 PM Spaulding, Eileen 2008 June 05 06:29 PM RE: RUSH - Clinic Emergency Order: Addiction Research/ Aurora, CO "spaulding, eileen l." 2008 June 05 Document Email 3 "wall, pat a" "grossius, lesle" Methadone MNKOIv002 MNKOI0002952256 2021 October 21 gnwm0240 Mallinckrodt Litigation Documents mnk public no restrictions 2001 September 17 Spaulding, Eileen SUPP OCT 2018 pre2014_4.pst\Top of Personal Folders\Archive MNKOI0002953214 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Discrepancy report - Addiction Research 11:02 PM Spaulding, Eileen 2001 September 17 11:02 PM Discrepancy report - Addiction Research "davis, venita a" 2001 September 17 Document Email 1 "spaulding, eileen l." "levy, joanne" opioids MNKOIv002 MNKOI0002953213 2021 October 21 lyjm0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 March 16 20181112_Emails\Neuman, Herb SUPP OCT 2018_2.pst\Top of Personal Folders\Archive MNKOI0002957376 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) For Review: Addiction Pro Bylined Article 10:07 PM Neuman, Herb 2011 March 16 10:07 PM For Review: Addiction Pro Bylined Article "schooler, joanna s" 2011 March 16 Document Email 1 "neuman, herbert r" "morelli, art" "littlejohn, stephen e" "stauder, nancy r" "medina, dawn" opioids MNKOIv002 MNKOI0002957375 2021 October 21 tpyl0240 Mallinckrodt Litigation Documents mnk public no restrictions 2009 February 09 Young, Jim SUPP OCT 2018 pre2014_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Genetic test for addiction risk IP - Another Idea 02:23 PM Young, Jim 2009 February 09 02:23 PM RE: Genetic test for addiction risk IP - Another Idea "heasley, ralph a" 2009 February 09 Document Email 2 "giuliani, michael" "young, jim l" "berberich, dave" "kaiman, vince j" opioids MNKOIv002 MNKOI0002947553 2021 October 21 fpcm0240 Mallinckrodt Litigation Documents mnk public no restrictions 2009 May 27 Spaulding, Eileen SUPP OCT 2018 pre2014_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Sinai Hospital Addictions DEA PS0122135 03:44 PM Spaulding, Eileen 2009 May 27 03:44 PM Sinai Hospital Addictions DEA PS0122135 "nelson, cheryl \\(hazelwood\\)" 2009 May 27 Document Email 1 "spaulding, eileen l." Methadone MNKOIv002 MNKOI0002951703 2021 October 21 rtkm0240 Mallinckrodt Litigation Documents mnk public no restrictions 2009 January 04 20181112_Emails\Neuman, Herb SUPP OCT 2018_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Opiate Addiction Treatment Diagnostic 02:03 AM Neuman, Herb 2009 January 04 02:03 AM Opiate Addiction Treatment Diagnostic "grearson, john k" 2009 January 04 Document Email 1 "henderson, varry e" "Cicero, Ted" <cicerot@psychiatry.wustl.edu> "neuman, herbert r" opioids MNKOIv002 MNKOI0002958796 2021 October 21 shfn0240 Mallinckrodt Litigation Documents mnk public no restrictions 2017 May 24 N\Hazelwood01\Shared Services\Finance\Sales&Mktg Ops\PSG\Contract Administration\All Contracts\Proposals 3 (Methadone)\Proposals\Addiction Resources\Approvals MNKOI0002965720 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Review - Addiction Resources - New AT Contract 12:37 PM Network Share 2017 May 24 12:37 PM Review - Addiction Resources - New AT Contract "Mindak, Barb J" <"/o=mkglobal/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=barb.mindak"> 2017 May 24 Document Email 1 "Lasker, Karen L" <karen.lasker@mallinckrodt.com> "Kilper, Jeff J" <jeff.kilper@mallinckrodt.com> "Kazemi, Kian L" <kian.kazemi@mallinckrodt.com> Methadone MNKOIv002 MNKOI0002965719 2021 October 21 lmkb0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 April 28 20181017_Emails\Phillips, Lynn All emails_12.pst\Top of Personal Folders\Archive MNKOI0002737658 MNKOI0002737660 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Approved Florida Op-Ed & Addiction Pro Article 06:15 PM Phillips, Lynn 2011 April 28 06:15 PM Approved Florida Op-Ed & Addiction Pro Article "schooler, joanna s" 2011 April 28 Document Email 1 "Brooks, Drea" <drea.brooks@edelman.com> "Page, Dan" <dan.page@edelman.com> "Cottle, Elizabeth" <elizabeth.cottle@edelman.com> "littlejohn, stephen e" "phillips, lynn" "stauder, nancy r" opioids MNKOIv002 MNKOI0002737657 2021 October 21 kscy0237 Mallinckrodt Litigation Documents mnk public no restrictions 2013 October 30 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NOW AVAILABLE - Methadone Module 1 - Opioid Addiction: A Historical Perspective 08:31 PM Holthaus, Gena 2013 October 30 08:31 PM RE: NOW AVAILABLE - Methadone Module 1 - Opioid Addiction: A Historical Perspective "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2013 October 30 Document Email 3 "Sigel, Tom J" <tom.sigel@mallinckrodt.com> Methadone MNKOIv001 MNKOI0001526635 2021 October 21 zzcy0237 Mallinckrodt Litigation Documents mnk public no restrictions 2014 January 17 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive MNKOI0001527099 MNKOI0001527100 MNKOI0001527101 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Opioid Addiction Treatment Education Sell Sheet Now Available 04:11 PM Holthaus, Gena 2014 January 17 04:11 PM Opioid Addiction Treatment Education Sell Sheet Now Available "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2014 January 17 Document Email 2 "Colvin, Darren A" <darren.colvin@mallinckrodt.com> "Ottosen, Danny J" <danny.ottosen@mallinckrodt.com> "Ryan, Edward R" <edward.ryan@mallinckrodt.com> "Sigel, Tom J" <tom.sigel@mallinckrodt.com> "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Schuster, Tammy H" <tammy.schuster@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> "Purcell, Tina M" <tina.purcell@mallinckrodt.com> "Matoushek, Theresa" <theresa.matoushek@mallinckrodt.com> "Bullerdick, Jennifer M" <jennifer.bullerdick@mallinckrodt.com> Methadone MNKOIv001 MNKOI0001527097 2021 October 21 rfdy0237 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 13 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive MNKOI0001527120 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Module 3 - PARC Requested Revisions 07:48 PM Holthaus, Gena 2014 February 13 07:48 PM Addiction Treatment Module 3 - PARC Requested Revisions "Ford, Carol" <carol.ford@mallinckrodt.com> 2014 February 13 Document Email 1 "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> "Estes, Penny L" <penny.estes@mallinckrodt.com> "Purcell, Tina M" <tina.purcell@mallinckrodt.com> "Matoushek, Theresa" <theresa.matoushek@mallinckrodt.com> Buprenorphine Methadone MNKOIv001 MNKOI0001527119 2021 October 21 ttwy0237 Mallinckrodt Litigation Documents mnk public no restrictions 2017 May 16 Holthaus, Gena\Gena Holthaus all_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) How opioid addiction affects swaths of Americans; 5 ways to land in top-tier publications; 13 French terms for writers; and much more . . . 03:31 PM Holthaus, Gena 2017 May 16 03:31 PM How opioid addiction affects swaths of Americans; 5 ways to land in top-tier publications; 13 French terms for writers; and much more . . . Health Care News Feed <healthcarenews@e.ragancomms.com> 2017 May 16 Document Email 10 gena.holthaus@mallinckrodt.com opioids MNKOIv001 MNKOI0001532345 2021 October 21 zzwn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 March 01 Holthaus, Gena\Gena Holthaus all_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Question about Addiction Treatment 07:41 PM Holthaus, Gena 2017 March 01 07:41 PM RE: Question about Addiction Treatment "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2017 March 01 Document Email 2 "Crandall, Margaret A" <margaret.crandall@mallinckrodt.com> "Alexander, Dan" <daniel.alexander@mallinckrodt.com> opioids MNKOIv002 MNKOI0001837173 2021 October 21 sqyv0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 April 28 Decker, John\Decker, John all_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Naldemedine Improves OIC; Psychosocial Interventions for Opioid Addiction; Malpractice Claims 09:32 PM Decker, John 2016 April 28 09:33 PM Naldemedine Improves OIC; Psychosocial Interventions for Opioid Addiction; Malpractice Claims Pain Medicine News <painmedicinenews@mcmahonmed.com> 2016 April 28 Document Email 2 john decker <john.decker@mallinckrodt.com> opioids MNKOIv001 MNKOI0001599075 2021 October 21 lpyv0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 April 26 Decker, John\Decker, John all_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Implant Technology and Refining Opioid Addiction Treatment 10:15 AM Decker, John 2016 April 26 10:15 AM Implant Technology and Refining Opioid Addiction Treatment PAINWeek Daily Dose <info@painweek.org> 2016 April 26 Document Email 3 John <john.decker@mallinckrodt.com> Buprenorphine MNKOIv001 MNKOI0001598987 2021 October 21 nnvb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 April 04 Decker, John\Decker, John all_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Treating Opioid Addiction—A Better Alternative to Methadone? 10:12 AM Decker, John 2016 April 04 10:12 AM Treating Opioid Addiction—A Better Alternative to Methadone? PAINWeek Daily Dose <newsletter@painweek.org> 2016 April 04 Document Email 2 John <john.decker@mallinckrodt.com> Methadone MNKOIv001 MNKOI0001603120 2021 October 21 ytvb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 October 02 Decker, John\Decker, John all_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Pharmacogenetics for Pain & Opioid Addiction 03:12 PM Decker, John 2015 October 02 03:12 PM Pharmacogenetics for Pain & Opioid Addiction Pain Medicine News <painmedicinenews@mcmahonmed.com> 2015 October 02 Document Email 2 john decker <john.decker@mallinckrodt.com> Fentanyl MNKOIv001 MNKOI0001603910 2021 October 21 frwb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 October 26 Long, Erika\Long, Erika all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Trump vows to 'liberate' American from 'scourge of drug addiction' 10:04 PM Long, Erika 2017 October 26 10:04 PM Trump vows to 'liberate' American from 'scourge of drug addiction' POLITICO Pro <politicoemail@politicopro.com> 2017 October 26 Document Email 4 erika.long@mallinckrodt.com Fentanyl MNKOIv001 MNKOI0001612044 2021 October 21 krwb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 October 27 Long, Erika\Long, Erika all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) President Donald J. Trump is Taking Action on Drug Addiction and the Opioid Crisis | whitehouse.gov 12:49 AM Long, Erika 2017 October 27 12:49 AM President Donald J. Trump is Taking Action on Drug Addiction and the Opioid Crisis | whitehouse.gov Jennifer Young <jyoung@tdyllc.com> 2017 October 27 Document Email 1 Elizabeth Murray <emurray@tdyllc.com> Charlotte Ivancic <civancic@tdyllc.com> Rai Downs <rdowns@tdyllc.com> Pamela Smith <psmith@tdyllc.com> Emma Boone <eboone@tdyllc.com> Linda Tarplin <ltarplin@tdyllc.com> Michelle Easton <measton@tdyllc.com> opioids MNKOIv001 MNKOI0001612067 2021 October 21 mtwb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 October 30 Long, Erika\Long, Erika all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) FDA Outreach: Commissioner statement regarding new strategies for addressing the crisis of opioid addiction 09:39 PM Long, Erika 2017 October 30 09:39 PM FW: FDA Outreach: Commissioner statement regarding new strategies for addressing the crisis of opioid addiction Rai Downs <rdowns@tdyllc.com> 2017 October 30 Document Email 2 Jennifer Young <jyoung@tdyllc.com> Charlotte Ivancic <civancic@tdyllc.com> Elizabeth Murray <emurray@tdyllc.com> Michelle Easton <measton@tdyllc.com> Pamela Smith <psmith@tdyllc.com> Emma Boone <eboone@tdyllc.com> Linda Tarplin <ltarplin@tdyllc.com> opioids MNKOIv001 MNKOI0001612358 2021 October 21 fyfb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 December 12 Long, Erika\Long, Erika all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) PhRMA and Addiction Policy Forum team to address opioid crisis 05:18 PM Long, Erika 2017 December 12 05:18 PM PhRMA and Addiction Policy Forum team to address opioid crisis POLITICO Pro Health Care Whiteboard <politicoemail@politicopro.com> 2017 December 12 Document Email 2 erika.long@mallinckrodt.com opioids MNKOIv001 MNKOI0001613872 2021 October 21 tgfb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 November 03 Long, Erika\Long, Erika all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) FDA raises concerns about oxymorphone addiction risk 05:30 PM Long, Erika 2017 November 03 05:30 PM FDA raises concerns about oxymorphone addiction risk POLITICO Pro Health Care Whiteboard <politicoemail@politicopro.com> 2017 November 03 Document Email 2 erika.long@mallinckrodt.com Oxymorphone MNKOIv001 MNKOI0001613077 2021 October 21 sfhb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 June 08 Long, Erika\Long, Erika all_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Painkillers: Seeing Our Opioid Addiction Crisis For What It Is | Cognoscenti 10:52 AM Long, Erika 2015 June 08 UCSF 10:52 AM Fwd: Painkillers: Seeing Our Opioid Addiction Crisis For What It Is | Cognoscenti "Naten, Derek" <derek.naten@mallinckrodt.com> 2015 June 08 Document Email 1 "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> "Long, Erika" <erika.long@mallinckrodt.com> opioids MNKOIv001 MNKOI0001616334 yes 2021 October 21 mphb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 October 11 Long, Erika\Long, Erika all_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) You're invited: Addiction in America event with Sens. Maggie Hassan and Rob Portman at The Washington Post 10/18 05:54 PM Long, Erika 2017 October 11 05:54 PM FW: You're invited: Addiction in America event with Sens. Maggie Hassan and Rob Portman at The Washington Post 10/18 Courtney Johnson <cjohnson@alpinegroup.com> 2017 October 11 Document Email 2 "Long, Erika" <erika.long@mallinckrodt.com> opioids MNKOIv001 MNKOI0001617447 2021 October 21 rhwn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 13 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Module 3 - PARC Requested Revisions 08:21 PM Holthaus, Gena 2014 February 13 08:21 PM RE: Addiction Treatment Module 3 - PARC Requested Revisions "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2014 February 13 Document Email 1 "Ford, Carol" <carol.ford@mallinckrodt.com> "Estes, Penny L" <penny.estes@mallinckrodt.com> "Purcell, Tina M" <tina.purcell@mallinckrodt.com> "Matoushek, Theresa" <theresa.matoushek@mallinckrodt.com> Buprenorphine Methadone MNKOIv002 MNKOI0001836748 2021 October 21 txwn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 March 06 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive MNKOI0001836783 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NOW AVAILABLE - Module 2: Understanding Addiction 08:23 PM Holthaus, Gena 2014 March 06 08:23 PM RE: NOW AVAILABLE - Module 2: Understanding Addiction "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2014 March 06 Document Email 2 "Purcell, Tina M" <tina.purcell@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001836781 2021 October 21 lxdv0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 17 Decker, John\Decker, John all_14.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) February 2014 newsletters 01:49 AM Decker, John 2014 February 17 UCSF 01:49 AM RE: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) February 2014 newsletters John Peppin XXXXXXXXXXX@msn.com> 2014 February 17 Document Email 4 "Decker, John F" <john.decker@mallinckrodt.com> opioids MNKOIv001 MNKOI0001580366 yes 2021 October 21 sxdv0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 17 Decker, John\Decker, John all_14.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Taxonomy; (was FW: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) February 2014 newsletters) 04:46 PM Decker, John 2014 February 17 04:46 PM RE: Taxonomy; (was FW: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) February 2014 newsletters) "Decker, John F" <john.decker@mallinckrodt.com> 2014 February 17 Document Email 4 "Peppin, John F" <john.peppin@mallinckrodt.com> opioids MNKOIv001 MNKOI0001580382 2021 October 21 hjdv0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 18 Decker, John\Decker, John all_14.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) TAXONOMY- FW: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) February 2014 newsletters 12:04 AM Decker, John 2014 February 18 12:04 AM RE: TAXONOMY- FW: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) February 2014 newsletters "Peppin, John F" <john.peppin@mallinckrodt.com> 2014 February 18 Document Email 4 "Decker, John F" <john.decker@mallinckrodt.com> opioids MNKOIv001 MNKOI0001580401 2021 October 21 xjdv0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 18 Decker, John\Decker, John all_14.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) TAXONOMY- FW: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) February 2014 newsletters 12:30 PM Decker, John 2014 February 18 12:30 PM RE: TAXONOMY- FW: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) February 2014 newsletters "Peppin, John F" <john.peppin@mallinckrodt.com> 2014 February 18 Document Email 4 "Decker, John F" <john.decker@mallinckrodt.com> opioids MNKOIv001 MNKOI0001580405 2021 October 21 pylv0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 April 25 Decker, John\Decker, John all_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Awareness 10:07 AM Decker, John 2017 April 25 10:07 AM Addiction Awareness PAINWeek Daily Dose <newsletter@painweek.org> 2017 April 25 Document Email 2 John <john.decker@mallinckrodt.com> opioids MNKOIv001 MNKOI0001593354 2021 October 21 jrdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 October 30 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NOW AVAILABLE - Methadone Module 1 - Opioid Addiction: A Historical Perspective 07:27 PM Holthaus, Gena 2013 October 30 UCSF 07:27 PM FW: NOW AVAILABLE - Methadone Module 1 - Opioid Addiction: A Historical Perspective "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2013 October 30 Document Email 2 "McCorkle, Kathy L" <kathy.mccorkle@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001836558 yes 2021 October 21 ngwn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 January 24 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive MNKOI0001836721 MNKOI0001836722 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NOW AVAILABLE - Module 2: Understanding Addiction 05:01 PM Holthaus, Gena 2014 January 24 05:01 PM NOW AVAILABLE - Module 2: Understanding Addiction "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2014 January 24 Document Email 2 "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001836719 2021 October 21 tgwn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 January 24 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive MNKOI0001836731 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NOW AVAILABLE - Module 2: Understanding Addiction 09:58 PM Holthaus, Gena 2014 January 24 UCSF 09:58 PM RE: NOW AVAILABLE - Module 2: Understanding Addiction "Williams, Jane L" <jane.williams@mallinckrodt.com> 2014 January 24 Document Email 2 "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001836729 yes 2021 October 21 qmpb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 06 Williams, Jane\Williams, Jane emails all_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending December 6, 2013 04:17 PM Williams, Jane 2013 December 06 UCSF 04:17 PM Addiction Treatment News - Week Ending December 6, 2013 XXXXXXX@aol.com 2013 December 06 Document Email 1 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com tina.purcell@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Methadone MNKOIv002 MNKOI0001882950 yes 2021 October 21 gfdc0239 Mallinckrodt Litigation Documents mnk public no restrictions 2013 May 02 Williams, Jane\Williams, Jane emails all_7.pst\Top of Personal Folders\Archive MNKOI0001885043 MNKOI0001885044 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Field Summary April 2013 05:52 AM Williams, Jane 2013 May 02 05:52 AM Addiction Treatment Field Summary April 2013 "Alexander, Dan" <daniel.alexander@covidien.com> 2013 May 02 Document Email 1 "Williams, Jane L" <jane.williams@covidien.com> opioids MNKOIv002 MNKOI0001885042 2021 October 21 txdc0239 Mallinckrodt Litigation Documents mnk public no restrictions 2013 February 07 Williams, Jane\Williams, Jane emails all_8.pst\Top of Personal Folders\Archive MNKOI0001885174 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mobile Intelligence - Addiction Treatment Usage and Metrics reports 07:22 PM Williams, Jane 2013 February 07 07:22 PM RE: Mobile Intelligence - Addiction Treatment Usage and Metrics reports "Williams, Jane L" <jane.williams@covidien.com> 2013 February 07 Document Email 2 "Holz, Bev B" <bev.holz@covidien.com> "Taylor, Patty L" <patty.taylor@covidien.com> opioids MNKOIv002 MNKOI0001885172 2021 October 21 lppm0239 Mallinckrodt Litigation Documents mnk public no restrictions 2017 October 26 \Additional_Data\Harper emails 2015 to Mar 19 2018_2\Harper emails 2015 to Mar 19 2018_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment FAQ 07:26 PM Harper, Karen 2017 October 26 07:26 PM RE: Addiction Treatment FAQ "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2017 October 26 Document Email 2 "Harper, Karen" <karen.harper@mallinckrodt.com> Buprenorphine Buprenorphine/Naloxone MNKOIv002 MNKOI0002633526 2021 October 21 xjpp0239 Mallinckrodt Litigation Documents mnk public no restrictions 2016 July 14 20181017_Emails\New, Bonnie All emails 1 1 14 to 10 3 18_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) July 14, 2016 - Senate votes overwhelmingly to approve opioid addiction bill 02:58 PM New, Bonnie 2016 July 14 02:58 PM July 14, 2016 - Senate votes overwhelmingly to approve opioid addiction bill PCMA SmartBrief <pcma@smartbrief.com> 2016 July 14 Document Email 8 bonnie.new@mallinckrodt.com opioids MNKOIv002 MNKOI0002680884 2021 October 21 qkpp0239 Mallinckrodt Litigation Documents mnk public no restrictions 2016 July 19 20181017_Emails\New, Bonnie All emails 1 1 14 to 10 3 18_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HDA Weekly Digest, July 19: Senate Passes the Comprehensive Addiction and Recovery Act 03:05 PM New, Bonnie 2016 July 19 03:06 PM HDA Weekly Digest, July 19: Senate Passes the Comprehensive Addiction and Recovery Act HDA Weekly Digest <digest@hda.org> 2016 July 19 Document Email 3 bonnie.new@mallinckrodt.com opioids MNKOIv002 MNKOI0002680999 2021 October 21 gzcn0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 November 21 Williams, Jane\Williams, Jane emails all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending November 21, 2014 02:45 PM Williams, Jane 2014 November 21 UCSF 02:45 PM Addiction Treatment News - Week Ending November 21, 2014 XXXXXXX@aol.com 2014 November 21 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine Methadone MNKOIv002 MNKOI0002635711 yes 2021 October 21 hzcn0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 December 12 Williams, Jane\Williams, Jane emails all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending December 12, 2014 05:11 PM Williams, Jane 2014 December 12 UCSF 05:11 PM Addiction Treatment News - Week Ending December 12, 2014 XXXXXXX@aol.com 2014 December 12 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0002635713 yes 2021 October 21 xzcn0239 Mallinckrodt Litigation Documents mnk public no restrictions 2015 January 09 Williams, Jane\Williams, Jane emails all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Happy New Year! Addiction Treatment News - Week Ending January 9, 2015 04:24 PM Williams, Jane 2015 January 09 UCSF 04:24 PM Happy New Year! Addiction Treatment News - Week Ending January 9, 2015 XXXXXXX@aol.com 2015 January 09 Document Email 1 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Methadone MNKOIv002 MNKOI0002635715 yes 2021 October 21 jzcn0239 Mallinckrodt Litigation Documents mnk public no restrictions 2015 January 17 Williams, Jane\Williams, Jane emails all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending January 16, 2015 04:31 PM Williams, Jane 2015 January 17 UCSF 04:31 PM Addiction Treatment News - Week Ending January 16, 2015 XXXXXXX@aol.com 2015 January 17 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0002635716 yes 2021 October 21 kzcn0239 Mallinckrodt Litigation Documents mnk public no restrictions 2015 January 30 Williams, Jane\Williams, Jane emails all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending January 30, 2015 05:10 PM Williams, Jane 2015 January 30 UCSF 05:10 PM Addiction Treatment News - Week Ending January 30, 2015 XXXXXXX@aol.com 2015 January 30 Document Email 3 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0002635718 yes 2021 October 21 lzcn0239 Mallinckrodt Litigation Documents mnk public no restrictions 2015 February 08 Williams, Jane\Williams, Jane emails all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending February 6, 2015 07:00 PM Williams, Jane 2015 February 08 UCSF 07:00 PM Addiction Treatment News - Week Ending February 6, 2015 XXXXXXX@aol.com 2015 February 08 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Methadone MNKOIv002 MNKOI0002635721 yes 2021 October 21 mzcn0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 November 07 Williams, Jane\Williams, Jane emails all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending November 7, 2014 06:21 PM Williams, Jane 2014 November 07 UCSF 06:21 PM Addiction Treatment News - Week Ending November 7, 2014 XXXXXXX@aol.com 2014 November 07 Document Email 1 "alexander, dan" "colvin, darren a" "ryan, edward r" "ottosen, danny j" "spencer, romney" "kaczmarek, walt" "williams, jane l" "purcell, tina m" "naten, derek" "bullerdick, jennifer m" "randall, louann" "crandall, margaret a" Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0002635723 yes 2021 October 21 yzcn0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 October 24 Williams, Jane\Williams, Jane emails all_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending October 24, 2014 04:37 PM Williams, Jane 2014 October 24 UCSF 04:37 PM Addiction Treatment News - Week Ending October 24, 2014 XXXXXXX@aol.com 2014 October 24 Document Email 2 "alexander, dan" "colvin, darren a" "ryan, edward r" "ottosen, danny j" "spencer, romney" "kaczmarek, walt" "williams, jane l" "purcell, tina m" "naten, derek" "bullerdick, jennifer m" "randall, louann" "crandall, margaret a" Methadone MNKOIv002 MNKOI0002635727 yes 2021 October 21 qlpn0239 Mallinckrodt Litigation Documents mnk public no restrictions 2012 October 10 Additional_Data\SRC24\Buist emails 1 1 08 fwd_11\Buist emails 1 1 08 fwd_11.pst\Top of Personal Folders\Archive MNKOI0002655267 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) WSJ Prescription for Addiction series: One Logical Response 05:14 PM Buist, Jennifer 2012 October 10 05:14 PM FW: WSJ Prescription for Addiction series: One Logical Response "Buist, Jennifer M" <jennifer.buist@covidien.com> 2012 October 10 Document Email 2 "Saake, Lisa M" <lisa.saake@covidien.com> opioids MNKOIv002 MNKOI0002655265 2021 October 21 htjb0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 April 27 20181017_Emails\Phillips, Lynn All emails_12.pst\Top of Personal Folders\Archive MNKOI0002737103 MNKOI0002737105 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) For Review - Florida Op-Ed & Updated Addiction Pro Op-Ed 01:17 AM Phillips, Lynn 2011 April 27 01:17 AM For Review - Florida Op-Ed & Updated Addiction Pro Op-Ed "Schooler, JoAnna S" <joanna.schooler@covidien.com> 2011 April 27 Document Email 1 "Farmer, Bruce" <bruce.farmer@covidien.com> "Clemence, Lisa" <lisa.clemence@covidien.com> "Kraus, Eric" <eric.kraus@covidien.com> "Littlejohn, Stephen E" <stephen.littlejohn@covidien.com> "Phillips, Lynn" <lynn.phillips@covidien.com> "Stauder, Nancy R" <nancy.stauder@covidien.com> opioids MNKOIv002 MNKOI0002737102 2021 October 21 pxjb0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 April 27 20181017_Emails\Phillips, Lynn All emails_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) For Review - Florida Op-Ed & Updated Addiction Pro Op-Ed 06:19 PM Phillips, Lynn 2011 April 27 06:19 PM RE: For Review - Florida Op-Ed & Updated Addiction Pro Op-Ed "farmer, bruce" 2011 April 27 Document Email 1 "schooler, joanna s" "clemence, lisa" "kraus, eric" "littlejohn, stephen e" "phillips, lynn" "stauder, nancy r" opioids MNKOIv002 MNKOI0002736152 2021 October 21 mygb0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 June 28 20181017_Emails\Phillips, Lynn All emails_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Harvard Drug Mention + Detroit, Southern Ohio, Florida: [RxNews] Detroit Feeding OxyContin Addiction;Supply Runs Down I-75 08:13 PM Phillips, Lynn 2011 June 28 08:13 PM FW: Harvard Drug Mention + Detroit, Southern Ohio, Florida: [RxNews] Detroit Feeding OxyContin Addiction;Supply Runs Down I-75 "Phillips, Lynn" <lynn.phillips@covidien.com> 2011 June 28 Document Email 6 "Littlejohn, Stephen E" <stephen.littlejohn@covidien.com> "Schooler, JoAnna S" <joanna.schooler@covidien.com> "Stauder, Nancy R" <nancy.stauder@covidien.com> Oxycodone Oxymorphone MNKOIv002 MNKOI0002733229 2021 October 21 mjhb0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 May 13 20181017_Emails\Phillips, Lynn All emails_11.pst\Top of Personal Folders\Archive MNKOI0002733932 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) LYNN -UPDATED pharma media update w/Addiction Pro Included 10:02 PM Phillips, Lynn 2011 May 13 10:02 PM LYNN -UPDATED pharma media update w/Addiction Pro Included "Schooler, JoAnna S" <joanna.schooler@covidien.com> 2011 May 13 Document Email 2 "Stauder, Nancy R" <nancy.stauder@covidien.com> "Phillips, Lynn" <lynn.phillips@covidien.com> Hydromorphone MNKOIv002 MNKOI0002733930 2021 October 21 fkkb0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 April 28 20181017_Emails\Phillips, Lynn All emails_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Approved Florida Op-Ed & Addiction Pro Article 06:20 PM Phillips, Lynn 2011 April 28 06:20 PM RE: Approved Florida Op-Ed & Addiction Pro Article "Brooks, Drea" <drea.brooks@edelman.com> 2011 April 28 Document Email 1 "schooler, joanna s" "Page, Dan" <dan.page@edelman.com> "Cottle, Elizabeth" <elizabeth.cottle@edelman.com> "littlejohn, stephen e" "phillips, lynn" "stauder, nancy r" opioids MNKOIv002 MNKOI0002737545 2021 October 21 xkkb0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 April 26 20181017_Emails\Phillips, Lynn All emails_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Pro Article - Revised to Reflect REMS Announcement 06:53 PM Phillips, Lynn 2011 April 26 06:53 PM RE: Addiction Pro Article - Revised to Reflect REMS Announcement "neuman, herbert r" 2011 April 26 Document Email 1 "schooler, joanna s" "morelli, art" "phillips, lynn" "littlejohn, stephen e" "stauder, nancy r" "medina, dawn" opioids MNKOIv002 MNKOI0002737551 2021 October 21 pflb0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 November 24 20181017_Emails\Phillips, Lynn All emails_13.pst\Top of Personal Folders\Archive MNKOI0002738199 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) C.A.R.E.S. Alliance Discussion - American Society of Addiction Medicine 04:58 PM Phillips, Lynn 2010 November 24 04:58 PM RE: C.A.R.E.S. Alliance Discussion - American Society of Addiction Medicine "stauder, nancy r" 2010 November 24 Document Email 3 Penny Mills <pmills@asam.org> "morelli, art" "littlejohn, stephen e" "neuman, herbert r" "schooler, joanna s" "mills, sherice r" "holman, kevin" "phillips, lynn" Matthew Bryant <mbryant@asam.org> Dawn Howell <dhowell@asam.org> Methadone MNKOIv002 MNKOI0002738196 2021 October 21 rglb0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 November 24 20181017_Emails\Phillips, Lynn All emails_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) C.A.R.E.S. Alliance Discussion - American Society of Addiction Medicine 04:59 PM Phillips, Lynn 2010 November 24 04:59 PM RE: C.A.R.E.S. Alliance Discussion - American Society of Addiction Medicine "morelli, art " 2010 November 24 Document Email 3 "stauder, nancy r" "littlejohn, stephen e" "neuman, herbert r" "schooler, joanna s" "mills, sherice r" "holman, kevin" "patrick, jeffrey" "walker, preston" "churchill, jessica" "phillips, lynn" Methadone MNKOIv002 MNKOI0002738241 2021 October 21 gjlb0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 December 11 20181017_Emails\Phillips, Lynn All emails_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) C.A.R.E.S. Alliance Discussion - American Society of Addiction Medicine 03:52 PM Phillips, Lynn 2010 December 11 03:52 PM RE: C.A.R.E.S. Alliance Discussion - American Society of Addiction Medicine Penny Mills <pmills@asam.org> 2010 December 11 Document Email 3 "stauder, nancy r" Matthew Bryant <mbryant@asam.org> "morelli, art" "littlejohn, stephen e" "neuman, herbert r" "schooler, joanna s" "mills, sherice r" "holman, kevin" "phillips, lynn" Dawn Howell <dhowell@asam.org> Methadone MNKOIv002 MNKOI0002738444 2021 October 21 rtpb0240 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 13 20181017_Emails\Phillips, Lynn All emails_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction to Prescription Opiates and Heroin Addressed by New Partnership Resource 02:59 PM Phillips, Lynn 2013 December 13 02:59 PM FW: Addiction to Prescription Opiates and Heroin Addressed by New Partnership Resource "Phillips, Lynn" <lynn.phillips@mallinckrodt.com> 2013 December 13 Document Email 2 "Lohman, Donald A" <donald.lohman@mallinckrodt.com> opioids MNKOIv002 MNKOI0002745454 2021 October 21 gzpb0240 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 13 20181017_Emails\Phillips, Lynn All emails_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Lifesaving Benefits of Medication-Assisted Treatment for Opiate Addiction 05:50 PM Phillips, Lynn 2013 December 13 05:50 PM Lifesaving Benefits of Medication-Assisted Treatment for Opiate Addiction Janine Serio <janine_serio@drugfree.org> 2013 December 13 Document Email 2 Janine Serio <janine_serio@drugfree.org> Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0002745468 2021 October 21 fjbw0241 Mallinckrodt Litigation Documents mnk public no restrictions 2012 May 20 2019-07-16 Opioids emails\Silver, David\Silver, David all_4.pst\Top of Personal Folders\Archive MNKOI0003128922 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) The Troubled Path to Painkiller Addiction - Syracuse.com 12:58 PM Silver, David 2012 May 20 12:58 PM The Troubled Path to Painkiller Addiction - Syracuse.com "Schooler, JoAnna S" <joanna.schooler@covidien.com> 2012 May 20 Document Email 1 "Silver, David" <david.silver@covidien.com> "Lohman, Donald A" <donald.lohman@covidien.com> "Kim, Stuart K." <stuart.kim@covidien.com> "Edwards, Peter G" <peter.edwards@covidien.com> "Littlejohn, Stephen E" <stephen.littlejohn@covidien.com> "Phillips, Lynn" <lynn.phillips@covidien.com> Oxycodone MNKOIv002 MNKOI0003128921 2021 October 21 zjxk0241 Mallinckrodt Litigation Documents mnk public no restrictions 2015 November 12 TX and PA custodians for opioids\Kisinger, Connie\Kisinger, Connie 2014-fwd all_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) November 12, 2015 - Insurers work to prevent, treat opioid addiction 04:15 PM Kisinger, Connie 2015 November 12 04:15 PM November 12, 2015 - Insurers work to prevent, treat opioid addiction PCMA SmartBrief <pcma@smartbrief.com> 2015 November 12 Document Email 2 connie.kisinger@mallinckrodt.com Hydrocodone Hydrocodone Bitartrate MNKOIv002 MNKOI0003208827 2021 October 21 mxjk0241 Mallinckrodt Litigation Documents mnk public no restrictions 2016 July 14 TX and PA custodians for opioids\Kisinger, Connie\Kisinger, Connie 2014-fwd all_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) July 14, 2016 - Senate votes overwhelmingly to approve opioid addiction bill 02:58 PM Kisinger, Connie 2016 July 14 02:58 PM July 14, 2016 - Senate votes overwhelmingly to approve opioid addiction bill PCMA SmartBrief <pcma@smartbrief.com> 2016 July 14 Document Email 3 connie.kisinger@mallinckrodt.com opioids MNKOIv002 MNKOI0003213158 2021 October 21 kxjk0241 Mallinckrodt Litigation Documents mnk public no restrictions 2016 July 12 TX and PA custodians for opioids\Kisinger, Connie\Kisinger, Connie 2014-fwd all_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Tell your Senator to vote for comprehensive addiction recovery. 05:44 PM Kisinger, Connie 2016 July 12 05:44 PM Tell your Senator to vote for comprehensive addiction recovery. AMCP Advocacy <advocacy@amcp.org> 2016 July 12 Document Email 1 connie.kisinger@mallinckrodt.com opioids MNKOIv002 MNKOI0003213138 2021 October 21 syjk0241 Mallinckrodt Litigation Documents mnk public no restrictions 2015 October 23 TX and PA custodians for opioids\Kisinger, Connie\Kisinger, Connie 2014-fwd all_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) AMCP Launches Addiction Treatment Advisory Group 03:43 PM Kisinger, Connie 2015 October 23 03:43 PM AMCP Launches Addiction Treatment Advisory Group Academy of Managed Care Pharmacy <media@amcp.org> 2015 October 23 Document Email 2 connie.kisinger@mallinckrodt.com opioids MNKOIv002 MNKOI0003214038 2021 October 21 yxmk0241 Mallinckrodt Litigation Documents mnk public no restrictions 2014 June 23 TX and PA custodians for opioids\Kisinger, Connie\Kisinger, Connie 2014-fwd all_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) AMCP Pain Management/Abuse/Addiction Treatment Initiative 05:26 PM Kisinger, Connie 2014 June 23 05:26 PM AMCP Pain Management/Abuse/Addiction Treatment Initiative Charlie Dragovich <cdragovich@amcp.org> 2014 June 23 Document Email 2 todd.killian@mallinckrodt.com connie.kisinger@mallinckrodt.com opioids MNKOIv002 MNKOI0003216756 2021 October 21 qjcd0240 Mallinckrodt Litigation Documents mnk public no restrictions 2014 September 19 20181017_Emails\Cardetti, Lisa All emails after 2013_11.pst\Top of Personal Folders\Archive MNKOI0002769520 MNKOI0002769523 MNKOI0002769526 MNKOI0002769529 MNKOI0002769532 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Business Reviews 09:36 PM Cardetti, Lisa 2014 September 19 09:36 PM RE: Addiction Treatment Business Reviews "Saul, Christopher" <christopher.saul@mallinckrodt.com> 2014 September 19 Document Email 2 "Cardetti, Lisa M" <lisa.cardetti@mallinckrodt.com> "Prouhet, Linda A" <linda.prouhet@mallinckrodt.com> opioids MNKOIv002 MNKOI0002769518 2021 October 21 mylj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 February 07 Collier, Ginger SUPP OCT 2018_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 04:30 AM Collier, Ginger 2011 February 07 04:30 AM My Alert: Addiction "market intelligence portal" 2011 February 07 Document Email 1 "collier, ginger l" Hydrocodone Hydrocodone Bitartrate MNKOIv002 MNKOI0002880207 2021 October 21 gnmj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 September 02 Collier, Ginger SUPP OCT 2018_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:34 AM Collier, Ginger 2010 September 02 03:34 AM My Alert: Addiction "market intelligence portal" 2010 September 02 Document Email 2 "collier, ginger l" Buprenorphine Buprenorphine/Naloxone Fentanyl Oxycodone Tapentadol MNKOIv002 MNKOI0002883467 2021 October 21 qznc0240 Mallinckrodt Litigation Documents mnk public no restrictions 2012 April 05 20181017_Emails\Kalavritinos, Jack All emails_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Painkiller Sales Soar Around US, Fuel Addiction 01:12 PM Kalavritinos, Jack 2012 April 05 01:12 PM AP: Painkiller Sales Soar Around US, Fuel Addiction "Schooler, JoAnna S" <joanna.schooler@covidien.com> 2012 April 05 Document Email 2 "McBride, Timothy J." <timothy.mcbride@covidien.com> "Kalavritinos, Jack" <jack.kalavritinos@covidien.com> "Barranco, Nicole" <nicole.barranco@covidien.com> "Littlejohn, Stephen E" <stephen.littlejohn@covidien.com> Buprenorphine/Naloxone Hydrocodone Oxycodone MNKOIv002 MNKOI0002765583 2021 October 21 mgyc0240 Mallinckrodt Litigation Documents mnk public no restrictions 2017 July 26 20181017_Emails\Cardetti, Lisa All emails after 2013_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Help - RE: Confidential - Attain Med Addiction Treatment Opportunities 06:41 PM Cardetti, Lisa 2017 July 26 06:41 PM Help - RE: Confidential - Attain Med Addiction Treatment Opportunities Lenny Rodriguez <lenny.rodriguez@attainmed.com> 2017 July 26 Document Email 4 "Cardetti, Lisa M" <lisa.cardetti@mallinckrodt.com> Melanie Meredith <melanie.meredith@attainmed.com> Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0002765645 2021 October 21 pgyc0240 Mallinckrodt Litigation Documents mnk public no restrictions 2017 July 27 20181017_Emails\Cardetti, Lisa All emails after 2013_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Confidential - Attain Med Addiction Treatment Opportunities 01:31 PM Cardetti, Lisa 2017 July 27 01:31 PM FW: Confidential - Attain Med Addiction Treatment Opportunities "Cardetti, Lisa M" <lisa.cardetti@mallinckrodt.com> 2017 July 27 Document Email 5 Lenny Rodriguez <lenny.rodriguez@attainmed.com> Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0002765658 2021 October 21 lnjj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 May 07 Collier, Ginger SUPP OCT 2018_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:35 AM Collier, Ginger 2011 May 07 03:35 AM My Alert: Addiction "market intelligence portal" 2011 May 07 Document Email 2 "collier, ginger l" Oxycodone MNKOIv002 MNKOI0002874909 2021 October 21 syjj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 June 28 Collier, Ginger SUPP OCT 2018_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:36 AM Collier, Ginger 2011 June 28 03:36 AM My Alert: Addiction "market intelligence portal" 2011 June 28 Document Email 1 "collier, ginger l" Oxycodone MNKOIv002 MNKOI0002875209 2021 October 21 rtkj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 December 18 Collier, Ginger SUPP OCT 2018_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 04:34 AM Collier, Ginger 2010 December 18 04:34 AM My Alert: Addiction "market intelligence portal" 2010 December 18 Document Email 3 "collier, ginger l" Methadone MNKOIv002 MNKOI0002878520 2021 October 21 rrkj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 June 27 Collier, Ginger SUPP OCT 2018_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:30 AM Collier, Ginger 2011 June 27 03:30 AM My Alert: Addiction "market intelligence portal" 2011 June 27 Document Email 1 "collier, ginger l" Hydrocodone Hydrocodone Bitartrate MNKOIv002 MNKOI0002877924 2021 October 21 rglj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 December 31 Collier, Ginger SUPP OCT 2018_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 04:30 AM Collier, Ginger 2010 December 31 04:30 AM My Alert: Addiction "market intelligence portal" 2010 December 31 Document Email 2 "collier, ginger l" Oxycodone MNKOIv002 MNKOI0002878804 2021 October 21 sxdv0241 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 05 Polesovsky, Daniel all_2\Polesovsky, Daniel all_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Pain Addiction and the Law - Save the Dates! 12:50 PM Polesovsky, Daniel 2013 December 05 UCSF 12:59 PM Pain Addiction and the Law - Save the Dates! "Robin Hoyle, JD Pain Society of the Carolinas" XXXXXXXXXXXXXXXXXXXX@gmail.com> 2013 December 05 Document Email 2 =?utf-8?Q??= <daniel.polesovsky@mallinckrodt.com> opioids MNKOIv002 MNKOI0003088208 yes 2021 October 21 xghc0241 Mallinckrodt Litigation Documents mnk public no restrictions 2016 August 02 2019-07-02 Opioids emails\Wolf, Gregg all_2.zip\Wolf, Gregg all_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) New Research: Opioid Addiction and Dependence After Surgery is Significantly Higher than Previously Known Nasdaq:PCRX 12:15 PM Wolf, Gregg 2016 August 02 12:15 PM Fwd: New Research: Opioid Addiction and Dependence After Surgery is Significantly Higher than Previously Known Nasdaq:PCRX "Maher, Daniel" <daniel.maher@mallinckrodt.com> 2016 August 02 Document Email 1 "Meneilly, Lisa" <lisa.meneilly@mallinckrodt.com> "Hadjandreas, Chris" <chris.hadjandreas@mallinckrodt.com> "Wolf, Gregg" <gregg.wolf@mallinckrodt.com> "Mulroy, John" <john.mulroy@mallinckrodt.com> "Vermane, Jonathan" <jonathan.vermane@mallinckrodt.com> "Abplanalp, Tammy M" <tammy.abplanalp@mallinckrodt.com> "McKee, Kristin" <kristin.mckee@mallinckrodt.com> opioids MNKOIv002 MNKOI0003106649 2021 October 21 hxxd0241 Mallinckrodt Litigation Documents mnk public no restrictions 2016 May 20 2019-07-16 Opioids emails\Schwartz, William\Schwartz, William_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) OFIRMEV mention: Hahnemann University Hospital's new effort against opioid addiction | 6abc.com 12:39 PM Schwartz, William 2016 May 20 12:39 PM OFIRMEV mention: Hahnemann University Hospital's new effort against opioid addiction | 6abc.com "Socha, Albert" <albert.socha@mallinckrodt.com> 2016 May 20 Document Email 1 "Brignall, Kenneth" <kenneth.brignall@mallinckrodt.com> "Hall, Kevin" <kevin.hall@mallinckrodt.com> "Hubbard-Jacobson, Leslie" <leslie.hubbard-jacobson@mallinckrodt.com> "Keiser, Marella" <marella.keiser@mallinckrodt.com> "McIlhenney, Kelly" <kelly.mcilhenney@mallinckrodt.com> "Rose, Stephanie" <stephanie.rose@mallinckrodt.com> "Schwartz, William F" <william.schwartz@mallinckrodt.com> "Williams, Geoffrey" <geoffrey.williams@mallinckrodt.com> opioids MNKOIv002 MNKOI0003117875 2021 October 21 ynxd0241 Mallinckrodt Litigation Documents mnk public no restrictions 2013 June 19 2019-07-16 Opioids emails\Silver, David\Silver, David all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction market 12:36 PM Silver, David 2013 June 19 12:36 PM Re: Addiction market "Klug, Melissa A" <melissa.klug@covidien.com> 2013 June 19 Document Email 1 "Silver, David" <david.silver@covidien.com> Methadone MNKOIv002 MNKOI0003118594 2021 October 21 pydv0241 Mallinckrodt Litigation Documents mnk public no restrictions 2014 January 24 Polesovsky, Daniel all_2\Polesovsky, Daniel all_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Pain Addiction and the Law - Save the Dates! 10:15 PM Polesovsky, Daniel 2014 January 24 UCSF 10:15 PM Pain Addiction and the Law - Save the Dates! "Robin Hoyle, JD Pain Society of the Carolinas" XXXXXXXXXXXXXXXXXXXX@gmail.com> 2014 January 24 Document Email 2 =?utf-8?Q??= <daniel.polesovsky@mallinckrodt.com> opioids MNKOIv002 MNKOI0003088389 yes 2021 October 21 jrwv0241 Mallinckrodt Litigation Documents mnk public no restrictions 2014 April 29 Polesovsky, Daniel all_2\Polesovsky, Daniel all_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Pain Addiction and the Law - May 3&4 at UNC Chapel Hill - Register Today! 12:29 PM Polesovsky, Daniel 2014 April 29 UCSF 12:29 PM Pain Addiction and the Law - May 3&4 at UNC Chapel Hill - Register Today! "Robin Hoyle, JD Pain Society of the Carolinas" XXXXXXXXXXXXXXXXXXXX@gmail.com> 2014 April 29 Document Email 3 =?utf-8?Q??= <daniel.polesovsky@mallinckrodt.com> opioids MNKOIv002 MNKOI0003088927 yes 2021 October 21 fyxb0241 Mallinckrodt Litigation Documents mnk public no restrictions 2012 January 04 2019-07-02 Opioids emails\Patterson, Steven all_4.zip\Patterson, Steven all_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment 06:01 PM Patterson, Steven 2012 January 04 06:01 PM Re: Addiction Treatment "Patterson, Steven J" <steven.patterson@covidien.com> 2012 January 04 Document Email 1 "Ryan, Edward R" <edward.ryan@covidien.com> Methadone MNKOIv002 MNKOI0003098113 2021 October 21 xsjm0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 April 21 20181112_Emails\Neuman, Herb SUPP OCT 2018_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) California Society of Addiction Medicine Contact 06:23 PM Neuman, Herb 2011 April 21 06:23 PM RE: California Society of Addiction Medicine Contact "lesnak, robert a" 2011 April 21 Document Email 1 "schooler, joanna s" "morelli, art" "stauder, nancy r" "littlejohn, stephen e" "neuman, herbert r" opioids MNKOIv002 MNKOI0002957537 2021 October 21 zmpl0240 Mallinckrodt Litigation Documents mnk public no restrictions 2008 October 22 Young, Jim SUPP OCT 2018 pre2014_5.pst\Top of Personal Folders\Archive MNKOI0002948499 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Avigen announced that it will now switch its focus to AV411, which is in development for neuropathic pain and opioid addiction and withdrawal 09:59 PM Young, Jim 2008 October 22 09:59 PM FW: Avigen announced that it will now switch its focus to AV411, which is in development for neuropathic pain and opioid addiction and withdrawal "young, jim l" 2008 October 22 Document Email 2 "giuliani, michael" Methadone MNKOIv002 MNKOI0002948497 2021 October 21 qfvm0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 August 11 Spaulding, Eileen SUPP OCT 2018 pre2014_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) ASR LOG-0928: - State Controlled Substance Reporting -- Design issue -- Identifying Addiction Treatment Clinics 12:27 PM Spaulding, Eileen 2010 August 11 12:27 PM RE: ASR LOG-0928: - State Controlled Substance Reporting -- Design issue -- Identifying Addiction Treatment Clinics "sanson, bob x" 2010 August 11 Document Email 4 "maher, laura a" "spaulding, eileen l." Fentanyl MNKOIv002 MNKOI0002949180 2021 October 21 rfcm0240 Mallinckrodt Litigation Documents mnk public no restrictions 2009 July 14 Spaulding, Eileen SUPP OCT 2018 pre2014_2.pst\Top of Personal Folders\Archive MNKOI0002950982 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Research and Treatment Services 01:18 PM Spaulding, Eileen 2009 July 14 01:18 PM FW: Addiction Research and Treatment Services "coffey, tracey r" 2009 July 14 Document Email 1 "nikolaus, richard p" "johnson, carrie m" "spaulding, eileen l." opioids MNKOIv002 MNKOI0002950981 2021 October 21 gybl0234 Mallinckrodt Litigation Documents mnk Mindak, Barb public no restrictions produced document; Paper In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Dosage Products Catalog : Analgesics, Addiction Treatment Products, ADHD Treatment Products, Compounding Powders, Other Products Mallinckrodt 1999 December 01 document 3 Hydrocodone Hydrocodone Bitartrate Hydromorphone Methadone Oxycodone MNKOIv001 MNKOI0000152458 2021 October 21 kgbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 10 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending August 8, 2014 09:17 PM Naten, Derek 2014 August 10 UCSF 09:17 PM Addiction Treatment News - Week Ending August 8, 2014 XXXXXXX@aol.com 2014 August 10 Document Email 1 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Methadone Oxycodone MNKOIv002 MNKOI0001671710 yes 2021 October 21 szbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 May 23 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending May 23, 2014 04:06 PM Naten, Derek 2014 May 23 UCSF 04:06 PM Addiction Treatment News - Week Ending May 23, 2014 XXXXXXX@aol.com 2014 May 23 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001672966 yes 2021 October 21 mkbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 29 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending August 29, 2014 03:33 PM Naten, Derek 2014 August 29 UCSF 03:33 PM Addiction Treatment News - Week Ending August 29, 2014 XXXXXXX@aol.com 2014 August 29 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001672133 yes 2021 October 21 qlbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 September 12 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending September 12, 2014 02:00 PM Naten, Derek 2014 September 12 UCSF 02:00 PM Addiction Treatment News - Week Ending September 12, 2014 XXXXXXX@aol.com 2014 September 12 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com thomas.brown@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001672200 yes 2021 October 21 zpbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 October 03 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending October 3, 2014 06:16 PM Naten, Derek 2014 October 03 UCSF 06:16 PM Addiction Treatment News - Week Ending October 3, 2014 XXXXXXX@aol.com 2014 October 03 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com thomas.brown@mallinckrodt.com Buprenorphine Hydrocodone Bitartrate Methadone MNKOIv002 MNKOI0001672563 yes 2021 October 21 ynbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 September 26 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending September 26, 2014 02:55 PM Naten, Derek 2014 September 26 UCSF 02:55 PM Addiction Treatment News - Week Ending September 26, 2014 XXXXXXX@aol.com 2014 September 26 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com thomas.brown@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001672353 yes 2021 October 21 hkcd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 June 13 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending June 13, 2014 05:40 PM Naten, Derek 2014 June 13 UCSF 05:41 PM Addiction Treatment News - Week Ending June 13, 2014 XXXXXXX@aol.com 2014 June 13 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001673521 yes 2021 October 21 kxcd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 June 10 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Medication-Assisted Addiction Therapies – Perspective Co-written by Nora Volkow 11:06 AM Naten, Derek 2014 June 10 11:06 AM Fwd: Medication-Assisted Addiction Therapies – Perspective Co-written by Nora Volkow "Burton, J Craig" <craig.burton@mallinckrodt.com> 2014 June 10 Document Email 9 "Naten, Derek" <derek.naten@mallinckrodt.com> Buprenorphine Methadone MNKOIv002 MNKOI0001673437 2021 October 21 gncd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 June 27 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending June 27, 2014 04:02 PM Naten, Derek 2014 June 27 UCSF 04:02 PM Addiction Treatment News - Week Ending June 27, 2014 XXXXXXX@aol.com 2014 June 27 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001673911 yes 2021 October 21 nncd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 July 04 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive MNKOI0001673931 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending July 4, 2014 02:48 PM Naten, Derek 2014 July 04 UCSF 02:48 PM Addiction Treatment News - Week Ending July 4, 2014 XXXXXXX@aol.com 2014 July 04 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001673929 yes 2021 October 21 xycd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 July 13 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending July 11, 2014 04:06 PM Naten, Derek 2014 July 13 UCSF 04:06 PM Addiction Treatment News - Week Ending July 11, 2014 XXXXXXX@aol.com 2014 July 13 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001673972 yes 2021 October 21 fpcd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 July 18 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending July 18, 2014 06:39 PM Naten, Derek 2014 July 18 UCSF 06:39 PM Addiction Treatment News - Week Ending July 18, 2014 XXXXXXX@aol.com 2014 July 18 Document Email 1 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001674070 yes 2021 October 21 yqcd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 July 25 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending July 25, 2014 01:42 PM Naten, Derek 2014 July 25 UCSF 01:42 PM Addiction Treatment News - Week Ending July 25, 2014 XXXXXXX@aol.com 2014 July 25 Document Email 2 daniel.alexander@mallinckrodt.com edward.ryan@mallinckrodt.com darren.colvin@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone Oxycodone Oxycodone Naloxone MNKOIv002 MNKOI0001674223 yes 2021 October 21 mfdd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 21 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending February 21, 2014 05:57 PM Naten, Derek 2014 February 21 UCSF 05:57 PM Addiction Treatment News - Week Ending February 21, 2014 XXXXXXX@aol.com 2014 February 21 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001674594 yes 2021 October 21 tndd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 March 07 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending March 7, 2014 03:35 PM Naten, Derek 2014 March 07 UCSF 03:35 PM Addiction Treatment News - Week Ending March 7, 2014 XXXXXXX@aol.com 2014 March 07 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Hydrocodone Bitartrate Methadone MNKOIv002 MNKOI0001675028 yes 2021 October 21 rmdd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 March 04 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Growing opiate addiction in NY troubles lawmakers 03:18 PM Naten, Derek 2014 March 04 03:18 PM FW: Growing opiate addiction in NY troubles lawmakers "Naten, Derek" <derek.naten@mallinckrodt.com> 2014 March 04 Document Email 2 "Kevin Walker (kwalker@PENNQUARTERPARTNERS.COM) (kwalker@PENNQUARTERPARTNERS.COM)" <kwalker@pennquarterpartners.com> opioids MNKOIv002 MNKOI0001674933 2021 October 21 jgwd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 April 18 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News Week Ending April 18, 2014 02:06 PM Naten, Derek 2014 April 18 UCSF 02:06 PM Addiction Treatment News Week Ending April 18, 2014 XXXXXXX@aol.com 2014 April 18 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001676180 yes 2021 October 21 yqhw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 August 09 Williams, Jane\Williams, Jane emails all_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending August 9, 2013 05:58 PM Williams, Jane 2013 August 09 UCSF 05:58 PM Addiction Treatment News - Week Ending August 9, 2013 XXXXXXX@aol.com 2013 August 09 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone Morphine MNKOIv002 MNKOI0001712609 yes 2021 October 21 hlpb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 May 26 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Implant for Opioid Addiction Wins FDA Approval 09:38 PM Naten, Derek 2016 May 26 UCSF 09:38 PM Implant for Opioid Addiction Wins FDA Approval Dan Cohen XXXXXXXXXXXXXX@gmail.com> 2016 May 26 Document Email 2 Rob Falb <rob.falb@tevapharm.com> "Green, Jody, Ph.D" <jody.green@rmpdc.org> Jan Chambers <jan.chambers@fmcpaware.org> mbarnes@claad.org "Rosen, Burt" <burt.rosen@pharma.com> Brian Munroe <munroe.brian@endo.com> Marcia Lee Taylor <marcialee_taylor@drugfree.org> dcarlson@collegiumpharma.com Marta Sokolowska <marta.sokolowska@grunenthal.com> Michael C. Barnes <mbarnes@claad.org> Nathan Langley <nlangley@thelockingcap.com> Nccdp XXXXXXXXXXXXX@aol.com> XXXXXXXXXXXXXX@gmail.com mst@egalet.com Mike Innaurato XXXXXXXXXXXXXXX@gmail.com> Alexander Kraus <alexander.kraus@grunenthal.com> Paul Gileno XXXXXXXXXXXXXXXXX@gmail.com> tcmickle@kempharm.com nlangley@thelockingcap.com "Baker, Clark" <clark.baker@grunenthal.com> "Naten, Derek" <derek.naten@mallinckrodt.com> mark.tyndall@mallinckrodt.com E. Blair Clark-Schoeb <bcs@egalet.com> Zachary Burkes <zburkes@gatekeeperinnovation.com> jmd@egalet.com gsturmer@elysiumrx.com pamela.bennett@pharma.com "Must, Alan" <alan.must@pharma.com> XXXXXXXXXXXXXX@yahoo.com XXXXXXXXXX@gmail.com Tim Hermes <thermes@collegiumpharma.com> "Marsha Stanton PhD,RN" <mstanton@pernixtx.com> "Hunter, Dianna" <dianna.hunter@grunenthal.com> asoscia@atlanticpharma.com Deborah Simpson <dsimpson@gatekeeperinnovation.com> pclemens@acurapharm.com bjones@acurapharm.com jemigh@acurapharm.com Andrea Golfinopoulos <agolfinopoulos@intellipharmaceutics.com> iodidi@intellipharmaceutics.com Domenic Della Penna <ddellapenna@intellipharmaceutics.com> sandra@nccdp.org XXXXXXXXX@gmail.com James Heins <jamesheins@optimum.net> Shaina Smith <shaina@uspainfoundation.org> XXXXXXXXX@aol.com Tracy Woody <twoody@kempharm.com> "Dart, Richard MD" <richard.dart@rmpdc.org> bjones@acurapharm.com Stefan Aigner <saigner@inspirionrx.com> Yvonne Klemets Wright <yklemetswright@egalet.com> Peter Pitts <ppitts@cmpi.org> "Robinson, Walter" <walter.robinson@purdue.ca> simonbudman@inflexxion.com adf@mcginnandcompany.com Michael C. Barnes <mbarnes@claad.org> "Slobodin, Alan" <alan.slobodin@mail.house.gov> "Manheim Jr., Bruce S." <bruce.manheim@wilmerhale.com> Samuel J. Spector <samuel.spector@mail.house.gov> Auger Dan <daniel_auger@ayotte.senate.gov> "Mielcarek, Sascha" <sascha.mielcarek@grunenthal.com> Will Loeb <wloeb@mcginnandcompany.com> "Grantz, Brad (Toomey)" <brad_grantz@toomey.senate.gov> Will Loeb <wloeb@mcginnandcompany.com> "Sulliman, Aimee" <aimee.sulliman@purdue.ca> Buprenorphine Buprenorphine/Naloxone MNKOIv001 MNKOI0001634484 yes 2021 October 21 qqpb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 11 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) ACT NOW! ACTION ALERT: TELL GOVERNOR CUOMO AND THE NEW YORK LEGISLATURE TO ELIMINATE BARRIERS AND INCREASE TO ADDICTION TREATMENT 04:53 PM Naten, Derek 2016 June 11 04:53 PM Fwd: ACT NOW! ACTION ALERT: TELL GOVERNOR CUOMO AND THE NEW YORK LEGISLATURE TO ELIMINATE BARRIERS AND INCREASE TO ADDICTION TREATMENT "Naten, Derek" <derek.naten@mallinckrodt.com> 2016 June 11 Document Email 3 Wayne Lair <wlair@statewidepublicaffairs.com> "Malasi, Julian F" <julian.malasi@mallinckrodt.com> opioids MNKOIv001 MNKOI0001635193 2021 October 21 ksfc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 June 12 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_16.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending June 12, 2015 08:15 PM Naten, Derek 2015 June 12 UCSF 08:14 PM Addiction Treatment News - Week Ending June 12, 2015 XXXXXXX@aol.com 2015 June 12 Document Email 3 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com kian.kazemi@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv001 MNKOI0001648862 yes 2021 October 21 hsgc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 May 15 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_17.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Federal government reversing its decision to allow generic OxyContin as addictions surge 11:32 AM Naten, Derek 2015 May 15 UCSF 11:38 AM Federal government reversing its decision to allow generic OxyContin as addictions surge Dan Cohen XXXXXXXXXXXXXX@gmail.com> 2015 May 15 Document Email 4 nlangley@thelockingcap.com wsterman@signaturerx.com Rob Falb <rob.falb@tevapharm.com> "Green, Jody, Ph.D" <jody.green@rmpdc.org> Jan Chambers <jan.chambers@fmcpaware.org> mbarnes@claad.org "Rosen, Burt" <burt.rosen@pharma.com> Brian Munroe <munroe.brian@endo.com> Marcia Lee Taylor <marcialee_taylor@drugfree.org> dcarlson@collegiumpharma.com Marta Sokolowska <marta.sokolowska@grunenthal.com> XXXXXXXXXXXXXXXXX@comcast.net Michael C. Barnes <mbarnes@claad.org> Nathan Langley <nlangley@thelockingcap.com> Nccdp XXXXXXXXXXXXX@aol.com> XXXXXXXXXXXXXX@gmail.com mst@egalet.com Mike Innaurato XXXXXXXXXXXXXXX@gmail.com> Wade Delk <wdelk@goamp.com> Alexander Kraus <alexander.kraus@grunenthal.com> Dan McGinn <dan@mcginnandcompany.com> Paul Gileno XXXXXXXXXXXXXXXXX@gmail.com> tcmickle@kempharm.com "Baker, Clark" <clark.baker@grunenthal.com> "Naten, Derek" <derek.naten@mallinckrodt.com> mark.tyndall@mallinckrodt.com E. Blair Clark-Schoeb <bcs@egalet.com> Zachary Burkes <zburkes@gatekeeperinnovation.com> jmd@egalet.com gsturmer@elysiumrx.com pamela.bennett@pharma.com "Must, Alan" <alan.must@pharma.com> XXXXXXXXXXXXXX@yahoo.com XXXXXXXXXX@gmail.com Tim Hermes <thermes@collegiumpharma.com> "Marsha Stanton PhD,RN" <mstanton@pernixtx.com> "Hunter, Dianna" <dianna.hunter@grunenthal.com> Solana Shaw <solana.shaw@pharma.com> adf@mcginnandcompany.com Michael C. Barnes <mbarnes@claad.org> "Thompson, Kristi" <kristi.thompson@mail.house.gov> "Slobodin, Alan" <alan.slobodin@mail.house.gov> Fentanyl Oxycodone MNKOIv001 MNKOI0001650559 yes 2021 October 21 tjhc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 February 28 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_18.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending February 27, 2015 01:40 PM Naten, Derek 2015 February 28 UCSF 01:40 PM Addiction Treatment News - Week Ending February 27, 2015 XXXXXXX@aol.com 2015 February 28 Document Email 3 daniel.alexander@mallinckrodt.com edward.ryan@mallinckrodt.com darren.colvin@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine Buprenorphine Hydrochloride Methadone MNKOIv001 MNKOI0001651158 yes 2021 October 21 flxc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 September 17 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) President’s Commission on Combating Drug Addiction and the Opioid Crisis ADC Sign-on Letter 02:18 AM Naten, Derek 2017 September 17 02:18 AM Automatic reply: President’s Commission on Combating Drug Addiction and the Opioid Crisis ADC Sign-on Letter "Naten, Derek" <derek.naten@mallinckrodt.com> 2017 September 17 Document Email 1 Sandra NCCDP <sandra@nccdp.org> opioids MNKOIv001 MNKOI0001653186 2021 October 21 pzhc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 January 20 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_19.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) USA Today Centerfold Medication Adherence and Addiction Campaign 09:49 PM Naten, Derek 2015 January 20 09:50 PM RE: USA Today Centerfold Medication Adherence and Addiction Campaign Kevin Walker <kwalker@pennquarterpartners.com> 2015 January 20 Document Email 4 "Naten, Derek" <derek.naten@mallinckrodt.com> opioids MNKOIv001 MNKOI0001652654 2021 October 21 ynxc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 September 20 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Update: President’s Commission on Combating Drug Addiction and the Opioid Crisis ADC Sign-on Letter 12:33 PM Naten, Derek 2017 September 20 12:33 PM Automatic reply: Update: President’s Commission on Combating Drug Addiction and the Opioid Crisis ADC Sign-on Letter "Naten, Derek" <derek.naten@mallinckrodt.com> 2017 September 20 Document Email 1 Cara Moon <cmoon@egalet.com> opioids MNKOIv001 MNKOI0001653564 2021 October 21 jskc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 May 09 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) A Call for Presentations - Advancing & Integrating Specialized Addiction Treatment & Recovery 07:46 PM Naten, Derek 2017 May 09 07:46 PM A Call for Presentations - Advancing & Integrating Specialized Addiction Treatment & Recovery "Kellie Rollins, PsyD - 2018 AATOD Workshop Committee Chair" <info@aatod.org> 2017 May 09 Document Email 3 derek.naten@mallinckrodt.com opioids MNKOIv001 MNKOI0001658800 2021 October 21 thbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 15 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending August 15, 2014 05:00 PM Naten, Derek 2014 August 15 UCSF 05:00 PM Addiction Treatment News - Week Ending August 15, 2014 XXXXXXX@aol.com 2014 August 15 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Methadone MNKOIv002 MNKOI0001671850 yes 2021 October 21 lzvd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 01 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending August 1, 2014 02:17 PM Naten, Derek 2014 August 01 UCSF 02:17 PM Addiction Treatment News - Week Ending August 1, 2014 XXXXXXX@aol.com 2014 August 01 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Methadone MNKOIv002 MNKOI0001671525 yes 2021 October 21 kfcd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 May 30 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending May 30, 2014 05:36 PM Naten, Derek 2014 May 30 UCSF 05:36 PM Addiction Treatment News - Week Ending May 30, 2014 XXXXXXX@aol.com 2014 May 30 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Methadone MNKOIv002 MNKOI0001673159 yes 2021 October 21 plcd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 June 20 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending June 20, 2014 04:01 PM Naten, Derek 2014 June 20 UCSF 04:01 PM Addiction Treatment News - Week Ending June 20, 2014 XXXXXXX@aol.com 2014 June 20 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Methadone MNKOIv002 MNKOI0001673614 yes 2021 October 21 fmdd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 28 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News Week Ending February 28, 2014 04:43 PM Naten, Derek 2014 February 28 UCSF 04:43 PM Addiction Treatment News Week Ending February 28, 2014 XXXXXXX@aol.com 2014 February 28 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Methadone MNKOIv002 MNKOI0001674909 yes 2021 October 21 gqdd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 March 14 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News Week Ending March 14, 2014 06:18 PM Naten, Derek 2014 March 14 UCSF 06:18 PM Addiction Treatment News Week Ending March 14, 2014 XXXXXXX@aol.com 2014 March 14 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001675223 yes 2021 October 21 nhwd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 April 25 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News Week Ending April 25, 2014 05:14 PM Naten, Derek 2014 April 25 UCSF 05:14 PM Addiction Treatment News Week Ending April 25, 2014 XXXXXXX@aol.com 2014 April 25 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001676229 yes 2021 October 21 pshv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 March 14 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) California Addiction Treatment meetings 04:12 PM Naten, Derek 2014 March 14 04:12 PM Re: California Addiction Treatment meetings "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2014 March 14 Document Email 2 "Naten, Derek" <derek.naten@mallinckrodt.com> Buprenorphine MNKOIv002 MNKOI0001867283 2021 October 21 zgpc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 October 26 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) [The 2016 Election] What the Results Mean for the Opioid Epidemic & Addiction Treatment Programs 02:01 PM Naten, Derek 2016 October 26 02:01 PM [The 2016 Election] What the Results Mean for the Opioid Epidemic & Addiction Treatment Programs National Rx Drug Abuse & Heroin Summit <no-reply@addictionpro.com> 2016 October 26 Document Email 2 derek.naten@mallinckrodt.com opioids MNKOIv001 MNKOI0001668908 2021 October 21 jfpc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 October 20 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) What you need to know about addiction in the workplace 01:27 PM Naten, Derek 2016 October 20 01:27 PM What you need to know about addiction in the workplace National Rx Drug Abuse & Heroin Summit <no-reply@addictionpro.com> 2016 October 20 Document Email 4 derek.naten@mallinckrodt.com Hydrocodone MNKOIv001 MNKOI0001668824 2021 October 21 ftbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 May 09 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News Week Ending May 9, 2014 06:21 PM Naten, Derek 2014 May 09 UCSF 06:21 PM Addiction Treatment News Week Ending May 9, 2014 XXXXXXX@aol.com 2014 May 09 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com danny.ottosen@mallinckrodt.com edward.ryan@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001672804 yes 2021 October 21 tmbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 September 20 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending September 19, 2014 04:18 PM Naten, Derek 2014 September 20 UCSF 04:19 PM Addiction Treatment News - Week Ending September 19, 2014 XXXXXXX@aol.com 2014 September 20 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com thomas.brown@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001672288 yes 2021 October 21 jjbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 22 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending August 22, 2014 01:55 PM Naten, Derek 2014 August 22 UCSF 01:55 PM Addiction Treatment News - Week Ending August 22, 2014 XXXXXXX@aol.com 2014 August 22 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine Hydrochloride Methadone MNKOIv002 MNKOI0001672020 yes 2021 October 21 jlbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 September 05 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending September 5, 2014 06:16 PM Naten, Derek 2014 September 05 UCSF 06:16 PM Addiction Treatment News - Week Ending September 5, 2014 XXXXXXX@aol.com 2014 September 05 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001672172 yes 2021 October 21 xnbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 September 24 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Fed Up! Coalition says FDA contributing to national surge in pain pill addiction 12:23 PM Naten, Derek 2014 September 24 12:23 PM Fed Up! Coalition says FDA contributing to national surge in pain pill addiction HDC - Regulatory Intelligence St Louis <regintel.stlouis@mallinckrodt.com> 2014 September 24 Document Email 2 "Healy, Kevin D" <kevin.healy@mallinckrodt.com> "Mercer, Jason" <jason.mercer@mallinckrodt.com> "Iezzi, Christa" <christa.iezzi@mallinckrodt.com> "Banker, Poonam S" <poonam.banker@mallinckrodt.com> "Servello, Diane L" <diane.servello@mallinckrodt.com> "Naten, Derek" <derek.naten@mallinckrodt.com> "Mannebach, Mark" <mark.mannebach@mallinckrodt.com> Hydrocodone Hydrocodone Bitartrate Hydromorphone Oxycodone Oxycodone Naloxone MNKOIv002 MNKOI0001672332 2021 October 21 nrbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 October 10 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending October 10, 2014 02:31 PM Naten, Derek 2014 October 10 UCSF 02:31 PM Addiction Treatment News - Week Ending October 10, 2014 XXXXXXX@aol.com 2014 October 10 Document Email 2 "alexander, dan" "colvin, darren a" "ryan, edward r" "ottosen, danny j" "spencer, romney" "kaczmarek, walt" "williams, jane l" "purcell, tina m" "naten, derek" "crandall, margaret a" thomas.brown@mallinckrodt.com "bullerdick, jennifer m" "randall, louann" Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001672664 yes 2021 October 21 yrbd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 October 17 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending October 17, 2014 04:01 PM Naten, Derek 2014 October 17 UCSF 04:01 PM Addiction Treatment News - Week Ending October 17, 2014 XXXXXXX@aol.com 2014 October 17 Document Email 2 "alexander, dan" "colvin, darren a" "ryan, edward r" "ottosen, danny j" "spencer, romney" "kaczmarek, walt" "williams, jane l" "purcell, tina m" "naten, derek" "bullerdick, jennifer m" "randall, louann" "crandall, margaret a" Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001672666 yes 2021 October 21 lrdd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 March 21 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending March 21, 2014 04:51 PM Naten, Derek 2014 March 21 UCSF 04:51 PM Addiction Treatment News - Week Ending March 21, 2014 XXXXXXX@aol.com 2014 March 21 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Methadone MNKOIv002 MNKOI0001675395 yes 2021 October 21 grdd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 March 20 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Senate Creates Task Force On Heroin, Opioid Addiction 08:07 PM Naten, Derek 2014 March 20 08:07 PM Senate Creates Task Force On Heroin, Opioid Addiction "Franco, Bill" <william.franco@mallinckrodt.com> 2014 March 20 Document Email 2 "Naten, Derek" <derek.naten@mallinckrodt.com> opioids MNKOIv002 MNKOI0001675302 2021 October 21 hfwd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 April 04 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News Week Ending April 4, 2014 10:18 PM Naten, Derek 2014 April 04 UCSF 10:18 PM Addiction Treatment News Week Ending April 4, 2014 XXXXXXX@aol.com 2014 April 04 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Methadone MNKOIv002 MNKOI0001676002 yes 2021 October 21 gzwd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 20 Naten, Derek\Naten, Derek pre 2015_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending December 20, 2013 07:28 PM Naten, Derek 2013 December 20 UCSF 07:28 PM Fwd: Addiction Treatment News - Week Ending December 20, 2013 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2013 December 20 Document Email 3 XXXXXXX@aol.com "Naten, Derek" <derek.naten@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001677210 yes 2021 October 21 yzwd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 27 Naten, Derek\Naten, Derek pre 2015_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending December 27, 2013 05:03 PM Naten, Derek 2013 December 27 UCSF 05:03 PM Addiction Treatment News - Week Ending December 27, 2013 XXXXXXX@aol.com 2013 December 27 Document Email 1 edward.ryan@mallinckrodt.com darren.colvin@mallinckrodt.com tom.sigel@mallinckrodt.com danny.ottosen@mallinckrodt.com daniel.alexander@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com elizabeth.haybron@mallinckrodt.com walt.kaczmarek@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jane.williams@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Methadone MNKOIv002 MNKOI0001677242 yes 2021 October 21 ggfd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 January 04 Naten, Derek\Naten, Derek pre 2015_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News Week Ending January 4, 2014 06:29 PM Naten, Derek 2014 January 04 UCSF 06:29 PM Addiction Treatment News Week Ending January 4, 2014 XXXXXXX@aol.com 2014 January 04 Document Email 1 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com derek.naten@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Methadone MNKOIv002 MNKOI0001677362 yes 2021 October 21 mxfd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 January 11 Naten, Derek\Naten, Derek pre 2015_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending January 10, 2014 02:58 AM Naten, Derek 2014 January 11 UCSF 02:58 AM Addiction Treatment News - Week Ending January 10, 2014 XXXXXXX@aol.com 2014 January 11 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com tom.sigel@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Methadone MNKOIv002 MNKOI0001677514 yes 2021 October 21 gnfd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 January 31 Naten, Derek\Naten, Derek pre 2015_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending January 31, 2014 03:15 PM Naten, Derek 2014 January 31 UCSF 03:15 PM Addiction Treatment News - Week Ending January 31, 2014 XXXXXXX@aol.com 2014 January 31 Document Email 2 daniel.alexander@mallinckrodt.com edward.ryan@mallinckrodt.com darren.colvin@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001677944 yes 2021 October 21 gmpb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 May 31 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Letter to the Editor NY Times Addicted to a Treatment for Addiction 08:36 PM Naten, Derek 2016 May 31 08:36 PM Letter to the Editor NY Times Addicted to a Treatment for Addiction COMPA <allschorr@westmidtownmedical.com> 2016 May 31 Document Email 2 derek.naten@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv001 MNKOI0001634562 2021 October 21 xqvc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 March 31 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Pulse, presented by the Coalition for Medicare Choices: Trump scrambles after abortion misstep — FDA's own big move on abortion — How NIH's top addiction expert wants to change opioid practice 09:46 AM Naten, Derek 2016 March 31 09:46 AM Pulse, presented by the Coalition for Medicare Choices: Trump scrambles after abortion misstep — FDA's own big move on abortion — How NIH's top addiction expert wants to change opioid practice POLITICO Pro Health Care <politicoemail@politicopro.com> 2016 March 31 Document Email 7 derek.naten@mallinckrodt.com opioids MNKOIv001 MNKOI0001637006 2021 October 21 tndc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 March 21 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) BAKER APPEALS FOR STRONGER FEDERAL ROLE OPIOID ADDICTION FIGHT 08:46 PM Naten, Derek 2016 March 21 08:46 PM Re: BAKER APPEALS FOR STRONGER FEDERAL ROLE OPIOID ADDICTION FIGHT "Naten, Derek" <derek.naten@mallinckrodt.com> 2016 March 21 Document Email 3 Jan Rose <jrose@mqmllp.com> "Lohman, Donald A" <donald.lohman@mallinckrodt.com> William McDermott <wmcdermott@mqmllp.com> opioids MNKOIv001 MNKOI0001641574 2021 October 21 gydc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 March 22 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) FDA announces enhanced warnings for immediate-release opioid pain medications related to risks of misuse, abuse, addiction, overdose and death 05:50 PM Naten, Derek 2016 March 22 UCSF 05:50 PM FDA announces enhanced warnings for immediate-release opioid pain medications related to risks of misuse, abuse, addiction, overdose and death Dan Cohen XXXXXXXXXXXXXX@gmail.com> 2016 March 22 Document Email 3 Rob Falb <rob.falb@tevapharm.com> "Green, Jody, Ph.D" <jody.green@rmpdc.org> Jan Chambers <jan.chambers@fmcpaware.org> mbarnes@claad.org "Rosen, Burt" <burt.rosen@pharma.com> Brian Munroe <munroe.brian@endo.com> Marcia Lee Taylor <marcialee_taylor@drugfree.org> dcarlson@collegiumpharma.com Marta Sokolowska <marta.sokolowska@grunenthal.com> Michael C. Barnes <mbarnes@claad.org> Nathan Langley <nlangley@thelockingcap.com> Nccdp XXXXXXXXXXXXX@aol.com> XXXXXXXXXXXXXX@gmail.com mst@egalet.com Mike Innaurato XXXXXXXXXXXXXXX@gmail.com> Alexander Kraus <alexander.kraus@grunenthal.com> Paul Gileno XXXXXXXXXXXXXXXXX@gmail.com> tcmickle@kempharm.com nlangley@thelockingcap.com "Baker, Clark" <clark.baker@grunenthal.com> "Naten, Derek" <derek.naten@mallinckrodt.com> mark.tyndall@mallinckrodt.com E. Blair Clark-Schoeb <bcs@egalet.com> Zachary Burkes <zburkes@gatekeeperinnovation.com> jmd@egalet.com gsturmer@elysiumrx.com pamela.bennett@pharma.com "Must, Alan" <alan.must@pharma.com> XXXXXXXXXXXXXX@yahoo.com XXXXXXXXXX@gmail.com Tim Hermes <thermes@collegiumpharma.com> "Marsha Stanton PhD,RN" <mstanton@pernixtx.com> "Hunter, Dianna" <dianna.hunter@grunenthal.com> asoscia@atlanticpharma.com Deborah Simpson <dsimpson@gatekeeperinnovation.com> pclemens@acurapharm.com bjones@acurapharm.com jemigh@acurapharm.com Andrea Golfinopoulos <agolfinopoulos@intellipharmaceutics.com> iodidi@intellipharmaceutics.com Domenic Della Penna <ddellapenna@intellipharmaceutics.com> sandra@nccdp.org XXXXXXXXX@gmail.com James Heins <jamesheins@optimum.net> Shaina Smith <shaina@uspainfoundation.org> XXXXXXXXX@aol.com Tracy Woody <twoody@kempharm.com> "Dart, Richard MD" <richard.dart@rmpdc.org> adf@mcginnandcompany.com Michael C. Barnes <mbarnes@claad.org> "Slobodin, Alan" <alan.slobodin@mail.house.gov> "Manheim Jr., Bruce S." <bruce.manheim@wilmerhale.com> Samuel J. Spector <samuel.spector@mail.house.gov> Auger Dan <daniel_auger@ayotte.senate.gov> "Mielcarek, Sascha" <sascha.mielcarek@grunenthal.com> Will Loeb <wloeb@mcginnandcompany.com> "Grantz, Brad (Toomey)" <brad_grantz@toomey.senate.gov> Buprenorphine Methadone Morphine Oxycodone MNKOIv001 MNKOI0001641582 yes 2021 October 21 qpwc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 October 19 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_14.pst\Top of Personal Folders\Archive MNKOI0001644690 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment 2016 Strategic Plan for discussion at NSM 05:47 PM Naten, Derek 2015 October 19 05:47 PM FW: Addiction Treatment 2016 Strategic Plan for discussion at NSM "Naten, Derek" <derek.naten@mallinckrodt.com> 2015 October 19 Document Email 1 "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> "Malasi, Julian F" <julian.malasi@mallinckrodt.com> opioids MNKOIv001 MNKOI0001644689 2021 October 21 qpfc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 June 05 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_16.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending June 5, 2015 05:23 PM Naten, Derek 2015 June 05 UCSF 05:23 PM Addiction Treatment News - Week Ending June 5, 2015 XXXXXXX@aol.com 2015 June 05 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com kian.kazemi@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv001 MNKOI0001648718 yes 2021 October 21 qqfc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 June 08 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_16.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Painkillers: Seeing Our Opioid Addiction Crisis For What It Is | Cognoscenti 10:52 AM Naten, Derek 2015 June 08 UCSF 10:52 AM Fwd: Painkillers: Seeing Our Opioid Addiction Crisis For What It Is | Cognoscenti "Naten, Derek" <derek.naten@mallinckrodt.com> 2015 June 08 Document Email 1 "Tilly, Jason" <jason.tilly@mallinckrodt.com> opioids MNKOIv001 MNKOI0001648753 yes 2021 October 21 mnfc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 September 25 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_15.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HHS unveils new rules for doctors treating opiate drug addiction 05:56 PM Naten, Derek 2015 September 25 05:56 PM HHS unveils new rules for doctors treating opiate drug addiction National Rx Drug Abuse Summit <dmorton@centertech.com> 2015 September 25 Document Email 6 derek.naten@mallinckrodt.com Buprenorphine MNKOIv001 MNKOI0001648467 2021 October 21 lyfc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 September 30 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_15.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Attorney General Kamala D. Harris, 37 Attorneys General Join in Support of the Comprehensive Addiction and Recovery Act of 2015 01:07 AM Naten, Derek 2015 September 30 01:07 AM Fwd: Attorney General Kamala D. Harris, 37 Attorneys General Join in Support of the Comprehensive Addiction and Recovery Act of 2015 Kris Rosa <kris@frednoteware.com> 2015 September 30 Document Email 2 Derek Naten <derek.naten@mallinckrodt.com> opioids MNKOIv001 MNKOI0001648567 2021 October 21 mzfc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 June 26 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_16.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending June 26, 2015 04:23 PM Naten, Derek 2015 June 26 UCSF 04:23 PM Addiction Treatment News - Week Ending June 26, 2015 XXXXXXX@aol.com 2015 June 26 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com kian.kazemi@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine/Naloxone Methadone MNKOIv001 MNKOI0001649086 yes 2021 October 21 jrfc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 June 10 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_16.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Alabama launches 'Zero Addiction' campaign to fight opioid abuse, heroin | AL.com 01:15 AM Naten, Derek 2015 June 10 01:15 AM Re: Alabama launches 'Zero Addiction' campaign to fight opioid abuse, heroin | AL.com Preston Baldwin <pbaldwin@centerpoint360.com> 2015 June 10 Document Email 1 "Naten, Derek" <derek.naten@mallinckrodt.com> opioids MNKOIv001 MNKOI0001648773 2021 October 21 llgc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 April 14 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_17.pst\Top of Personal Folders\Archive MNKOI0001649865 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Senate Opioid Addiction Task Force Hearings 03:58 PM Naten, Derek 2015 April 14 03:59 PM Senate Opioid Addiction Task Force Hearings Wayne Lair <wlair@statewidepublicaffairs.com> 2015 April 14 Document Email 1 derek.naten@mallinckrodt.com opioids MNKOIv001 MNKOI0001649864 2021 October 21 zhgc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 July 11 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_16.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News Week Ending July 10, 2015 04:02 AM Naten, Derek 2015 July 11 UCSF 04:02 AM Addiction Treatment News Week Ending July 10, 2015 XXXXXXX@aol.com 2015 July 11 Document Email 3 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com kian.kazemi@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine/Naloxone Fentanyl Methadone MNKOIv001 MNKOI0001649513 yes 2021 October 21 krgc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 May 09 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_17.pst\Top of Personal Folders\Archive MNKOI0001650491 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) PRC approved Addiction treatment catalogue 06:33 PM Naten, Derek 2015 May 09 06:33 PM FW: PRC approved Addiction treatment catalogue "Naten, Derek" <derek.naten@mallinckrodt.com> 2015 May 09 Document Email 1 "Kris Rosa (Kris@frednoteware.com)" <kris@frednoteware.com> opioids MNKOIv001 MNKOI0001650490 2021 October 21 fhvc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 24 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Is DEA a bad guy in opioid addiction fight? - The Washington Post 03:58 PM Naten, Derek 2016 June 24 03:59 PM RE: Is DEA a bad guy in opioid addiction fight? - The Washington Post "Zook, David R." <dave.zook@faegrebd.com> 2016 June 24 Document Email 4 "Naten, Derek" <derek.naten@mallinckrodt.com> Fentanyl Hydromorphone Oxycodone MNKOIv001 MNKOI0001635830 2021 October 21 ttpb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 16 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) PhRMA-Illinois Task Force: Article--Durbin Introduces Bill to Prevent Opioid Addiction 09:00 PM Naten, Derek 2016 June 16 08:59 PM PhRMA-Illinois Task Force: Article--Durbin Introduces Bill to Prevent Opioid Addiction "Baker, Sonya" <sbaker@phrma.org> 2016 June 16 Document Email 1 "Baker, Sonya" <sbaker@phrma.org> opioids MNKOIv001 MNKOI0001635544 2021 October 21 hfbc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 April 13 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Opioid Addiction Campaign - USA Today 04:25 PM Naten, Derek 2016 April 13 UCSF 04:25 PM FW: Opioid Addiction Campaign - USA Today "Rosen, Burt" <burt.rosen@pharma.com> 2016 April 13 Document Email 4 Aaron Gilson <amgilson@wisc.edu> Aimee Welch champion <awelch_champion@compassionandchoices.org> Alec Stone <astone@ons.org> Alex Bardakh <abardakh@amda.com> Alice Mead <apm@gwpharm.com> Amy Goldstein <agoldstein@aapainmanage.org> Amy Melnick <amym@nationalcoalitionhpc.org> Amy Shank <ashank@pccarx.com> Andrew Scott <scott.andrew@endo.com> Anita Ducca <aducca@hdmanet.org> Anna Hyde <ahyde@arthritis.org> Annelies Hall <annelies.hall@rmpdc.org> Aqeel Fatmi <aqeel.fatmi@bannerls.com> Ashley Walton <a.walton@asahq.org> Barbara Marcanti <bmarcanti@sjm.com> "Bennett, Pamela (Gov't Affairs)" <pamela.bennett@pharma.com> "Blair Clark-Schoeb (bcs@egalet.com)" <bcs@egalet.com> Brian Munroe <munroe.brian@endo.com> Bruce Colligen <bcollig@its.jnj.com> Catherine Underwood <cunderwood@americanpainsociety.org> Chris Krese <ckrese@nacds.org> Chris Rorick <chris.rorick@bryancave.com> Chris Topoleski <ctopoleski@ashp.org> Christin Veasley <cveasley@cpralliance.org> Christopher Timmerman <christopher.timmerman@bsci.com> Cindy Steinberg <csteinberg@rcn.com> CLAAD Policy <policy@claad.org> Claudia Campbell XXXXXXXXXXXX@yahoo.com> Crystal Muilenburg <muilenburg_crystal@allergan.com> Cynthia Bens <cbens@agingresearch.org> Dan Cohen XXXXXXXXXXXXXX@gmail.com> Dan Ignaszewski <dan@amputee-coalition.org> Daniel Raymond <raymond@harmreduction.org> Dave Duhrkoop XXXXXXXXXXXXXX@gmail.com> David E. Joranson <joranson@wisc.edu> David Swankin <davidswankin@cacenter.org> David Woodmansee <david.woodmansee@cancer.org> Deborah Pasko <dpasko@ashp.org> Derek Naten <derek.naten@mallinckrodt.com> Diane Millman <diane.millman@ppsv.com> Donna Kalauokalani XXXXXXXXXXXXXX@yahoo.com> Dr. Alexander Kraus <alexander.kraus@grunenthal.com> Elizabeth Hanpeter <elizabeth.hanpeter@abbvie.com> "Erensen, Jennifer" <jennifer.erensen@pharma.com> Fred Branson II <fbrason@projectlazarus.org> Gaby Geise <ggeise@amda.com> Gail Amalia B. Katz XXXXXXXXXXXXX@gmail.com> Gina Angelo <gina.angelo@abbvie.com> Gregory Terman <gwt@u.washington.edu> gwenn herman <gwenn@pain-connection.org> "Haddox, Dr. J. David" <dr.j.david.haddox@pharma.com> Hayden Rhudy <hayden.rhudy@abbvie.com> Henrietta Ukwu <henrietta.ukwu@otsuka-us.com> Isaac Fordjour <isaac.fordjour@bsci.com> Jacquelin Harris <jacquelin.harris@abbvie.com> James Lavery <james.lavery@abbvie.com> Jan Chambers XXXXXXXXXXXXXXX@gmail.com> Janet Favero Chambers <jan.chambers@fmcpaware.org> Janet McUlsky <janet.mculsky@pfizer.com> Jason Crosby <jcrosby@ichelp.org> Jenna Ventresca <jventresca@aphanet.org> Jeremy Scott <jeremy.scott@dbr.com> Jerrica Mathis <jerrica.mathis@dbr.com> Jewelyn Wellborn Cosgrove <jwellborn@hdmanet.org> Jillanne Schulte <jschulte@aphanet.org> Jillian Manley <jillian@aapainmanage.org> Jim Broatch XXXXXXXXXX@gmail.com> Joan Baird <jbaird@ascp.com> Joanna Morales <jm@triagecancer.org> Jody Green <jody.green@rmpdc.org> John Halliwell <john.p.halliwell@pfizer.com> John Kraemer <john.w.kraemer@pfizer.com> Jonathan Jagoda <jjagoda@fsmb.org> Jonathan Keyserling <jkeyserling@nhpco.org> Jordan Wildermuth <jwildermuth@connect2amc.com> Joseph Hill <jhill@ashp.org> Joy Buck <jbuck@hsc.wvu.edu> Judi Lund Person <jlundperson@nhpco.org> Julian Malasi <julian.malasi@mallinckrodt.com> June Dahl PhD <jldahl@wisc.edu> Karen Hill <karen.hill@tevapharm.com> Kathleen Strauser <kstrauser@highwaterpartners.net> Katie Duensing <kduensing@aapainmanage.org> Kayla Lindsay <klindsay@arthritis.org> Ken Cole <ken.cole@pfizer.com> Kevin Nicholson <knicholson@nacds.org> Kevin Zacharoff XXXXXXXXXXXXX@gmail.com> Keysha Brooks-Coley <keysha.brooks-coley@cancer.org> Kirsten Sloan <kirsten.sloan@cancer.org> Kristen Freitas <kfreitas@hdmanet.org> Kristin Recchiuti <krecchiu@its.jnj.com> Kristina Pisanelli <kristina.m.pisanelli@medtronic.com> "Lauryl Jackson (LJackso1@ITS.JNJ.com)" <ljackso1@its.jnj.com> Lee Claassen <lclaassen@ichelp.org> Lenore Duensing <lduensing@aapainmanage.org> Lisa Pearlstein <l.pearlstein@asahq.org> Lisa Robin <lrobin@fsmb.org> Lisa Saake XXXXXXXXXXXXX@gmail.com> Loyce Pace Bass <loyce.pace@livestrong.org> Maggie Buckley XXXXXXXXXXXXXXX@gmail.com> Marcia Lee Taylor <marcialee_taylor@drugfree.org> Mark Fleury <mark.fleury@cancer.org> Mark Tyndall <mark.tyndall@mallinckrodt.com> Marsha Stanton <mstanton@pernixtx.com> Marta Sokolowska <marta.sokolowska@grunenthal.com> Matt Gunderman <matthew.gunderman@bsci.com> "McNeil, Melodi" <melodi.mcneil@abbvie.com> Melea Lusk <melea.lusk@abbvie.com> Michael C. Barnes <mbarnes@claad.org> Michael Fahmy <michael.fahmy@otsuka-us.com> Michael Jarvis <michael.jarvis@abbvie.com> Michael Keegan <michael.keegan@ncpanet.org> Michael Spira <mspira@aphanet.org> Michelle Cope <mcope@nacds.org> Micke Brown XXXXXXXXXXXXXX@gmail.com> Mike Heffernan <mheffernan@collegiumpharma.com> Mike Innaurato <mike.innaurato@inspirionrx.com> Mike Walsh <mwalsh@allianceforpatientaccess.org> Myra Christopher <mchristopher@practicalbioethics.org> Nicole Kelly XXXXXXXXXXXX@verizon.net> Nina DeLorenzo <nina.delorenzo@abbvie.com> Patrick Coyne XXXXXXXXXXX@aol.com> Paul Arnstein <pmarnstein@partners.org> Paul Gileno XXXXXXXXXXXXXXXXX@gmail.com> Paul Scott O'Neill <pso@dcbalaw.com> "Paul, Ilisa Halpern" <ilisa.halpernpaul@dbr.com> Peggy Tighe <peggy.tighe@ppsv.com> Penny Cowan <pcowan@theacpa.org> Peter Pitts <ppitts@cmpi.org> Peter Rankin <prankin@ascp.com> Peter Reinecke <peter@rssinc.us> Philip Goglas <goglas@hmcw.org> Philip Saigh Jr. <psaigh@connect2amc.com> Phyllis Whitehead <pbwhitehead@carilionclinic.org> Robert Falb <rob.falb@tevapharm.com> Robert Radie <rr@egalet.com> Robert Saner <robert.saner@ppsv.com> Robert Twillman <btwillman@aapainmanage.org> Ron Kuntz <rkuntz@its.jnj.com> Ronna Hauser <ronna.hauser@ncpanet.org> Rosalie Abbott <rosalie.abbott@cancer.org> Rosemary Garza <rosemary.garza@medtronic.com> "Rosen, Burt" <burt.rosen@pharma.com> "Ruth Miller (rmiller@hdmanet.org)" <rmiller@hdmanet.org> Ryne Carney <rcarney@agingresearch.org> Saira Sultan <saira.sultan@connect4strategies.com> Sally Welsh <sallyw@hpna.org> Sandie Preiss <spreiss@arthritis.org> Sara Rosta <sara.rosta@ppsv.com> Sarah Buchanan <sbuchanan@hmcw.org> Sharon Brigner <sbrigner@phrma.org> Sharon Stancliff <stancliff@harmreduction.org> "Shaw, Solana" <solana.shaw@pharma.com> Sherrie Dornberger <executive@nadona.org> Stephanie Fajuri <stephanie.fajuri@drlcenter.org> Steve LaPierre <steve.lapierre@bsci.com> Steve Marmaras <smarmaras@ghlf.org> Sue Thau XXXXXXXXX@aol.com> Susan Peschin <speschin@agingresearch.org> Susan Rogers XXXXXXXXXXXXXXX@verizon.net> Susan Stone <stone_susan@allergan.com> Susan Weinstein <sweinstein@namsdl.org> Teresa Shaffer <teresa.shaffer@paincommunity.org> "Tiller, Kimberley" <kimberley.tiller@pharma.com> Tim Hermes <thermes@collegiumpharma.com> Timothy Byrne <byrne.timothy@endo.com> Todd Stamps XXXXXXXXXXX@gmail.com> Tom O'Donnell <todonnell@nacds.org> Wade Delk XXXXXXXXXX@gmail.com> William Gray <william.gray@abbvie.com> Windy Y. Carson-Smith XXXXXXXXX@aol.com> Yvonne Klemets Wright <yklemetswright@egalet.com> opioids MNKOIv001 MNKOI0001637477 yes 2021 October 21 zryc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 October 14 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Diverse Medicaid rules hurt in fighting addiction 02:34 PM Naten, Derek 2016 October 14 02:37 PM Diverse Medicaid rules hurt in fighting addiction NCSL TODAY <enews@ncsl.org> 2016 October 14 Document Email 2 Derek Naten <derek.naten@mallinckrodt.com> Buprenorphine MNKOIv001 MNKOI0001668502 2021 October 21 gsyc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 October 14 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Ontario's opioid plan could lead to more overdoses, death, say drug addiction experts 03:30 PM Naten, Derek 2016 October 14 UCSF 03:30 PM Ontario's opioid plan could lead to more overdoses, death, say drug addiction experts Dan Cohen XXXXXXXXXXXXXX@gmail.com> 2016 October 14 Document Email 3 Rob Falb <rob.falb@tevapharm.com> "Green, Jody, Ph.D" <jody.green@rmpdc.org> Jan Chambers <jan.chambers@fmcpaware.org> mbarnes@claad.org "Rosen, Burt" <burt.rosen@pharma.com> Brian Munroe <munroe.brian@endo.com> Marcia Lee Taylor <marcialee_taylor@drugfree.org> dcarlson@collegiumpharma.com Marta Sokolowska <marta.sokolowska@grunenthal.com> XXXXXXXXX@aol.com Michael C. Barnes <mbarnes@claad.org> Nathan Langley <nlangley@thelockingcap.com> XXXXXXXXXXXXXX@gmail.com mst@egalet.com Mike Innaurato XXXXXXXXXXXXXXX@gmail.com> XXXXXXXXX@gmail.com Alexander Kraus <alexander.kraus@grunenthal.com> Paul Gileno XXXXXXXXXXXXXXXXX@gmail.com> tcmickle@kempharm.com nlangley@thelockingcap.com "Baker, Clark" <clark.baker@grunenthal.com> "Naten, Derek" <derek.naten@mallinckrodt.com> mark.tyndall@mallinckrodt.com E. Blair Clark-Schoeb <bcs@egalet.com> Zachary Burkes <zburkes@gatekeeperinnovation.com> jmd@egalet.com gsturmer@elysiumrx.com pamela.bennett@pharma.com "Must, Alan" <alan.must@pharma.com> XXXXXXXXXXXXXX@yahoo.com XXXXXXXXXX@gmail.com Tim Hermes <thermes@collegiumpharma.com> "Marsha Stanton PhD,RN" <mstanton@pernixtx.com> "Hunter, Dianna" <dianna.hunter@grunenthal.com> asoscia@atlanticpharma.com Deborah Simpson <dsimpson@gatekeeperinnovation.com> pclemens@acurapharm.com bjones@acurapharm.com jemigh@acurapharm.com Andrea Golfinopoulos <agolfinopoulos@intellipharmaceutics.com> iodidi@intellipharmaceutics.com Domenic Della Penna <ddellapenna@intellipharmaceutics.com> sandra@nccdp.org Robert Twillman <btwillman@aapainmanage.org> James Heins <jamesheins@optimum.net> nccdpcorporate@nccdp.org sandra@nccdp.org dsmith@altusformulation.com adf@mcginnandcompany.com Michael C. Barnes <mbarnes@claad.org> "Slobodin, Alan" <alan.slobodin@mail.house.gov> "Manheim Jr., Bruce S." <bruce.manheim@wilmerhale.com> mwalsh@allianceforpatientaccess.org Samuel J. Spector <samuel.spector@mail.house.gov> Auger Dan <daniel_auger@ayotte.senate.gov> "Mielcarek, Sascha" <sascha.mielcarek@grunenthal.com> "Dart, Richard MD" <richard.dart@rmpdc.org> Fentanyl Methadone MNKOIv001 MNKOI0001668506 yes 2021 October 21 phcd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 June 06 Naten, Derek\Naten, Derek pre 2015_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News Week Ending June 6, 2014 05:05 PM Naten, Derek 2014 June 06 UCSF 05:05 PM Addiction Treatment News Week Ending June 6, 2014 XXXXXXX@aol.com 2014 June 06 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001673352 yes 2021 October 21 rybd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 September 29 Naten, Derek\Naten, Derek pre 2015_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) FDA says no to anti-addiction rule on Ritalin, painkiller -- Citizen Petition denied 04:35 PM Naten, Derek 2014 September 29 UCSF 04:36 PM FW: FDA says no to anti-addiction rule on Ritalin, painkiller -- Citizen Petition denied "Naten, Derek" <derek.naten@mallinckrodt.com> 2014 September 29 Document Email 2 "William Sarraille (wsarraille@sidley.com)" <wsarraille@sidley.com> jsenger@sidley.com "Dickson, Sean (sdickson@sidley.com)" <sdickson@sidley.com> opioids MNKOIv002 MNKOI0001672490 yes 2021 October 21 nsdd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 March 28 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending March 28, 2014 04:51 PM Naten, Derek 2014 March 28 UCSF 04:51 PM Addiction Treatment News - Week Ending March 28, 2014 XXXXXXX@aol.com 2014 March 28 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001675771 yes 2021 October 21 qxwd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 May 02 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending May 2, 2014 02:26 PM Naten, Derek 2014 May 02 UCSF 02:27 PM Addiction Treatment News - Week Ending May 2, 2014 XXXXXXX@aol.com 2014 May 02 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Methadone MNKOIv002 MNKOI0001676331 yes 2021 October 21 yfwd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 April 11 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending April 11, 2014 03:11 PM Naten, Derek 2014 April 11 UCSF 03:11 PM Addiction Treatment News - Week Ending April 11, 2014 XXXXXXX@aol.com 2014 April 11 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001676032 yes 2021 October 21 qjfd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 January 18 Naten, Derek\Naten, Derek pre 2015_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending January 17, 2014 05:46 AM Naten, Derek 2014 January 18 UCSF 05:47 AM Addiction Treatment News - Week Ending January 17, 2014 XXXXXXX@aol.com 2014 January 18 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Methadone MNKOIv002 MNKOI0001677607 yes 2021 October 21 xyfd0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 07 Naten, Derek\Naten, Derek pre 2015_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending February 7, 2014 03:20 PM Naten, Derek 2014 February 07 UCSF 03:20 PM Addiction Treatment News - Week Ending February 7, 2014 XXXXXXX@aol.com 2014 February 07 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com derek.naten@mallinckrodt.com tina.purcell@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Methadone MNKOIv002 MNKOI0001678052 yes 2021 October 21 jsxw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 July 26 Williams, Jane\Williams, Jane emails all_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending July 26, 2013 04:17 PM Williams, Jane 2013 July 26 UCSF 04:17 PM Addiction Treatment News - Week Ending July 26, 2013 XXXXXXX@aol.com 2013 July 26 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001714003 yes 2021 October 21 xyfw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 September 21 Williams, Jane\Williams, Jane emails all_2.pst\Top of Personal Folders\Archive MNKOI0001710697 MNKOI0001710700 MNKOI0001710703 MNKOI0001710706 MNKOI0001710709 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Business Reviews - FYI Only 09:05 PM Williams, Jane 2014 September 21 09:05 PM FW: Addiction Treatment Business Reviews - FYI Only "Williams, Jane L" <jane.williams@mallinckrodt.com> 2014 September 21 Document Email 2 "Kaczmarek, Walt" <walt.kaczmarek@mallinckrodt.com> opioids MNKOIv002 MNKOI0001710695 2021 October 21 nhxw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 October 12 Williams, Jane\Williams, Jane emails all_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending October 11, 2013 02:59 PM Williams, Jane 2013 October 12 UCSF 02:59 PM Addiction Treatment News - Week Ending October 11, 2013 XXXXXXX@aol.com 2013 October 12 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001713173 yes 2021 October 21 yxxw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 October 18 Williams, Jane\Williams, Jane emails all_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending October 18, 2013 04:16 PM Williams, Jane 2013 October 18 UCSF 04:16 PM Addiction Treatment News - Week Ending October 18, 2013 XXXXXXX@aol.com 2013 October 18 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001713249 yes 2021 October 21 ngxm0237 Mallinckrodt Litigation Documents mnk public no restrictions 2016 July 19 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_8\Spaulding emails 1 1 14 to 5 9 18_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HDA Weekly Digest, July 19: Senate Passes the Comprehensive Addiction and Recovery Act 02:55 PM Spaulding, Eileen 2016 July 19 02:56 PM HDA Weekly Digest, July 19: Senate Passes the Comprehensive Addiction and Recovery Act HDA Weekly Digest <digest@hda.org> 2016 July 19 Document Email 3 eileen.spaulding@mallinckrodt.com opioids MNKOIv001 MNKOI0001482232 2021 October 21 qflm0237 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 14 Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) AMCP - Pain Management Abuse and Addiction Forum - 9/9/2014 04:19 PM Jackson, Catherine 2014 August 14 04:19 PM Re: AMCP - Pain Management Abuse and Addiction Forum - 9/9/2014 "Anderson, Jan" <jan.anderson@mallinckrodt.com> 2014 August 14 Document Email 2 "Corson, Maureen E" <maureen.corson@mallinckrodt.com> "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> Sonya C. Martin <smartin@tmacmail.com> opioids MNKOIv001 MNKOI0001487295 2021 October 21 sflm0237 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 14 Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) AMCP - Pain Management Abuse and Addiction Forum - 9/9/2014 05:30 PM Jackson, Catherine 2014 August 14 05:30 PM RE: AMCP - Pain Management Abuse and Addiction Forum - 9/9/2014 "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> 2014 August 14 Document Email 3 "Corson, Maureen E" <maureen.corson@mallinckrodt.com> Sonya C. Martin <smartin@tmacmail.com> "Anderson, Jan" <jan.anderson@mallinckrodt.com> opioids MNKOIv001 MNKOI0001487298 2021 October 21 hglm0237 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 18 Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) AMCP - Pain Management Abuse and Addiction Forum - 9/9/2014 06:45 PM Jackson, Catherine 2014 August 18 06:45 PM RE: AMCP - Pain Management Abuse and Addiction Forum - 9/9/2014 "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> 2014 August 18 Document Email 3 "Sciame, Maria C" <maria.sciame@mallinckrodt.com> opioids MNKOIv001 MNKOI0001487323 2021 October 21 rghm0237 Mallinckrodt Litigation Documents mnk public no restrictions 2017 May 31 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_5\Spaulding emails 1 1 14 to 5 9 18_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Shipping History Report for DEA - Methadose Oral Conc 10mg/mL - Addiction Treatment Center - DEA # PA0203024 - MA 04:21 PM Spaulding, Eileen 2017 May 31 04:21 PM RE: Mallinckrodt Shipping History Report for DEA - Methadose Oral Conc 10mg/mL - Addiction Treatment Center - DEA # PA0203024 - MA "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> 2017 May 31 Document Email 4 "Lee, Andrew M." <andrew.m.lee@usdoj.gov> Methadone MNKOIv001 MNKOI0001481270 2021 October 21 yflm0237 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 13 Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive MNKOI0001487288 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) AMCP - Pain Management Abuse and Addiction Forum - 9/9/2014 10:41 PM Jackson, Catherine 2014 August 13 10:41 PM AMCP - Pain Management Abuse and Addiction Forum - 9/9/2014 "Anderson, Jan" <jan.anderson@mallinckrodt.com> 2014 August 13 Document Email 1 "Melikian, David" <david.melikian@mallinckrodt.com> "Patel, Teresa" <teresa.patel@mallinckrodt.com> "Chopra, Lalit K" <lalit.chopra@mallinckrodt.com> "Ouranos, Haleh" <haleh.ouranos@mallinckrodt.com> "Corson, Maureen E" <maureen.corson@mallinckrodt.com> "Warnick, Meredith" <meredith.warnick@mallinckrodt.com> "Cheng, Ladia" <ladia.cheng@mallinckrodt.com> "De Fiebre, Christopher M" <christopher.defiebre@mallinckrodt.com> "Johnson, Andrew W (Medical Science Liaison)" <andrew.w.johnson@mallinckrodt.com> "Mount, Joshua" <joshua.mount@mallinckrodt.com> "Nelson, Sally" <sally.nelson@mallinckrodt.com> "Sciame, Maria C" <maria.sciame@mallinckrodt.com> "Sutton, Blair C" <blair.sutton@mallinckrodt.com> "Toler, Wendy" <wendy.toler@mallinckrodt.com> "Pennell, Andrew" <andrew.pennell@mallinckrodt.com> "Lohr, Cynthia" <cynthia.lohr@mallinckrodt.com> "Pasedis, Georgea" <georgea.pasedis@mallinckrodt.com> "Sonya C. Martin (smartin@tmacmail.com)" <smartin@tmacmail.com> "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> opioids MNKOIv001 MNKOI0001487287 2021 October 21 pglm0237 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 25 Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) AMCP - Pain Management Abuse and Addiction Forum - 9/9/2014 05:48 PM Jackson, Catherine 2014 August 25 05:48 PM RE: AMCP - Pain Management Abuse and Addiction Forum - 9/9/2014 "Patel, Teresa" <teresa.patel@mallinckrodt.com> 2014 August 25 Document Email 4 "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> opioids MNKOIv001 MNKOI0001487403 2021 October 21 xmjm0237 Mallinckrodt Litigation Documents mnk public no restrictions 2014 November 13 Jackson, Catherine\Catherine Jackson all_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Here’s one thing Charlie Baker should do to address opiate addiction - Boston Business Journal 08:13 PM Jackson, Catherine 2014 November 13 08:13 PM FW: Here’s one thing Charlie Baker should do to address opiate addiction - Boston Business Journal "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> 2014 November 13 Document Email 3 "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> Hydrocodone Bitartrate Oxycodone MNKOIv001 MNKOI0001484391 2021 October 21 jmjm0237 Mallinckrodt Litigation Documents mnk public no restrictions 2014 November 13 Jackson, Catherine\Catherine Jackson all_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Here’s one thing Charlie Baker should do to address opiate addiction - Boston Business Journal 08:40 PM Jackson, Catherine 2014 November 13 08:40 PM RE: Here’s one thing Charlie Baker should do to address opiate addiction - Boston Business Journal "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> 2014 November 13 Document Email 4 "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> Hydrocodone Bitartrate Oxycodone MNKOIv001 MNKOI0001484394 2021 October 21 kmjm0237 Mallinckrodt Litigation Documents mnk public no restrictions 2014 November 13 Jackson, Catherine\Catherine Jackson all_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Here’s one thing Charlie Baker should do to address opiate addiction - Boston Business Journal 08:41 PM Jackson, Catherine 2014 November 13 08:41 PM RE: Here’s one thing Charlie Baker should do to address opiate addiction - Boston Business Journal "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> 2014 November 13 Document Email 4 "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> Hydrocodone Bitartrate Oxycodone MNKOIv001 MNKOI0001484398 2021 October 21 pzlm0237 Mallinckrodt Litigation Documents mnk public no restrictions 2017 November 02 Jackson, Catherine\Catherine Jackson all_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Video: Opioid Addiction, Hepatitis C & Unborn Babies 03:14 PM Jackson, Catherine 2017 November 02 03:35 PM Video: Opioid Addiction, Hepatitis C & Unborn Babies Alliance for Patient Access <info@allianceforpatientaccess.org> 2017 November 02 Document Email 1 catherine.jackson@mallinckrodt.com opioids MNKOIv001 MNKOI0001490019 2021 October 21 mmjm0237 Mallinckrodt Litigation Documents mnk public no restrictions 2014 November 14 Jackson, Catherine\Catherine Jackson all_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Here’s one thing Charlie Baker should do to address opiate addiction - Boston Business Journal 01:38 AM Jackson, Catherine 2014 November 14 01:38 AM RE: Here’s one thing Charlie Baker should do to address opiate addiction - Boston Business Journal "Sciarra, Rhonda" <rhonda.sciarra@mallinckrodt.com> 2014 November 14 Document Email 3 "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> Hydrocodone Bitartrate Oxycodone MNKOIv001 MNKOI0001484416 2021 October 21 klnx0237 Mallinckrodt Litigation Documents mnk public no restrictions 2017 August 17 \Additional_Data\018-01\N_\Hazelwood01\Legal\Controlled_Substances_Compliance\Suspicious Order Monitoring\Correspondence Log and Documents (DEA, SOM, SOR, General, etc.)\2017\20170817.msg produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Shipping History Report for DEA - METHADOSE ORAL CONC 10MG/ML - QUALITY ADDICTION MANAGEMENT, ASHAUB - DEA # RQ0304573 - WI 03:23 PM Network Share 2017 August 17 03:23 PM Mallinckrodt Shipping History Report for DEA - METHADOSE ORAL CONC 10MG/ML - QUALITY ADDICTION MANAGEMENT, ASHAUB - DEA # RQ0304573 - WI "Chase, Amanda L (Larock)" <"/o=mkglobal/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=amanda.chase"> 2017 August 17 Document Email 2 james.t.arana@usdoj.gov Methadone MNKOIv001 MNKOI0001356150 2021 October 21 ztpl0237 Mallinckrodt Litigation Documents mnk public no restrictions 2010 August 11 Additional_Data\SRC24\Spaulding emails 1 1 08 to 12 31 13_11\Spaulding emails 1 1 08 to 12 31 13_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) ASR LOG-0928: - State Controlled Substance Reporting -- Design issue -- Identifying Addiction Treatment Clinics 12:29 PM Spaulding, Eileen 2010 August 11 12:29 PM RE: ASR LOG-0928: - State Controlled Substance Reporting -- Design issue -- Identifying Addiction Treatment Clinics "maher, laura a" 2010 August 11 Document Email 5 "sanson, bob x" "spaulding, eileen l." Fentanyl MNKOIv001 MNKOI0001468327 2021 October 21 ntyx0237 Mallinckrodt Litigation Documents mnk public no restrictions 2016 May 02 \Additional_Data\018-01\N_\Hazelwood01\Legal\Controlled_Substances_Compliance\Suspicious Order Monitoring\Pharmacies\Pharmacy Information\1 MISCELLANEOUS FILES\MEDIA PHARMS REVIEWED BUT NOT LISTED ON CBs\Addiction Specialists Uniontown PA.msg produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) URGENT - Addiction Specialists Uniontown, PA - DEA Reg# RA0249335 - Account to be closed 01:52 PM Network Share 2016 May 02 01:52 PM RE: URGENT - Addiction Specialists Uniontown, PA - DEA Reg# RA0249335 - Account to be closed Data Integrity Mailbox - US <data.integrity@mallinckrodt.com> 2016 May 02 Document Email 2 "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> "Pharmaceuticals, Dosage Products Division" <dpharma@mallinckrodt.com> "Harper, Karen" <karen.harper@mallinckrodt.com> opioids MNKOIv001 MNKOI0001357361 2021 October 21 gxnx0237 Mallinckrodt Litigation Documents mnk public no restrictions 2016 May 20 \Additional_Data\018-01\N_\Hazelwood01\Legal\Controlled_Substances_Compliance\Suspicious Order Monitoring\Correspondence Log and Documents (DEA, SOM, SOR, General, etc.)\2016\20160520.msg produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Shipping History Report for DEA - Methadose Oral - Addiction Research Treatment DEA #RA0356697 and BAART DEA # RB0356700- CA 06:08 PM Network Share 2016 May 20 06:08 PM Mallinckrodt Shipping History Report for DEA - Methadose Oral - Addiction Research Treatment DEA #RA0356697 and BAART DEA # RB0356700- CA "Harper, Karen" <"/o=mkglobal/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=karen.harper"> 2016 May 20 Document Email 2 brenda.l.law@usdoj.gov "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> Methadone MNKOIv001 MNKOI0001356025 2021 October 21 hmnx0237 Mallinckrodt Litigation Documents mnk public no restrictions 2017 September 27 \Additional_Data\018-01\N_\Hazelwood01\Legal\Controlled_Substances_Compliance\Suspicious Order Monitoring\Correspondence Log and Documents (DEA, SOM, SOR, General, etc.)\2017\20170927-1.msg produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Shipping History Report for DEA - METHADOSE - ADDICTION TREATMENT SERVICES - DEA # PS0138164 -MD 06:55 PM Network Share 2017 September 27 06:55 PM Mallinckrodt Shipping History Report for DEA - METHADOSE - ADDICTION TREATMENT SERVICES - DEA # PS0138164 -MD "Chase, Amanda L (Larock)" <"/o=mkglobal/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=amanda.chase"> 2017 September 27 Document Email 2 "Rees, Sharon E" <sharon.e.rees@usdoj.gov> Methadone MNKOIv001 MNKOI0001356179 2021 October 21 rmnx0237 Mallinckrodt Litigation Documents mnk public no restrictions 2017 November 17 \Additional_Data\018-01\N_\Hazelwood01\Legal\Controlled_Substances_Compliance\Suspicious Order Monitoring\Correspondence Log and Documents (DEA, SOM, SOR, General, etc.)\2017\20171117-1.msg produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Shipping History Report for DEA - METHADONE HCL POWDER - ADDICTION RECOVERY INSTITUTE - DEA # RA0186975- RI 05:49 PM Network Share 2017 November 17 05:49 PM Mallinckrodt Shipping History Report for DEA - METHADONE HCL POWDER - ADDICTION RECOVERY INSTITUTE - DEA # RA0186975- RI "Chase, Amanda L (Larock)" <"/o=mkglobal/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=amanda.chase"> 2017 November 17 Document Email 2 tiffany.m.turner@usdoj.gov Methadone MNKOIv001 MNKOI0001356203 2021 October 21 tzyx0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 June 13 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_5\Spaulding emails 1 1 14 to 5 9 18_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Shipping History Report for DEA - Methadose products - Addiction Research Treatment - DEA # RA0269856- CO 09:14 PM Spaulding, Eileen 2017 June 13 09:14 PM FW: Mallinckrodt Shipping History Report for DEA - Methadose products - Addiction Research Treatment - DEA # RA0269856- CO "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> 2017 June 13 Document Email 3 "Chase, Amanda L (Larock)" <amanda.chase@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001787763 2021 October 21 ysbj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 September 09 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_8\Spaulding emails 1 1 14 to 5 9 18_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) OKAY TO PROCEED Request for Emergency Methadone Tablet Shipment to NTP - CENTRAL ILLINOIS CENTER FOR THE TREATMENT OF ADDICTIONS 05:39 PM Spaulding, Eileen 2016 September 09 05:39 PM Read: RE: OKAY TO PROCEED Request for Emergency Methadone Tablet Shipment to NTP - CENTRAL ILLINOIS CENTER FOR THE TREATMENT OF ADDICTIONS "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> 2016 September 09 Document Email 1 "Palmer, Shelley" <shelley.palmer@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001790052 2021 October 21 hmfj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 January 14 Additional_Data\SRC26\K Webb 1 1 14 to 6 5 18_13\K Webb 1 1 14 to 6 5 18_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Advocacy Support of Addiction Treatment 10:43 PM Webb, Kevin 2015 January 14 10:43 PM Advocacy Support of Addiction Treatment "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2015 January 14 Document Email 1 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Ottosen, Danny J" <danny.ottosen@mallinckrodt.com> "Colvin, Darren A" <darren.colvin@mallinckrodt.com> "Ryan, Edward R" <edward.ryan@mallinckrodt.com> "Spencer, Romney" <romney.spencer@mallinckrodt.com> "Bullerdick, Jennifer M" <jennifer.bullerdick@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> "Naten, Derek" <derek.naten@mallinckrodt.com> "Webb, Kevin J" <kevin.webb@mallinckrodt.com> "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> "Sciarra, Rhonda" <rhonda.sciarra@mallinckrodt.com> "Hazelw - 10-2-C, Room 259 (Cap 8, P)" <tahaze.exres0241@mallinckrodt.com> opioids MNKOIv002 MNKOI0001792418 2021 October 21 hxgj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 June 16 Additional_Data\SRC26\K Webb 1 1 14 to 6 5 18_4\K Webb 1 1 14 to 6 5 18_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Jessica Nichol from Addiction Policy forum testifying at WH Opioid Commission 06:21 PM Webb, Kevin 2017 June 16 06:21 PM RE: Jessica Nichol from Addiction Policy forum testifying at WH Opioid Commission "Webb, Kevin J" <kevin.webb@mallinckrodt.com> 2017 June 16 Document Email 1 "Zook, David R." <dave.zook@faegrebd.com> opioids MNKOIv002 MNKOI0001792764 2021 October 21 xxgj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 June 16 Additional_Data\SRC26\K Webb 1 1 14 to 6 5 18_4\K Webb 1 1 14 to 6 5 18_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Jessica Nichol from Addiction Policy forum testifying at WH Opioid Commission 06:27 PM Webb, Kevin 2017 June 16 06:28 PM Re: Jessica Nichol from Addiction Policy forum testifying at WH Opioid Commission "Zook, David R." <dave.zook@faegrebd.com> 2017 June 16 Document Email 2 "Webb, Kevin J" <kevin.webb@mallinckrodt.com> opioids MNKOIv002 MNKOI0001792765 2021 October 21 qkgj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 August 01 Additional_Data\SRC26\K Webb 1 1 14 to 6 5 18_4\K Webb 1 1 14 to 6 5 18_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) There’s a highly successful treatment for opioid addiction. But stigma is holding it back. - Vox 11:09 AM Webb, Kevin 2017 August 01 11:09 AM There’s a highly successful treatment for opioid addiction. But stigma is holding it back. - Vox "Zook, David R." <dave.zook@faegrebd.com> 2017 August 01 Document Email 1 Kevin Webb <kevin.webb@mallinckrodt.com> "Bono, Mary" <mary.bono@faegrebd.com> "Rubin, Matthew J." <matthew.rubin@faegrebd.com> Buprenorphine Methadone MNKOIv002 MNKOI0001792851 2021 October 21 rkgj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 August 01 Additional_Data\SRC26\K Webb 1 1 14 to 6 5 18_4\K Webb 1 1 14 to 6 5 18_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) There’s a highly successful treatment for opioid addiction. But stigma is holding it back. - Vox 01:07 PM Webb, Kevin 2017 August 01 01:07 PM RE: There’s a highly successful treatment for opioid addiction. But stigma is holding it back. - Vox "Webb, Kevin J" <kevin.webb@mallinckrodt.com> 2017 August 01 Document Email 1 "Zook, David R." <dave.zook@faegrebd.com> "Bono, Mary" <mary.bono@faegrebd.com> "Rubin, Matthew J." <matthew.rubin@faegrebd.com> Buprenorphine Methadone MNKOIv002 MNKOI0001792852 2021 October 21 ssgj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 February 02 Additional_Data\SRC26\K Webb 1 1 14 to 6 5 18_6\K Webb 1 1 14 to 6 5 18_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Another name for addiction treatment summit 11:59 PM Webb, Kevin 2017 February 02 11:59 PM Re: Another name for addiction treatment summit "Webb, Kevin J" <kevin.webb@mallinckrodt.com> 2017 February 02 Document Email 1 "Zook, David R." <dave.zook@faegrebd.com> opioids MNKOIv002 MNKOI0001793097 2021 October 21 tsgj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 February 06 Additional_Data\SRC26\K Webb 1 1 14 to 6 5 18_6\K Webb 1 1 14 to 6 5 18_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Initial Addiction Treatment Strat Plan slide deck 03:25 PM Webb, Kevin 2017 February 06 03:25 PM RE: Initial Addiction Treatment Strat Plan slide deck "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> 2017 February 06 Document Email 2 "Webb, Kevin J" <kevin.webb@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001793098 2021 October 21 xfjj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2007 February 21 Additional_Data\SRC29\Harper supplement pre 1 1 08_1\Harper supplement pre 1 1 08_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Read: Upcoming Conferences re: Opioid Risk Management & Addiction 06:40 PM Harper, Karen 2007 February 21 06:40 PM Read: Upcoming Conferences re: Opioid Risk Management & Addiction "harper, karen" 2007 February 21 Document Email 1 "cay, melissa d" opioids MNKOIv002 MNKOI0001794232 2021 October 21 nqkj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 January 14 Additional_Data\SRC29\Jim Young all pre 1 1 18_11\Jim Young all pre 1 1 18_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Medidata - Addiction Studies 11:17 PM Young, Jim 2013 January 14 11:17 PM RE: Medidata - Addiction Studies "Donohue, Bernadette" <bernadette.donohue@covidien.com> 2013 January 14 Document Email 1 "Young, Jim L (Hazelwood)" <jim.young@covidien.com> opioids MNKOIv002 MNKOI0001795081 2021 October 21 knpj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 September 14 Additional_Data\SRC29\Kilper all 2014-fwd_5\Kilper all 2014-fwd_5.pst\Top of Personal Folders\Archive MNKOI0001797489 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Specialists Termination 02:45 PM Kilper, Jeff 2016 September 14 02:45 PM Addiction Specialists Termination "Hanne, Rhonda J" <rhonda.hanne@mallinckrodt.com> 2016 September 14 Document Email 1 "Kilper, Jeff J" <jeff.kilper@mallinckrodt.com> "Forshee, Kay" <kay.forshee@mallinckrodt.com> "Digby, Debbie L" <debbie.digby@mallinckrodt.com> "Thomas, Angie F" <angie.thomas@mallinckrodt.com> "Daley, Misi L" <misi.daley@mallinckrodt.com> "Lafeber, Terese E" <terese.lafeber@mallinckrodt.com> "Randall, LouAnn" <louann.randall@mallinckrodt.com> "Vorderstrasse, Kevin" <kevin.vorderstrasse@mallinckrodt.com> "Montgomery, Marc" <marc.montgomery@mallinckrodt.com> "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Kazemi, Kian L" <kian.kazemi@mallinckrodt.com> "Block, Jennifer M (Bullerdick)" <jennifer.block@mallinckrodt.com> "Norwood, Gayla J" <gayla.norwood@mallinckrodt.com> "Colvin, Darren A" <darren.colvin@mallinckrodt.com> opioids MNKOIv002 MNKOI0001797488 2021 October 21 qsmk0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 September 09 Harper, Karen\Harper emails 2015 to Mar 19 2018_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) DEA has authorized ------ Request for Emergency Methadone Tablet Shipment to NTP - CENTRAL ILLINOIS CENTER FOR THE TREATMENT OF ADDICTIONS 05:12 PM Harper, Karen 2016 September 09 05:11 PM DEA has authorized ------ Request for Emergency Methadone Tablet Shipment to NTP - CENTRAL ILLINOIS CENTER FOR THE TREATMENT OF ADDICTIONS "Harper, Karen" <karen.harper@mallinckrodt.com> 2016 September 09 Document Email 3 "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001805699 2021 October 21 srnk0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 April 28 Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) MAT for Opioid Addiction in the Criminal Justice System 03:02 PM Jackson, Catherine 2014 April 28 03:02 PM FW: MAT for Opioid Addiction in the Criminal Justice System "Saake, Lisa M" <lisa.saake@mallinckrodt.com> 2014 April 28 Document Email 3 "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> opioids MNKOIv002 MNKOI0001806303 2021 October 21 ktnk0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 11 Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) AMCP Meeting - Abuse & Addiction Meeting 03:30 PM Jackson, Catherine 2014 August 11 03:30 PM RE: AMCP Meeting - Abuse & Addiction Meeting "Hasse, Debra C" <debra.hasse@mallinckrodt.com> 2014 August 11 Document Email 2 "Jackson, Catherine" <catherine.jackson@mallinckrodt.com> opioids MNKOIv002 MNKOI0001806359 2021 October 21 xpym0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 April 03 Webb, Kevin\K Webb 1 1 14 to 6 5 18_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Distinguishing Misuse and Addiction in Opioid Therapy 10:08 AM Webb, Kevin 2015 April 03 10:08 AM Distinguishing Misuse and Addiction in Opioid Therapy PAINWeek Daily Dose <noreply-alert@painweek.org> 2015 April 03 Document Email 2 Kevin <kevin.webb@mallinckrodt.com> opioids MNKOIv002 MNKOI0001833778 2021 October 21 hmdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 September 25 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Request for Reference for Methadone Module 2 (0253a) - Escalation of drug self-administration as a hallmark of persistent addiction - Rotzell 01:20 PM Holthaus, Gena 2013 September 25 01:20 PM RE: Request for Reference for Methadone Module 2 (0253a) - Escalation of drug self-administration as a hallmark of persistent addiction - Rotzell Jessica Rotzell <jrotzell@synchronymed.com> 2013 September 25 Document Email 3 "Eliceiri, Dennis B" <dennis.eliceiri@mallinckrodt.com> "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001836377 2021 October 21 gkyc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 September 22 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Assemblyman calls for more access to medical treatment for opioid addiction 08:59 PM Naten, Derek 2016 September 22 08:59 PM Re: Assemblyman calls for more access to medical treatment for opioid addiction "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2016 September 22 Document Email 3 "Naten, Derek" <derek.naten@mallinckrodt.com> Methadone MNKOIv001 MNKOI0001667228 2021 October 21 hkyc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 September 22 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Attorney General Kamala D. Harris Files Lawsuit Against Pharmaceutical Company for Inflating Prices for Opioid Addiction Treatment 10:56 PM Naten, Derek 2016 September 22 10:56 PM Attorney General Kamala D. Harris Files Lawsuit Against Pharmaceutical Company for Inflating Prices for Opioid Addiction Treatment Kris Rosa <kris@frednoteware.com> 2016 September 22 Document Email 3 Derek Naten <derek.naten@mallinckrodt.com> Buprenorphine/Naloxone MNKOIv001 MNKOI0001667231 2021 October 21 ymhb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 September 20 Long, Erika\Long, Erika all_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Update: President’s Commission on Combating Drug Addiction and the Opioid Crisis ADC Sign-on Letter 12:49 PM Long, Erika 2017 September 20 UCSF 12:49 PM Fwd: Update: President’s Commission on Combating Drug Addiction and the Opioid Crisis ADC Sign-on Letter "Naten, Derek" <derek.naten@mallinckrodt.com> 2017 September 20 Document Email 5 "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> "Long, Erika" <erika.long@mallinckrodt.com> "Martello, Kendra" <kendra.martello@mallinckrodt.com> opioids MNKOIv001 MNKOI0001617109 yes 2021 October 21 hrhw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 August 16 Williams, Jane\Williams, Jane emails all_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending August 16, 2013 04:43 PM Williams, Jane 2013 August 16 UCSF 04:43 PM Addiction Treatment News - Week Ending August 16, 2013 XXXXXXX@aol.com 2013 August 16 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Methadone MNKOIv002 MNKOI0001712627 yes 2021 October 21 gshw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 August 23 Williams, Jane\Williams, Jane emails all_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending August 23, 2013 07:06 PM Williams, Jane 2013 August 23 UCSF 07:06 PM Addiction Treatment News - Week Ending August 23, 2013 XXXXXXX@aol.com 2013 August 23 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Methadone MNKOIv002 MNKOI0001712872 yes 2021 October 21 rhxw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 October 14 Williams, Jane\Williams, Jane emails all_6.pst\Top of Personal Folders\Archive MNKOI0001713183 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HA153 Addiction Catalog 04:12 PM Williams, Jane 2013 October 14 UCSF 04:12 PM FW: HA153 Addiction Catalog "Bullerdick, Jennifer M" <jennifer.bullerdick@mallinckrodt.com> 2013 October 14 Document Email 1 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> "Randall, LouAnn" <louann.randall@mallinckrodt.com> Buprenorphine MNKOIv002 MNKOI0001713182 yes 2021 October 21 yljx0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 October 17 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_15\Spaulding emails 1 1 14 to 5 9 18_15.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Verification of Methadone Shipments to Addiction Research and Treatment, 433 Turk St, San Francisco, CA 94102, DEA Number RA0240111 02:29 AM Spaulding, Eileen 2014 October 17 02:29 AM FW: Verification of Methadone Shipments to Addiction Research and Treatment, 433 Turk St, San Francisco, CA 94102, DEA Number RA0240111 "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> 2014 October 17 Document Email 2 "Buist, Jennifer M" <jennifer.buist@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001784398 2021 October 21 rhwj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2008 July 22 Additional_Data\SRC26\K Webb 1 1 08 to 12 31 13_13\K Webb 1 1 08 to 12 31 13_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) TPM in addiction therapy 02:09 PM Webb, Kevin 2008 July 22 UCSF 02:09 PM RE: TPM in addiction therapy "webb, kevin j" 2008 July 22 Document Email 1 Rich Sipes XXXXXXXXXX@hotmail.com> opioids MNKOIv002 MNKOI0001791705 yes 2021 October 21 rzdj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2008 July 14 Additional_Data\SRC26\K Webb 1 1 08 to 12 31 13_13\K Webb 1 1 08 to 12 31 13_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) TPM in addiction therapy 05:47 PM Webb, Kevin 2008 July 14 UCSF 05:47 PM RE: TPM in addiction therapy Rich Sipes XXXXXXXXXX@hotmail.com> 2008 July 14 Document Email 1 "webb, kevin j" opioids MNKOIv002 MNKOI0001791571 yes 2021 October 21 xqdl0238 Mallinckrodt Litigation Documents mnk public no restrictions 2010 December 15 Spaulding, Eileen\Spaulding emails 1 1 08 to 12 31 13_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NY/ Addiction Res & Trt: MKG NY Ship date 12/13/10 Service Delay 4th update 02:39 PM Spaulding, Eileen 2010 December 15 02:39 PM RE: NY/ Addiction Res & Trt: MKG NY Ship date 12/13/10 Service Delay 4th update Darlett Oliver <dvoliver@fedex.com> 2010 December 15 Document Email 5 "wall, pat a" "cahill, lois l" "nelson, cheryl (hazelwood)" "rehkop, brenda d" "spaulding, eileen l." "banks, sharron" Lorin Boudreau <lboudreau@fedex.com> "keeven, charity a (aranda)" "coffey, tracey r" "o'leary, dan j" "myers, penny" "rausch, jim h" Methadone MNKOIv002 MNKOI0001810667 2021 October 21 ftwj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 November 11 Additional_Data\SRC26\K Webb 1 1 14 to 6 5 18_10\K Webb 1 1 14 to 6 5 18_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Signs of hope, but also heartbreak in the fight against opioid addiction - The Washington Post 02:30 PM Webb, Kevin 2015 November 11 02:30 PM RE: Signs of hope, but also heartbreak in the fight against opioid addiction - The Washington Post "Naten, Derek" <derek.naten@mallinckrodt.com> 2015 November 11 Document Email 1 "Bono, Mary" <mary.bono@faegrebd.com> "Zook, David R." <dave.zook@faegrebd.com> "Andrews, Joshua L." <joshua.andrews@faegrebd.com> "Webb, Kevin J" <kevin.webb@mallinckrodt.com> Vince J. Ventimiglia Jr. <vince@leavittpartners.com> Kevin Walker <kwalker@pennquarterpartners.com> opioids MNKOIv002 MNKOI0001791974 2021 October 21 qlfj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 January 09 Additional_Data\SRC26\K Webb 1 1 14 to 6 5 18_13\K Webb 1 1 14 to 6 5 18_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Advocacy Support of Addiction Treatment 06:59 PM Webb, Kevin 2015 January 09 06:59 PM Re: Advocacy Support of Addiction Treatment "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2015 January 09 Document Email 4 "Naten, Derek" <derek.naten@mallinckrodt.com> "Webb, Kevin J" <kevin.webb@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> opioids MNKOIv002 MNKOI0001792403 2021 October 21 fsgj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 January 18 Additional_Data\SRC26\K Webb 1 1 14 to 6 5 18_6\K Webb 1 1 14 to 6 5 18_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Medicaid Coverage for Addiction Treatment Varies Dramatically by State 05:55 PM Webb, Kevin 2017 January 18 05:55 PM Medicaid Coverage for Addiction Treatment Varies Dramatically by State email@addthis.com 2017 January 18 Document Email 1 kevin.webb@mallinckrodt.com Methadone MNKOIv002 MNKOI0001793075 2021 October 21 hsgj0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 January 24 Additional_Data\SRC26\K Webb 1 1 14 to 6 5 18_6\K Webb 1 1 14 to 6 5 18_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) YaleNews | Yale faculty lead a four-city effort to study best practices for opioid addiction 01:16 PM Webb, Kevin 2017 January 24 01:16 PM FW: YaleNews | Yale faculty lead a four-city effort to study best practices for opioid addiction "Griffin, Maura" <maura.griffin@mallinckrodt.com> 2017 January 24 Document Email 1 "Lovelace, Belinda" <belinda.lovelace@mallinckrodt.com> "Bichajian, Lynn" <lynn.bichajian@mallinckrodt.com> "Webb, Kevin J" <kevin.webb@mallinckrodt.com> Buprenorphine MNKOIv002 MNKOI0001793077 2021 October 21 xqdm0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 July 24 Spaulding, Eileen\Spaulding emails 1 1 14 to 5 9 18_16.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HCMC Addiction Medicine Program - MSP 10:29 PM Spaulding, Eileen 2014 July 24 10:29 PM RE: HCMC Addiction Medicine Program - MSP Lorin Boudreau <lboudreau@fedex.com> 2014 July 24 Document Email 2 "Banks, Sharron" <sharron.banks@mallinckrodt.com> "Coffey, Tracey R" <tracey.coffey@mallinckrodt.com> lois.cahill@mallinckrodt.com cheryl.nelson2@mallinckrodt.com "Rehkop, Brenda D" <brenda.rehkop@mallinckrodt.com> Darlett Oliver <dvoliver@fedex.com> "Adams, Rose H" <rose.adams2@mallinckrodt.com> "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001823803 2021 October 21 jyhm0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 July 25 Spaulding, Eileen\Spaulding emails 1 1 14 to 5 9 18_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Shipping History Report for DEA - Methadose Oral Conc 10mg/mL - Addiction Research & Treatment - DEA # RA0491237 - CA 10:06 PM Spaulding, Eileen 2017 July 25 10:06 PM RE: Mallinckrodt Shipping History Report for DEA - Methadose Oral Conc 10mg/mL - Addiction Research & Treatment - DEA # RA0491237 - CA "Tongson, Alma S." <alma.s.tongson@usdoj.gov> 2017 July 25 Document Email 2 "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001827962 2021 October 21 ylym0238 Mallinckrodt Litigation Documents mnk public no restrictions 2018 May 07 Webb, Kevin\K Webb 1 1 14 to 6 5 18_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) [EXTERNAL] Addiction Treatment News Week Ending May 6, 2018 02:43 PM Webb, Kevin 2018 May 07 UCSF 02:43 PM [EXTERNAL] Addiction Treatment News Week Ending May 6, 2018 XXXXXXX@aol.com 2018 May 07 Document Email 3 daniel.alexander@mnk.com edward.ryan@mnk.com darren.colvin@mnk.com romney.spencer@mnk.com oliver.technow@mnk.com kevin.webb@mnk.com derek.naten@mnk.com jake.longenecker@mnk.com elizabeth.haybron@mnk.com kevin.vorderstrasse@mnk.com bonnie.new@mnk.com elva.ramsaran@mnk.com Methadone MNKOIv002 MNKOI0001833680 yes 2021 October 21 gjpm0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 October 01 Webb, Kevin\K Webb 1 1 14 to 6 5 18_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NYTimes: America’s 8-Step Program for Opioid Addiction 11:55 PM Webb, Kevin 2017 October 01 UCSF 11:55 PM Re: NYTimes: America’s 8-Step Program for Opioid Addiction Mark Tyndall XXXXXXXXXXXX@gmail.com> 2017 October 01 Document Email 1 "Webb, Kevin J" <kevin.webb@mallinckrodt.com> opioids MNKOIv002 MNKOI0001834057 yes 2021 October 21 nqpm0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 June 23 Webb, Kevin\K Webb 1 1 14 to 6 5 18_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Reference for 10% treated for opioid addiction 08:10 PM Webb, Kevin 2017 June 23 UCSF 08:10 PM Reference for 10% treated for opioid addiction "Webb, Kevin J" <kevin.webb@mallinckrodt.com> 2017 June 23 Document Email 1 XXXXXXX@aol.com "Alison Insinger (insinger@bestweb.net)" <insinger@bestweb.net> XXXXXXXXXXXXXXXX@hotmail.com "Alexander, Dan" <daniel.alexander@mallinckrodt.com> opioids MNKOIv002 MNKOI0001834295 yes 2021 October 21 yqpm0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 June 23 Webb, Kevin\K Webb 1 1 14 to 6 5 18_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Reference for 10% treated for opioid addiction 08:20 PM Webb, Kevin 2017 June 23 UCSF 08:20 PM Re: Reference for 10% treated for opioid addiction XXXXXXX@aol.com 2017 June 23 Document Email 2 kevin.webb@mallinckrodt.com opioids MNKOIv002 MNKOI0001834296 yes 2021 October 21 lfvn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 April 26 Webb, Kevin\K Webb 1 1 14 to 6 5 18_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Adequately Addressing Addiction? 10:07 AM Webb, Kevin 2017 April 26 11:52 AM Adequately Addressing Addiction? PAINWeek Daily Dose <newsletter@painweek.org> 2017 April 26 Document Email 2 Kevin <kevin.webb@mallinckrodt.com> opioids MNKOIv002 MNKOI0001834435 2021 October 21 hxvn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 February 21 Webb, Kevin\K Webb 1 1 14 to 6 5 18_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) CMS & addiction treatment next steps. 05:58 PM Webb, Kevin 2017 February 21 05:58 PM CMS & addiction treatment next steps. "Webb, Kevin J" <kevin.webb@mallinckrodt.com> 2017 February 21 Document Email 1 "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> "Long, Erika" <erika.long@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001834510 2021 October 21 njvn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 September 23 Webb, Kevin\K Webb 1 1 14 to 6 5 18_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending September 23, 2016 11:26 PM Webb, Kevin 2016 September 23 UCSF 11:26 PM Re: Addiction Treatment News - Week Ending September 23, 2016 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2016 September 23 Document Email 1 XXXXXXX@aol.com "Colvin, Darren A" <darren.colvin@mallinckrodt.com> "Ryan, Edward R" <edward.ryan@mallinckrodt.com> "Ottosen, Danny J" <danny.ottosen@mallinckrodt.com> "Spencer, Romney" <romney.spencer@mallinckrodt.com> "Kazemi, Kian L" <kian.kazemi@mallinckrodt.com> "Webb, Kevin J" <kevin.webb@mallinckrodt.com> "Owen, Roger" <roger.owen@mallinckrodt.com> "Montgomery, Marc" <marc.montgomery@mallinckrodt.com> "Purcell, Tina M" <tina.purcell@mallinckrodt.com> "Naten, Derek" <derek.naten@mallinckrodt.com> "Block, Jennifer M (Bullerdick)" <jennifer.block@mallinckrodt.com> "Crandall, Margaret A" <margaret.crandall@mallinckrodt.com> Buprenorphine/Naloxone MNKOIv002 MNKOI0001834551 yes 2021 October 21 lfpm0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 November 21 Webb, Kevin\K Webb 1 1 14 to 6 5 18_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) addiction treatment & anti-dote product ideas 10:20 PM Webb, Kevin 2017 November 21 10:20 PM RE: addiction treatment & anti-dote product ideas "Webb, Kevin J" <kevin.webb@mallinckrodt.com> 2017 November 21 Document Email 2 "Yue, Baohua" <baohua.yue@mallinckrodt.com> "Milton, J Matthew" <matthew.milton@mallinckrodt.com> "Nichols, Gary" <gary.nichols@mallinckrodt.com> "Fussner, Andrew S" <andrew.fussner@mallinckrodt.com> "Franke, Ryan M" <ryan.franke@mallinckrodt.com> "Alexander, Dan" <daniel.alexander@mallinckrodt.com> opioids MNKOIv002 MNKOI0001833953 2021 October 21 sgpm0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 December 07 Webb, Kevin\K Webb 1 1 14 to 6 5 18_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Highest opioid addiction rates 11:26 PM Webb, Kevin 2017 December 07 11:26 PM Highest opioid addiction rates "Webb, Kevin J" <kevin.webb@mallinckrodt.com> 2017 December 07 Document Email 1 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> opioids MNKOIv002 MNKOI0001833993 2021 October 21 rspm0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 August 22 Webb, Kevin\K Webb 1 1 14 to 6 5 18_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Alert: Aurora Advocate: Western Reserve Hospital partners with county to battle opiate addiction 08:47 PM Webb, Kevin 2017 August 22 08:47 PM RE: Alert: Aurora Advocate: Western Reserve Hospital partners with county to battle opiate addiction "Webb, Kevin J" <kevin.webb@mallinckrodt.com> 2017 August 22 Document Email 2 "Sciarra, Rhonda" <rhonda.sciarra@mallinckrodt.com> "Malasi, Julian F" <julian.malasi@mallinckrodt.com> "Naten, Derek" <derek.naten@mallinckrodt.com> opioids MNKOIv002 MNKOI0001834354 2021 October 21 sfvn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 May 11 Webb, Kevin\K Webb 1 1 14 to 6 5 18_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Sec Price: Faith based better than addiction treatment 09:36 PM Webb, Kevin 2017 May 11 09:36 PM RE: Sec Price: Faith based better than addiction treatment Kevin Walker <kwalker@pennquarterpartners.com> 2017 May 11 Document Email 1 "Webb, Kevin J" <kevin.webb@mallinckrodt.com> opioids MNKOIv002 MNKOI0001834446 2021 October 21 kxvn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 March 03 Webb, Kevin\K Webb 1 1 14 to 6 5 18_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) EXTERNAL: Funds to pay for addiction 07:28 PM Webb, Kevin 2017 March 03 07:28 PM Re: EXTERNAL: Funds to pay for addiction "Long, Erika" <erika.long@mallinckrodt.com> 2017 March 03 Document Email 3 "Webb, Kevin J" <kevin.webb@mallinckrodt.com> "Naten, Derek" <derek.naten@mallinckrodt.com> "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> "Malasi, Julian F" <julian.malasi@mallinckrodt.com> opioids MNKOIv002 MNKOI0001834514 2021 October 21 mkvn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 28 Webb, Kevin\K Webb 1 1 14 to 6 5 18_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) New organization aims to break down barriers to effective recovery for opioid addiction 02:07 PM Webb, Kevin 2016 June 28 02:07 PM New organization aims to break down barriers to effective recovery for opioid addiction "Sciarra, Rhonda" <rhonda.sciarra@mallinckrodt.com> 2016 June 28 Document Email 1 "Naten, Derek" <derek.naten@mallinckrodt.com> "Webb, Kevin J" <kevin.webb@mallinckrodt.com> "Long, Erika" <erika.long@mallinckrodt.com> "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> opioids MNKOIv002 MNKOI0001834573 2021 October 21 lfbn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 January 15 Young, Jim\Jim Young all pre 1 1 18_11.pst\Top of Personal Folders\Archive MNKOI0001834903 MNKOI0001834904 MNKOI0001834905 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Medidata - Addiction Studies 05:37 PM Young, Jim 2013 January 15 05:37 PM RE: Medidata - Addiction Studies "Young, Jim L (Hazelwood)" <jim.young@covidien.com> 2013 January 15 Document Email 2 "Donohue, Bernadette" <bernadette.donohue@covidien.com> "Ward, Julie A" <julie.ward@covidien.com> opioids MNKOIv002 MNKOI0001834901 2021 October 21 tgdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 06 Holthaus, Gena\Gena Holthaus all_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) GEN00413 Opioid Addiction Treatment Educ Series 06:39 PM Holthaus, Gena 2014 August 06 06:39 PM RE: GEN00413 Opioid Addiction Treatment Educ Series "Crandall, Margaret A" <margaret.crandall@mallinckrodt.com> 2014 August 06 Document Email 4 Marie Diekemper <mdiekemper@smartsourcellc.com> "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> "Schuster, Tammy H" <tammy.schuster@mallinckrodt.com> Katie Herman <kherman@smartsourcellc.com> Methadone MNKOIv002 MNKOI0001836184 2021 October 21 sgdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 06 Holthaus, Gena\Gena Holthaus all_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) GEN00413 Opioid Addiction Treatment Educ Series 06:37 PM Holthaus, Gena 2014 August 06 06:37 PM RE: GEN00413 Opioid Addiction Treatment Educ Series "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2014 August 06 Document Email 3 "Crandall, Margaret A" <margaret.crandall@mallinckrodt.com> "Matoushek, Theresa" <theresa.matoushek@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001836181 2021 October 21 zgdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 06 Holthaus, Gena\Gena Holthaus all_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) GEN00413 Opioid Addiction Treatment Educ Series 06:42 PM Holthaus, Gena 2014 August 06 06:42 PM RE: GEN00413 Opioid Addiction Treatment Educ Series Marie Diekemper <mdiekemper@smartsourcellc.com> 2014 August 06 Document Email 4 "Crandall, Margaret A" <margaret.crandall@mallinckrodt.com> "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> "Schuster, Tammy H" <tammy.schuster@mallinckrodt.com> Katie Herman <kherman@smartsourcellc.com> Methadone MNKOIv002 MNKOI0001836188 2021 October 21 jhdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 August 12 Holthaus, Gena\Gena Holthaus all_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) GEN00413 Opioid Addiction Treatment Educ Series 04:49 PM Holthaus, Gena 2014 August 12 04:49 PM RE: GEN00413 Opioid Addiction Treatment Educ Series Katie Herman <kherman@smartsourcellc.com> 2014 August 12 Document Email 4 "Crandall, Margaret A" <margaret.crandall@mallinckrodt.com> "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> "Schuster, Tammy H" <tammy.schuster@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001836197 2021 October 21 xsdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 November 07 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive MNKOI0001836587 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HM599 Addiction Treatment Education Series Sheet 05:39 PM Holthaus, Gena 2013 November 07 UCSF 05:39 PM RE: HM599 Addiction Treatment Education Series Sheet "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2013 November 07 Document Email 1 Barbara Rausch XXXXXXXXXXX@earthlink.net> opioids MNKOIv002 MNKOI0001836586 yes 2021 October 21 qsdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 November 08 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NOW AVAILABLE - Methadone Module 1 - Opioid Addiction: A Historical Perspective 06:08 PM Holthaus, Gena 2013 November 08 UCSF 06:08 PM RE: NOW AVAILABLE - Methadone Module 1 - Opioid Addiction: A Historical Perspective "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2013 November 08 Document Email 3 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> Ottosen, Danny 3 Sigel, Tom 3 Colvin, Darren A Ryan, Edward R Methadone MNKOIv002 MNKOI0001836600 yes 2021 October 21 qrdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 November 06 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive MNKOI0001836569 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HM599 Addiction Treatment Education Series Sheet 04:50 PM Holthaus, Gena 2013 November 06 UCSF 04:50 PM HM599 Addiction Treatment Education Series Sheet Barbara Rausch XXXXXXXXXXX@earthlink.net> 2013 November 06 Document Email 1 "Gena M (Brennan) Holthaus .com>" <gena.holthaus@mallinckrodt.com> opioids MNKOIv002 MNKOI0001836568 yes 2021 October 21 rgwn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 January 24 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive MNKOI0001836728 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NOW AVAILABLE - Module 2: Understanding Addiction 07:32 PM Holthaus, Gena 2014 January 24 UCSF 07:32 PM RE: NOW AVAILABLE - Module 2: Understanding Addiction "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2014 January 24 Document Email 2 "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> "Colvin, Darren A" <darren.colvin@mallinckrodt.com> "Ottosen, Danny J" <danny.ottosen@mallinckrodt.com> "Ryan, Edward R" <edward.ryan@mallinckrodt.com> "Sigel, Tom J" <tom.sigel@mallinckrodt.com> "Purcell, Tina M" <tina.purcell@mallinckrodt.com> "Matoushek, Theresa" <theresa.matoushek@mallinckrodt.com> "Bullerdick, Jennifer M" <jennifer.bullerdick@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> "Schuster, Tammy H" <tammy.schuster@mallinckrodt.com> XXXXXXX@aol.com Methadone MNKOIv002 MNKOI0001836726 yes 2021 October 21 ytdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 November 27 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Opioid Addiction Education Sell Sheet E-Template 05:38 AM Holthaus, Gena 2013 November 27 05:38 AM Read: FW: Opioid Addiction Education Sell Sheet E-Template "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2013 November 27 Document Email 1 "Ford, Carol" <carol.ford@mallinckrodt.com> opioids MNKOIv002 MNKOI0001836625 2021 October 21 hzdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 17 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Module #1 Opioid Addiction - A Historical Perspective Updated Status Report 06:07 PM Holthaus, Gena 2013 December 17 UCSF 06:07 PM Module #1 Opioid Addiction - A Historical Perspective Updated Status Report XXXXXXX@aol.com 2013 December 17 Document Email 1 gena.holthaus@mallinckrodt.com daniel.alexander@mallinckrodt.com opioids MNKOIv002 MNKOI0001836638 yes 2021 October 21 yzdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 19 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Filing for Methadone CE Series: Module 2 - Understanding Addiction (MK13 0300 143F) (sah) 06:13 PM Holthaus, Gena 2013 December 19 06:13 PM Read: Filing for Methadone CE Series: Module 2 - Understanding Addiction (MK13 0300 143F) (sah) "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2013 December 19 Document Email 1 "McCorkle, Kathy L" <kathy.mccorkle@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001836654 2021 October 21 pzdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 21 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Filing for Methadone CE Series: Module 2 - Understanding Addiction (MK13 0300 143F) 07:54 PM Holthaus, Gena 2013 December 21 07:54 PM FW: Filing for Methadone CE Series: Module 2 - Understanding Addiction (MK13 0300 143F) "McCorkle, Kathy L" <kathy.mccorkle@mallinckrodt.com> 2013 December 21 Document Email 2 "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> "Estes, Penny L" <penny.estes@mallinckrodt.com> "Ford, Carol" <carol.ford@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001836655 2021 October 21 qzdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 21 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Filing for Methadone CE Series: Module 2 - Understanding Addiction (MK13 0300 143F) 08:18 PM Holthaus, Gena 2013 December 21 08:18 PM Read: FW: Filing for Methadone CE Series: Module 2 - Understanding Addiction (MK13 0300 143F) "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2013 December 21 Document Email 1 "McCorkle, Kathy L" <kathy.mccorkle@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001836657 2021 October 21 fmwn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 August 15 Holthaus, Gena\Gena Holthaus all_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction vs. Dependence vs. Opioid Use Disorder 07:31 PM Holthaus, Gena 2013 August 15 UCSF 07:31 PM FW: Addiction vs. Dependence vs. Opioid Use Disorder "Purcell, Tina M" <tina.purcell@mallinckrodt.com> 2013 August 15 Document Email 2 "Schuster, Tammy H" <tammy.schuster@mallinckrodt.com> "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> "Hudson, Elizabeth" <elizabeth.hudson@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001836877 yes 2021 October 21 szwn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 March 01 Holthaus, Gena\Gena Holthaus all_4.pst\Top of Personal Folders\Archive MNKOI0001837172 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Question about Addiction Treatment 07:26 PM Holthaus, Gena 2017 March 01 07:26 PM Question about Addiction Treatment "Crandall, Margaret A" <margaret.crandall@mallinckrodt.com> 2017 March 01 Document Email 1 "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> "Alexander, Dan" <daniel.alexander@mallinckrodt.com> opioids MNKOIv002 MNKOI0001837171 2021 October 21 tlfn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 January 15 Holthaus, Gena\Gena Holthaus all_9.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Advocacy Support of Addiction Treatment 02:36 PM Holthaus, Gena 2015 January 15 02:36 PM RE: Advocacy Support of Addiction Treatment "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2015 January 15 Document Email 2 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> opioids MNKOIv002 MNKOI0001837451 2021 October 21 zlfn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 January 15 Holthaus, Gena\Gena Holthaus all_9.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Advocacy Support of Addiction Treatment 02:40 PM Holthaus, Gena 2015 January 15 02:40 PM RE: Advocacy Support of Addiction Treatment "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2015 January 15 Document Email 2 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> opioids MNKOIv002 MNKOI0001837453 2021 October 21 kgyl0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 February 04 Spaulding, Eileen\Spaulding emails 1 1 14 to 5 9 18_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) RI -RE: Request for confirmation of shipment to Addiction Recovery Institute RA0186975 03:38 PM Spaulding, Eileen 2016 February 04 03:45 PM RE: RI -RE: Request for confirmation of shipment to Addiction Recovery Institute RA0186975 "Cook, Thomas A." <thomas.a.cook@usdoj.gov> 2016 February 04 Document Email 3 "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001819029 2021 October 21 frgg0238 Mallinckrodt Litigation Documents mnk public no restrictions 2010 October 04 Additional_Data\Harper emails 2010 to 2014_14\Harper emails 2010 to 2014_14.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Customer Service Week, Addiction Therapy Group Presentation, Patient Testimonials 06:05 PM Harper, Karen 2010 October 04 06:05 PM Customer Service Week, Addiction Therapy Group Presentation, Patient Testimonials "harper, karen" 2010 October 04 Document Email 1 "saffold, george r" "bonds, doris a (terry-cox)" Methadone MNKOIv002 MNKOI0001763978 2021 October 21 hjch0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 27 Additional_Data\Cox, Erin- all emails_1.zip\Cox, Erin- all emails_1.zip.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) FDA-approved Zohydro called next OxyContin by anti-addiction groups - CBS News 05:02 PM Cox, Erin 2014 February 27 05:02 PM RE: FDA-approved Zohydro called next OxyContin by anti-addiction groups - CBS News "Dress, Timothy" <timothy.dress@mallinckrodt.com> 2014 February 27 Document Email 1 "Jolliff, Susan T" <susan.jolliff@mallinckrodt.com> "Cox, Erin (Dunford)" <erin.cox@mallinckrodt.com> "Leonard, Jennifer" <jennifer.leonard@mallinckrodt.com> "Sage, Steven" <steven.sage@mallinckrodt.com> "Skop, Ashley (Seaman)" <ashley.skop@mallinckrodt.com> Hydrocodone Bitartrate Hydromorphone Oxycodone MNKOIv002 MNKOI0001769602 2021 October 21 jrch0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 April 13 Additional_Data\Dress, Timothy - all emails_1.zip\Dress, Timothy - all emails_1.zip.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Many Opioid Addictions Surface After Surgery, Study Finds 02:19 PM Dress, Timothy 2017 April 13 02:19 PM Fwd: Many Opioid Addictions Surface After Surgery, Study Finds "Vernon, Brett" <brett.vernon@mallinckrodt.com> 2017 April 13 Document Email 1 #Hospital Dist Michigan <hospitaldistrictmichigan@mallinckrodt.com> opioids MNKOIv002 MNKOI0001769842 2021 October 21 mykg0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 September 09 Additional_Data\Harper emails 2015 to Mar 19 2018_6\Harper emails 2015 to Mar 19 2018_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) OKAY TO PROCEED Request for Emergency Methadone Tablet Shipment to NTP - CENTRAL ILLINOIS CENTER FOR THE TREATMENT OF ADDICTIONS 05:13 PM Harper, Karen 2016 September 09 05:13 PM RE: OKAY TO PROCEED Request for Emergency Methadone Tablet Shipment to NTP - CENTRAL ILLINOIS CENTER FOR THE TREATMENT OF ADDICTIONS "Palmer, Shelley" <shelley.palmer@mallinckrodt.com> 2016 September 09 Document Email 4 "Coffey, Tracey R" <tracey.coffey@mallinckrodt.com> "Harper, Karen" <karen.harper@mallinckrodt.com> "McKenzie, Heather" <heather.mckenzie@mallinckrodt.com> "Knapp, Jeffrey A" <jeffrey.knapp@mallinckrodt.com> "Sechrist, Bill" <bill.sechrist@mallinckrodt.com> "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001766158 2021 October 21 lmlg0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 November 18 Additional_Data\Harper emails 2015 to Mar 19 2018_9\Harper emails 2015 to Mar 19 2018_9.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) ADDICTION RESEARCH AND TREATMENT INC, DEA #RA0421987 03:59 AM Harper, Karen 2015 November 18 03:59 AM FW: ADDICTION RESEARCH AND TREATMENT INC, DEA #RA0421987 "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> 2015 November 18 Document Email 1 "Harper, Karen" <karen.harper@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001766663 2021 October 21 fgcw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 December 09 Williams, Jane\Williams, Jane emails all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Strategic Plan Update 12:51 AM Williams, Jane 2014 December 09 12:51 AM FW: Addiction Treatment Strategic Plan Update "Williams, Jane L" <jane.williams@mallinckrodt.com> 2014 December 09 Document Email 2 "Kaczmarek, Walt" <walt.kaczmarek@mallinckrodt.com> Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001707171 2021 October 21 jfgw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 May 13 Williams, Jane\Williams, Jane emails all_3.pst\Top of Personal Folders\Archive MNKOI0001711071 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Monthly Report 04:27 PM Williams, Jane 2014 May 13 04:27 PM Addiction Treatment Monthly Report "Williams, Jane L" <jane.williams@mallinckrodt.com> 2014 May 13 Document Email 2 "Kaczmarek, Walt" <walt.kaczmarek@mallinckrodt.com> Buprenorphine Methadone MNKOIv002 MNKOI0001711069 2021 October 21 mtgw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 April 03 Williams, Jane\Williams, Jane emails all_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Trade Shows 11:23 PM Williams, Jane 2014 April 03 11:23 PM Re: Addiction Treatment Trade Shows "Ryan, Edward R" <edward.ryan@mallinckrodt.com> 2014 April 03 Document Email 2 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Ottosen, Danny J" <danny.ottosen@mallinckrodt.com> "Rauschenbach, Ashley M" <ashley.rauschenbach@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001711980 2021 October 21 pjhw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 10 Williams, Jane\Williams, Jane emails all_5.pst\Top of Personal Folders\Archive MNKOI0001712299 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Catalog 03:18 PM Williams, Jane 2013 December 10 03:18 PM Addiction Treatment Catalog "Randall, LouAnn" <louann.randall@mallinckrodt.com> 2013 December 10 Document Email 1 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Ottosen, Danny J" <danny.ottosen@mallinckrodt.com> "Ryan, Edward R" <edward.ryan@mallinckrodt.com> "Colvin, Darren A" <darren.colvin@mallinckrodt.com> "Sigel, Tom J" <tom.sigel@mallinckrodt.com> "Buelterman, Jacqueline A" <jacqueline.buelterman@mallinckrodt.com> "Tharp, Tracey L" <tracey.tharp@mallinckrodt.com> "Reiter, Jane" <jane.reiter@mallinckrodt.com> "Hopkins, Vickie A" <vickie.hopkins@mallinckrodt.com> "Kovac, Debbie A" <debbie.kovac@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> "Bullerdick, Jennifer M" <jennifer.bullerdick@mallinckrodt.com> opioids MNKOIv002 MNKOI0001712298 2021 October 21 kkhw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 13 Williams, Jane\Williams, Jane emails all_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending December 13, 2013 11:11 PM Williams, Jane 2013 December 13 UCSF 11:11 PM Addiction Treatment News - Week Ending December 13, 2013 XXXXXXX@aol.com 2013 December 13 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com tina.purcell@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Methadone MNKOIv002 MNKOI0001712326 yes 2021 October 21 mfxw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 September 27 Williams, Jane\Williams, Jane emails all_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending September 27, 2013 05:55 PM Williams, Jane 2013 September 27 UCSF 05:55 PM Addiction Treatment News - Week Ending September 27, 2013 XXXXXXX@aol.com 2013 September 27 Document Email 1 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001713043 yes 2021 October 21 kjxw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 October 25 Williams, Jane\Williams, Jane emails all_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending October 25, 2013 06:33 PM Williams, Jane 2013 October 25 UCSF 06:33 PM Addiction Treatment News - Week Ending October 25, 2013 XXXXXXX@aol.com 2013 October 25 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001713332 yes 2021 October 21 nhjw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 March 07 Williams, Jane\Williams, Jane emails all_8.pst\Top of Personal Folders\Archive MNKOI0001714259 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Update on Addiction Treatment 01:56 PM Williams, Jane 2013 March 07 01:56 PM Update on Addiction Treatment "Williams, Jane L" <jane.williams@covidien.com> 2013 March 07 Document Email 1 "Kaczmarek, Walt" <walt.kaczmarek@covidien.com> opioids MNKOIv002 MNKOI0001714258 2021 October 21 txjw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 March 15 Williams, Jane\Williams, Jane emails all_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) JT Daily News: Addiction Expert: Care Needed in Implementing New Buprenorphine Prescribing Rules 03:22 PM Williams, Jane 2013 March 15 UCSF 03:22 PM Fwd: JT Daily News: Addiction Expert: Care Needed in Implementing New Buprenorphine Prescribing Rules "Alexander, Dan" <daniel.alexander@covidien.com> 2013 March 15 Document Email 3 "Williams, Jane L" <jane.williams@covidien.com> "Bullerdick, Jennifer M" <jennifer.bullerdick@covidien.com> "Sengsavang, Scotty" <scotty.sengsavang@covidien.com> Buprenorphine Buprenorphine/Naloxone Hydrocodone MNKOIv002 MNKOI0001714297 yes 2021 October 21 zrxw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 July 19 Williams, Jane\Williams, Jane emails all_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Addiction Treatment News - Week Ending July 19, 2013 06:36 PM Williams, Jane 2013 July 19 UCSF 06:36 PM Mallinckrodt Addiction Treatment News - Week Ending July 19, 2013 XXXXXXX@aol.com 2013 July 19 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Buprenorphine Methadone MNKOIv002 MNKOI0001713992 yes 2021 October 21 hsxw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 July 22 Williams, Jane\Williams, Jane emails all_7.pst\Top of Personal Folders\Archive MNKOI0001714000 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Module 2: Understanding Addiction Brainstorming Session 09:55 PM Williams, Jane 2013 July 22 09:55 PM Module 2: Understanding Addiction Brainstorming Session "Hudson, Elizabeth" <elizabeth.hudson@mallinckrodt.com> 2013 July 22 Document Email 1 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Ryan, Edward R" <edward.ryan@mallinckrodt.com> "Bullerdick, Jennifer M" <jennifer.bullerdick@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> "Schuster, Tammy H" <tammy.schuster@mallinckrodt.com> "Purcell, Tina M" <tina.purcell@mallinckrodt.com> opioids MNKOIv002 MNKOI0001713999 2021 October 21 zycy0237 Mallinckrodt Litigation Documents mnk public no restrictions 2013 September 24 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive MNKOI0001526477 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Request for Reference for Methadone Module 2 (0253a) - Escalation of drug self-administration as a hallmark of persistent addiction - Rotzell 10:20 PM Holthaus, Gena 2013 September 24 10:20 PM RE: Request for Reference for Methadone Module 2 (0253a) - Escalation of drug self-administration as a hallmark of persistent addiction - Rotzell "Eliceiri, Dennis B" <dennis.eliceiri@mallinckrodt.com> 2013 September 24 Document Email 2 Jessica Rotzell <jrotzell@synchronymed.com> "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> Methadone MNKOIv001 MNKOI0001526475 2021 October 21 tzwb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 November 01 Long, Erika\Long, Erika all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Information for Wednesday's Final Meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis - November 1, 2017 02:31 PM Long, Erika 2017 November 01 02:31 PM RE: Information for Wednesday's Final Meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis - November 1, 2017 "Long, Erika" <erika.long@mallinckrodt.com> 2017 November 01 Document Email 2 "Naten, Derek" <derek.naten@mallinckrodt.com> "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> "Martello, Kendra" <kendra.martello@mallinckrodt.com> opioids MNKOIv001 MNKOI0001612573 2021 October 21 sqfb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 December 21 Long, Erika\Long, Erika all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Seniors face barrier for common opioid addiction treatment 02:52 PM Long, Erika 2017 December 21 02:52 PM Seniors face barrier for common opioid addiction treatment POLITICO Pro Health Care <politicoemail@politicopro.com> 2017 December 21 Document Email 3 erika.long@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv001 MNKOI0001614279 2021 October 21 qqhc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 March 27 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_18.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending March 27, 2015 05:01 PM Naten, Derek 2015 March 27 UCSF 05:02 PM Addiction Treatment News - Week Ending March 27, 2015 XXXXXXX@aol.com 2015 March 27 Document Email 2 daniel.alexander@mallinckrodt.com edward.ryan@mallinckrodt.com darren.colvin@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine Methadone MNKOIv001 MNKOI0001652203 yes 2021 October 21 ftxc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 October 06 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Breaking down tax reform and combating the addiction epidemic (The Ledger) 01:06 PM Naten, Derek 2017 October 06 01:08 PM Breaking down tax reform and combating the addiction epidemic (The Ledger) AEI Economics <aeieconomics@aei.org> 2017 October 06 Document Email 5 Derek Naten <derek.naten@mallinckrodt.com> opioids MNKOIv001 MNKOI0001654287 2021 October 21 mmjc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 October 23 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Attorney General Laxalt Launches “Nevada’s Prescription for Addiction” Opioid Initiative with Unanimous Bipartisan Approval from the Legislatures 04:57 PM Naten, Derek 2017 October 23 UCSF 04:57 PM Fwd: Attorney General Laxalt Launches “Nevada’s Prescription for Addiction” Opioid Initiative with Unanimous Bipartisan Approval from the Legislatures Katie Tinney XXXXXXXXX@gmail.com> 2017 October 23 Document Email 2 derek.naten@mallinckrodt.com opioids MNKOIv001 MNKOI0001655870 yes 2021 October 21 nmjc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 October 23 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Attorney General Laxalt Launches “Nevada’s Prescription for Addiction” Opioid Initiative with Unanimous Bipartisan Approval from the Legislatures 05:11 PM Naten, Derek 2017 October 23 UCSF 05:11 PM RE: Attorney General Laxalt Launches “Nevada’s Prescription for Addiction” Opioid Initiative with Unanimous Bipartisan Approval from the Legislatures "Naten, Derek" <derek.naten@mallinckrodt.com> 2017 October 23 Document Email 3 Katie Tinney XXXXXXXXX@gmail.com> opioids MNKOIv001 MNKOI0001655872 yes 2021 October 21 qhmc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 April 05 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) States seek Medicaid dollars for addiction treatment beds 03:00 PM Naten, Derek 2017 April 05 03:01 PM States seek Medicaid dollars for addiction treatment beds NCSL TODAY <enews@ncsl.org> 2017 April 05 Document Email 2 derek.naten@mallinckrodt.com opioids MNKOIv001 MNKOI0001662034 2021 October 21 yxnc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 February 16 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Law requires docs to discuss addiction 02:43 PM Naten, Derek 2017 February 16 02:43 PM Law requires docs to discuss addiction National Rx Drug Abuse & Heroin Summit <no-reply@addictionpro.com> 2017 February 16 Document Email 4 derek.naten@mallinckrodt.com Oxycodone MNKOIv001 MNKOI0001664929 2021 October 21 pqmc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 January 24 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Christie sends draft of bill outlining drug addiction plan to legislators 08:51 PM Naten, Derek 2017 January 24 08:51 PM RE: Christie sends draft of bill outlining drug addiction plan to legislators "Malasi, Julian F" <julian.malasi@mallinckrodt.com> 2017 January 24 Document Email 3 "Naten, Derek" <derek.naten@mallinckrodt.com> opioids MNKOIv001 MNKOI0001663985 2021 October 21 ffyc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 January 04 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Opioid Addiction in America 10:23 PM Naten, Derek 2017 January 04 UCSF 10:23 PM FW: Opioid Addiction in America "Rosen, Burt" <burt.rosen@pharma.com> 2017 January 04 Document Email 6 Aimee Welch champion <awelch_champion@compassionandchoices.org> Alec Stone <astone@ons.org> Alex Bardakh <abardakh@amda.com> Alice Mead <apm@gwpharm.com> Amy Goldstein <agoldstein@aapainmanage.org> Amy Melnick <amym@nationalcoalitionhpc.org> Amy Shank <ashank@pccarx.com> Andrew Scott <scott.andrew@endo.com> Anita Ducca <aducca@hda.org> Anna Hyde <ahyde@arthritis.org> Annelies Hall <annelies.hall@rmpdc.org> Aqeel Fatmi <aqeel.fatmi@bannerls.com> Ashley Walton <a.walton@asahq.org> Barbara Marcanti <bmarcanti@sjm.com> "Bennett, Pamela (Gov't Affairs)" <pamela.bennett@pharma.com> "Blair Clark-Schoeb (bcs@egalet.com)" <bcs@egalet.com> Brian Meshkin <bmeshkin@proove.com> Brian Munroe <munroe.brian@endo.com> Bruce Colligen <bcollig@its.jnj.com> Catherine Underwood <cunderwood@americanpainsociety.org> Chris Krese <ckrese@nacds.org> Chris Rorick <chris.rorick@bryancave.com> Chris Topoleski <ctopoleski@ashp.org> Christin Veasley <cveasley@cpralliance.org> Christopher Timmerman <christopher.timmerman@bsci.com> Cindy Steinberg <csteinberg@rcn.com> CLAAD Policy <policy@claad.org> Claudia Campbell XXXXXXXXXXXX@yahoo.com> Crystal Muilenburg <muilenburg_crystal@allergan.com> Cynthia Bens <cbens@agingresearch.org> Dan Cohen XXXXXXXXXXXXXX@gmail.com> Dan Ignaszewski <dan@amputee-coalition.org> Dave Duhrkoop XXXXXXXXXXXXXX@gmail.com> David E. Joranson <joranson@wisc.edu> David Swankin <davidswankin@cacenter.org> David Williams <daveawms@med.umich.edu> David Woodmansee <david.woodmansee@cancer.org> Deborah Pasko <dpasko@ashp.org> Derek Naten <derek.naten@mallinckrodt.com> Diane Millman <diane.millman@ppsv.com> Donna Kalauokalani XXXXXXXXXXXXXX@yahoo.com> Dr. Alexander Kraus <alexander.kraus@grunenthal.com> Elizabeth Hanpeter <elizabeth.hanpeter@abbvie.com> "Erensen, Jennifer" <jennifer.erensen@pharma.com> Fred Branson II <fbrason@projectlazarus.org> Gaby Geise <ggeise@amda.com> Gail Amalia B. Katz XXXXXXXXXXXXX@gmail.com> Gina Angelo <gina.angelo@abbvie.com> gwenn herman <gwenn@pain-connection.org> "Haddox, Dr. J. David" <dr.j.david.haddox@pharma.com> Hayden Rhudy <hayden.rhudy@abbvie.com> Heather Boyd <heather@swhr.org> Henrietta Ukwu <henrietta.ukwu@otsuka-us.com> Isaac Fordjour <isaac.fordjour@bsci.com> Jacquelin Harris <jacquelin.harris@abbvie.com> James Lavery <james.lavery@abbvie.com> Jan Chambers XXXXXXXXXXXXXXX@gmail.com> Janet McUlsky <janet.mculsky@pfizer.com> Jason Crosby <jcrosby@ichelp.org> Jenna Ventresca <jventresca@aphanet.org> Jeremy Scott <jeremy.scott@dbr.com> Jerrica Mathis <jerrica.mathis@dbr.com> Jewelyn Cosgrove <jcosgrove@hda.org> Jillanne Schulte <jschulte@aphanet.org> Jim Broatch XXXXXXXXXX@gmail.com> Jim Murty <jmurty@clunegc.com> Joan Baird <jbaird@ascp.com> Joanna Morales <jm@triagecancer.org> Jody Green <jody.green@rmpdc.org> John Halliwell <john.p.halliwell@pfizer.com> John Kraemer <john.w.kraemer@pfizer.com> Jonathan Jagoda <jjagoda@fsmb.org> Jonathan Keyserling <jkeyserling@nhpco.org> Jordan Wildermuth <jwildermuth@connect2amc.com> Joseph Hill <jhill@ashp.org> Joy Buck <jbuck@hsc.wvu.edu> Judi Lund Person <jlundperson@nhpco.org> Julian Malasi <julian.malasi@mallinckrodt.com> June Dahl PhD <jldahl@wisc.edu> Kara Gainer <kara.gainer@dbr.com> Kathleen Strauser <kstrauser@highwaterpartners.net> Katie Duensing <kduensing@aapainmanage.org> Kayla Lindsay <klindsay@arthritis.org> Ken Cole <ken.cole@pfizer.com> Kevin Nicholson <knicholson@nacds.org> Kevin Zacharoff XXXXXXXXXXXXX@gmail.com> Keysha Brooks-Coley <keysha.brooks-coley@cancer.org> Kirsten Sloan <kirsten.sloan@cancer.org> Kristen Freitas <kfreitas@hdmanet.org> Kristin Recchiuti <krecchiu@its.jnj.com> Kristina Pisanelli <kristina.m.pisanelli@medtronic.com> Laura Hunter <lhunter@proove.com> "Lauryl Jackson (LJackso1@ITS.JNJ.com)" <ljackso1@its.jnj.com> Lee Claassen <lclaassen@ichelp.org> Lenore Duensing <lduensing@aapainmanage.org> Lindsay Bohlander <bohlander> Lindsay <lindsay.bohlander@shionogi.com> Lisa Pearlstein <l.pearlstein@asahq.org> Lisa Robin <lrobin@fsmb.org> Lisa Saake XXXXXXXXXXXXX@gmail.com> Liza Tresser <liza.tresser@tevapharm.com> Loyce Pace Bass <loyce.pace@livestrong.org> Maggie Buckley XXXXXXXXXXXXXXX@gmail.com> Marcia Lee Taylor <marcialee_taylor@drugfree.org> Mark Fleury <mark.fleury@cancer.org> Mark Tyndall <mark.tyndall@mallinckrodt.com> Marsha Stanton <mstanton@pernixtx.com> Marta Sokolowska <marta.sokolowska@grunenthal.com> Matt Gunderman <matthew.gunderman@bsci.com> "McNeil, Melodi" <melodi.mcneil@abbvie.com> Melea Lusk <melea.lusk@abbvie.com> Michael C. Barnes <mbarnes@claad.org> Michael Fahmy <michael.fahmy@otsuka-us.com> Michael Jarvis <michael.jarvis@abbvie.com> Michael Keegan <michael.keegan@ncpanet.org> Michelle Cope <mcope@nacds.org> Micke Brown XXXXXXXXXXXXXX@gmail.com> Mike Heffernan <mheffernan@collegiumpharma.com> Mike Innaurato <mike.innaurato@inspirionrx.com> Mike Walsh <mwalsh@allianceforpatientaccess.org> Myra Christopher <mchristopher@practicalbioethics.org> Nicole Kelly XXXXXXXXXXXX@verizon.net> Nina DeLorenzo <nina.delorenzo@abbvie.com> Patrick Coyne XXXXXXXXXXX@aol.com> Paul Arnstein <pmarnstein@partners.org> Paul Gileno XXXXXXXXXXXXXXXXX@gmail.com> Paul Scott O'Neill <pso@dcbalaw.com> "Paul, Ilisa Halpern" <ilisa.halpernpaul@dbr.com> Peggy Tighe <peggy.tighe@ppsv.com> Penny Cowan <pcowan@theacpa.org> Peter Pitts <ppitts@cmpi.org> Peter Rankin <prankin@ascp.com> Peter Reinecke <peter@rssinc.us> Philip Goglas <goglas@hmcw.org> Phyllis Whitehead <pbwhitehead@carilionclinic.org> Robert Falb <rob.falb@tevapharm.com> Robert Radie <rr@egalet.com> Robert Saner <robert.saner@ppsv.com> Robert Twillman <btwillman@aapainmanage.org> Ronna Hauser <ronna.hauser@ncpanet.org> Rosalie Abbott <rosalie.abbott@cancer.org> Rosemary Garza <rosemary.garza@medtronic.com> "Rosen, Burt" <burt.rosen@pharma.com> "Ruth Miller (rmiller@hdmanet.org)" <rmiller@hdmanet.org> Ryne Carney <rcarney@agingresearch.org> Saira Sultan <saira.sultan@connect4strategies.com> Sally Welsh <sallyw@hpna.org> Sandie Preiss <spreiss@arthritis.org> Sara Rosta <sara.rosta@ppsv.com> Shannon Dzubin <shannon.dzubin@tevapharm.com> Sharon Brigner <sbrigner@phrma.org> "Shaw, Solana" <solana.shaw@pharma.com> Steve LaPierre <steve.lapierre@bsci.com> Steve Marmaras <smarmaras@ghlf.org> Sue Thau XXXXXXXXX@aol.com> Susan Peschin <speschin@agingresearch.org> Susan Stone <stone_susan@allergan.com> Teresa Shaffer <teresa.shaffer@paincommunity.org> "Tiller, Kimberley" <kimberley.tiller@pharma.com> Tim Hermes <thermes@collegiumpharma.com> Timothy Byrne <byrne.timothy@endo.com> Todd Stamps XXXXXXXXXXX@gmail.com> Tom O'Donnell <todonnell@nacds.org> Tracie Thomas <tthomas@painsproject.org> Wade Delk XXXXXXXXXX@gmail.com> Windy Y. Carson-Smith XXXXXXXXX@aol.com> Yvonne Klemets Wright <yklemetswright@egalet.com> opioids MNKOIv001 MNKOI0001666742 yes 2021 October 21 hfyc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 January 04 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_7.pst\Top of Personal Folders\Archive MNKOI0001666751 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) We need your input! Treating Opioid Addiction with Patient Centered Care 02:47 PM Naten, Derek 2017 January 04 UCSF 02:47 PM We need your input! Treating Opioid Addiction with Patient Centered Care Paul Samuels <psamuels@lac.org> 2017 January 04 Document Email 1 Derek Naten <derek.naten@mallinckrodt.com> Dan Alexander <daniel.alexander@mallinckrodt.com> Paul Samuels <psamuels@lac.org> Gabrielle de la Gueronniere <gdelagueronniere@lac-dc.org> Melody Heaps XXXXXXXXX@gmail.com> Pam Rodriguez <prodriguez@tasc-il.org> Tim Condon XXXXXXXXXXX@gmail.com> Braeden Kelly <bkelly@addictionpolicy.org> Casey Elliott <celliott@addictionpolicy.org> Jessica Nickel <jnickel@addictionpolicy.org> Julianne Pulvirenti <jpulvirenti@addictionpolicy.org> opioids MNKOIv001 MNKOI0001666750 yes 2021 October 21 lsjb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 December 02 Long, Erika\Long, Erika all_6.pst\Top of Personal Folders\Archive MNKOI0001622658 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Pharmaceuticals Comments to Section 704 of the Comprehensive Addiction and Recovery Act of 2016 08:21 PM Long, Erika 2016 December 02 08:21 PM FW: Mallinckrodt Pharmaceuticals Comments to Section 704 of the Comprehensive Addiction and Recovery Act of 2016 "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> 2016 December 02 Document Email 1 "Long, Erika" <erika.long@mallinckrodt.com> opioids MNKOIv001 MNKOI0001622657 2021 October 21 nsjb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 December 02 Long, Erika\Long, Erika all_6.pst\Top of Personal Folders\Archive MNKOI0001622667 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Pharmaceuticals Comments to Section 704 of the Comprehensive Addiction and Recovery Act of 2016 08:22 PM Long, Erika 2016 December 02 08:22 PM FW: Mallinckrodt Pharmaceuticals Comments to Section 704 of the Comprehensive Addiction and Recovery Act of 2016 "Fernandez, Wandaly E." <wfernandez@sidley.com> 2016 December 02 Document Email 2 "Long, Erika" <erika.long@mallinckrodt.com> "Sarraille, William" <wsarraille@sidley.com> opioids MNKOIv001 MNKOI0001622665 2021 October 21 yjlb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 24 Long, Erika\Long, Erika all_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Is DEA a bad guy in opioid addiction fight? - The Washington Post 04:01 PM Long, Erika 2016 June 24 04:01 PM Fwd: Is DEA a bad guy in opioid addiction fight? - The Washington Post "Naten, Derek" <derek.naten@mallinckrodt.com> 2016 June 24 Document Email 4 "Lohman, Donald A" <donald.lohman@mallinckrodt.com> "Long, Erika" <erika.long@mallinckrodt.com> "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> Fentanyl Hydromorphone Oxycodone MNKOIv001 MNKOI0001626033 2021 October 21 pjlb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 24 Long, Erika\Long, Erika all_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry 04:30 PM Long, Erika 2016 June 24 04:30 PM RE: NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry Courtney Johnson <cjohnson@alpinegroup.com> 2016 June 24 Document Email 2 "Long, Erika" <erika.long@mallinckrodt.com> opioids MNKOIv001 MNKOI0001626037 2021 October 21 qjlb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 24 Long, Erika\Long, Erika all_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry 04:32 PM Long, Erika 2016 June 24 04:32 PM RE: NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry "Randon, Breon" <breon.randon@mallinckrodt.com> 2016 June 24 Document Email 3 "Long, Erika" <erika.long@mallinckrodt.com> Elizabeth Murray <emurray@tdyllc.com> Rai Downs <rdowns@tdyllc.com> cjohnson@alpinegroup.com opioids MNKOIv001 MNKOI0001626039 2021 October 21 rjlb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 24 Long, Erika\Long, Erika all_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry 04:48 PM Long, Erika 2016 June 24 04:48 PM Re: NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry Rai Downs <rdowns@tdyllc.com> 2016 June 24 Document Email 3 Courtney Johnson <cjohnson@alpinegroup.com> "Long, Erika" <erika.long@mallinckrodt.com> Elizabeth Murray <emurray@tdyllc.com> "Randon, Breon" <breon.randon@mallinckrodt.com> opioids MNKOIv001 MNKOI0001626042 2021 October 21 hnmb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 April 11 Long, Erika\Long, Erika all_9.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Heroin Taskforce & Addiction, Treatment, and Recovery Caucus Panel on Opioid Prescribing Practices 07:03 PM Long, Erika 2016 April 11 07:03 PM RE: Heroin Taskforce & Addiction, Treatment, and Recovery Caucus Panel on Opioid Prescribing Practices Courtney Johnson <cjohnson@alpinegroup.com> 2016 April 11 Document Email 2 "Long, Erika" <erika.long@mallinckrodt.com> Rai Downs <rdowns@tdyllc.com> Elizabeth Murray <emurray@tdyllc.com> opioids MNKOIv001 MNKOI0001628980 2021 October 21 kqjb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 November 17 Long, Erika\Long, Erika all_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Pulse, presented by PhRMA: GOP aims to start Obamacare repeal in January — Mixed picture on Trump transition — Surgeon General releases landmark report on addiction 10:42 AM Long, Erika 2016 November 17 10:43 AM Pulse, presented by PhRMA: GOP aims to start Obamacare repeal in January — Mixed picture on Trump transition — Surgeon General releases landmark report on addiction POLITICO Pro Health Care <politicoemail@politicopro.com> 2016 November 17 Document Email 15 erika.long@mallinckrodt.com Buprenorphine MNKOIv001 MNKOI0001622293 2021 October 21 sjlb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 24 Long, Erika\Long, Erika all_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry 04:57 PM Long, Erika 2016 June 24 04:57 PM RE: NEWS: Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry Courtney Johnson <cjohnson@alpinegroup.com> 2016 June 24 Document Email 3 Rai Downs <rdowns@tdyllc.com> "Randon, Breon" <breon.randon@mallinckrodt.com> "Long, Erika" <erika.long@mallinckrodt.com> Elizabeth Murray <emurray@tdyllc.com> opioids MNKOIv001 MNKOI0001626045 2021 October 21 qjmb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 March 31 Long, Erika\Long, Erika all_9.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Pulse, presented by the Coalition for Medicare Choices: Trump scrambles after abortion misstep — FDA's own big move on abortion — How NIH's top addiction expert wants to change opioid practice 09:46 AM Long, Erika 2016 March 31 09:46 AM Pulse, presented by the Coalition for Medicare Choices: Trump scrambles after abortion misstep — FDA's own big move on abortion — How NIH's top addiction expert wants to change opioid practice POLITICO Pro Health Care <politicoemail@politicopro.com> 2016 March 31 Document Email 7 erika.long@mallinckrodt.com opioids MNKOIv001 MNKOI0001628298 2021 October 21 zslb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 August 15 Long, Erika\Long, Erika all_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Menendez, Booker Try To Expand Access To Addiction Treatment 02:38 PM Long, Erika 2016 August 15 02:38 PM RE: Menendez, Booker Try To Expand Access To Addiction Treatment "Malasi, Julian F" <julian.malasi@mallinckrodt.com> 2016 August 15 Document Email 3 Eric Orlando <eorlando@kzgrp.com> Brendan Graziano <bgraziano@kzgrp.com> "Long, Erika" <erika.long@mallinckrodt.com> Buprenorphine MNKOIv001 MNKOI0001627435 2021 October 21 tskc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 May 16 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) A Call for Presentations - Advancing & Integrating Specialized Addiction Treatment & Recovery 10:47 PM Naten, Derek 2017 May 16 10:47 PM A Call for Presentations - Advancing & Integrating Specialized Addiction Treatment & Recovery "Mark W. Parrino, MPA - AATOD President" <info@aatod.org> 2017 May 16 Document Email 2 derek.naten@mallinckrodt.com opioids MNKOIv001 MNKOI0001658925 2021 October 21 sflc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 June 08 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) ERs are getting people into addiction treatment 01:49 PM Naten, Derek 2017 June 08 01:49 PM ERs are getting people into addiction treatment National Rx Drug Abuse & Heroin Summit <no-reply@rx-summit.com> 2017 June 08 Document Email 3 derek.naten@mallinckrodt.com Fentanyl MNKOIv001 MNKOI0001659667 2021 October 21 pzlc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 April 03 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Presidential Executive Order Establishing the President’s Commission on Combating Drug Addiction and the Opioid Crisis & House Hearing Opioid This Week 01:21 PM Naten, Derek 2017 April 03 UCSF 01:23 PM Presidential Executive Order Establishing the President’s Commission on Combating Drug Addiction and the Opioid Crisis & House Hearing Opioid This Week "LaPierre, Steven" <steve.lapierre@bsci.com> 2017 April 03 Document Email 3 Aimee Welch champion <awelch_champion@compassionandchoices.org> Alec Stone <astone@ons.org> Alex Bardakh <abardakh@amda.com> Alice Mead <apm@gwpharm.com> Amy Goldstein <agoldstein@aapainmanage.org> Amy Melnick <amym@nationalcoalitionhpc.org> Amy Shank <ashank@pccarx.com> Andrew Scott <scott.andrew@endo.com> Anita Ducca <aducca@hda.org> Anna Hyde <ahyde@arthritis.org> Annelies Hall <annelies.hall@rmpdc.org> Aqeel Fatmi <aqeel.fatmi@bannerls.com> Ashley Walton <a.walton@asahq.org> "Bennett, Pamela (Gov't Affairs" <pamela.bennett@pharma.com> Bill Tighe <wtighe@nacds.org> Blair Clark-Schoeb <bcs@egalet.com> Brian Meshkin <bmeshkin@proove.com> Brian Munroe <munroe.brian@endo.com> Bruce Colligen <bcollig@its.jnj.com> Cara Moon <cmoon@egalet.com> Catherine Underwood <cunderwood@americanpainsociety.org> Chris Krese <ckrese@nacds.org> Chris Rorick <chris.rorick@bryancave.com> Chris Topoleski <ctopoleski@ashp.org> Christin Veasley <cveasley@cpralliance.org> Cindy Steinberg <csteinberg@rcn.com> CLAAD Policy <policy@claad.org> Claudia Campbell XXXXXXXXXXXX@yahoo.com> Crystal Muilenburg <muilenburg_crystal@allergan.com> Cynthia Bens <cbens@agingresearch.org> Dan Cohen XXXXXXXXXXXXXX@gmail.com> Dan Ignaszewski <dan@amputee-coalition.org> Dave Duhrkoop XXXXXXXXXXXXXX@gmail.com> David Swankin <davidswankin@cacenter.org> David Williams <daveawms@med.umich.edu> David Woodmansee <david.woodmansee@cancer.org> "Davis, Kimberly" <kimberly.davis@bsci.com> Deborah Pasko <dpasko@ashp.org> Derek Naten <derek.naten@mallinckrodt.com> Diane Millman <diane.millman@ppsv.com> Donna Kalauokalani XXXXXXXXXXXXXX@yahoo.com> Dr. Alexander Kraus <alexander.kraus@grunenthal.com> Elizabeth Hanpeter <elizabeth.hanpeter@abbvie.com> "Erensen, Jennifer" <jennifer.erensen@pharma.com> "Fordjour, Isaac" <isaac.fordjour@bsci.com> Fred Branson II <fbrason@projectlazarus.org> Gaby Geise <ggeise@amda.com> Gail Amalia B. Katz XXXXXXXXXXXXX@gmail.com> Gina Angelo <gina.angelo@abbvie.com> "Gunderman, Matthew" <matthew.gunderman@bsci.com> gwenn herman <gwenn@pain-connection.org> "Haddox, Dr. J. David" <dr.j.david.haddox@pharma.com> Hayden Rhudy <hayden.rhudy@abbvie.com> Heather Boyd <heather@swhr.org> Henrietta Ukwu <henrietta.ukwu@otsuka-us.com> Jacquelin Harris <jacquelin.harris@abbvie.com> James Lavery <james.lavery@abbvie.com> Jan Chambers XXXXXXXXXXXXXXX@gmail.com> Janet McUlsky <janet.mculsky@pfizer.com> Jason Crosby <jcrosby@ichelp.org> Jenna Ventresca <jventresca@aphanet.org> Jeremy Scott <jeremy.scott@dbr.com> Jerrica Mathis <jerrica.mathis@dbr.com> Jewelyn Cosgrove <jcosgrove@hda.org> Jillanne Schulte <jschulte@aphanet.org> Jim Broatch XXXXXXXXXX@gmail.com> Jim Murty <jmurty@clunegc.com> Joan Baird <jbaird@ascp.com> Joanna Morales <jm@triagecancer.org> Jody Green <jody.green@rmpdc.org> John Halliwell <john.p.halliwell@pfizer.com> John Kraemer <john.w.kraemer@pfizer.com> Jonathan Jagoda <jjagoda@fsmb.org> Jonathan Keyserling <jkeyserling@nhpco.org> Jordan Wildermuth <jwildermuth@connect2amc.com> Joseph Hill <jhill@ashp.org> Judi Lund Person <jlundperson@nhpco.org> Julian Malasi <julian.malasi@mallinckrodt.com> June Dahl PhD <jldahl@wisc.edu> Kara Gainer <kara.gainer@dbr.com> Kathleen Strauser <kstrauser@highwaterpartners.net> Katie Duensing <kduensing@aapainmanage.org> Kayla Lindsay <klindsay@arthritis.org> Ken Cole <ken.cole@pfizer.com> Kevin Nicholson <knicholson@nacds.org> Keysha Brooks-Coley <keysha.brooks-coley@cancer.org> Kirsten Sloan <kirsten.sloan@cancer.org> Kristen Freitas <kfreitas@hdmanet.org> Kristin Recchiuti <krecchiu@its.jnj.com> Kristina Pisanelli <kristina.m.pisanelli@medtronic.com> Laura Hunter <lhunter@proove.com> Lauryl Jackson <ljackso1@its.jnj.com> Lee Lowery <llowery@ichelp.org> Lindsay Bohlander <lindsay.bohlander@shionogi.com> Lisa Robin <lrobin@fsmb.org> Lisa Saake XXXXXXXXXXXXX@gmail.com> Liza Tresser <liza.tresser@tevapharm.com> Loyce Pace Bass <loyce.pace@livestrong.org> Maggie Buckley XXXXXXXXXXXXXXX@gmail.com> Marcia Lee Taylor <marcialee_taylor@drugfree.org> Mark Fleury <mark.fleury@cancer.org> Mark Tyndall <mark.tyndall@mallinckrodt.com> Marsha Stanton <mstanton@pernixtx.com> Marta Sokolowska <msokolowska@depomed.com> "McNeil, Melodi" <melodi.mcneil@abbvie.com> Melea Lusk <melea.lusk@abbvie.com> Michael C. Barnes <mbarnes@claad.org> Michael DeGeorge <mdegeorge@collegiumpharma.com> Michael Fahmy <michael.fahmy@otsuka-us.com> Michael Jarvis <michael.jarvis@abbvie.com> Michael Keegan <michael.keegan@ncpanet.org> Michelle Cope <mcope@nacds.org> Micke Brown XXXXXXXXXXXXXX@gmail.com> Mike Heffernan <mheffernan@collegiumpharma.com> Mike Innaurato <mike.innaurato@inspirionrx.com> Mike Walsh <mwalsh@allianceforpatientaccess.org> Myra Christopher <mchristopher@practicalbioethics.org> Nicole Kelly XXXXXXXXXXXX@verizon.net> Nina DeLorenzo <nina.delorenzo@abbvie.com> Patricia Knight <pknight@knight-cap.us> Patrick Coyne XXXXXXXXXXX@aol.com> Paul Arnstein <pmarnstein@partners.org> Paul Gileno XXXXXXXXXXXXXXXXX@gmail.com> Paul Scott O'Neill <pso@dcbalaw.com> "Paul, Ilisa Halpern" <ilisa.halpernpaul@dbr.com> Peggy Tighe <peggy.tighe@ppsv.com> Penny Cowan <pcowan@theacpa.org> Peter Pitts <ppitts@cmpi.org> Peter Reinecke <peter@rssinc.us> Philip Goglas <goglas@hmcw.org> Phyllis Whitehead <pbwhitehead@carilionclinic.org> Robert Falb <rob.falb@tevapharm.com> Robert Radie <rr@egalet.com> Robert Saner <robert.saner@ppsv.com> Robert Twillman <btwillman@aapainmanage.org> Ronna Hauser <ronna.hauser@ncpanet.org> Rosalie Abbott <rosalie.abbott@cancer.org> Rosemary Garza <rosemary.garza@medtronic.com> "Rosen, Burt" <burt.rosen@pharma.com> Ruth Miller <rmiller@hdmanet.org> Ryne Carney <rcarney@agingresearch.org> Saira Sultan <saira.sultan@connect4strategies.com> Sally Welsh <sallyw@hpna.org> Sandie Preiss <spreiss@arthritis.org> Sara Rosta <sara.rosta@ppsv.com> Shannon Dzubin <shannon.dzubin@tevapharm.com> Sharon Brigner <sbrigner@phrma.org> "Shaw, Solana" <solana.shaw@pharma.com> Steve Marmaras <smarmaras@ghlf.org> Sue Thau XXXXXXXXX@aol.com> Susan Peschin <speschin@agingresearch.org> Susan Stone <stone_susan@allergan.com> Teresa Shaffer <teresa.shaffer@paincommunity.org> "Tiller, Kimberley" <kimberley.tiller@pharma.com> Tim Hermes XXXXXXXXXX@gmail.com> "Timmerman, Christopher" <christopher.timmerman@bsci.com> Timothy Byrne <byrne.timothy@endo.com> Todd Stamps XXXXXXXXXXX@gmail.com> Tom O'Donnell <todonnell@nacds.org> Tracie Thomas <tthomas@painsproject.org> Wade Delk XXXXXXXXXX@gmail.com> Windy Y. Carson-Smith XXXXXXXXX@aol.com> Yvonne Klemets Wright <yklemetswright@egalet.com> opioids MNKOIv001 MNKOI0001661725 yes 2021 October 21 ngmb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 March 22 Long, Erika\Long, Erika all_9.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Drug Information Update- FDA announces enhanced warnings for immediate-release opioid pain medications related to risks of misuse, abuse, addiction, overdose and death 05:27 PM Long, Erika 2016 March 22 05:28 PM Drug Information Update- FDA announces enhanced warnings for immediate-release opioid pain medications related to risks of misuse, abuse, addiction, overdose and death U.S. Food & Drug Administration (FDA) <fda@service.govdelivery.com> 2016 March 22 Document Email 2 erika.long@mallinckrodt.com opioids MNKOIv001 MNKOI0001627980 2021 October 21 xpjb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 March 16 Long, Erika\Long, Erika all_5.pst\Top of Personal Folders\Archive MNKOI0001622037 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Policy Forum briefing on new technologies 3/20 at 2:00 pm 05:56 PM Long, Erika 2017 March 16 05:56 PM FW: Addiction Policy Forum briefing on new technologies 3/20 at 2:00 pm "Long, Erika" <erika.long@mallinckrodt.com> 2017 March 16 Document Email 9 "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> "Naten, Derek" <derek.naten@mallinckrodt.com> opioids MNKOIv001 MNKOI0001622028 2021 October 21 kpjb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 March 16 Long, Erika\Long, Erika all_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Policy Forum briefing on new technologies 3/20 at 2:00 pm 06:23 PM Long, Erika 2017 March 16 06:23 PM Re: Addiction Policy Forum briefing on new technologies 3/20 at 2:00 pm "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> 2017 March 16 Document Email 9 "Long, Erika" <erika.long@mallinckrodt.com> "Naten, Derek" <derek.naten@mallinckrodt.com> opioids MNKOIv001 MNKOI0001622038 2021 October 21 jykb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2016 September 29 Long, Erika\Long, Erika all_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Pulse Check: The White House drug czar on fighting addictions — including his own 03:40 PM Long, Erika 2016 September 29 03:40 PM Pulse Check: The White House drug czar on fighting addictions — including his own POLITICO Pro Health Care <politicoemail@politicopro.com> 2016 September 29 Document Email 3 erika.long@mallinckrodt.com opioids MNKOIv001 MNKOI0001624566 2021 October 21 shmy0237 Mallinckrodt Litigation Documents mnk public no restrictions 2013 July 29 Additional_Data\SRC24\Spaulding emails 1 1 08 to 12 31 13_2\Spaulding emails 1 1 08 to 12 31 13_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) ADDICTION RESEARCH AND TREATMENT INC and BAART BEHAVIORAL HEALTH SERVICES, INC 08:37 PM Spaulding, Eileen 2013 July 29 08:37 PM RE: ADDICTION RESEARCH AND TREATMENT INC and BAART BEHAVIORAL HEALTH SERVICES, INC "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> 2013 July 29 Document Email 1 "Newman, Larry L." <larry.l.newman@usdoj.gov> "Flores, Ariel B." <ariel.b.flores@usdoj.gov> Methadone MNKOIv001 MNKOI0001543462 2021 October 21 thmy0237 Mallinckrodt Litigation Documents mnk public no restrictions 2013 July 29 Additional_Data\SRC24\Spaulding emails 1 1 08 to 12 31 13_2\Spaulding emails 1 1 08 to 12 31 13_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) ADDICTION RESEARCH AND TREATMENT INC and BAART BEHAVIORAL HEALTH SERVICES, INC 08:39 PM Spaulding, Eileen 2013 July 29 08:39 PM RE: ADDICTION RESEARCH AND TREATMENT INC and BAART BEHAVIORAL HEALTH SERVICES, INC "Flores, Ariel B." <ariel.b.flores@usdoj.gov> 2013 July 29 Document Email 2 "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> "Newman, Larry L." <larry.l.newman@usdoj.gov> Methadone MNKOIv001 MNKOI0001543463 2021 October 21 gxmy0237 Mallinckrodt Litigation Documents mnk public no restrictions 2013 August 05 Additional_Data\SRC24\Spaulding emails 1 1 08 to 12 31 13_2\Spaulding emails 1 1 08 to 12 31 13_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) ADDICTION RESEARCH AND TREATMENT INC and BAART BEHAVIORAL HEALTH SERVICES, INC 04:27 PM Spaulding, Eileen 2013 August 05 04:27 PM RE: ADDICTION RESEARCH AND TREATMENT INC and BAART BEHAVIORAL HEALTH SERVICES, INC "Flores, Ariel B." <ariel.b.flores@usdoj.gov> 2013 August 05 Document Email 4 "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> "Newman, Larry L." <larry.l.newman@usdoj.gov> Methadone MNKOIv001 MNKOI0001543477 2021 October 21 rlmy0237 Mallinckrodt Litigation Documents mnk public no restrictions 2016 February 04 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_10\Spaulding emails 1 1 14 to 5 9 18_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) RI -RE: Request for confirmation of shipment to Addiction Recovery Institute RA0186975 07:05 PM Spaulding, Eileen 2016 February 04 07:05 PM RE: RI -RE: Request for confirmation of shipment to Addiction Recovery Institute RA0186975 "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> 2016 February 04 Document Email 4 "Cook, Thomas A." <thomas.a.cook@usdoj.gov> Methadone MNKOIv001 MNKOI0001543584 2021 October 21 sxny0237 Mallinckrodt Litigation Documents mnk public no restrictions 2016 November 18 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_7\Spaulding emails 1 1 14 to 5 9 18_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Shipping History Report for DEA - METHADOSE ORAL CONC 10MG/ML - Addiction Research and Treatment, Inc. - DEA # RA0240123 - CA 05:53 PM Spaulding, Eileen 2016 November 18 05:53 PM Re: Mallinckrodt Shipping History Report for DEA - METHADOSE ORAL CONC 10MG/ML - Addiction Research and Treatment, Inc. - DEA # RA0240123 - CA "Flores, Ariel B." <ariel.b.flores@usdoj.gov> 2016 November 18 Document Email 4 "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> Methadone MNKOIv001 MNKOI0001544024 2021 October 21 fgny0237 Mallinckrodt Litigation Documents mnk public no restrictions 2017 August 04 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_4\Spaulding emails 1 1 14 to 5 9 18_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Shipping History Report for DEA - Methadose Oral Concentrate 10mg/mL - Quality Addiction Management - DEA #RQ0343981 - WI 07:26 PM Spaulding, Eileen 2017 August 04 07:27 PM RE: Mallinckrodt Shipping History Report for DEA - Methadose Oral Concentrate 10mg/mL - Quality Addiction Management - DEA #RQ0343981 - WI "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> 2017 August 04 Document Email 3 "Feraldo, Michael J." <michael.j.feraldo@usdoj.gov> Methadone MNKOIv001 MNKOI0001543915 2021 October 21 rxny0237 Mallinckrodt Litigation Documents mnk public no restrictions 2016 November 16 Additional_Data\SRC24\Spaulding emails 1 1 14 to 5 9 18_7\Spaulding emails 1 1 14 to 5 9 18_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Shipping History Report for DEA - METHADOSE ORAL CONC 10MG/ML - Addiction Research and Treatment, Inc. - DEA # RA0240123 - CA 07:33 PM Spaulding, Eileen 2016 November 16 07:33 PM Mallinckrodt Shipping History Report for DEA - METHADOSE ORAL CONC 10MG/ML - Addiction Research and Treatment, Inc. - DEA # RA0240123 - CA "Spaulding, Eileen L." <eileen.spaulding@mallinckrodt.com> 2016 November 16 Document Email 2 "Flores, Ariel B." <ariel.b.flores@usdoj.gov> "McKenzie, Heather" <heather.mckenzie@mallinckrodt.com> Methadone MNKOIv001 MNKOI0001544022 2021 October 21 fgcl0234 Mallinckrodt Litigation Documents mnk Mindak, Barb public no restrictions produced document; Paper In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Letter from Mallinckrodt Pharmaceuticals to Joe Zigmund (of Redwood Empire Addictions Program, Re: Invoice prices) Mallinckrodt Pharmaceuticals Ryon, Denise 2003 October 01 document 2 Methadone MNKOIv001 MNKOI0000153562 2021 October 21 hgcl0234 Mallinckrodt Litigation Documents mnk Mindak, Barb public no restrictions produced document; Paper In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Letter from Mallinckrodt to Joe Zigmund (of Redwood Empire Addictions Program) (Re: Invoice pricing) Mallinckrodt 2003 October 01 document 1 opioids MNKOIv001 MNKOI0000153566 2021 October 21 fjcl0234 Mallinckrodt Litigation Documents mnk Mindak, Barb public no restrictions 2002 January 15 produced document; Paper In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Award/Contract between the Government of the District of Columbia. Department of Health. Addiction, Prevention, and Recovery Administration and Mallinckrodt, Inc. (Re: Purchase of 2100 liter size containers of Methadone Hydrochloride (Cherry Flavored), Contract Number POHC-2002-C-00401) Government of the District of Columbia Mallinckrodt, Inc. 2002 January 15 document 6 Methadone Morphine MNKOIv001 MNKOI0000153790 2021 October 21 hlfg0230 raf71j00 Oklahoma Opioid Litigation Documents okopioid public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] publication; article health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 What Percentage of Chronic Nonmalignant Pain Patients Exposed to Chronic Opioid Analgesic Therapy Develop Abuse/Addiction and/or Aberrant Drug-Related Behaviors? A Structured Evidence-Based Review Fishbain, David A Cole, Brandly Lewis, John Rosomoff, Hubert L Rosomoff, R Steele 2018 December 12 Document 16 Butorphanol Fentanyl Hydrocodone Methadone Morphine Oxycodone Oxymorphone Propoxyphene Tramadol J0398 2020 January 23 jfgg0230 xgf71j00 Oklahoma Opioid Litigation Documents okopioid public no restrictions [{"type":"plaintext","title":"Nix, Patterson and Roach, L.L.P."}] report, scientific; table health risks; marketing and sales State of Oklahoma vs. Purdue Pharma LP et al.; Case No. CJ-2017-816 National Addictions Vigilance Intervention and Prevention Program Surveillance Report Ortho-McNeil Janssen Pharmaceuticals Inflexxion Inc 2011 March 31 Document Image 58 Hydrocodone Oxycodone Oxymorphone Tapentadol Tramadol J1349 2020 January 23 tkwv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2016 June 24 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_10.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Is DEA a bad guy in opioid addiction fight? - The Washington Post 12:50 PM Naten, Derek 2016 June 24 UCSF 12:50 PM Fwd: Is DEA a bad guy in opioid addiction fight? - The Washington Post "Naten, Derek" <derek.naten@mallinckrodt.com> 2016 June 24 Document Email 1 XXXXXXXXXXX@gmail.com opioids MNKOIv002 MNKOI0001864546 yes 2021 October 21 kywv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2016 May 08 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Expand Access to Specialty Addiction Treatment! 07:00 PM Naten, Derek 2016 May 08 07:00 PM Expand Access to Specialty Addiction Treatment! ASAM Action Alert <advocacy@asam.org> 2016 May 08 Document Email 2 Derek Naten <derek.naten@mallinckrodt.com> Buprenorphine MNKOIv002 MNKOI0001864674 2021 October 21 zpwv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2016 February 11 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Waiting Lists Grow for Medicine to Fight Opioid Addiction 06:15 PM Naten, Derek 2016 February 11 UCSF 06:15 PM Fwd: Waiting Lists Grow for Medicine to Fight Opioid Addiction "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2016 February 11 Document Email 2 "Colvin, Darren A" <darren.colvin@mallinckrodt.com> "Ottosen, Danny J" <danny.ottosen@mallinckrodt.com> "Ryan, Edward R" <edward.ryan@mallinckrodt.com> "Spencer, Romney" <romney.spencer@mallinckrodt.com> "Block, Jennifer M (Bullerdick)" <jennifer.block@mallinckrodt.com> "Kazemi, Kian L" <kian.kazemi@mallinckrodt.com> "Vorderstrasse, Kevin" <kevin.vorderstrasse@mallinckrodt.com> XXXXXXX@aol.com "Naten, Derek" <derek.naten@mallinckrodt.com> opioids MNKOIv002 MNKOI0001864730 yes 2021 October 21 yshv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 March 14 Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) California Addiction Treatment meetings 10:58 AM Naten, Derek 2014 March 14 10:58 AM Re: California Addiction Treatment meetings "Franco, Bill" <william.franco@mallinckrodt.com> 2014 March 14 Document Email 1 "Naten, Derek" <derek.naten@mallinckrodt.com> Buprenorphine MNKOIv002 MNKOI0001867282 2021 October 21 fffv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2015 October 21 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_14.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Hill update: addiction treatment / generics pricing 04:39 PM Naten, Derek 2015 October 21 04:39 PM RE: Hill update: addiction treatment / generics pricing Rai Downs <rdowns@tdyllc.com> 2015 October 21 Document Email 1 "Naten, Derek" <derek.naten@mallinckrodt.com> "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> "Malasi, Julian F" <julian.malasi@mallinckrodt.com> opioids MNKOIv002 MNKOI0001864982 2021 October 21 mtfv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2017 July 14 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Response statement review: Justice Dept. takes action through Medicare Fraud Strike Force; involves in part opioids, addiction treatment 01:17 AM Naten, Derek 2017 July 14 01:17 AM Response statement review: Justice Dept. takes action through Medicare Fraud Strike Force; involves in part opioids, addiction treatment "Stauder, Nancy R" <nancy.stauder@mallinckrodt.com> 2017 July 14 Document Email 1 "Fischer, Meredith B" <meredith.fischer@mallinckrodt.com> "Scholz, Frank" <frank.scholz@mallinckrodt.com> "Hicks, Michael-Bryant" <michael-bryant.hicks@mallinckrodt.com> "Lohman, Donald A" <donald.lohman@mallinckrodt.com> "Tyndall, Mark" <mark.tyndall@mallinckrodt.com> "Naten, Derek" <derek.naten@mallinckrodt.com> "Lannum, Coleman" <cole.lannum@mallinckrodt.com> "Speciale, Daniel" <daniel.speciale@mallinckrodt.com> "Miller, Stephanie D" <stephanie.d.miller@mallinckrodt.com> "Sciarra, Rhonda" <rhonda.sciarra@mallinckrodt.com> "Hoyt, Rick A" <rick.hoyt@mallinckrodt.com> opioids MNKOIv002 MNKOI0001865699 2021 October 21 hfgv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2017 May 03 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) A Call for Presentations - Advancing & Integrating Specialized Addiction Treatment & Recovery 08:51 PM Naten, Derek 2017 May 03 08:51 PM A Call for Presentations - Advancing & Integrating Specialized Addiction Treatment & Recovery Allegra Schorr - 2018 AATOD Conference Chair <info@aatod.org> 2017 May 03 Document Email 2 derek.naten@mallinckrodt.com opioids MNKOIv002 MNKOI0001865754 2021 October 21 jhhv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 October 20 Naten, Derek\Naten, Derek pre 2015_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction-riddled Kentucky out for blood in $1B suit against OxyContin-maker Purdue 08:32 PM Naten, Derek 2014 October 20 UCSF 08:32 PM Addiction-riddled Kentucky out for blood in $1B suit against OxyContin-maker Purdue Dan Cohen XXXXXXXXXXXXXX@gmail.com> 2014 October 20 Document Email 2 nlangley@thelockingcap.com wsterman@signaturerx.com Todd Stamps <tstamps@pisgahlabs.com> Rob Falb <rob.falb@tevapharm.com> "Green, Jody, Ph.D" <jody.green@rmpdc.org> Jan Chambers <jan.chambers@fmcpaware.org> mbarnes@claad.org "Rosen, Burt" <burt.rosen@pharma.com> Brian Munroe <munroe.brian@endo.com> Marsha Stanton <mstanton@zogenix.com> Marcia Lee Taylor <marcialee_taylor@drugfree.org> dcarlson@collegiumpharma.com Marta Sokolowska <marta.sokolowska@grunenthal.com> XXXXXXXXXXXXXXXXX@comcast.net Michael C. Barnes <mbarnes@claad.org> Nathan Langley <nlangley@thelockingcap.com> Nccdp XXXXXXXXXXXXX@aol.com> XXXXXXXXXXXXXX@gmail.com mst@egalet.com Mike Innaurato XXXXXXXXXXXXXXX@gmail.com> Wade Delk <wdelk@goamp.com> Alexander Kraus <alexander.kraus@grunenthal.com> Dan McGinn <dan@mcginnandcompany.com> Paul Gileno XXXXXXXXXXXXXXXXX@gmail.com> tcmickle@kempharm.com "Baker, Clark" <clark.baker@grunenthal.com> "naten, derek" "tyndall, mark" E. Blair Clark-Schoeb <bcs@egalet.com> Solana Shaw <solana.shaw@pharma.com> adf@mcginnandcompany.com Michael C. Barnes <mbarnes@claad.org> Kyle Simon <ksimon@claad.org> Jeff Kimbell <jkimbell@kimbell-associates.com> Madeline Kroll <mkroll@kimbell-associates.com> Oxycodone MNKOIv002 MNKOI0001866712 yes 2021 October 21 yxwv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2017 November 28 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) AEI Today: Helping retention rates in drug addiction programs 11:02 AM Naten, Derek 2017 November 28 11:02 AM AEI Today: Helping retention rates in drug addiction programs American Enterprise Institute <aei_today@aei.org> 2017 November 28 Document Email 3 derek.naten@mallinckrodt.com opioids MNKOIv002 MNKOI0001864447 2021 October 21 jtwv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2016 January 18 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) FDA Panel Recommends Long-Acting Implant For Opioid Addiction : Shots - Health News : NPR 02:54 PM Naten, Derek 2016 January 18 UCSF 02:54 PM RE: FDA Panel Recommends Long-Acting Implant For Opioid Addiction : Shots - Health News : NPR "Naten, Derek" <derek.naten@mallinckrodt.com> 2016 January 18 Document Email 2 "Vorderstrasse, Kevin" <kevin.vorderstrasse@mallinckrodt.com> "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Kazemi, Kian L" <kian.kazemi@mallinckrodt.com> Buprenorphine MNKOIv002 MNKOI0001864931 yes 2021 October 21 trgv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2016 October 24 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Check out Methadone remains vital in buprenorphine era | Addiction Profession 07:18 PM Naten, Derek 2016 October 24 UCSF 07:18 PM Fwd: Check out Methadone remains vital in buprenorphine era | Addiction Profession "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2016 October 24 Document Email 1 "Kazemi, Kian L" <kian.kazemi@mallinckrodt.com> "Owen, Roger" <roger.owen@mallinckrodt.com> "Block, Jennifer M (Bullerdick)" <jennifer.block@mallinckrodt.com> "Ottosen, Danny J" <danny.ottosen@mallinckrodt.com> "Colvin, Darren A" <darren.colvin@mallinckrodt.com> "Ryan, Edward R" <edward.ryan@mallinckrodt.com> "Spencer, Romney" <romney.spencer@mallinckrodt.com> "Naten, Derek" <derek.naten@mallinckrodt.com> XXXXXXX@aol.com Buprenorphine Methadone MNKOIv002 MNKOI0001866473 yes 2021 October 21 ympp0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 April 18 Decker, John\Decker, John all_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Access Denied: Insurers slowly removing barriers to addiction treatment 12:31 PM Decker, John 2017 April 18 12:31 PM Access Denied: Insurers slowly removing barriers to addiction treatment Modern Healthcare A.M. <modernhealthcare@crainalerts.com> 2017 April 18 Document Email 4 john.decker@mallinckrodt.com opioids MNKOIv002 MNKOI0001860969 2021 October 21 npyb0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 December 05 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Opioid Addiction Epidemic, CR Stragetizing: What to Watch Today 01:47 PM Naten, Derek 2017 December 05 01:47 PM Opioid Addiction Epidemic, CR Stragetizing: What to Watch Today BGOV Congress Tracker <alerts@bgov.com> 2017 December 05 Document Email 6 derek.naten@mallinckrodt.com Methadone Oxycodone MNKOIv001 MNKOI0001633147 2021 October 21 yxgc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 July 17 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_16.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending July 17, 2015 11:50 AM Naten, Derek 2015 July 17 UCSF 11:50 AM Addiction Treatment News - Week Ending July 17, 2015 XXXXXXX@aol.com 2015 July 17 Document Email 3 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com kian.kazemi@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv001 MNKOI0001649564 yes 2021 October 21 jtfc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 June 19 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_16.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending June 19, 2015 04:23 PM Naten, Derek 2015 June 19 UCSF 04:23 PM Addiction Treatment News - Week Ending June 19, 2015 XXXXXXX@aol.com 2015 June 19 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com kian.kazemi@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine Methadone MNKOIv001 MNKOI0001648953 yes 2021 October 21 myfc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 September 30 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_15.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Attorney General Kamala D. Harris, 37 Attorneys General Join in Support of the Comprehensive Addiction and Recovery Act of 2015 02:30 AM Naten, Derek 2015 September 30 02:31 AM Re: Attorney General Kamala D. Harris, 37 Attorneys General Join in Support of the Comprehensive Addiction and Recovery Act of 2015 "Zook, David R." <dave.zook@faegrebd.com> 2015 September 30 Document Email 3 "Naten, Derek" <derek.naten@mallinckrodt.com> "Bono, Mary" <mary.bono@faegrebd.com> "Andrews, Joshua L." <joshua.andrews@faegrebd.com> opioids MNKOIv001 MNKOI0001648569 2021 October 21 tjgc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 April 03 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_17.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending April 3, 2015 02:19 PM Naten, Derek 2015 April 03 UCSF 02:20 PM Addiction Treatment News - Week Ending April 3, 2015 XXXXXXX@aol.com 2015 April 03 Document Email 3 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com kian.kazemi@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine Methadone MNKOIv001 MNKOI0001649672 yes 2021 October 21 tsfc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 June 18 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_16.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Stop Addiction in its Tracks 02:07 PM Naten, Derek 2015 June 18 02:08 PM Fwd: Stop Addiction in its Tracks Jan Rose <jrose@mqmllp.com> 2015 June 18 Document Email 2 Derek L. Naten <derek.naten@mallinckrodt.com> William McDermott <wmcdermott@mqmllp.com> opioids MNKOIv001 MNKOI0001648894 2021 October 21 rlgc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 April 17 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_17.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News Week Ending 4-17-15 09:34 PM Naten, Derek 2015 April 17 UCSF 09:34 PM Addiction Treatment News Week Ending 4-17-15 XXXXXXX@aol.com 2015 April 17 Document Email 3 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com kian.kazemi@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone Oxycodone MNKOIv001 MNKOI0001649902 yes 2021 October 21 phgc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 July 10 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_16.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending July 10, 2015 04:43 PM Naten, Derek 2015 July 10 UCSF 04:43 PM Addiction Treatment News - Week Ending July 10, 2015 XXXXXXX@aol.com 2015 July 10 Document Email 3 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com kian.kazemi@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine/Naloxone Fentanyl Methadone MNKOIv001 MNKOI0001649493 yes 2021 October 21 hhhc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 February 21 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_18.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending February 20, 2015 08:46 PM Naten, Derek 2015 February 21 UCSF 08:46 PM Addiction Treatment News - Week Ending February 20, 2015 XXXXXXX@aol.com 2015 February 21 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine/Naloxone Methadone MNKOIv001 MNKOI0001650920 yes 2021 October 21 ghhc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 February 20 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_18.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Massachusetts - Opioid Addiction Crisis 09:01 PM Naten, Derek 2015 February 20 09:01 PM Massachusetts - Opioid Addiction Crisis Jan Rose <jrose@mqmllp.com> 2015 February 20 Document Email 8 "Derek L. Naten (derek.naten@mallinckrodt.com)" <derek.naten@mallinckrodt.com> William McDermott <wmcdermott@mqmllp.com> Jan Rose <jrose@mqmllp.com> Buprenorphine Hydrocodone Oxycodone MNKOIv001 MNKOI0001650912 2021 October 21 xmhc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2015 March 06 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_18.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending March 6, 2015 07:42 PM Naten, Derek 2015 March 06 UCSF 07:42 PM Addiction Treatment News - Week Ending March 6, 2015 XXXXXXX@aol.com 2015 March 06 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv001 MNKOI0001651694 yes 2021 October 21 rmxc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 September 19 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) President’s Commission on Combating Drug Addiction and the Opioid Crisis ADC Sign-on Letter 01:57 PM Naten, Derek 2017 September 19 01:57 PM Automatic reply: President’s Commission on Combating Drug Addiction and the Opioid Crisis ADC Sign-on Letter "Naten, Derek" <derek.naten@mallinckrodt.com> 2017 September 19 Document Email 1 Stephanie Lowet <slowet@mcginnandcompany.com> opioids MNKOIv001 MNKOI0001653395 2021 October 21 mjjc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 October 18 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) GOVERNOR CUOMO ANNOUNCES $19 MILLION IN FEDERAL FUNDING TO EXPAND ACCESS TO ADDICTION SERVICES IN NEW YORK STATE 06:02 PM Naten, Derek 2017 October 18 06:02 PM FW: GOVERNOR CUOMO ANNOUNCES $19 MILLION IN FEDERAL FUNDING TO EXPAND ACCESS TO ADDICTION SERVICES IN NEW YORK STATE "Malasi, Julian F" <julian.malasi@mallinckrodt.com> 2017 October 18 Document Email 6 "Naten, Derek" <derek.naten@mallinckrodt.com> opioids MNKOIv001 MNKOI0001655375 2021 October 21 rxlc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 June 15 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) TUNE IN FRIDAY: The President’s Commission on Combating Drug Addiction and the Opioid Epidemic 02:11 PM Naten, Derek 2017 June 15 02:21 PM TUNE IN FRIDAY: The President’s Commission on Combating Drug Addiction and the Opioid Epidemic "LaPierre, Steven" <steve.lapierre@bsci.com> 2017 June 15 Document Email 3 "LaPierre, Steven" <steve.lapierre@bsci.com> Fentanyl MNKOIv001 MNKOI0001660101 2021 October 21 rklc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 June 19 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) July 12 and 19- Buffalo and Long Island: Joint Task Force on Heroin and Opioid Addiction Hearings 07:06 PM Naten, Derek 2017 June 19 07:06 PM July 12 and 19- Buffalo and Long Island: Joint Task Force on Heroin and Opioid Addiction Hearings COMPA <allschorr@westmidtownmedical.com> 2017 June 19 Document Email 3 derek.naten@mallinckrodt.com opioids MNKOIv001 MNKOI0001660335 2021 October 21 ptmc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 February 06 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) ACA repeal seen thwarting state addiction efforts 03:58 PM Naten, Derek 2017 February 06 03:58 PM ACA repeal seen thwarting state addiction efforts NCSL TODAY <enews@ncsl.org> 2017 February 06 Document Email 3 derek.naten@mallinckrodt.com opioids MNKOIv001 MNKOI0001664289 2021 October 21 rfyc0238 Mallinckrodt Litigation Documents mnk public no restrictions 2017 January 05 Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) PA Task Force: CO-SPONSORSHIP MEMORANDUM - Patient-Centered Opioid Addiction Treatment 07:34 PM Naten, Derek 2017 January 05 07:34 PM PA Task Force: CO-SPONSORSHIP MEMORANDUM - Patient-Centered Opioid Addiction Treatment "Groves, Paula" <pgroves@phrma.org> 2017 January 05 Document Email 2 mmarks@celgene.com jerry.moore@tevapharm.com mark.o'rourke@astellas.com alan.must@pharma.com anne.berry@astrazeneca.com clayton.wright@takeda.com tony.severoni@sunovion.com adam.taliaferro@bms.com dird@novonordisk.com paul.miller@astellas.com neely.frye@novartis.com jessica.dipaolo@jgadvocacy.com domenick.argento@merck.com jane.weirich@boehringer-ingelheim.com john.gibson@biogen.com steven.gardner@bms.com brian.rosen@pharma.com "Garofalo, Ryan" <rgarofalo@phrma.org> wendy.lazarus@pfizer.com bravacos@thebravogroup.com dapp@thebravogroup.com kathryn.lavriha@sanofi.com judy.jenkins@otsuka-us.com kevin.fuller@bayer.com jennifer.bland@merck.com karla.white@cslbehring.com jcohen6@its.jnj.com jim.delatte@takeda.com timothy.x.sullivan@gsk.com linda.martens@allergan.com piper@thebravogroup.com riley@thebravogroup.com jim.m.campolongo@gsk.com elizabeth.brewer@sanofi.com ctucker@pabio.org peter.gleason@klgates.com "VanderVeer, Priscilla" <pvanderveer@phrma.org> chris@pennsylvaniabio.org donna.huang@astrazeneca.com "Carroll, Caitlin" <ccarroll@phrma.org> "Wood, Nicole" <npalyawood@phrma.org> andrew.sandusky@abbvie.com derek.naten@mallinckrodt.com lyden_timothy@lilly.com panorton@amgen.com ethan.hasbrouck@bms.com Buprenorphine/Naloxone Methadone MNKOIv001 MNKOI0001666806 2021 October 21 lsdn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 November 07 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive MNKOI0001836593 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HM599 Opioid Addiction Treatment Education Series Sheet_Rev11-7-13 08:13 PM Holthaus, Gena 2013 November 07 UCSF 08:13 PM HM599 Opioid Addiction Treatment Education Series Sheet_Rev11-7-13 Barbara Rausch XXXXXXXXXXX@earthlink.net> 2013 November 07 Document Email 1 "Gena M (Brennan) Holthaus .com>" <gena.holthaus@mallinckrodt.com> opioids MNKOIv002 MNKOI0001836592 yes 2021 October 21 fxwn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 17 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Module 3 - PARC Requested Revisions 07:47 PM Holthaus, Gena 2014 February 17 07:47 PM RE: Addiction Treatment Module 3 - PARC Requested Revisions "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2014 February 17 Document Email 2 "Ford, Carol" <carol.ford@mallinckrodt.com> "Estes, Penny L" <penny.estes@mallinckrodt.com> Buprenorphine Methadone MNKOIv002 MNKOI0001836752 2021 October 21 tkwn0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 March 19 Holthaus, Gena\Gena Holthaus all_11.pst\Top of Personal Folders\Archive MNKOI0001836843 MNKOI0001836844 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NOW AVAILABLE - Module 2: Understanding Addiction 08:30 PM Holthaus, Gena 2014 March 19 UCSF 08:30 PM FW: NOW AVAILABLE - Module 2: Understanding Addiction "Holthaus, Gena M (Brennan)" <gena.holthaus@mallinckrodt.com> 2014 March 19 Document Email 2 "Schuster, Tammy H" <tammy.schuster@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001836841 yes 2021 October 21 mynp0238 Mallinckrodt Litigation Documents mnk public no restrictions 2014 January 24 Decker, John\Decker, John all_14.pst\Top of Personal Folders\Archive MNKOI0001859767 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NOW AVAILABLE - Module 2: Understanding Addiction 07:15 PM Decker, John 2014 January 24 07:15 PM Re: NOW AVAILABLE - Module 2: Understanding Addiction "Patrick, Jeffrey" <jeffrey.patrick@mallinckrodt.com> 2014 January 24 Document Email 3 "Purcell, Tina M" <tina.purcell@mallinckrodt.com> "Decker, John F" <john.decker@mallinckrodt.com> "Matoushek, Theresa" <theresa.matoushek@mallinckrodt.com> "Smith, Thomas" <thomas.smith@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001859764 2021 October 21 khbv0239 Mallinckrodt Litigation Documents mnk public no restrictions 2015 December 28 Decker, John\Decker, John all_7.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Opioid addiction treatment argued as 'essential' insurance benefit 01:31 PM Decker, John 2015 December 28 01:31 PM Opioid addiction treatment argued as 'essential' insurance benefit Modern Healthcare A.M. <modernhealthcare@crainalerts.com> 2015 December 28 Document Email 3 john.decker@mallinckrodt.com opioids MNKOIv002 MNKOI0001862337 2021 October 21 ygyc0240 Mallinckrodt Litigation Documents mnk public no restrictions 2017 July 27 20181017_Emails\Cardetti, Lisa All emails after 2013_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Confidential - Attain Med Addiction Treatment Opportunities 01:30 PM Cardetti, Lisa 2017 July 27 01:31 PM RE: Confidential - Attain Med Addiction Treatment Opportunities "Cardetti, Lisa M" <lisa.cardetti@mallinckrodt.com> 2017 July 27 Document Email 5 "Rausch, Ryan" <ryan.rausch@mallinckrodt.com> Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0002765653 2021 October 21 pfjb0234 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 12 MNKOI0000005680 MNKOI0000005688 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Generics and Addiction Catalogs - Pdf Files 03:59:45 PM Rehkop, Brenda 2014 February 12 UCSF 03:59:46 PM 0000000069FE12634E408C48888DAF1B4056B6DF645A2200.MSG FW: Generics and Addiction Catalogs - Pdf Files Rehkop, Brenda D Rehkop, Brenda D [Brenda.Rehkop@mallinckrodt.com] 2014 February 12 Document Email 1 Martinez, Amy [Amy.Martinez@mallinckrodt.com] opioids MNKOIv001 MNKOI0000005679 yes 2021 October 21 qfjb0234 Mallinckrodt Litigation Documents mnk Rehkop, Brenda public no restrictions HA153 Addiction Catalog_Rev12-9-13.pdf produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HA153 Addiction Catalog_Rev12-9-13.pdf 2013 December 09 Document 8 Buprenorphine Buprenorphine Hydrochloride Methadone MNKOIv001 MNKOI0000005680 2021 October 21 jgjb0234 Mallinckrodt Litigation Documents mnk Rehkop, Brenda public no restrictions HA153 Addiction Catalog_Rev12-9-13.pdf produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HA153 Addiction Catalog_Rev12-9-13.pdf 2013 December 09 Document 8 Buprenorphine Buprenorphine Hydrochloride Methadone MNKOIv001 MNKOI0000005716 2021 October 21 rgjb0234 Mallinckrodt Litigation Documents mnk Rehkop, Brenda public no restrictions HA153 Addiction Catalog_Rev12-9-13.pdf produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HA153 Addiction Catalog_Rev12-9-13.pdf 2013 December 09 Document 8 Buprenorphine Buprenorphine Hydrochloride Methadone MNKOIv001 MNKOI0000005770 2021 October 21 fxkb0234 Mallinckrodt Litigation Documents mnk public no restrictions 2014 April 16 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Research in Brooklyn, NY 02:27:42 PM Rehkop, Brenda 2014 April 16 02:27:43 PM 0000000069FE12634E408C48888DAF1B4056B6DF040B2500.MSG Re: Addiction Research in Brooklyn, NY Ryan, Edward R Ryan, Edward R [Edward.Ryan@mallinckrodt.com] 2014 April 16 Document Email 1 Rehkop, Brenda D [Brenda.Rehkop@mallinckrodt.com] Methadone MNKOIv001 MNKOI0000006750 2021 October 21 kjwc0234 Mallinckrodt Litigation Documents mnk Rehkop, Brenda public no restrictions Bob Lesnak Promotion.doc produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) I am pleased to announce the promotion of Mike Neely to the position of Director of Marketing, Addiction Treatment MENEELY 2005 January 04 Document 1 Methadone MNKOIv001 MNKOI0000014202 2021 October 21 ymwc0234 Mallinckrodt Litigation Documents mnk public no restrictions 2007 November 08 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Center for Addiction Recovery - ship to 52000467/sold to 50010111 11:28:43 AM Rehkop, Brenda 2007 November 08 11:28:43 AM 00000000A35CBAB0224BBB459FD61B1AC1951FFA842B2400.MSG RE: Center for Addiction Recovery - ship to 52000467/sold to 50010111 Rehkop, Brenda D Rehkop, Brenda D 2007 November 08 Document Email 1 Marlatt, Susan B Lesnak, Robert A Ryan, Edward R O'Brien, Jean Methadone MNKOIv001 MNKOI0000014269 2021 October 21 nmmc0234 Mallinckrodt Litigation Documents mnk public no restrictions 2013 September 13 Brendel all_2.zip\Brendel all_2.pst\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) This Monday: "The Doctors" to Air Episode re: Mike Sorrentino's Prescription Pill Addiction 05:12:22 PM Brendel, Diane 2013 September 13 05:11:58 PM 000000007FB852849A4C9C408ACB034BA2E1B198244D2000.MSG This Monday: "The Doctors" to Air Episode re: Mike Sorrentino's Prescription Pill Addiction Melissa Beglin Melissa Beglin [melissa@greenroompr.com] 2013 September 13 Document Email 1 'Brendel, Diane' [Diane.Brendel@mallinckrodt.com] 'Kathy Lauri ' [kathy@greenroompr.com] 'Samantha Koons' [samantha@greenroompr.com] 'Caren Begun' [caren@greenroompr.com] 'Alex Schnabel' [alex@greenroompr.com] 'Samantha Koons' [samantha@greenroompr.com] Buprenorphine/Naloxone MNKOIv001 MNKOI0000021350 2021 October 21 rmmc0234 Mallinckrodt Litigation Documents mnk public no restrictions 2013 September 16 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Recap of "The Doctors" Episode, Featuring Mike Sorrentino's Addiction to Opioids 05:01:19 PM Brendel, Diane 2013 September 16 05:00:55 PM 000000007FB852849A4C9C408ACB034BA2E1B19804582000.MSG Recap of "The Doctors" Episode, Featuring Mike Sorrentino's Addiction to Opioids Melissa Beglin Melissa Beglin [melissa@greenroompr.com] 2013 September 16 Document Email 3 'Brendel, Diane' [Diane.Brendel@mallinckrodt.com] 'Kathy Lauri ' [kathy@greenroompr.com] 'Stephanie Koze' [stephanie@greenroompr.com] 'Samantha Koons' [samantha@greenroompr.com] 'Alex Schnabel' [alex@greenroompr.com] 'Caren Begun' [caren@greenroompr.com] Buprenorphine/Naloxone Hydrocodone Oxycodone MNKOIv001 MNKOI0000021356 2021 October 21 tnmc0234 Mallinckrodt Litigation Documents mnk public no restrictions 2013 September 18 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Recap of "The Doctors" Episode, Featuring Mike Sorrentino's Addiction to Opioids 08:31:55 AM Brendel, Diane 2013 September 18 08:31:56 AM 000000007FB852849A4C9C408ACB034BA2E1B19824852000.MSG FW: Recap of "The Doctors" Episode, Featuring Mike Sorrentino's Addiction to Opioids Brendel, Diane Brendel, Diane [Diane.Brendel@mallinckrodt.com] 2013 September 18 Document Email 3 Webb, Kevin J [Kevin.Webb@mallinckrodt.com] LaRue, Leah J [Leah.LaRue@mallinckrodt.com] Buprenorphine/Naloxone Hydrocodone Oxycodone MNKOIv001 MNKOI0000021438 2021 October 21 znmc0234 Mallinckrodt Litigation Documents mnk public no restrictions 2013 September 18 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Recap of "The Doctors" Episode, Featuring Mike Sorrentino's Addiction to Opioids 08:37:01 AM Brendel, Diane 2013 September 18 08:37:02 AM 000000007FB852849A4C9C408ACB034BA2E1B198E4852000.MSG RE: Recap of "The Doctors" Episode, Featuring Mike Sorrentino's Addiction to Opioids Webb, Kevin J Webb, Kevin J [Kevin.Webb@mallinckrodt.com] 2013 September 18 Document Email 3 Brendel, Diane [Diane.Brendel@mallinckrodt.com] Buprenorphine/Naloxone Hydrocodone Oxycodone MNKOIv001 MNKOI0000021441 2021 October 21 fymc0234 Mallinckrodt Litigation Documents mnk public no restrictions 2013 September 18 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Recap of "The Doctors" Episode, Featuring Mike Sorrentino's Addiction to Opioids 08:37:48 AM Brendel, Diane 2013 September 18 08:37:49 AM 000000007FB852849A4C9C408ACB034BA2E1B19804862000.MSG RE: Recap of "The Doctors" Episode, Featuring Mike Sorrentino's Addiction to Opioids Brendel, Diane Brendel, Diane [Diane.Brendel@mallinckrodt.com] 2013 September 18 Document Email 3 Webb, Kevin J [Kevin.Webb@mallinckrodt.com] Buprenorphine/Naloxone Hydrocodone Oxycodone MNKOIv001 MNKOI0000021444 2021 October 21 yykb0234 Mallinckrodt Litigation Documents mnk public no restrictions 2013 February 18 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Clinics 03:04:48 PM Rehkop, Brenda 2013 February 18 03:04:46 PM 0000000013B354E87E60764E91AAF4BF3DB7C91A44E52200.MSG RE: Addiction Treatment Clinics Cahill, Lois L Cahill, Lois L [Lois.Cahill@Covidien.com] 2013 February 18 Document Email 1 Bullerdick, Jennifer M [Jennifer.Bullerdick@covidien.com] Tharp, Tracey L [Tracey.Tharp@Covidien.com] Rehkop, Brenda D [Brenda.Rehkop@Covidien.com] Randall, LouAnn [Louann.Randall@Covidien.com] Methadone MNKOIv001 MNKOI0000006984 2021 October 21 gkyb0234 Mallinckrodt Litigation Documents mnk public no restrictions 2010 December 15 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NY/ Addiction Res & Trt: MKG NY Ship date 12/13/10 Service Delay 4th update 08:39:41 AM Rehkop, Brenda 2010 December 15 08:39:41 AM 00000000E27F42EE6C513A49AE9B556C1B0D53FF24192100.MSG RE: NY/ Addiction Res & Trt: MKG NY Ship date 12/13/10 Service Delay 4th update Darlett Oliver Darlett Oliver [dvoliver@fedex.com] 2010 December 15 Document Email 5 Wall, Pat A Cahill, Lois L Nelson, Cheryl (Hazelwood) Rehkop, Brenda D Spaulding, Eileen L. Banks, Sharron Lorin Boudreau [lboudreau@fedex.com] Keeven, Charity A (Aranda) Coffey, Tracey R O'Leary, Dan J Myers, Penny Rausch, Jim H Methadone MNKOIv001 MNKOI0000009231 2021 October 21 kyyb0234 Mallinckrodt Litigation Documents mnk public no restrictions 2010 October 07 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Comprehensive Addiction Clinic (CO): Renewed DEA License 12:45:04 PM Rehkop, Brenda 2010 October 07 12:45:04 PM 00000000E27F42EE6C513A49AE9B556C1B0D53FFA4AF2200.MSG RE: Comprehensive Addiction Clinic (CO): Renewed DEA License Wall, Pat A Wall, Pat A 2010 October 07 Document Email 5 Spaulding, Eileen L. Coffey, Tracey R Jensen Jr, Edward R Rehkop, Brenda D Adams, Rose H Methadone MNKOIv001 MNKOI0000009434 2021 October 21 qrfy0419 Endo Documents endo Cooper, Steven Privacy public no restrictions 2010 March 05 2010 March 05 Hi Steven, I hope you are doing well - I am seeking your input regarding our research for our 3rd Annual Pain & Addiction Management For Health Plans Conference. Can we talk tomorrow or Monday?.msg Cooper, Steven - \Cooper, Steven\20190422\Email\04.19.2019_Cooper\Messages ENDO_ANK_CHI_0254442 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Hi Steven, I hope you are doing well - I am seeking your input regarding our research for our 3rd Annual Pain & Addiction Management For Health Plans Conference. Can we talk tomorrow or Monday? Mark.Coulter@worldrg.com 2010 March 05 other 3 Cooper, Steven /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=COOPER.STEVEN ENDO_ANK_CHI_0254439 yes 2026 March 26 kswn0419 Endo Documents endo Tormo, Vin public no restrictions America's Elderly Face Growing Drug Addiction Problem.htm Tormo, Vin\MyDocs\tormo.vin\My Documents\Sync My Documents\Desktop May 2006 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) America's Elderly Face Growing Drug Addiction Problem (Contribution by Rita Stevens) 2006 May 19 html 3 Polish ENDO_ANK_000281853 2026 March 26 nxhv0418 Endo Documents endo Shusterman, Neil public no restrictions Endo ASI-MV Epi Study Protocol_DRAFT_12 07 2012_nhs.docx Shusterman, Neil\MyDocs\shusterman.neil\Documents\Projects\Opana CRF\Epi Program In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Endo ASI-MV Epi Study Protocol_DRAFT_12 07 2012_nhs.docx;NATIONAL ADDICTIONS VIGILANCE Kimberly Lobo 2013 January 08 document 1 English ENDO-OPIOID_MDL-00889525 2026 March 26 mhcb0418 Endo Documents endo Collins, Mark public no restrictions Endo Report 2008_Q1.pdf Collins, Mark\06.20.2018_Opioids\Endo_Journal\06.20.2018_Collins_EndoJournal\06.20.2018_Collins_EndoJournal_0005.pst\Top of Outlook data file\Root Items\FW: Q1 2008 NAVIPPRO Report In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Endo Report 2008_Q1.pdf;NATIONAL ADDICTIONS VIGILANCE jcunningham 2008 April 14 document 1 English ENDO-OPIOID_MDL-01309997 2026 March 26 sxdb0418 Endo Documents endo Collins, Mark public no restrictions Endo_Opana_Supplemental Document_MediaGRIID_Articles_Q1 2011.pdf Collins, Mark\My Documents\Opana\collins.mark\Documents\Inflexxion NAVIPPRO\Reports\2010-2011.zip In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Endo_Opana_Supplemental Document_MediaGRIID_Articles_Q1 2011.pdf;NATIONAL ADDICTIONS VIGILANCE Meliessa Hennessy 2012 November 16 document 1 English ENDO-OPIOID_MDL-01382873 2026 March 26 flly0417 Endo Documents endo Galer, Brad public no restrictions SOAP Synopsis Final Draft.doc E:\MS0004\420D642B - Vol_0001\D\Files\Personal Folders\Galer.Bradley\GALER\GALER\SOAP\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential KFernandez 2003 April 01 document 1 ENDO-CHI_LIT-01413498 2026 March 26 prny0417 Endo Documents endo Tormo, Vin public no restrictions SOAP Synopsis Final Draft.doc \D0002\044372-SET000001\470BF628\000\L_\Exchsrvr\Mdbdata\Users (L-Z)\Users (T-Z).edb\Tormo.Vin\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential KFernandez 2003 March 06 document 1 ENDO-CHI_LIT-01485024 2026 March 26 qzvp0417 Endo Documents endo Chapman, Tara public no restrictions Endo Report 2008_Q1.pdf Chapman, Tara\My Documents\Opana\Chapman.Tara\My Documents\Opana EN3202 EN3203\Navippro Reports In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) NATIONAL ADDICTIONS VIGILANCE jcunningham 2012 April 24 document 1 English ENDO-NVAG-00064897 2026 March 26 lhgv0418 Endo Documents endo Journal public no restrictions Endo_Interim Analysis of Reformulated Opana ER_FINAL_2.5.2013.pdf Journal\Opana Master Case Export\Opana Master Case Export 3_0015.pst\Top of Outlook data file\Root Items\Reformulated Opana ER - Interim Report Final In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Endo_Interim Analysis of Reformulated Opana ER_FINAL_2.5.2013.pdf;NATIONAL ADDICTIONS VIGILANCE Kimberly Lobo 2013 February 05 document 1 English ENDO-OPIOID_MDL-00843149 2026 March 26 lhnm0417 Endo Documents endo Journal Privacy public no restrictions 2007 October 22 2007 October 22 RE: Out of scope - Opana - iatrogenic rate of addiction Journal\Opana Master Case Export\Opana Master Case Export 3_0074.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: Out of scope - Opana - iatrogenic rate of addiction "Alvarez, Nancy" <alvarez.nancy@endo.com> 2007 October 22 email 2 Robin Reap <robin.reap@durham.ppdi.com> "Terleckyj, Oksana" <terleckyj.oksana@endo.com> Margaret Haas <margaret.haas@durham.ppdi.com> William Gallimore <william.gallimore@durham.ppdi.com> Vida Farrar <vida.farrar@durham.ppdi.com> Ross Carter <ross.carter@durham.ppdi.com> Kristy Norman <kristy.norman@durham.ppdi.com> Jina Lee <jina.lee@durham.ppdi.com> END00419707 yes 2026 March 26 jhnm0417 Endo Documents endo Journal Privacy public no restrictions 2007 October 22 2007 October 22 FW: Out of scope - Opana - iatrogenic rate of addiction Journal\Opana Master Case Export\Opana Master Case Export 3_0074.pst\Top of Outlook data file\Root Items END00419706 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: Out of scope - Opana - iatrogenic rate of addiction "Alvarez, Nancy" <alvarez.nancy@endo.com> 2007 October 22 email 2 "Reder, Robert" <reder.robert@endo.com> END00419704 yes 2026 March 26 mhnm0417 Endo Documents endo Journal Privacy public no restrictions 2007 October 22 2007 October 22 RE: Out of scope - Opana - iatrogenic rate of addiction Journal\Opana Master Case Export\Opana Master Case Export 3_0074.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: Out of scope - Opana - iatrogenic rate of addiction Robin Reap <robin.reap@durham.ppdi.com> 2007 October 22 email 2 "Alvarez, Nancy" <alvarez.nancy@endo.com> END00419709 yes 2026 March 26 hfym0417 Endo Documents endo Journal Privacy public no restrictions 2013 May 16 2013 May 16 FW: [pain] screening tools for addiction? Journal\Opana Master Case Export\Opana Master Case Export 3_0179.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: [pain] screening tools for addiction? "Alvarez, Nancy" <alvarez.nancy@endo.com> 2013 May 16 email 2 naalvarez@zoominternet.net END00426317 yes 2026 March 26 grvm0417 Endo Documents endo Journal public no restrictions 2010 August 11 2010 August 11 RE: Ad hoc - Opana ER and use in addiction recovery patients Journal\Opana Master Case Export\Opana Master Case Export 3_0890.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: Ad hoc - Opana ER and use in addiction recovery patients Nora Tu <nora.tu@ppdi.com> 2010 August 11 email 2 "Alvarez, Nancy" <alvarez.nancy@endo.com> "Terleckyj, Oksana" <terleckyj.oksana@endo.com> Robin Reap <robin.reap@ppdi.com> Kajal Bhika <kajal.bhika@ppdi.com> END00345123 2026 March 26 hrvm0417 Endo Documents endo Journal public no restrictions 2010 August 11 2010 August 11 RE: Ad hoc - Opana ER and use in addiction recovery patients Journal\Opana Master Case Export\Opana Master Case Export 3_0890.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: Ad hoc - Opana ER and use in addiction recovery patients "Alvarez, Nancy" <alvarez.nancy@endo.com> 2010 August 11 email 2 "Terleckyj, Oksana" <terleckyj.oksana@endo.com> END00345125 2026 March 26 rrvm0417 Endo Documents endo Journal public no restrictions 2010 August 06 2010 August 06 RE: Ad hoc - Opana ER and use in addiction recovery patients Journal\Opana Master Case Export\Opana Master Case Export 3_0892.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: Ad hoc - Opana ER and use in addiction recovery patients Nora Tu <nora.tu@ppdi.com> 2010 August 06 email 1 "Terleckyj, Oksana" <terleckyj.oksana@endo.com> END00345194 2026 March 26 qmwf0418 Endo Documents endo Quaranta, Lynn public no restrictions 2007 September 22 2007 September 22 FW: EA Arizona Society of Addiction Medicine, Inc. - PER 09127 Quaranta, Lynn\Email\01.26.2018_GJS_EndoJournal_Quaranta_Extended\Messages\01.26.2018_GJS_EndoJournal_Quaranta_Extended_0001.pst\Top of Outlook data file\Root Items ENDO-OPIOID_MDL-03350445 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: EA Arizona Society of Addiction Medicine, Inc. - PER 09127 "Dekker, Anthony (IHS/PHX)" <anthony.dekker@ihs.gov> 2007 September 22 email 1 "Quaranta,Lynn" <quaranta.lynn@endo.com> xxxxxxxx@cox.net "Dekker, Anthony (IHS/PHX)" <anthony.dekker@ihs.gov> [REDACTED] Michel Sucher <[REDACTED]> English ENDO-OPIOID_MDL-03350441 2026 March 26 zrxg0418 Endo Documents endo Camper, Steve public no restrictions SOAPiSOAPCOMMExecutive Summary.doc Camper, Steve\Email\01.26.2018_GJS_EndoJournal_Camper\Messages\01.26.2018_GJS_EndoJournal_Camper_0015.pst\Top of Outlook data file\Root Items\RE: SOAP Synopsis - Final Draft for APS\oledata.mso\[Unnamed Container]\[Unnamed Container]\[Unnamed Container] In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential;SOAPiSOAPCOMMExecutive Summary.doc KFernandez 2003 March 09 document 1 English ENDO-OPIOID_MDL-04262531 2026 March 26 xsxg0418 Endo Documents endo Camper, Steve public no restrictions SOAPiSOAPCOMMExecutive Summary.doc Camper, Steve\Email\01.26.2018_GJS_EndoJournal_Camper\Messages\01.26.2018_GJS_EndoJournal_Camper_0015.pst\Top of Outlook data file\Root Items\RE: SOAP Synopsis - Final Draft for APS\oledata.mso\[Unnamed Container]\[Unnamed Container]\[Unnamed Container] In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential;SOAPiSOAPCOMMExecutive Summary.doc KFernandez 2003 March 09 document 1 English ENDO-OPIOID_MDL-04262536 2026 March 26 lsxg0418 Endo Documents endo Camper, Steve public no restrictions SOAPiSOAPCOMMExecutive Summary.doc Camper, Steve\Email\01.26.2018_GJS_EndoJournal_Camper\Messages\01.26.2018_GJS_EndoJournal_Camper_0015.pst\Top of Outlook data file\Root Items\RE: SOAP Synopsis - Final Draft for APS\oledata.mso\[Unnamed Container]\[Unnamed Container]\[Unnamed Container] In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential;SOAPiSOAPCOMMExecutive Summary.doc KFernandez 2003 March 09 document 1 English ENDO-OPIOID_MDL-04262540 2026 March 26 rsxg0418 Endo Documents endo Camper, Steve public no restrictions SOAPiSOAPCOMMExecutive Summary.doc Camper, Steve\Email\01.26.2018_GJS_EndoJournal_Camper\Messages\01.26.2018_GJS_EndoJournal_Camper_0015.pst\Top of Outlook data file\Root Items\RE: SOAP Synopsis - Final Draft for APS\oledata.mso\[Unnamed Container]\[Unnamed Container]\[Unnamed Container] In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential;SOAPiSOAPCOMMExecutive Summary.doc KFernandez 2003 March 09 document 1 English ENDO-OPIOID_MDL-04262549 2026 March 26 ssxg0418 Endo Documents endo Camper, Steve public no restrictions SOAPiSOAPCOMMExecutive Summary.doc Camper, Steve\Email\01.26.2018_GJS_EndoJournal_Camper\Messages\01.26.2018_GJS_EndoJournal_Camper_0015.pst\Top of Outlook data file\Root Items\RE: SOAP Synopsis - Final Draft for APS\oledata.mso\[Unnamed Container]\[Unnamed Container]\[Unnamed Container] In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential;SOAPiSOAPCOMMExecutive Summary.doc KFernandez 2003 March 09 document 1 English ENDO-OPIOID_MDL-04262554 2026 March 26 jkjg0418 Endo Documents endo Collins, Mark public no restrictions Endo ASI-MV Epi Study Protocol_DRAFT_12 07 2012_nhs.docx Collins, Mark\My Documents\Opana\collins.mark\Documents\Inflexxion NAVIPPRO\Epi stuff In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Endo ASI-MV Epi Study Protocol_DRAFT_12 07 2012_nhs.docx;NATIONAL ADDICTIONS VIGILANCE Kimberly Lobo 2013 January 08 document 1 English ENDO-OPIOID_MDL-04320637 2026 March 26 tzjh0418 Endo Documents endo Reder, Robert public no restrictions Endo Report 2008_Q1.pdf Reder, Robert\10.24.2018_Opioids_Reder_EndoJournal.7z\10.24.2018_Reder_EJ.pst\Top of Outlook data file\Root Items\FW: Q1 2008 NAVIPPRO Report In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) NATIONAL ADDICTIONS VIGILANCE jcunningham 2008 April 14 document 1 English ENDO-OPIOID_MDL-06177362 2026 March 26 pxvc0418 Endo Documents endo Tormo, Vin public no restrictions SOAP Synopsis Final.doc Tormo, Vin\MyDocs\tormo.vin\My Documents\Sync My Documents\SOAPP\FW SOAP for Ed Covington.msg\FW: SOAP for Ed Covington In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential;SOAP for Ed Covington KFernandez 2003 September 23 document 1 English ENDO-OPIOID_MDL-01998318 2026 March 26 qxvc0418 Endo Documents endo Tormo, Vin public no restrictions SOAP Synopsis Final.doc Tormo, Vin\MyDocs\tormo.vin\My Documents\Sync My Documents\SOAPP\FW SOAP information.msg\FW: SOAP information In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential;SOAP information KFernandez 2003 August 25 document 1 English ENDO-OPIOID_MDL-01998322 2026 March 26 sxvc0418 Endo Documents endo Tormo, Vin public no restrictions SOAP Synopsis Final Draft.doc Tormo, Vin\MyDocs\tormo.vin\My Documents\Sync My Documents\SOAPP\RE iSOAP.msg\RE: iSOAP In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential;iSOAP KFernandez 2003 March 18 document 1 English ENDO-OPIOID_MDL-01998325 2026 March 26 sgdc0418 Endo Documents endo Journal public no restrictions Addiction Behaviors Checklist.pdf Journal\Opana Master Case Export 3_1547.pst\Top of Outlook data file\Root Items\Jo, could you please print this out for me? THNAKS! In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Addiction Behaviors Checklist.pdf 2012 February 22 document 2 English ENDO-OPIOID_MDL-02161030 2026 March 26 mkgm0417 Endo Documents endo Journal Privacy public no restrictions Butler et al, Initial Validation of a computer-administered addiction severity index, the ASI-MV.pdf Journal\Opana Master Case Export 3_1473.pst\Top of Outlook data file\Root Items\RE: Inflexxion Handouts\RE: Inflexxion Handouts In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Butler et al, Initial Validation of a computer-administered addiction severity index, the ASI-MV.pdf 2009 March 16 document 9 END00376501 yes 2026 March 26 txgc0418 Endo Documents endo Journal public no restrictions [Unnamed Document] Journal\Opana Master Case Export\Opana Master Case Export 3_0497.pst\Top of Outlook data file\Root Items\FW: Risk MAP and last report\EOC discussion March 2011 v2.pptx\ppt\embeddings\oleObject1.bin In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) NATIONAL ADDICTIONS VIGILANCE;[Unnamed Document] tcassidy tdailey 2011 March 04 document 1 English ENDO-OPIOID_MDL-02217513 2026 March 26 lpfc0418 Endo Documents endo Journal public no restrictions Route of abuse NAVIPPRO.pdf Journal\Opana Master Case Export\Opana Master Case Export 3_0901.pst\Top of Outlook data file\Root Items\RE: Hi (as in run away, run away...) In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) NATIONAL ADDICTIONS VIGILANCE;Route of abuse NAVIPPRO.pdf jcunningham 2010 August 05 document 13 English ENDO-OPIOID_MDL-02207521 2026 March 26 rylp0418 Endo Documents endo Armstrong, Simone Privacy public no restrictions 2012 August 15 2012 August 15 RE: Addiction Specialist.msg \Armstrong_Simone_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: Addiction Specialist /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=ARMSTRONG.SIMONE 2012 August 15 other 3 Odem, Joshua /O=ENDO PHARMACEUTICALS INC/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=Odem.Joshua ENDO_ALAG-00387585 yes 2026 March 26 xmyj0418 Endo Documents endo Alvarez, Nancy public no restrictions SOAP Synopsis Final Draft.doc Alvarez, Nancy\My Documents\Opana\Alvarez.Nancy\My Documents\FILED\Clinical Development and Education\SOAP In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential;iSOAP KFernandez 2003 March 18 document 1 English ENDO-OPIOID_MDL-07554903 2026 March 26 jmyj0418 Endo Documents endo Alvarez, Nancy public no restrictions SOAP Synopsis Final Draft.doc Alvarez, Nancy\My Documents\Opana\Alvarez.Nancy\My Documents\FILED\Clinical Development and Education In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential;SOAP Synopsis - Final Draft for APS KFernandez 2003 March 13 document 1 English ENDO-OPIOID_MDL-07554906 2026 March 26 qnpj0418 Endo Documents endo Alvarez, Nancy public no restrictions 2008 December 31 2008 December 31 Annual Review and Update of Lidoderm ADE - Addiction with Lidoderm SRL (V1D3) \Opana Master Case Export 3_1459.pst\Top of Outlook data file\Root Items ENDO-OPIOID_MDL-07591032 ENDO-OPIOID_MDL-07591033 ENDO-OPIOID_MDL-07591035 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Annual Review and Update of Lidoderm ADE - Addiction with Lidoderm SRL (V1D3) Robin Reap <robin.reap@rtp.ppdi.com> 2008 December 31 email 1 "Terleckyj, Oksana" <terleckyj.oksana@endo.com> "Alvarez, Nancy" <alvarez.nancy@endo.com> Nora Tu <nora.tu@durham.ppdi.com> Robin Reap <robin.reap@rtp.ppdi.com> English ENDO-OPIOID_MDL-07591031 2026 March 26 snpj0418 Endo Documents endo Alvarez, Nancy public no restrictions ADE - Addiction with Lidoderm_Update Dec 2008_V1D3.doc \Opana Master Case Export 3_1459.pst\Top of Outlook data file\Root Items\Annual Review and Update of Lidoderm ADE - Addiction with Lidoderm SRL (V1D3)\Annual Review and Update of Lidoderm ADE - Addiction with Lidoderm SRL (V1D3) In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) This response concerns the issue of addiction caused by the use of LIDODERM® Gammaitoni.Arnold 2009 January 01 document 1 English ENDO-OPIOID_MDL-07591033 2026 March 26 fhnk0418 Endo Documents endo Kitlinski, Linda public no restrictions UNC 2005 Pain, Addiction and the Law 1.doc Kitlinski, Linda\PSTs\09.18.2017 - Kitlinski_Vault_CO\Messages\09.18.2017 - Kitlinski_Vault_CO.pst\Top of Outlook data file\Root Items\PER UNC Finally In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) UNC 2005 Pain, Addiction and the Law 1.doc Jackie McNeil 2005 July 05 document 1 English ENDO-OPIOID_MDL-08208056 2026 March 26 zgfm0418 Endo Documents endo Thomson, Heather public no restrictions Endo Report 2008_Q1.pdf \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) NATIONAL ADDICTIONS VIGILANCE jcunningham 2008 April 14 document 1 ENDO-OPIOID_MDL-08385821 2026 March 26 nfxm0418 Endo Documents endo Journal Privacy public no restrictions 2009 January 28 RE: 11th Annual Fundamentals of Addiction Medicine Conference - March 5-6, 2009 Journal\07.26.2016 - Opana ER FTC\Messages\07.26.2016 - Opana ER FTC_0027.pst\Top of Outlook data file\Root Items ENDO-OR-CID-01280664 ENDO-OR-CID-01280666 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: 11th Annual Fundamentals of Addiction Medicine Conference - March 5-6, 2009 "Njuguna, Ruth" <njuguna.ruth@endo.com> 2009 January 28 email 3 "Keane,Ellen" <keane.ellen@endo.com> "Chambliss, Richard" <chambliss.richard@endo.com> ENDO-OR-CID-01280661 yes 2026 March 26 rfxm0418 Endo Documents endo Journal Privacy public no restrictions 2009 January 30 RE: 11th Annual Fundamentals of Addiction Medicine Conference - March 5-6, 2009 Journal\07.26.2016 - Opana ER FTC\Messages\07.26.2016 - Opana ER FTC_0027.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: 11th Annual Fundamentals of Addiction Medicine Conference - March 5-6, 2009 "Njuguna, Ruth" <njuguna.ruth@endo.com> 2009 January 30 email 3 "Chambliss, Richard" <chambliss.richard@endo.com> ENDO-OR-CID-01280742 yes 2026 March 26 nxpf0418 Endo Documents endo Journal public no restrictions 110512_TIRF Dear Inpatient Pharmacy Letter MAC Endo.doc Journal\Opana Master Case Export\Opana Master Case Export 3_0659.pst\Top of Outlook data file\Root Items\RE: TIRF REMS - review required - URGENT\110512_TIRF REMS MAC REad 1.zip\110512_TIRF REMS MAC REad 1 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) 110512_TIRF Dear Inpatient Pharmacy Letter MAC Endo.doc;Subject: Products for which there is a potential risk of misuse, abuse, addiction or overdose;this is a FDA required restrict Valerie Cullen 2011 May 13 document 6 English ENDO-OPIOID_MDL-03908509 2026 March 26 splg0418 Endo Documents endo Journal public no restrictions 110512_TIRF Dear Inpatient Pharmacy Letter MAC Endo.doc Journal\Opana Master Case Export\Opana Master Case Export 3_0659.pst\Top of Outlook data file\Root Items\Emailing: 110512_TIRF REMS MAC REad 1 (2)\110512_TIRF REMS MAC REad 1 (2).zip\110512_TIRF REMS MAC REad 1 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) 110512_TIRF Dear Inpatient Pharmacy Letter MAC Endo.doc;Subject: Products for which there is a potential risk of misuse, abuse, addiction or overdose;this is a FDA required restrict Valerie Cullen 2011 May 13 document 6 English ENDO-OPIOID_MDL-04727927 2026 March 26 fslg0418 Endo Documents endo Journal Privacy public no restrictions Inpatient Pharmacy Letter + FDA 11.01.11.doc Journal\Opana Master Case Export\Opana Master Case Export 3_1125.pst\Top of Outlook data file\Root Items\FW: FDA Call Follow-up and Docs attached\2nd Round of comments for the TRIG**** In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Inpatient Pharmacy Letter + FDA 11.01.11.doc;Subject: Products for which there is a potential risk of misuse, abuse, addiction or overdose;this is a FDA required restrict 2011 November 03 document 8 English ENDO-OPIOID_MDL-04728760 yes 2026 March 26 xzpd0418 Endo Documents endo Journal Privacy public no restrictions Addiction.1999.94(4).479-488.pdf Journal\Opana Master Case Export\Opana Master Case Export 3_0376.pst\Top of Outlook data file\Root Items\RE: Looking for papers In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Addiction.1999.94(4).479-488.pdf;The cost-effectiveness of methadone maintenance as a health care intervention 2010 January 22 document 10 English ENDO-OPIOID_MDL-02521802 yes 2026 March 26 nzxw0418 Endo Documents endo Journal Privacy public no restrictions 2012 May 16 2012 May 16 Re: R&D Lunch and Learn: The Intersection of Pain Management and Addiction Journal\Opana Master Case Export\Opana Master Case Export 3_1647.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Re: R&D Lunch and Learn: The Intersection of Pain Management and Addiction "Kelly, Marv" <kelly.marv@endo.com> 2012 May 16 email 2 "Shuey, Dana" <shuey.dana@endo.com> "Loughead, Catherine" <loughead.catherine@endo.com> "McDermott, Laurel" <mcdermott.laurel@endo.com> "Gergel, Ivan" <gergel.ivan@endo.com> English ENDO-OPIOID_MDL-02912457 yes 2026 March 26 ljjf0418 Endo Documents endo Journal Privacy public no restrictions 2012 May 16 2012 May 16 RE: R&D Lunch and Learn: The Intersection of Pain Management and Addiction Journal\Opana Master Case Export\Opana Master Case Export 3_1647.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: R&D Lunch and Learn: The Intersection of Pain Management and Addiction "Loughead, Catherine" <loughead.catherine@endo.com> 2012 May 16 email 2 "Kelly, Marv" <kelly.marv@endo.com> English ENDO-OPIOID_MDL-03490010 yes 2026 March 26 ysxg0418 Endo Documents endo Camper, Steve public no restrictions SOAPiSOAPCOMMExecutive Summary.doc Camper, Steve\Email\01.26.2018_GJS_EndoJournal_Camper\Messages\01.26.2018_GJS_EndoJournal_Camper_0015.pst\Top of Outlook data file\Root Items\RE: SOAP Synopsis - Final Draft for APS\oledata.mso\[Unnamed Container]\[Unnamed Container]\[Unnamed Container] In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Innovation Diffusion Project: Development of the Screener for Opioid Addiction Potential;SOAPiSOAPCOMMExecutive Summary.doc KFernandez 2003 March 09 document 1 English ENDO-OPIOID_MDL-04262544 2026 March 26 hpdb0418 Endo Documents endo Collins, Mark public no restrictions ATTACHMENT E Endo_Interim Analysis of Reformulated Opana ER_FINAL_2 5 2013.pdf Collins, Mark\My Documents\Opana\collins.mark\Documents\Opana ER CRF\Info for SL\Attachments In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) ATTACHMENT E Endo_Interim Analysis of Reformulated Opana ER_FINAL_2 5 2013.pdf;NATIONAL ADDICTIONS VIGILANCE Kimberly Lobo 2013 June 27 document 1 English ENDO-OPIOID_MDL-01395211 2026 March 26 xjwb0418 Endo Documents endo Journal public no restrictions Endo_Interim Analysis of Reformulated Opana ER_FINAL_1.30.2013.docx Journal\Opana Master Case Export\Opana Master Case Export 3_0079.pst\Top of Outlook data file\Root Items\Endo Draft Interim Report In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Endo_Interim Analysis of Reformulated Opana ER_FINAL_1.30.2013.docx;NATIONAL ADDICTIONS VIGILANCE Kimberly Lobo 2013 January 31 document 1 English ENDO-OPIOID_MDL-01416096 2026 March 26 jjwb0418 Endo Documents endo Journal public no restrictions Endo_Interim Analysis of Reformulated Opana ER_FINAL_1.30.2013.pdf Journal\Opana Master Case Export\Opana Master Case Export 3_0079.pst\Top of Outlook data file\Root Items\Endo Draft Interim Report In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Endo_Interim Analysis of Reformulated Opana ER_FINAL_1.30.2013.pdf;NATIONAL ADDICTIONS VIGILANCE Kimberly Lobo 2013 January 31 document 1 English ENDO-OPIOID_MDL-01416125 2026 March 26 tmwb0418 Endo Documents endo Journal Privacy public no restrictions 2012 April 26 2012 April 26 FW: R&D Lunch and Learn: The Intersection of Pain Management and Addiction Journal\Opana Master Case Export\Opana Master Case Export 3_1606.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: R&D Lunch and Learn: The Intersection of Pain Management and Addiction "Shuey, Dana" <shuey.dana@endo.com> 2012 April 26 email 2 "Birner, Tim" <birner.tim@endo.com> "Collins, Mark" <collins.mark@endo.com> English ENDO-OPIOID_MDL-01426362 yes 2026 March 26 mqmb0418 Endo Documents endo Journal public no restrictions Endo Report 2008_Q1.pdf Journal\Opana Master Case Export\Opana Master Case Export 3_1044.pst\Top of Outlook data file\Root Items\FW: Q1 2008 NAVIPPRO Report In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Endo Report 2008_Q1.pdf;NATIONAL ADDICTIONS VIGILANCE jcunningham 2008 April 14 document 1 English ENDO-OPIOID_MDL-01874527 2026 March 26 qncn0421 Endo Documents endo Vitanza, Kristin public no restrictions NAVIPPROReportQ12007.pdf Vitanza, Kristen\vitanza\Vitanza,Kristin_Export_0003.pst\Top of Personal Folders\Inbox\Compliance\OPANA BRAND 2007\Tony Mack\FW: IM Subteam Meeting - April 25, 2007, 1-2pm In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) NATIONAL ADDICTIONS VIGILANCE jcunningham 2007 April 24 document 46 English ENDO_FLAG-00354070 2026 April 30 nrjn0421 Endo Documents endo Camper, Steve Privacy public no restrictions 2003 July 25 2003 July 25 FW: Possible addiction med speakers for sales training.msg \ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: Possible addiction med speakers for sales training Kitlinski, Linda 2003 July 25 other 4 Vandal, Eric <Vandal.Eric@Endo.com> Galer, Bradley <Galer.Bradley@Endo.com> Speiller,Marcia <speiller.marcia@Endo.com> Clark,Matthew <Clark.matthew@Endo.com> Tormo, Vin <Tormo.Vin@Endo.com> Aron, Carey <aron.carey@Endo.com> ENDO_FLAG-00375915 yes 2026 April 30 qxcn0421 Endo Documents endo Vitanza, Kristin Privacy public no restrictions PainPractitioner 11-20- 06.doc Vitanza, Kristen\vitanza\Vitanza,Kristin_Export_0002.pst\Top of Personal Folders\Inbox\2009 Emails\2007 Old Email\FW: Jennifer Schneider's CV In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Opioids, Pain Management, and Addiction Jennifer Schneider 2007 January 06 document 12 English ENDO_FLAG-00353543 yes 2026 April 30 sgkn0421 Endo Documents endo Camper, Steve Privacy public no restrictions 2004 February 22 2004 February 22 FW: [PAIN_CHEM_DEP] Chronic Pain & Opioid Addiction, Mutually Exclusive?.msg \ ENDO_FLAG-00376283 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: [PAIN_CHEM_DEP] Chronic Pain & Opioid Addiction, Mutually Exclusive? Kitlinski, Linda 2004 February 22 other 1 Aron, Carey <aron.carey@Endo.com> Clark,Matthew <Clark.matthew@Endo.com> Tormo, Vin <Tormo.Vin@Endo.com> Speiller,Marcia <speiller.marcia@Endo.com> Yuen,Frank <yuen.frank@Endo.com> Alvarez, Nancy <Alvarez.Nancy@Endo.com> Gammaitoni, Arnold <Gammaitoni.Arnold@Endo.com> Gould,Errol <Gould.Errol@Endo.com> White,Richard <white.richard@Endo.com> Varughese,Sajan <varughese.sajan@Endo.com> Pinizzotto,Marie <Pinizzotto.Marie@Endo.com> Galer, Bradley <Galer.Bradley@Endo.com> ENDO_FLAG-00376282 yes 2026 April 30 gfby0421 Endo Documents endo Kitlinski, Linda public no restrictions Addiction Behaviors Checklist.pdf \Kitlinski, Linda\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Addiction Behaviors Checklist.pdf 2012 March 01 document 2 ENDO_FLAG-00413612 2026 April 30 mfhy0421 Endo Documents endo Kitlinski, Linda Privacy public no restrictions Iatrogenic addiction - Jamison.pdf Kitlinski, Linda\My Documents\Opana\Kitlinski.Linda\My Documents\Opioid Publications In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Iatrogenic addiction - Jamison.pdf 2006 February 23 document 7 ENDO_FLAG-00427210 yes 2026 April 30 hsyy0421 Endo Documents endo Kitlinski, Linda public no restrictions Addiction Behaviors Checklist.pdf Kitlinski, Linda\Kitlinski,Linda_Export_0029.pst\Top of Personal Folders\Inbox\RE: SAPRT Next Steps\Doctor-Facing SAPRT Module (for eventual NPRC Review).docx\word\embeddings\oleObject4.bin In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Addiction Behaviors Checklist.pdf 2012 February 22 document 2 English ENDO_FLAG-00447338 2026 April 30 mryy0421 Endo Documents endo Kitlinski, Linda public no restrictions Addiction Behaviors Checklist.pdf Kitlinski, Linda\Kitlinski,Linda_Export_0029.pst\Top of Personal Folders\Inbox\SAPRT Tools Ownership Details\SAPRT Risk Asst w Ownership Info.docx\word\embeddings\oleObject4.bin In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Addiction Behaviors Checklist.pdf 2012 February 22 document 2 English ENDO_FLAG-00447307 2026 April 30 hqyy0421 Endo Documents endo Kitlinski, Linda public no restrictions Addiction Behaviors Checklist.pdf Kitlinski, Linda\Kitlinski,Linda_Export_0028.pst\Top of Personal Folders\Inbox\FW: SAPRT Module 2 Table In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Addiction Behaviors Checklist.pdf 2012 February 22 document 2 English ENDO_FLAG-00447055 2026 April 30 yfhy0421 Endo Documents endo Kitlinski, Linda public no restrictions Opioid Addiction Terminology.pdf Kitlinski, Linda\My Documents\Opana\Kitlinski.Linda\My Documents\Opioid Publications In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Opioid Addiction Terminology.pdf 2006 February 28 document 8 ENDO_FLAG-00427228 2026 April 30 frmy0421 Endo Documents endo Kitlinski, Linda public no restrictions FDA_Docket_February 22.2010.docx Kitlinski, Linda\Kitlinski,Linda_Export_0011.pst\Top of Personal Folders\Sent Items\FW: NAVIPPRO Info for Docket In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) NATIONAL ADDICTIONS VIGILANCE jcunningham 2010 February 23 document 17 English ENDO_FLAG-00438504 2026 April 30 lrmy0421 Endo Documents endo Kitlinski, Linda public no restrictions Inflexxion February 22nd Opioid REMS NAVIPPRO Docket.pdf Kitlinski, Linda\Kitlinski,Linda_Export_0012.pst\Top of Personal Folders\Inbox\Information Requested from Inflexxion In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) NATIONAL ADDICTIONS VIGILANCE jcunningham 2010 April 16 document 17 English ENDO_FLAG-00438629 2026 April 30 kgcp0421 Endo Documents endo Kitlinski, Linda public no restrictions Addiction Behaviors Checklist.pdf Opana Master Case Export 3_1539.pst\Top of Outlook data file\Root Items\FW: SAPRT Module 2 Table In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Addiction Behaviors Checklist.pdf 2012 February 22 document 2 English ENDO_FLAG-00459789 2026 April 30 tjpp0421 Endo Documents endo Tormo, Vin public no restrictions NP Courtesy Review - Topical vs Transdermal & Lidocaine patch desc & Addiction info.ppt \F\Tormo, Vin\MyDocs\tormo.vin\My Documents\DESKTOPS 2012-14\Desktop July 2012\outlook pst files\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) NP Courtesy Review - Topical vs Transdermal & Lidocaine patch desc & Addiction info.ppt Tormo.Vin 2006 October 04 presentation 1 ENDO_FLAG-00558887 2026 April 30 gqlm0421 Endo Documents endo Kitlinski, Linda Privacy public no restrictions Opioid Dependence and Addiction Pain 2007.pdf \RV019\\Opana Master Case Export\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Opioid Dependence and Addiction Pain 2007.pdf 2008 May 05 document 21 ENDO_FLAG-00300610 yes 2026 April 30 lslm0421 Endo Documents endo Kitlinski, Linda Privacy public no restrictions Butler et al, Initial Validation of a computer-administered addiction severity index, the ASI-MV.pdf \V\Kitlinski, Linda\MyDocs\kitlinski.linda\Will Not Sync\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Butler et al, Initial Validation of a computer-administered addiction severity index, the ASI-MV.pdf 2009 May 28 document 9 ENDO_FLAG-00301041 yes 2026 April 30 prhn0421 Endo Documents endo Burrell, Frank Privacy public no restrictions 2012 May 16 2012 May 16 FW: R&D Lunch and Learn: The Intersection of Pain Management and Addiction Opana Master Case Export\Opana Master Case Export 3_1645.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: R&D Lunch and Learn: The Intersection of Pain Management and Addiction "Shuey, Dana" <shuey.dana@endo.com> 2012 May 16 calendar 2 "Albert, Nicholas" <albert.nicholas@endo.com> "Azzalina, Doug" <azzalina.doug@endo.com> "Baker, Clark" <baker.clark@endo.com> "Burrell, Frank" <burrell.frank@endo.com> "Dempsey, Teresa" <dempsey.teresa@endo.com> "Dierks, Jeff" <dierks.jeff@endo.com> "Ibach, Nancy" <ibach.nancy@endo.com> "Jackson, Traci" <jackson.traci@endo.com> "Kelly, Marv" <kelly.marv@endo.com> "Leinhos, William" <leinhos.william@endo.com> "Lemmy, Simon" <lemmy.simon@endo.com> "Logan, Alicia" <logan.alicia@endo.com> "Lortie, Brian" <lortie.brian@endo.com> "Loughead, Catherine" <loughead.catherine@endo.com> "Makowka, Kate" <makowka.kate@endo.com> "McDermott, Laurel" <mcdermott.laurel@endo.com> "Nyairo, Tom" <nyairo.tom@endo.com> "Pyszczymuka, Gregory" <pyszczymuka.gregory@endo.com> "Reckner, Jason" <reckner.jason@endo.com> "Settembrino, Dana" <settembrino.dana@endo.com> "Swisher, Kathleen" <swisher.kathleen@endo.com> "Tarantello, Frank" <tarantello.frank@endo.com> "Vitanza, Kristin" <vitanza.kristin@endo.com> "Ward, Michael" <ward.michael@endo.com> "Wilson, Lanice" <wilson.lanice@endo.com> "Zubey, Kara" <zubey.kara@endo.com> English ENDO_FLAG-00369099 yes 2026 April 30 tgkn0421 Endo Documents endo Camper, Steve public no restrictions 2004 February 17 2004 February 17 Re [PAIN_CHEM_DEP] Chronic Pain & Opioid Addiction, Mutually Exclusive.msg \ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Re: [PAIN_CHEM_DEP] Chronic Pain & Opioid Addiction, Mutually Exclusive? The Project on Pain Management and Chemical Dependency <PAIN_CHEM_DEP@PEACH.EASE.LSOFT.COM> 2004 February 17 other 4 PAIN_CHEM_DEP@PEACH.EASE.LSOFT.COM ENDO_FLAG-00376283 yes 2026 April 30 gtmv0422 Endo Documents endo Dyce, Geoffrey public no restrictions 2013 September 29 2013 September 29 FW: EXTERNAL: Psychiatric Annals: Addiction in Chronic Pain Patients: Evidence-Based Approaches for Monitoring Chronic Opioid Therapy.msg Dyce_Geoffrey_Email_0001.7z\ ENDO_FLAG-00608597 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: EXTERNAL: Psychiatric Annals: Addiction in Chronic Pain Patients: Evidence-Based Approaches for Monitoring Chronic Opioid Therapy /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=MCCADDON.CELINE 2013 September 29 other 1 Dyce, Geoffrey dyce.geoffrey@endo.com ENDO_FLAG-00608596 2026 April 30 ltmv0422 Endo Documents endo Dyce, Geoffrey Privacy public no restrictions 2013 September 30 2013 September 30 FW: EXTERNAL: Psychiatric Annals: Addiction in Chronic Pain Patients: Evidence-Based Approaches for Monitoring Chronic Opioid Therapy.msg Dyce_Geoffrey_Email_0001.7z\ ENDO_FLAG-00608625 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: EXTERNAL: Psychiatric Annals: Addiction in Chronic Pain Patients: Evidence-Based Approaches for Monitoring Chronic Opioid Therapy /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=DYCE.GEOFFREY 2013 September 30 other 2 zzS10601 zzs10601@endo.com Jackson, Ronald jackson.ronald@endo.com ENDO_FLAG-00608623 yes 2026 April 30 ngxw0238 Mallinckrodt Litigation Documents mnk public no restrictions 2013 October 04 Williams, Jane\Williams, Jane emails all_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending October 4, 2013 04:39 PM Williams, Jane 2013 October 04 UCSF 04:40 PM Addiction Treatment News - Week Ending October 4, 2013 XXXXXXX@aol.com 2013 October 04 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com tom.sigel@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com elizabeth.haybron@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com Methadone MNKOIv002 MNKOI0001713099 yes 2021 October 21 zybj0393 Endo Documents endo Byrne, Timothy public no restrictions 2017 May 12 2017 May 12 EXTERNAL: Pulse, presented by PhRMA: Addiction specialists blast Tom Price for opioids comments — Senate GOP making its tax credits more like Obamacare — Governors seek 5-year extension of CHIP funding.msg \Byrne_Timothy_Email_0002.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) EXTERNAL: Pulse, presented by PhRMA: Addiction specialists blast Tom Price for opioids comments — Senate GOP making its tax credits more like Obamacare — Governors seek 5-year extension of CHIP funding politicoemail@politicopro.com 2017 May 12 email 8 Byrne, Timothy byrne.timothy@endo.com ENDO-OPIOID_MDL-07342786 2025 October 23 rhwj0393 Endo Documents endo Manser, James public no restrictions 2017 May 12 2017 May 12 EXTERNAL: Pulse, presented by PhRMA: Addiction specialists blast Tom Price for opioids comments — Senate GOP making its tax credits more like Obamacare — Governors seek 5-year extension of CHIP funding.msg \Manser_James_Email_0002.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) EXTERNAL: Pulse, presented by PhRMA: Addiction specialists blast Tom Price for opioids comments — Senate GOP making its tax credits more like Obamacare — Governors seek 5-year extension of CHIP funding politicoemail@politicopro.com 2017 May 12 email 8 Manser, James manser.james@endo.com ENDO-OPIOID_MDL-07353142 2025 October 23 yffj0393 Endo Documents endo Manser, James Attorney-Client;Privacy public no restrictions 2017 March 02 2017 March 02 Re: EXTERNAL: State Lawmaker Proposes Fighting Drug Addiction With A Tax.msg \Manser_James_Email_0003.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Re: EXTERNAL: State Lawmaker Proposes Fighting Drug Addiction With A Tax Jvalencia@wilkefleury.com 2017 March 02 email 2 Manser, James manser.james@endo.com ENDO-OPIOID_MDL-07355043 yes 2025 October 23 spgl0395 Endo Documents endo McConkey, Ian public no restrictions 2016 June 03 2016 June 03 Weekly Roundup Weekly roundup How successful people manage money Apple shares look ripe Prince's death and America's opioid addiction.msg \McConkey_Ian\Email\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Weekly Roundup: Weekly roundup: How successful people manage money | Apple shares look ripe | Prince's death and America's opioid addiction reports@marketwatchmail.com 2016 June 03 email 3 McConkey, Ian /O=ENDO PHARMACEUTICALS INC/OU=ENDO/cn=Recipients/cn=McConkey.Ian ENDO_TXMDL_00487507 2025 October 23 qmwp0394 Endo Documents endo Thomson, Heather Privacy public no restrictions 2008 December 09 2008 December 08 The Global Anti-Addiction Market, 2008-2023.msg \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) The Global Anti-Addiction Market, 2008-2023 pharmaceuticals@vg-sales.com 2008 December 09 email 8 Thomson, Heather thomson.heather@endo.com ENDO-OPIOID_MDL-08386527 yes 2025 October 23 jxxp0394 Endo Documents endo Thomson, Heather Privacy public no restrictions 2010 January 21 2010 January 21 Interesting Article on Opioid Use and Addiction.msg \Thomson_Heather_Email.7z\ ENDO-OPIOID_MDL-08397930 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Interesting Article on Opioid Use and Addiction /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=CAMPER.STEVE 2010 January 21 email 1 Berner, Todd berner.todd@endo.com Hartry, Ann hartry.ann@endo.com Thomson, Heather thomson.heather@endo.com Summers, Kent summers.kent@endo.com Ben-Joseph, Rami ben-joseph.rami@endo.com Rubino, Mark rubino.mark@endo.com ENDO-OPIOID_MDL-08397929 yes 2025 October 23 kxxp0394 Endo Documents endo Thomson, Heather public no restrictions MedScape News (012110) Low Risk of Addiction Review.docx \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) MedScape News (012110) Low Risk of Addiction Review.docx camper.steve 2010 January 21 document 3 ENDO-OPIOID_MDL-08397930 2025 October 23 tqxp0394 Endo Documents endo Thomson, Heather Privacy public no restrictions 2008 December 09 2008 December 08 The Global Anti-Addiction Market, 2008-2023.msg.msg \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) The Global Anti-Addiction Market, 2008-2023 pharmaceuticals@vg-sales.com 2008 December 09 email 8 Thomson, Heather thomson.heather@endo.com ENDO-OPIOID_MDL-08398753 yes 2025 October 23 xlwp0394 Endo Documents endo Thomson, Heather public no restrictions 2008 November 25 2008 November 25 E-delivery of your order 32921: "Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: A pilot case-control study".msg \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) E-delivery of your order 32921: "Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: A pilot case-control study" endo@infotrieve.com 2008 November 25 email 1 Thomson, Heather thomson.heather@endo.com endo@infotrieve.com ENDO-OPIOID_MDL-08386304 2025 October 23 fqxp0394 Endo Documents endo Thomson, Heather public no restrictions 2008 November 25 2008 November 25 E-delivery of your order 32921: "Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: A pilot case-control study".msg \Thomson_Heather_Email.7z\ ENDO-OPIOID_MDL-08398685 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) E-delivery of your order 32921: "Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: A pilot case-control study" endo@infotrieve.com 2008 November 25 email 1 Thomson, Heather thomson.heather@endo.com endo@infotrieve.com ENDO-OPIOID_MDL-08398684 2025 October 23 gqxp0394 Endo Documents endo Thomson, Heather public no restrictions 2008 November 25 2008 November 25 E-delivery of your order 32921_ _Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction_ A pilot case-control study_.msg.msg \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) E-delivery of your order 32921: "Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: A pilot case-control study" endo@infotrieve.com 2008 November 25 email 1 Thomson, Heather thomson.heather@endo.com endo@infotrieve.com ENDO-OPIOID_MDL-08398685 2025 October 23 kknp0394 Endo Documents endo Thomson, Heather Privacy public no restrictions 2010 October 13 2010 October 13 Oct. 13: FDA Approves Vivitrol To Combat Opioid Addictions.msg \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Oct. 13: FDA Approves Vivitrol To Combat Opioid Addictions membership@amcp.custombriefings.com 2010 October 13 email 7 Thomson, Heather thomson.heather@endo.com ENDO-OPIOID_MDL-08411199 yes 2025 October 23 mlnp0394 Endo Documents endo Thomson, Heather Privacy public no restrictions 2010 October 19 2010 October 19 From Neil Paul(xxxxxxxxxxxx@gmail.com) and other Addiction Technology Transfer Center Network group members on LinkedIn.msg \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) From Neil Paul(xxxxxxxxxxxx@gmail.com) and other Addiction Technology Transfer Center Network group members on LinkedIn messages-noreply@bounce.linkedin.com 2010 October 19 email 2 Thomson, Heather thomson.heather@endo.com ENDO-OPIOID_MDL-08411524 yes 2025 October 23 mpcv0395 Endo Documents endo Thomson, Heather Privacy public no restrictions 2012 February 18 2012 February 18 Out of Office: Interesting news article about opioid addiction among Canadian native tribes.msg \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Out of Office: Interesting news article about opioid addiction among Canadian native tribes /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=KITLINSKI.LINDA 2012 February 18 email 1 Thomson, Heather thomson.heather@endo.com ENDO-OPIOID_MDL-08426119 yes 2025 October 23 npcv0395 Endo Documents endo Thomson, Heather Privacy public no restrictions 2012 February 19 2012 February 19 RE: Interesting news article about opioid addiction among Canadian native tribes.msg \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: Interesting news article about opioid addiction among Canadian native tribes /O=ENDO PHARMACEUTICALS INC/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=UTT.JAMES 2012 February 19 email 2 Thomson, Heather thomson.heather@endo.com ENDO-OPIOID_MDL-08426120 yes 2025 October 23 lsjy0394 Endo Documents endo Thomson, Heather Privacy public no restrictions 2011 October 09 2011 October 09 Meeting the Challenges of Professional Health: “Science and Art of Treating Alcohol and Opiate Addictions” November 4, 2011.msg \Thomson_Heather_Email.7z\ ENDO-OPIOID_MDL-08344981 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Meeting the Challenges of Professional Health: “Science and Art of Treating Alcohol and Opiate Addictions” November 4, 2011 Pain Nurse Redacted - Privacy j 2011 October 09 email 1 Pain Nurse Redacted - Privacy ENDO-OPIOID_MDL-08344980 yes 2025 October 23 nsjy0394 Endo Documents endo Thomson, Heather Privacy public no restrictions 2011 October 26 2011 October 26 Meeting the Challenges of Professional Health series "Science and Art of Treating Alcohol and Opiate Addictions" November 4, 2011.msg \Thomson_Heather_Email.7z\ ENDO-OPIOID_MDL-08344984 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Meeting the Challenges of Professional Health series "Science and Art of Treating Alcohol and Opiate Addictions" November 4, 2011 Pain Nurse [ Redacted-Privacy j 2011 October 26 email 1 Pain Nurse [ Redacted - Privacy ENDO-OPIOID_MDL-08344983 yes 2025 October 23 ltmp0394 Endo Documents endo Thomson, Heather public no restrictions 2010 August 31 2010 August 31 From dhara khakhar and other Addiction Technology Transfer Center Network group members on LinkedIn.msg \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) From dhara khakhar and other Addiction Technology Transfer Center Network group members on LinkedIn messages-noreply@bounce.linkedin.com 2010 August 31 email 2 Thomson, Heather thomson.heather@endo.com ENDO-OPIOID_MDL-08410100 2025 October 23 hfyj0394 Endo Documents endo Mastro, Tracy Privacy public no restrictions 2017 January 25 2017 January 25 RE: NEED ADVICE: Dr. Shawn Ryan - Addiction Specialist.msg H:\Mastro_Tracy_Email_09.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: NEED ADVICE: Dr. Shawn Ryan - Addiction Specialist Pool, Garrett <Pool.Garrett@endo.com> 2017 January 25 email 3 Shusterman, Neil <Shusterman.Neil@endo.com> Camper, Steve <Camper.Steve@Endo.com> Mastro, Tracy <Mastro.Tracy@endo.com> Grim, Stacie <Grim.Stacie@endo.com> Williamson, Susan <Williamson.Susan@endo.com> Passik, Steven <Passik.Steven@endo.com> ENDO-OPIOID_MDL-08006324 yes 2025 October 23 nygm0394 Endo Documents endo Kitlinski, Linda public no restrictions 2015 January 12 Undeliverable: Addiction Medicine Webinar ~ Earn 1-A CME Journal\PSTs\09.18.2017 - EndoJournal_CO_2\Messages\09.18.2017 - EndoJournal_CO_2.pst\Top of Outlook data file\Root Items ENDO-OPIOID_MDL-08208186 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Undeliverable: Addiction Medicine Webinar ~ Earn 1-A CME postmaster@endocorp.com 2015 January 12 email 2 kitlinski.linda@endo.com English ENDO-OPIOID_MDL-08208184 yes 2025 October 23 yygm0394 Endo Documents endo Kitlinski, Linda Privacy public no restrictions 2015 January 12 2015 January 12 Addiction Medicine Webinar ~ Earn 1-A CME Journal\PSTs\09.18.2017 - EndoJournal_CO_2\Messages\09.18.2017 - EndoJournal_CO_2.pst\Top of Outlook data file\Root Items\Undeliverable: Addiction Medicine Webinar ~ Earn 1-A CME In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Addiction Medicine Webinar ~ Earn 1-A CME AOAAM - American Osteopathic Academy of Addiction Medicine <nvidmer@aoaam.org> 2015 January 12 email 2 "Kitlinski, Linda" <kitlinski.linda@endo.com> English ENDO-OPIOID_MDL-08208186 yes 2025 October 23 qygm0394 Endo Documents endo Kitlinski, Linda Privacy public no restrictions 2015 January 19 2015 January 19 Earn 1-A CME ~ Addiction Medicine Webinar Journal\PSTs\09.18.2017 - EndoJournal_CO_2\Messages\09.18.2017 - EndoJournal_CO_2.pst\Top of Outlook data file\Root Items\Undeliverable: Earn 1-A CME ~ Addiction Medicine Webinar In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Earn 1-A CME ~ Addiction Medicine Webinar AOAAM - American Osteopathic Academy of Addiction Medicine <nvidmer@aoaam.org> 2015 January 19 email 2 "Kitlinski, Linda" <kitlinski.linda@endo.com> English ENDO-OPIOID_MDL-08208190 yes 2025 October 23 sygm0394 Endo Documents endo Kitlinski, Linda Privacy public no restrictions 2015 March 22 2015 March 22 Masters Conference & Think Tank in Addiction Treatment & Recovery Journal\PSTs\09.18.2017 - EndoJournal_CO_2\Messages\09.18.2017 - EndoJournal_CO_2.pst\Top of Outlook data file\Root Items\Undeliverable: Masters Conference & Think Tank in Addiction Treatment & Recovery In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Masters Conference & Think Tank in Addiction Treatment & Recovery CME Outfitters <webmaster@cmeoutfitters.com> 2015 March 22 email 2 "Kitlinski, Linda" <kitlinski.linda@endo.com> English ENDO-OPIOID_MDL-08208194 yes 2025 October 23 pygm0394 Endo Documents endo Kitlinski, Linda public no restrictions 2015 January 19 Undeliverable: Earn 1-A CME ~ Addiction Medicine Webinar Journal\PSTs\09.18.2017 - EndoJournal_CO_2\Messages\09.18.2017 - EndoJournal_CO_2.pst\Top of Outlook data file\Root Items ENDO-OPIOID_MDL-08208190 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Undeliverable: Earn 1-A CME ~ Addiction Medicine Webinar postmaster@endocorp.com 2015 January 19 email 2 kitlinski.linda@endo.com English ENDO-OPIOID_MDL-08208188 yes 2025 October 23 rygm0394 Endo Documents endo Kitlinski, Linda public no restrictions 2015 March 22 Undeliverable: Masters Conference & Think Tank in Addiction Treatment & Recovery Journal\PSTs\09.18.2017 - EndoJournal_CO_2\Messages\09.18.2017 - EndoJournal_CO_2.pst\Top of Outlook data file\Root Items ENDO-OPIOID_MDL-08208194 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Undeliverable: Masters Conference & Think Tank in Addiction Treatment & Recovery postmaster@endocorp.com 2015 March 22 email 2 kitlinski.linda@endo.com English ENDO-OPIOID_MDL-08208192 yes 2025 October 23 qfbd0394 Endo Documents endo Terleckyj, Oksana Privacy public no restrictions 2008 February 29 RE: Out of Scope-Opana ER-Addiction ER vs. IR \Opana Master Case Export\Opana Master Case Export 3_0736.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: Out of Scope-Opana ER-Addiction ER vs. IR "Terleckyj, Oksana" <terleckyj.oksana@endo.com> 2008 February 29 email 2 Sarai Faison <sarai.faison@durham.ppdi.com> Robin Reap <robin.reap@durham.ppdi.com> English ENDO-OPIOID_MDL-07765126 yes 2025 October 23 mqbh0394 Endo Documents endo Bingol, Demir Privacy public no restrictions 2011 May 05 2011 May 05 FW: Pain and Addiction Therapy Florida Initiative Azzalina, Doug\Opaia Message Archives\Azzalina,Doug_Export_0008.pst\Top of Personal Folders\Sent Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: Pain and Addiction Therapy Florida Initiative "Azzalina, Doug" <azzalina.doug@endo.com> 2011 May 05 email 1 "Bingol, Demir" <bingol.demir@endo.com> English ENDO-OPIOID_MDL-07857273 yes 2025 October 23 jmll0394 Endo Documents endo Mastro, Tracy Privacy public no restrictions 2017 January 25 2017 January 25 RE: NEED ADVICE: Dr. Shawn Ryan - Addiction Specialist.msg H:\Mastro_Tracy_Email_09.7z\ ENDO-OPIOID_MDL-08150535 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: NEED ADVICE: Dr. Shawn Ryan - Addiction Specialist /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=SHUSTERMAN.NEIL 2017 January 25 email 2 Camper, Steve /O=ENDO PHARMACEUTICALS INC/OU=ENDO/cn=Recipients/cn=Camper.Steve Pool, Garrett /O=ENDO PHARMACEUTICALS INC/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=Pool, Garrett554 Mastro, Tracy /O=ENDO PHARMACEUTICALS INC/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=Mastro, Tracyb0c Grim, Stacie /O=ENDO PHARMACEUTICALS INC/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=Grim, Stacie326 Williamson, Susan /O=ENDO PHARMACEUTICALS INC/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=Williamson.Susan Passik, Steven /O=ENDO PHARMACEUTICALS INC/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=Passik, Steven21a ENDO-OPIOID_MDL-08150533 yes 2025 October 23 qpmg0394 Endo Documents endo Bingol, Demir public no restrictions Caulkins JC Nicosia N What economics can contribute to the addiction sciences Addiction 2010.pdf \Opana Master Case Export\Opana Master Case Export 3_0803.pst\Top of Outlook data file\Root Items\No Subject.EML In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) What economics can contribute to the addiction sciences 2010 July 02 document 8 English ENDO-OPIOID_MDL-07850754 2025 October 23 kjyg0394 Endo Documents endo Bingol, Demir Privacy public no restrictions 2010 October 13 2010 October 13 FDA Approved Vivitrol now for Opioid addiction \Opana Master Case Export\Opana Master Case Export 3_1043.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FDA Approved Vivitrol now for Opioid addiction "Albert, Nicholas" <"/o=endo pharmaceuticals inc/ou=endo/cn=recipients/cn=albert.nicholas"> 2010 October 13 email 1 "Bingol, Demir" <bingol.demir@endo.com> "Simon, Chad" <simon.chad@endo.com> English ENDO-OPIOID_MDL-07852390 yes 2025 October 23 mjyg0394 Endo Documents endo Bingol, Demir Privacy public no restrictions 2010 October 13 2010 October 13 RE: FDA Approved Vivitrol now for Opioid addiction \Opana Master Case Export\Opana Master Case Export 3_1043.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) RE: FDA Approved Vivitrol now for Opioid addiction "Bingol, Demir" <"/o=endo pharmaceuticals inc/ou=endo/cn=recipients/cn=bingol.demir"> 2010 October 13 email 1 "Albert, Nicholas" <albert.nicholas@endo.com> "Simon, Chad" <simon.chad@endo.com> English ENDO-OPIOID_MDL-07852395 yes 2025 October 23 xzbx0394 Endo Documents endo Gould, Errol public no restrictions Caulkins JC Nicosia N What economics can contribute to the addiction sciences Addiction 2010.pdf Gould, Errol\Opaia Message Archives\Gould,Errol_Export_0025.pst\Top of Personal Folders\Inbox\No Subject-2272.EML In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) What economics can contribute to the addiction sciences 2010 July 02 document 8 English ENDO-OPIOID_MDL-07886222 2025 October 23 kscx0394 Endo Documents endo Kitlinski, Linda Privacy public no restrictions 2007 December 10 2007 December 10 Addiction and gateway drugs. Kitlinski, Linda\My Documents\Opana\Kitlinski.Linda\My Documents\Will Not Sync\archive.pst\Top of Personal Folders\Inbox In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Addiction and gateway drugs. "Reder, Robert" <reder.robert@endo.com> 2007 December 10 email 2 "Ahdieh, Harry" <ahdieh.harry@endo.com> "Alvarez, Nancy" <alvarez.nancy@endo.com> "Aron, Carey" <aron.carey@endo.com> "Avila, Juan" <avila.juan@endo.com> "Barber, Barbara" <barber.barbara@endo.com> "Benedek, Irma" <benedek.irma@endo.com> "Berner,Todd" <berner.todd@endo.com> "Beville, Deborah" <beville.deborah@endo.com> "Brophy, Francine" <brophy.francine@endo.com> "Brown, Bobbie-Sue" <brown.bobbiesue@endo.com> "Campbell, John" <campbell.john@endo.com> "Camper, Steve" <camper.steve@endo.com> "Lihou, Christine" <"lihou, christine"> "Clark, Michael" <clark.michael@endo.com> "Cullen, Eileen" <cullen.eileen@endo.com> "Davis, Tina" <"davis, tina"> "deJong, Bert" <dejong.bert@endo.com> "Gould, Errol" <gould.errol@endo.com> "Harper, Samira" <harper.samira@endo.com> "Harris, Rochelle" <harris.rochelle@endo.com> "Howell, Brian" <howell.brian@endo.com> "Jackson, Elizabeth" <jackson.elizabeth@endo.com> "Kerwin, Rosemary" <kerwin.rosemary@endo.com> "Kirby, Todd" <kirby.todd@endo.com> "Kitlinski, Linda" <kitlinski.linda@endo.com> "Kopecky , Ernest" <kopecky.ernest@endo.com> "Lai, William" <lai.william@endo.com> "Lee, Robert" <lee.robert@endo.com> "Ma, Tina" <ma.tina@endo.com> "Maiers, Anita" <maiers.anita@endo.com> "Marinelli, Virginia" <marinelli.virginia@endo.com> "McNeil, Jackie" <mcneil.jackie@endo.com> "Orvidas, Mark" <orvidas.mark@endo.com> "Overdorf, Maria" <overdorf.maria@endo.com> "Puenpatom, Amy" <puenpatom.amy@endo.com> "Quaranta, Lynn" <quaranta.lynn@endo.com> "Reder, Robert" <reder.robert@endo.com> "Reese, Alicia" <reese.alicia@endo.com> "Ridley, Lynn" <ridley.lynn@endo.com> "Schoen, Mary Ann" <schoen.maryann@endo.com> "Schwartz, Phillip" <schwartz.phillip@endo.com> "Sendlinger, Cathy" <sendlinger.cathy@endo.com> "Speiller, Marcia" <speiller.marcia@endo.com> "Speiser, Ann" <speiser.ann@endo.com> "Taylor, Liz" <taylor.liz@endo.com> "Terleckyj, Oksana" <terleckyj.oksana@endo.com> "Thomson, Heather" <thomson.heather@endo.com> "Tormo, Vin" <tormo.vin@endo.com> "Victor,Timothy" <victor.timothy@endo.com> "White, Richard" <white.richard@endo.com> "Wieman, Matthew" <wieman.matthew@endo.com> "Williams, Andrea" <williams.andrea@endo.com> "Williams, Neil" <williams.neil@endo.com> "Xiang, Steve" <xiang.qinfang@endo.com> "Yuen, Frank" <yuen.frank@endo.com> "Zerbe, Kathy" <zerbe.kathy@endo.com> English ENDO-OPIOID_MDL-07922422 yes 2025 October 23 ffcx0394 Endo Documents endo Gould, Errol public no restrictions Haertzen-Addiction research CEnter.pdf SharePoint\SharePoint\clinical\Clinical SubTeams\EN3324 Axomadol\EN3324-201 (LBP)\15. Assessment Tools\ARCI In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Haertzen-Addiction research CEnter.pdf 2010 June 11 document 8 ENDO-OPIOID_MDL-07886301 2025 October 23 sygx0394 Endo Documents endo Simon, Chad public no restrictions Caulkins JC Nicosia N What economics can contribute to the addiction sciences Addiction 2010.pdf Simon, Chad\Opaia Message Archives\Simon,Chad_Export_0034.pst\Top of Personal Folders\HOPE\No Subject-9.EML In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) What economics can contribute to the addiction sciences 2010 July 02 document 8 English ENDO-OPIOID_MDL-07935072 2025 October 23 grjk0395 Endo Documents endo Guillory, Clayton public no restrictions 2012 April 09 2012 April 09 FW: Painkiller sales soar around U.S. and fuel addiction - USATODAY.com.msg \Robertson_Patricia\Email\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: Painkiller sales soar around U.S. and fuel addiction - USATODAY.com /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=HAYES.TAMI 2012 April 09 email 1 zzP50601 /O=ENDO PHARMACEUTICALS INC/OU=ENDO/cn=Recipients/cn=zzP50601 ENDO_TXMDL_00439266 2025 October 23 phkk0395 Endo Documents endo Guillory, Clayton public no restrictions 2012 April 09 2012 April 09 FW: Painkiller sales soar around U.S. and fuel addiction - USATODAY.com Craanen, Linda\Email\Craahen_Email_3.7z\07.22.2019_JrnlArch_Craahen_0003.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: Painkiller sales soar around U.S. and fuel addiction - USATODAY.com "Hayes, Tami" <hayes.tami@endo.com> 2012 April 09 email 1 zzP50601 <zzp50601@endo.com> English ENDO_TXMDL_00439926 2025 October 23 rpgl0395 Endo Documents endo McConkey, Ian public no restrictions 2016 June 03 Undeliverable: Weekly Roundup: Weekly roundup: How successful people manage money | Apple shares look ripe | Prince's death and America's opioid addiction.msg \McConkey_Ian\Email\ ENDO_TXMDL_00487507 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Undeliverable: Weekly Roundup: Weekly roundup: How successful people manage money | Apple shares look ripe | Prince's death and America's opioid addiction /O=ENDO PHARMACEUTICALS INC/OU=ENDO/CN=RECIPIENTS/CN=POSTMASTER 2016 June 03 email 2 mcconkey.ian@endo.com ENDO_TXMDL_00487505 2025 October 23 nqll0395 Endo Documents endo McConkey, Ian public no restrictions 2014 May 23 Undeliverable: | 05.23.14 | California sues J&J, others for addiction 'epidemic'; BlackRock won't surrender on Pfizer-AZ deal.msg \McConkey_Ian\Email\ ENDO_TXMDL_00499743 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Undeliverable: | 05.23.14 | California sues J&J, others for addiction 'epidemic'; BlackRock won't surrender on Pfizer-AZ deal postmaster@endocorp.com 2014 May 23 email 2 mcconkey.ian@endo.com ENDO_TXMDL_00499741 2025 October 23 yqll0395 Endo Documents endo McConkey, Ian public no restrictions 2014 May 23 2014 May 23 05.23.14 California sues J&J, others for addiction 'epidemic'; BlackRock won't surrender on Pfizer-AZ deal.msg \McConkey_Ian\Email\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) | 05.23.14 | California sues J&J, others for addiction 'epidemic'; BlackRock won't surrender on Pfizer-AZ deal FiercePharma <editors@fiercepharma.com> 2014 May 23 email 17 McConkey, Ian <McConkey.Ian@Endo.com> ENDO_TXMDL_00499743 yes 2025 October 23 pzly0394 Endo Documents endo Thomson, Heather public no restrictions Caulkins JC Nicosia N What economics can contribute to the addiction sciences Addiction 2010.pdf \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) What economics can contribute to the addiction sciences 2010 June 08 document 8 ENDO-OPIOID_MDL-08354386 2025 October 23 sqxp0394 Endo Documents endo Thomson, Heather public no restrictions 2008 December 09 2008 December 08 The Global Anti-Addiction Market, 2008-2023.msg \Thomson_Heather_Email.7z\ ENDO-OPIOID_MDL-08398753 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) The Global Anti-Addiction Market, 2008-2023 pharmaceuticals@vg-sales.com 2008 December 09 email 1 Thomson, Heather thomson.heather@endo.com ENDO-OPIOID_MDL-08398752 2025 October 23 ltlp0394 Endo Documents endo Thomson, Heather public no restrictions Caulkins JC Nicosia N What economics can contribute to the addiction sciences Addiction 2010.pdf \Thomson_Heather_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) What economics can contribute to the addiction sciences 2010 June 08 document 8 ENDO-OPIOID_MDL-08406890 2025 October 23 yhkj0395 Endo Documents endo Lutz, Michael public no restrictions 2010 September 15 2010 September 15 FDA cites concerns with Alkermes addiction drug Craanen, Linda\Email\Craahen_Email_2.7z\07.22.2019_JrnlArch_Craahen_0002.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FDA cites concerns with Alkermes addiction drug "McConkey, Ian" <mcconkey.ian@endo.com> 2010 September 15 email 2 "Bailey, Michael" <bailey.michael@endo.com> "Craanen, Linda" <craanen.linda@endo.com> "Hebert, Diane" <hebert.diane@endo.com> "Leach, Trish" <leach.trish@endo.com> "Lutz, Michael" <lutz.michael@endo.com> "Mathis, Todd" <mathis.todd@endo.com> "Medina, Fernando" <medina.fernando@endo.com> "Nangle, Kristen" <nangle.kristen@endo.com> "Neal, Charles" <neal.charles@endo.com> "Patel, Abeer" <patel.abeer@endo.com> "Trueheart, Yolanda" <trueheart.yolanda@endo.com> English ENDO_TXMDL_00399049 yes 2025 October 23 phkj0395 Endo Documents endo Lutz, Michael public no restrictions 2010 September 17 2010 September 17 FDA panel recommends approval of Alkermes' Vivitrol for opioid addiction Craanen, Linda\Email\Craahen_Email_2.7z\07.22.2019_JrnlArch_Craahen_0002.pst\Top of Outlook data file\Root Items In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FDA panel recommends approval of Alkermes' Vivitrol for opioid addiction "McConkey, Ian" <mcconkey.ian@endo.com> 2010 September 17 email 1 "Bailey, Michael" <bailey.michael@endo.com> "Craanen, Linda" <craanen.linda@endo.com> "Hebert, Diane" <hebert.diane@endo.com> "Leach, Trish" <leach.trish@endo.com> "Lutz, Michael" <lutz.michael@endo.com> "Mathis, Todd" <mathis.todd@endo.com> "Medina, Fernando" <medina.fernando@endo.com> "Nangle, Kristen" <nangle.kristen@endo.com> "Neal, Charles" <neal.charles@endo.com> "Patel, Abeer" <patel.abeer@endo.com> "Trueheart, Yolanda" <trueheart.yolanda@endo.com> English ENDO_TXMDL_00399051 yes 2025 October 23 jndm0393 Endo Documents endo Yuen, Frank Privacy public no restrictions 2012 September 25 2012 September 25 ASAM Weekly -- News in Addiction Medicine: Sept. 25, 2012.msg Yuen_Frank_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) ASAM Weekly -- News in Addiction Medicine: Sept. 25, 2012 ASAMWeekly@multibriefs.com 2012 September 25 email 9 Yuen, Frank yuen.frank@endo.com ENDO-OPIOID_MDL-07482138 yes 2025 October 23 pmwm0393 Endo Documents endo Yuen, Frank public no restrictions 2012 April 24 2012 April 24 ASAM Weekly -- News in Addiction Medicine: April 24, 2012.msg Yuen_Frank_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) ASAM Weekly -- News in Addiction Medicine: April 24, 2012 ASAMWeekly@multibriefs.com 2012 April 24 email 10 Yuen, Frank yuen.frank@endo.com ENDO-OPIOID_MDL-07483810 yes 2025 October 23 qsdm0393 Endo Documents endo Yuen, Frank public no restrictions 2012 June 26 2012 June 26 ASAM Weekly -- News in Addiction Medicine: June 26, 2012.msg Yuen_Frank_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) ASAM Weekly -- News in Addiction Medicine: June 26, 2012 ASAMWeekly@multibriefs.com 2012 June 26 email 8 Yuen, Frank yuen.frank@endo.com ENDO-OPIOID_MDL-07482870 yes 2025 October 23 pjwm0393 Endo Documents endo Yuen, Frank public no restrictions 2012 March 30 2012 March 30 Requested Copyright Permission Granted on order 2057662: "Understanding and Treating Opioid Addiction in a Patient With Cancer Pain".msg Yuen_Frank_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Requested Copyright Permission Granted on order 2057662: "Understanding and Treating Opioid Addiction in a Patient With Cancer Pain" endo@infotrieve.com 2012 March 30 email 1 Yuen, Frank yuen.frank@endo.com ENDO-OPIOID_MDL-07483513 2025 October 23 pkwm0393 Endo Documents endo Yuen, Frank public no restrictions 2012 April 10 2012 April 10 ASAM Weekly -- News in Addiction Medicine: April 10, 2012.msg Yuen_Frank_Email.7z\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) ASAM Weekly -- News in Addiction Medicine: April 10, 2012 ASAMWeekly@multibriefs.com 2012 April 10 email 7 Yuen, Frank yuen.frank@endo.com ENDO-OPIOID_MDL-07483621 yes 2025 October 23 kxkc0394 Endo Documents endo public no restrictions 2007 October 22 Terleckyj, Oksana\Opaia Message Archives\Terleckyj,Oksana_Export_0002.pst\Top of Personal Folders\Deleted Items ENDO-OPIOID_MDL-07747376 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Terleckyj, Oksana Privacy 2007 October 22 Out of scope - Opana - iatrogenic rate of addiction Out of scope - Opana - iatrogenic rate of addiction Robin Reap <robin.reap@durham.ppdi.com> 2007 October 22 email 1 "Alvarez, Nancy" <alvarez.nancy@endo.com>, "Terleckyj, Oksana" <terleckyj.oksana@endo.com> Margaret Haas <margaret.haas@durham.ppdi.com>, William Gallimore <william.gallimore@durham.ppdi.com>, Vida Farrar <vida.farrar@durham.ppdi.com>, Ross Carter <ross.carter@durham.ppdi.com>, Kristy Norman <kristy.norman@durham.ppdi.com>, Jina Lee <jina.lee@durham.ppdi.com>, Robin Reap <robin.reap@durham.ppdi.com> English ENDO-OPIOID_MDL-07747375 yes 2025 October 23 nzgh0394 Endo Documents endo Camper, Steve public no restrictions Caulkins JC Nicosia N What economics can contribute to the addiction sciences Addiction 2010.pdf Camper, Steve\Opaia Message Archives\Camper,Steve_Export_0012.pst\Top of Personal Folders\Inbox\No Subject-2419.EML In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) What economics can contribute to the addiction sciences 2010 July 02 document 8 English ENDO-OPIOID_MDL-07868229 2025 October 23 tfvh0393 Endo Documents endo Cooper, Steven public no restrictions 2013 November 23 2013 November 23 Opioids: Overdose and Addiction.msg \Cooper, Steven\20190422\Email\04.19.2019_Cooper\Messages\ In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) Opioids: Overdose and Addiction webmaster@naccme.com 2013 November 23 email 2 Cooper, Steven /O=ENDO PHARMACEUTICALS INC/OU=ENDO/cn=Recipients/cn=Cooper.Steven ENDO-OPIOID_MDL-07254408 yes 2025 October 23 zyxh0393 Endo Documents endo Grausso, Sal Privacy public no restrictions 2017 November 30 2017 November 30 [EXTERNAL] Custom Competitor Coverage ? Addiction Pipeline & Sample Report Attached.msg \Grausso_Salvador_Email_0002.7z\ ENDO-OPIOID_MDL-07273879 ENDO-OPIOID_MDL-07273880 In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) [EXTERNAL] Custom Competitor Coverage ? Addiction Pipeline & Sample Report Attached andrewburke@larvol.com 2017 November 30 email 1 Grausso, Sal grausso.sal@endo.com ENDO-OPIOID_MDL-07273878 yes 2025 October 23 nlvm0392 Endo Documents endo O'Brien, Kevin public no restrictions 2011 January 03 x27_61166.olk14MsgSource O'Brian, Kevin\My Documents\Opana\Obrien.kevin\Documents\Microsoft User Data\Office 2011 Identities\Main Identity\Data Records\Message Sources\0T\0B\0M\61K In Re: Endo International plc, et al. Debtors. Case No. 22-22549 (JLG) FW: State information on addiction "OBrien, Kevin" <obrien.kevin@endo.com> 2011 January 03 email 1 "Persico, Jai" <persico.peter@endo.com> "Karelas, Richard" <karelas.richard@endo.com> "Fuller, TJ" <fuller.tj@endo.com> English ENDO-OPIOID_MDL-06616118 2025 October 23 gkyd0243 Mallinckrodt Litigation Documents mnk Mallinckrodt Grant Files Redacted AC public no restrictions Mallinckrodt produced document; Paper In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Mallinckrodt Grant Compliance Committee Approvals FY '14 : Request for Funding for Maryland Society of Addiction Medicine (MMDSAM) #1 (Sept'14) (Sponsorship for $1,000) Mallinckrodt Lassiter, Anthony 2014 September 05 document 1 opioids MNKOIv003 MNKOI0003529281 yes 2021 October 21 grfd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Controlled Substance Registration Certificate for Addiction Research & Treatment, Inc. (fdba BAART, Facet & Bay Area, of Fresno, California - DEA Registration Numbers : RA0240161 & ZA0240161 (Maintenance)) United States. Drug Enforcement Administration 2011 June 02 document 1 opioids MNKOIv002 MNKOI0003320134 2021 October 21 gpfd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Facsimile Communication from Carolyn Lichtenberg (of Covidien) to Addiction Recovery Institute (Re: DEA license checklist) Covidien Lichtenberg, Carolyn 2011 June 22 document 1 opioids MNKOIv002 MNKOI0003320102 2021 October 21 fqfd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Letter from Covidien to Addiction Research (of Los Angeles, California, Re : Checklist for DEA Registration Numbers RA0240212 (Maintenance) & RC0147959 (Detox)) Covidien 2011 July 12 document 1 opioids MNKOIv002 MNKOI0003320117 2021 October 21 frgd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Controlled Substance Registration Certificate for BAART [Bay Area Addiction Research and Treatment Center] Behavioral Health Services, Inc. (of Chandler, Arizona - Maintenance & Detox - DEA Registration Numbers : RB0364341 & ZB0364341) United States. Drug Enforcement Administration 2011 June 03 document 1 opioids MNKOIv002 MNKOI0003320395 2021 October 21 gnxd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Fax cover sheet from Pam Manuel (of Comprehensive Addiction Treatment Services, Inc.) to [illegible] (Re: DEA license) Comprehensive Addiction Treatment Services, Inc. Manuel, Pam 2011 January 31 document 1 opioids MNKOIv002 MNKOI0003320914 2021 October 21 fnxd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Controlled Substance Registration Certificate for Comprehensive Addiction Treatment Services, Inc. (of Denver, Colorado, Maintenance & Detox, DEA Registration Numbers : RC0125321 & ZC0125321A) United States. Drug Enforcement Administration 2011 January 26 document 1 opioids MNKOIv002 MNKOI0003320913 2021 October 21 hgkd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Controlled Substance Registration Certificate for HFA Addiction Medicine Program (of Minneapolis, Minnesota - DEA Registration Numbers : RH0195924 & ZH0195924 (Maintenance & Detox)) (with handwritten notes) United States. Drug Enforcement Administration 2011 September 16 document 1 opioids MNKOIv002 MNKOI0003321354 2021 October 21 ggkd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Controlled Substance Registration Certificate for Hennepin Faculty Association, Addiction Medicine Program (of Minneapolis, Minnesota - DEA Registration Numbers : RH0281288 & ZH0281288 (Maintenance & Detox)) United States. Drug Enforcement Administration 2011 September 16 document 1 opioids MNKOIv002 MNKOI0003321353 2021 October 21 fznd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Facsimile Communication from Amy Gowen (of Covidien) to SAACS [Successful Alternatives for Addiction Counseling Services, Inc.] (of Vallejo, California - Re: Compliance for DEA Registration Number RS0383098) Covidien Gowen, Amy 2011 February 25 document 1 opioids MNKOIv002 MNKOI0003322451 2021 October 21 fnyd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Letter from Covidien to Van Dyke Addiction Treatment Center (a.k.a. Van Dyke ATC, of Ovid, New York, Re: Expiration dates for DEA certificate numbers RV0288503 (Distributor) & ZV0288503A (Detox)) Covidien 2011 June 16 document 1 opioids MNKOIv002 MNKOI0003322617 2021 October 21 fpfd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Letter from Covidien to Addiction Recovery (of Warwick, Rhode Island, Re : Checklist for DEA Registration Number RA0222163) Covidien 2011 June 22 document 1 Methadone MNKOIv002 MNKOI0003320101 2021 October 21 gsfd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Letter from Covidien to Addiction Research Treatment (of Aurora, Colorado) (Re: Checklist for DEA certificate number RA0269856 (OTP)) Covidien 2011 June 29 document 1 opioids MNKOIv002 MNKOI0003320151 2021 October 21 fsfd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Controlled Substance Registration Certificate for Addiction Research/Treatment (of Aurora, Colorado - Maintenance & Detox - DEA Registration Numbers : RA0269856 & ZA0269856) United States. Drug Enforcement Administration 2011 June 28 document 1 opioids MNKOIv002 MNKOI0003320150 2021 October 21 fsgd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Controlled Substance Registration Certificate for BAART [Bay Area Addiction Research and Treatment Center] Behavioral Health Services (i.e. BBHS), 14th Street Clinic (of Oakland, California - Maintenance & Detox - DEA Registration Numbers : RB0356700 & ZB0356700) United States. Drug Enforcement Administration 2011 June 02 document 1 opioids MNKOIv002 MNKOI0003320411 2021 October 21 gthd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Controlled Substance Registration Certificate for Center for Addiction Medicine (of Baltimore, Maryland - DEA Registration Numbers : RC0272257 & ZC0272257 (Maintenance & Detox)) United States. Drug Enforcement Administration 2011 July 08 document 1 opioids MNKOIv002 MNKOI0003320744 2021 October 21 lnpb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 14 Williams, Jane\Williams, Jane emails all_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) New York Society of Addiction Medicine - Statewide Conference February 7-8, 2014, NYC 03:26 AM Williams, Jane 2013 December 14 03:26 AM Re: New York Society of Addiction Medicine - Statewide Conference February 7-8, 2014, NYC "Ryan, Edward R" <edward.ryan@mallinckrodt.com> 2013 December 14 Document Email 2 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Colvin, Darren A" <darren.colvin@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> "Rauschenbach, Ashley M" <ashley.rauschenbach@mallinckrodt.com> "Paulus, CJ (Porter)" <cj.paulus@mallinckrodt.com> opioids MNKOIv002 MNKOI0001882971 2021 October 21 nnpb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2013 December 16 Williams, Jane\Williams, Jane emails all_5.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) New York Society of Addiction Medicine - Statewide Conference February 7-8, 2014, NYC 02:48 PM Williams, Jane 2013 December 16 02:48 PM RE: New York Society of Addiction Medicine - Statewide Conference February 7-8, 2014, NYC "Williams, Jane L" <jane.williams@mallinckrodt.com> 2013 December 16 Document Email 2 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> opioids MNKOIv002 MNKOI0001882974 2021 October 21 zqdc0239 Mallinckrodt Litigation Documents mnk public no restrictions 2013 February 07 Williams, Jane\Williams, Jane emails all_8.pst\Top of Personal Folders\Archive MNKOI0001885499 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Meetings 05:16 PM Williams, Jane 2013 February 07 05:16 PM FW: Addiction Treatment Meetings "Alexander, Dan" <daniel.alexander@covidien.com> 2013 February 07 Document Email 3 "Williams, Jane L" <jane.williams@covidien.com> opioids MNKOIv002 MNKOI0001885496 2021 October 21 xzdc0239 Mallinckrodt Litigation Documents mnk public no restrictions 2013 March 06 Williams, Jane\Williams, Jane emails all_8.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Demand by Customer: Addiction Treatment FYI #3 02:26 AM Williams, Jane 2013 March 06 02:26 AM FW: Demand by Customer: Addiction Treatment FYI #3 "Alexander, Dan" <daniel.alexander@covidien.com> 2013 March 06 Document Email 3 "Williams, Jane L" <jane.williams@covidien.com> Methadone MNKOIv002 MNKOI0001885621 2021 October 21 tphc0239 Mallinckrodt Litigation Documents mnk public no restrictions 2002 November 09 \Additional_Data\008-01\008-01.L01\008_mfs01\008\N_\Hazelwood01\Pharma Business\Specialty Pharma\PSG_Brands\MARKETING\Mike Kast\K Brown\Kendall Brown.zip\Kendall Brown\Documents\Exchange\mailbox.pst\Top of Personal Folders\Michael Allen Company produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Next Steps 03:18 PM Network Share 2002 November 09 03:18 PM Addiction Treatment Next Steps "Kaiman, Vince J" <"/o=thcg/ou=hazelwood01/cn=recipients/cn=vjkaima"> 2002 November 09 Document Email 1 "Lesnak, Robert A" <robert.lesnak@tycohealthcare.com> "Brown, Kendall D" <kendall.brown@tycohealthcare.com> "Fisher, Julia S" <julia.fisher@tycohealthcare.com> Buprenorphine MNKOIv002 MNKOI0001889466 2021 October 21 lpkb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 September 22 Williams, Jane\Williams, Jane emails all_2.pst\Top of Personal Folders\Archive MNKOI0001880009 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Business Reviews 01:56 PM Williams, Jane 2014 September 22 01:56 PM RE: Addiction Treatment Business Reviews "Saul, Christopher" <christopher.saul@mallinckrodt.com> 2014 September 22 Document Email 2 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Prouhet, Linda A" <linda.prouhet@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> "Cardetti, Lisa M" <lisa.cardetti@mallinckrodt.com> opioids MNKOIv002 MNKOI0001880007 2021 October 21 npkb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 September 22 Williams, Jane\Williams, Jane emails all_2.pst\Top of Personal Folders\Archive MNKOI0001880014 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Business Reviews 02:04 PM Williams, Jane 2014 September 22 02:04 PM RE: Addiction Treatment Business Reviews "Saul, Christopher" <christopher.saul@mallinckrodt.com> 2014 September 22 Document Email 2 "Cardetti, Lisa M" <lisa.cardetti@mallinckrodt.com> "Alexander, Dan" <daniel.alexander@mallinckrodt.com> "Prouhet, Linda A" <linda.prouhet@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> opioids MNKOIv002 MNKOI0001880012 2021 October 21 pqmb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 June 12 Williams, Jane\Williams, Jane emails all_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Link to Addiction Treatment Modules 08:46 PM Williams, Jane 2014 June 12 UCSF 08:46 PM FW: Link to Addiction Treatment Modules "Williams, Jane L" <jane.williams@mallinckrodt.com> 2014 June 12 Document Email 4 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001881233 yes 2021 October 21 pmnb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 13 Williams, Jane\Williams, Jane emails all_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Quota and Business update 07:32 PM Williams, Jane 2014 February 13 07:32 PM Re: Addiction Treatment Quota and Business update "Williams, Jane L" <jane.williams@mallinckrodt.com> 2014 February 13 Document Email 3 "Dillon-Eckhard, Karen S" <karen.dillon-eckhard@mallinckrodt.com> "Mindak, Barb J" <barb.mindak@mallinckrodt.com> Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001881748 2021 October 21 qlnb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 06 Williams, Jane\Williams, Jane emails all_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Quota and Business update 06:06 PM Williams, Jane 2014 February 06 06:06 PM RE: Addiction Treatment Quota and Business update "Mindak, Barb J" <barb.mindak@mallinckrodt.com> 2014 February 06 Document Email 3 "Williams, Jane L" <jane.williams@mallinckrodt.com> "Brueggeman, Patrick S" <patrick.brueggeman@mallinckrodt.com> "Dillon-Eckhard, Karen S" <karen.dillon-eckhard@mallinckrodt.com> Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001881720 2021 October 21 mnyb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 April 28 Williams, Jane\Williams, Jane emails all_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) MAT for Opioid Addiction in the Criminal Justice System 02:58 PM Williams, Jane 2014 April 28 02:58 PM MAT for Opioid Addiction in the Criminal Justice System "Mark W. Parrino, M.P.A. (AATOD President)" <mark.parrino@aatod.org> 2014 April 28 Document Email 2 jane.williams@mallinckrodt.com opioids MNKOIv002 MNKOI0001882372 2021 October 21 hzpb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 January 24 Williams, Jane\Williams, Jane emails all_5.pst\Top of Personal Folders\Archive MNKOI0001883333 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Educational Modules 10:04 PM Williams, Jane 2014 January 24 10:04 PM Addiction Treatment Educational Modules "Williams, Jane L" <jane.williams@mallinckrodt.com> 2014 January 24 Document Email 1 "Kaczmarek, Walt" <walt.kaczmarek@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001883332 2021 October 21 xhvc0239 Mallinckrodt Litigation Documents mnk public no restrictions 2013 July 30 Williams, Jane\Williams, Jane emails all_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) USP Medicare Model guidelines for treatment of opioid addiction 01:30 AM Williams, Jane 2013 July 30 UCSF 01:30 AM RE: USP Medicare Model guidelines for treatment of opioid addiction "Alexander, Dan" <daniel.alexander@mallinckrodt.com> 2013 July 30 Document Email 1 Kelly Clark XXXXXXXXXX@yahoo.com> "Purcell, Tina M" <tina.purcell@mallinckrodt.com> "Burton, J Craig" <craig.burton@mallinckrodt.com> "Williams, Jane L" <jane.williams@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001883458 yes 2021 October 21 yqmb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 June 12 Williams, Jane\Williams, Jane emails all_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Link to Addiction Treatment Modules 08:46 PM Williams, Jane 2014 June 12 UCSF 08:46 PM RE: Link to Addiction Treatment Modules "Williams, Jane L" <jane.williams@mallinckrodt.com> 2014 June 12 Document Email 4 "Bullerdick, Jennifer M" <jennifer.bullerdick@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001881229 yes 2021 October 21 ynnb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 20 Williams, Jane\Williams, Jane emails all_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Quota and Business update 01:46 AM Williams, Jane 2014 February 20 01:46 AM Re: Addiction Treatment Quota and Business update "Williams, Jane L" <jane.williams@mallinckrodt.com> 2014 February 20 Document Email 3 "Mindak, Barb J" <barb.mindak@mallinckrodt.com> "Dillon-Eckhard, Karen S" <karen.dillon-eckhard@mallinckrodt.com> "Brueggeman, Patrick S" <patrick.brueggeman@mallinckrodt.com> Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv002 MNKOI0001881774 2021 October 21 ysyb0239 Mallinckrodt Litigation Documents mnk public no restrictions 2013 November 05 Williams, Jane\Williams, Jane emails all_5.pst\Top of Personal Folders\Archive MNKOI0001882596 MNKOI0001882597 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NOW AVAILABLE - Methadone Module 1 - Opioid Addiction: A Historical Perspective 05:09 PM Williams, Jane 2013 November 05 UCSF 05:09 PM FW: NOW AVAILABLE - Methadone Module 1 - Opioid Addiction: A Historical Perspective "Williams, Jane L" <jane.williams@mallinckrodt.com> 2013 November 05 Document Email 2 "Nickelson, Trudy" <trudy.nickelson@mallinckrodt.com> Methadone MNKOIv002 MNKOI0001882594 yes 2021 October 21 htmp0239 Mallinckrodt Litigation Documents mnk public no restrictions 2016 September 23 20181017_Emails\New, Bonnie All emails 1 1 14 to 10 3 18_6.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Comprehensive Addiction and Recovery Act Updates 03:02 PM New, Bonnie 2016 September 23 03:02 PM Comprehensive Addiction and Recovery Act Updates Jon Stock <jon.stock@wrldhealthcare.com> 2016 September 23 Document Email 4 bonnie.new@mallinckrodt.com opioids MNKOIv002 MNKOI0002677696 2021 October 21 jfym0239 Mallinckrodt Litigation Documents mnk public no restrictions 2017 November 15 \Additional_Data\SRC26\K Webb 1 1 14 to 6 5 18_3\K Webb 1 1 14 to 6 5 18_3.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) STAT: Long-awaited study finds monthly Vivitrol as effective as daily pill for opioid addiction 04:33 PM Webb, Kevin 2017 November 15 04:40 PM RE: STAT: Long-awaited study finds monthly Vivitrol as effective as daily pill for opioid addiction "Zook, David R." <dave.zook@faegrebd.com> 2017 November 15 Document Email 1 "Webb, Kevin J" <kevin.webb@mallinckrodt.com> Buprenorphine/Naloxone MNKOIv002 MNKOI0002632485 2021 October 21 fzcn0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 November 14 Williams, Jane\Williams, Jane emails all_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment News - Week Ending November 14, 2014 06:16 PM Williams, Jane 2014 November 14 UCSF 06:16 PM Addiction Treatment News - Week Ending November 14, 2014 XXXXXXX@aol.com 2014 November 14 Document Email 2 daniel.alexander@mallinckrodt.com darren.colvin@mallinckrodt.com edward.ryan@mallinckrodt.com danny.ottosen@mallinckrodt.com romney.spencer@mallinckrodt.com walt.kaczmarek@mallinckrodt.com jane.williams@mallinckrodt.com tina.purcell@mallinckrodt.com derek.naten@mallinckrodt.com jennifer.bullerdick@mallinckrodt.com louann.randall@mallinckrodt.com margaret.crandall@mallinckrodt.com Methadone MNKOIv002 MNKOI0002635709 yes 2021 October 21 zgkn0239 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 27 Additional_Data\Jolliff, Susan- all_1.zip\Jolliff, Susan- all_1.zip.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) FDA-approved Zohydro called next OxyContin by anti-addiction groups - CBS News 04:46 PM Jolliff, Susan 2014 February 27 04:46 PM Re: FDA-approved Zohydro called next OxyContin by anti-addiction groups - CBS News "Skop, Ashley (Seaman)" <ashley.skop@mallinckrodt.com> 2014 February 27 Document Email 1 "Jolliff, Susan T" <susan.jolliff@mallinckrodt.com> Hydrocodone Bitartrate Oxycodone MNKOIv002 MNKOI0002651272 2021 October 21 nqfp0240 Mallinckrodt Litigation Documents mnk public no restrictions 2004 August 03 20181127_Emails\Rowley-Kilper, Tiffany\Rowley-Kilper, Tiffany all emails_19.pst\Top of Personal Folders\Archive MNKOI0003063498 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment NAM territory coverage 03:05 PM Rowley-Kilper, Tiffany 2004 August 03 03:05 PM Addiction Treatment NAM territory coverage "grimes, margie m" 2004 August 03 Document Email 1 "gregory, connie j" "hart, rhonda l" "davis, venita a" "buelterman, jacqueline a" "jordan, polly" "kovac, debbie a" "allen, linda s" "rybarczyk, carol j" "reiter, jane" "rowley, tiffany l" "mcgowan, frena a" opioids MNKOIv002 MNKOI0003063497 2021 October 21 klxv0240 Mallinckrodt Litigation Documents mnk public no restrictions 2000 December 21 20181017_Emails\New, Bonnie All emails pre 2014_12.pst\Top of Personal Folders\Archive MNKOI0002719155 MNKOI0002719156 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Call Reports: Addiction Resources Phoenix, NTN-Portland 11:32 PM New, Bonnie 2000 December 21 UCSF 11:32 PM FW: Call Reports: Addiction Resources Phoenix, NTN-Portland "alexander, dan" 2000 December 21 Document Email 1 "lesnak, robert a" "bonnie new" "claudette warren" "debbie lavelle" "denise krause" "ed hesterlee" "edward jensen jr" "joanne levy" "karon houck" "kathleen westbrook" "kendall brown" "larry unger" "lori minnihan" "marco polizzi" "margie grimes" "michael johnson" "mike collins" "mike perry" "vince kaiman" opioids MNKOIv002 MNKOI0002719154 yes 2021 October 21 qfvx0240 Mallinckrodt Litigation Documents mnk public no restrictions 2009 April 15 Muhlenkamp, Kate All emails SUPP OCT 2018_2\Muhlenkamp, Kate All emails SUPP OCT 2018_2.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) CNN - With anti-addiction pill, 'no urge, no craving' 09:51 PM Muhlenkamp, Kate 2009 April 15 09:51 PM RE: CNN - With anti-addiction pill, 'no urge, no craving' "muhlenkamp, kate m \\(neely\\)" 2009 April 15 Document Email 4 "handzic-smith, tony j" opioids MNKOIv002 MNKOI0002852321 2021 October 21 frfd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Controlled Substance Registration Certificate for Addiction Research & Treatment Inc. (of La Puente, California - Maintenance - DEA Registration Numbers : RA0240200 & ZA0240200) United States. Drug Enforcement Administration 2011 June 02 document 1 opioids MNKOIv002 MNKOI0003320133 2021 October 21 gznd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Controlled Substance Registration Certificate for Successful Alternative for Addiction & C (of Vallejo, California - DEA Registration Numbers : RS0383098 & ZS0383098A (Maintenance & Detox)) (with handwritten notes) United States. Drug Enforcement Administration 2011 February 22 document 1 opioids MNKOIv002 MNKOI0003322452 2021 October 21 gnyd0242 Mallinckrodt Litigation Documents mnk Maher, Laura public no restrictions produced document In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Facsimile Transmission cover sheet from Kate Venturino (of Van Dyke Addiction Treatment Center, in Ovid, New York) to Covidien Van Dyke Addiction Treatment Center Venturino, Kate 2011 June 22 document 1 opioids MNKOIv002 MNKOI0003322618 2021 October 21 ztjj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 May 14 Collier, Ginger SUPP OCT 2018_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:35 AM Collier, Ginger 2011 May 14 03:35 AM My Alert: Addiction "market intelligence portal" 2011 May 14 Document Email 3 "collier, ginger l" opioids MNKOIv002 MNKOI0002875728 2021 October 21 mzjj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 May 13 Collier, Ginger SUPP OCT 2018_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:33 AM Collier, Ginger 2011 May 13 03:33 AM My Alert: Addiction "market intelligence portal" 2011 May 13 Document Email 1 "collier, ginger l" Fentanyl MNKOIv002 MNKOI0002875782 2021 October 21 tpkj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 June 25 Collier, Ginger SUPP OCT 2018_11.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:35 AM Collier, Ginger 2011 June 25 03:35 AM My Alert: Addiction "market intelligence portal" 2011 June 25 Document Email 2 "collier, ginger l" Oxycodone Oxymorphone MNKOIv002 MNKOI0002877692 2021 October 21 ytlj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 March 09 Collier, Ginger SUPP OCT 2018_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 04:34 AM Collier, Ginger 2011 March 09 04:34 AM My Alert: Addiction "market intelligence portal" 2011 March 09 Document Email 2 "collier, ginger l" Fentanyl MNKOIv002 MNKOI0002881453 2021 October 21 tzlj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 March 03 Collier, Ginger SUPP OCT 2018_12.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 04:34 AM Collier, Ginger 2011 March 03 04:34 AM My Alert: Addiction "market intelligence portal" 2011 March 03 Document Email 2 "collier, ginger l" Oxycodone MNKOIv002 MNKOI0002881697 2021 October 21 khnj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 February 19 Collier, Ginger SUPP OCT 2018_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 04:31 AM Collier, Ginger 2010 February 19 04:31 AM My Alert: Addiction "market intelligence portal" 2010 February 19 Document Email 2 "collier, ginger l" Hydromorphone MNKOIv002 MNKOI0002885433 2021 October 21 qmnj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 August 04 Collier, Ginger SUPP OCT 2018_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:30 AM Collier, Ginger 2010 August 04 03:30 AM My Alert: Addiction "market intelligence portal" 2010 August 04 Document Email 2 "collier, ginger l" Buprenorphine MNKOIv002 MNKOI0002885809 2021 October 21 jynj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 July 24 Collier, Ginger SUPP OCT 2018_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:30 AM Collier, Ginger 2010 July 24 03:30 AM My Alert: Addiction "market intelligence portal" 2010 July 24 Document Email 3 "collier, ginger l" Oxycodone Tapentadol MNKOIv002 MNKOI0002885964 2021 October 21 spnj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 May 05 Collier, Ginger SUPP OCT 2018_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:33 AM Collier, Ginger 2010 May 05 03:33 AM My Alert: Addiction "market intelligence portal" 2010 May 05 Document Email 3 "collier, ginger l" Oxycodone MNKOIv002 MNKOI0002886167 2021 October 21 jhyj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 July 03 Collier, Ginger SUPP OCT 2018_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:34 AM Collier, Ginger 2010 July 03 03:34 AM My Alert: Addiction "market intelligence portal" 2010 July 03 Document Email 3 "collier, ginger l" Buprenorphine MNKOIv002 MNKOI0002886781 2021 October 21 lkyj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 April 01 Collier, Ginger SUPP OCT 2018_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 04:30 AM Collier, Ginger 2010 April 01 04:30 AM My Alert: Addiction "market intelligence portal" 2010 April 01 Document Email 2 "collier, ginger l" Buprenorphine MNKOIv002 MNKOI0002887000 2021 October 21 jpyj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 June 03 Collier, Ginger SUPP OCT 2018_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:30 AM Collier, Ginger 2010 June 03 03:30 AM My Alert: Addiction "market intelligence portal" 2010 June 03 Document Email 2 "collier, ginger l" Fentanyl Methadone MNKOIv002 MNKOI0002887440 2021 October 21 mryj0240 Mallinckrodt Litigation Documents mnk public no restrictions 2010 April 01 Collier, Ginger SUPP OCT 2018_13.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Titan Initiates Confirmatory Phase 3 Study of Probuphine in the Treatment of Opioid Addiction 01:59 PM Collier, Ginger 2010 April 01 01:59 PM Titan Initiates Confirmatory Phase 3 Study of Probuphine in the Treatment of Opioid Addiction "hasse, debra c" 2010 April 01 Document Email 3 "collier, ginger l" "myers, penny" "vorderstrasse, kevin" Buprenorphine Buprenorphine/Naloxone MNKOIv002 MNKOI0002887663 2021 October 21 fhxd0241 Mallinckrodt Litigation Documents mnk public no restrictions 2016 February 29 2019-07-16 Opioids emails\Schwartz, William\Schwartz, William_1.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) To curb opioid addiction, give physicians and patients more choices for pain | TheHill 07:43 PM Schwartz, William 2016 February 29 07:43 PM FW: To curb opioid addiction, give physicians and patients more choices for pain | TheHill "Socha, Albert" <albert.socha@mallinckrodt.com> 2016 February 29 Document Email 1 "Brignall, Kenneth" <kenneth.brignall@mallinckrodt.com> "Bruni, Kelley" <kelley.bruni@mallinckrodt.com> "Hall, Kevin" <kevin.hall@mallinckrodt.com> "Hubbard-Jacobson, Leslie" <leslie.hubbard-jacobson@mallinckrodt.com> "Keiser, Marella" <marella.keiser@mallinckrodt.com> "McIlhenney, Kelly" <kelly.mcilhenney@mallinckrodt.com> "Rose, Stephanie" <stephanie.rose@mallinckrodt.com> "Schwartz, William F" <william.schwartz@mallinckrodt.com> "Williams, Geoffrey" <geoffrey.williams@mallinckrodt.com> opioids MNKOIv002 MNKOI0003117836 2021 October 21 znxb0241 Mallinckrodt Litigation Documents mnk public no restrictions 2012 January 04 2019-07-02 Opioids emails\Patterson, Steven all_4.zip\Patterson, Steven all_4.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment 06:00 PM Patterson, Steven 2012 January 04 06:00 PM Fwd: Addiction Treatment "Patterson, Steven J" <steven.patterson@covidien.com> 2012 January 04 Document Email 1 "Szymczak, Dorothy" <dorothy.szymczak@covidien.com> Methadone MNKOIv002 MNKOI0003098112 2021 October 21 qhfn0240 Mallinckrodt Litigation Documents mnk public no restrictions 2017 May 23 N\Hazelwood01\Shared Services\Finance\Sales&Mktg Ops\PSG\Contract Administration\All Contracts\Proposals 3 (Methadone)\Proposals\Addiction Resources\Approvals MNKOI0002965716 produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Review - Addiction Resources - New AT Contract 09:00 PM Network Share 2017 May 23 09:00 PM Review - Addiction Resources - New AT Contract "Mindak, Barb J" <"/o=mkglobal/ou=exchange administrative group (fydibohf23spdlt)/cn=recipients/cn=barb.mindak"> 2017 May 23 Document Email 1 "Alexander, Dan" <daniel.alexander@mallinckrodt.com> Methadone MNKOIv002 MNKOI0002965715 2021 October 21 sggp0240 Mallinckrodt Litigation Documents mnk public no restrictions 2011 January 25 20181127_Emails\Rowley-Kilper, Tiffany\Rowley-Kilper, Tiffany all emails_9.pst\Top of Personal Folders\Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Pricing Contract Import for new CRM 09:41 PM Rowley-Kilper, Tiffany 2011 January 25 09:41 PM Addiction Treatment Pricing Contract Import for new CRM "holz, bev b" 2011 January 25 Document Email 2 "kilper, tiffany l (rowley)" "bates, dennis j" "maclin, tim" "aubuchon, susan k" "clevenger, chris" "taylor, patty l" "hazelw - h-3-e, rm 317 (cap 8)" "mcgowan, frena a" "wetzler, brent a" Methadone Morphine MNKOIv002 MNKOI0003063762 2021 October 21 pflm0237 Mallinckrodt Litigation Documents mnk Jackson, Catherine public no restrictions 2014 AMCP Pain Management Substance Abuse Addiction Forum Cardinal Giacalone.doc Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) 2014 AMCP Pain Management Substance Abuse Addiction Forum Cardinal Giacalone.doc jmacdonald 2014 July 18 Document 7 opioids MNKOIv001 MNKOI0001487288 2021 October 21 rglm0237 Mallinckrodt Litigation Documents mnk Jackson, Catherine public no restrictions 2014 AMCP Pain Management Substance Abuse Addiction Forum Cardinal Giacalone.doc Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) 2014 AMCP Pain Management Substance Abuse Addiction Forum Cardinal Giacalone.doc jmacdonald 2014 July 18 Document 7 opioids MNKOIv001 MNKOI0001487408 2021 October 21 nhlm0237 Mallinckrodt Litigation Documents mnk Jackson, Catherine public no restrictions 2014 AMCP Pain Management Substance Abuse Addiction Forum Cardinal Giacalone.doc Jackson, Catherine\Catherine Jackson all_11.pst\Top of Personal Folders\Archive produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) 2014 AMCP Pain Management Substance Abuse Addiction Forum Cardinal Giacalone.doc jmacdonald 2014 July 18 Document 7 opioids MNKOIv001 MNKOI0001487461 2021 October 21 hnpm0237 Mallinckrodt Litigation Documents mnk LaRue, Leah public no restrictions JPain_OpioidsChronicPain_Barry_11_12_2010_1442.pdf LaRue, Leah\Leah LaRue all_4.pst\Top of Personal Folders\Archive produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Opioids, Chronic Pain, and Addiction in Primary Care Declan T. Barry 2010 November 26 Document 9 Buprenorphine Methadone Morphine Oxycodone MNKOIv001 MNKOI0001501354 2021 October 21 gpdm0236 Mallinckrodt Litigation Documents mnk Central Files public no restrictions HA142 Addiction 24x40 Booth Graphics.pdf /Additional_Data/FINAL - 2010/FINAL - 2010/FINAL Brand Documents/Addiction Treatment produced document; Electronic File In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HA142 Addiction 24x40 Booth Graphics.pdf 2012 April 10 document 2 opioids MNKOIv001 MNKOI0000996390 2021 October 21 fpdm0236 Mallinckrodt Litigation Documents mnk Central Files public no restrictions Addiction Booth Graphics FINAL 101510 .pdf /Additional_Data/FINAL - 2010/FINAL - 2010/FINAL Brand Documents/Addiction Treatment produced document; Electronic File In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Booth Graphics FINAL 101510 .pdf 2010 October 25 document 4 opioids MNKOIv001 MNKOI0000996386 2021 October 21 kndy0235 Mallinckrodt Litigation Documents mnk public no restrictions 2010 August 10 /005/005-03-Email collection/Collier, Ginger/Collier emails 1 1 10 fwd_24/Collier emails 1 1 10 fwd_24.pst/Top of Personal Folders/Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:34:05 AM Collier, Ginger 2010 August 10 03:34:05 AM My Alert: Addiction My Alert: Addiction "market intelligence portal" 2010 August 10 Document Email 2 "collier, ginger l" Morphine Oxycodone MNKOIv001 MNKOI0000560289 2021 October 21 fpwy0235 Mallinckrodt Litigation Documents mnk public no restrictions 2010 July 21 /005/005-03-Email collection/Collier, Ginger/Collier emails 1 1 10 fwd_24/Collier emails 1 1 10 fwd_24.pst/Top of Personal Folders/Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:33:30 AM Collier, Ginger 2010 July 21 03:33:30 AM My Alert: Addiction My Alert: Addiction "market intelligence portal" 2010 July 21 Document Email 5 "collier, ginger l" Fentanyl Morphine Oxycodone Oxymorphone Tapentadol Tramadol MNKOIv001 MNKOI0000562338 2021 October 21 hswy0235 Mallinckrodt Litigation Documents mnk public no restrictions 2010 September 09 /005/005-03-Email collection/Collier, Ginger/Collier emails 1 1 10 fwd_24/Collier emails 1 1 10 fwd_24.pst/Top of Personal Folders/Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:34:09 AM Collier, Ginger 2010 September 09 03:34:09 AM My Alert: Addiction My Alert: Addiction "market intelligence portal" 2010 September 09 Document Email 2 "collier, ginger l" Fentanyl Morphine MNKOIv001 MNKOI0000562674 2021 October 21 gswy0235 Mallinckrodt Litigation Documents mnk public no restrictions 2010 October 20 /005/005-03-Email collection/Collier, Ginger/Collier emails 1 1 10 fwd_24/Collier emails 1 1 10 fwd_24.pst/Top of Personal Folders/Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) My Alert: Addiction 03:34:38 AM Collier, Ginger 2010 October 20 03:34:38 AM My Alert: Addiction My Alert: Addiction "market intelligence portal" 2010 October 20 Document Email 3 "collier, ginger l" opioids MNKOIv001 MNKOI0000562671 2021 October 21 jjcc0238 Mallinckrodt Litigation Documents mnk Naten, Derek public no restrictions 2016 Senate Task Force Report.pdf Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_11.pst\Top of Personal Folders\Archive produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Joint Senate Task Force on Heroin and Opioid Addiction senateuser 2016 May 17 Document 49 Buprenorphine Buprenorphine/Naloxone Fentanyl Methadone Morphine MNKOIv001 MNKOI0001639593 2021 October 21 jqbv0238 Mallinckrodt Litigation Documents mnk Decker, John public no restrictions 1-s2.0-S0740547213002201-main.pdf Decker, John\Decker, John all_14.pst\Top of Personal Folders\Archive produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) “The chief of the service is very enthusiastic about it”: A qualitative study of the adoption of buprenorphine for opioid addiction treatment Carla A. Green Ph.D. M.P.H. 2013 October 23 Document 12 Buprenorphine Buprenorphine Hydrochloride Buprenorphine/Naloxone Methadone Oxycodone Propoxyphene MNKOIv001 MNKOI0001577751 2021 October 21 lrgc0238 Mallinckrodt Litigation Documents mnk Naten, Derek public no restrictions Addiction Treatment Catalog 5-6-15 FINAL.pdf Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_17.pst\Top of Personal Folders\Archive produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Treatment Catalog 5-6-15 FINAL.pdf 2015 May 06 Document 12 Buprenorphine Buprenorphine Hydrochloride Methadone MNKOIv001 MNKOI0001650491 2021 October 21 xxwd0238 Mallinckrodt Litigation Documents mnk Naten, Derek public no restrictions MedAssistQandA.pdf Naten, Derek\Naten, Derek pre 2015_4.pst\Top of Personal Folders\Archive produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Hazelden's response to opioid addiction Sarah Townsend Williams 2013 August 29 Document 3 Buprenorphine Buprenorphine/Naloxone Hydrocodone Meperidine Morphine Oxycodone MNKOIv002 MNKOI0001676257 2021 October 21 zgbf0237 Mallinckrodt Litigation Documents mnk Kilper, Jeff public no restrictions FINAL DOS Addiction Treatment CY17 SICP.docx /Additional_Data/SRC29/Kilper all 2014-fwd_4/Kilper all 2014-fwd_4.pst/Top of Personal Folders/Archive/SICP Plans NAD & AT produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) FINAL DOS Addiction Treatment CY17 SICP.docx Terese.Lafeber 2017 February 08 Document 6 Methadone MNKOIv001 MNKOI0001181268 2021 October 21 ftgc0238 Mallinckrodt Litigation Documents mnk Naten, Derek public no restrictions Opioid Addiction Treatment Education Series Ad - 08-28-2014.pdf Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_17.pst\Top of Personal Folders\Archive produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Opioid Addiction Treatment Education Series Ad - 08-28-2014.pdf 2014 December 05 Document 1 Buprenorphine Buprenorphine/Naloxone Methadone MNKOIv001 MNKOI0001650612 2021 October 21 smhc0238 Mallinckrodt Litigation Documents mnk Naten, Derek public no restrictions Bill would fund drug-addiction fight _ TheHill.pdf Naten, Derek\Naten, Derek 1 1 15 to 12 31 17_18.pst\Top of Personal Folders\Archive produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Bill would fund drug-addiction fight _ TheHill.pdf 2015 March 09 Document 1 opioids MNKOIv001 MNKOI0001651726 2021 October 21 qjhw0238 Mallinckrodt Litigation Documents mnk Williams, Jane public no restrictions HA153 Addiction Catalog_FINAL Rev12-5-13.pdf Williams, Jane\Williams, Jane emails all_5.pst\Top of Personal Folders\Archive produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) HA153 Addiction Catalog_FINAL Rev12-5-13.pdf 2013 December 05 Document 8 Buprenorphine Buprenorphine Hydrochloride Methadone MNKOIv002 MNKOI0001712299 2021 October 21 xkpx0236 Mallinckrodt Litigation Documents mnk Synchrony public no restrictions Fishbain 2008 444-459.pdf /011/011/011.L01/FILES FROM SYNCHRONY MEDICAL/Project Folders/Exalgo Manuscripts/2-COV-X-PUB-309-2/References/Old refs produced document; Electronic File In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) What Percentage of Chronic Nonmalignant Pain Patients Exposed to Chronic Opioid Analgesic Therapy Develop Abuse/Addiction and/or Aberrant Drug-Related Behaviors? A Structured Evidence-Based Review B 2015 June 20 document 17 Butorphanol Fentanyl Hydrocodone Hydromorphone Methadone Morphine Oxycodone Oxymorphone Propoxyphene Tramadol MNKOIv001 MNKOI0000792744 2021 October 21 jkpx0236 Mallinckrodt Litigation Documents mnk Synchrony public no restrictions Fishbain 2008 Pain Med.pdf /011/011/011.L01/FILES FROM SYNCHRONY MEDICAL/Project Folders/Exalgo Manuscripts/2-COV-X-PUB-309-2/References/Old refs produced document; Electronic File In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) What Percentage of Chronic Nonmalignant Pain Patients Exposed to Chronic Opioid Analgesic Therapy Develop Abuse/Addiction and/or Aberrant Drug-Related Behaviors? A Structured Evidence-Based Review B 2015 June 20 document 17 Butorphanol Fentanyl Hydrocodone Hydromorphone Methadone Morphine Oxycodone Oxymorphone Propoxyphene Tramadol MNKOIv001 MNKOI0000792761 2021 October 21 hjbj0236 Mallinckrodt Litigation Documents mnk Synchrony public no restrictions Fishbain 2008.pdf /011/011/011.L01/FILES FROM SYNCHRONY MEDICAL/Project Folders/Exalgo Manuscripts/2-COV-X-PUB-309-4/References/No longer used/clean produced document; Electronic File In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) What Percentage of Chronic Nonmalignant Pain Patients Exposed to Chronic Opioid Analgesic Therapy Develop Abuse/Addiction and/or Aberrant Drug-Related Behaviors? A Structured Evidence-Based Review B 2015 June 20 document 16 Butorphanol Fentanyl Hydrocodone Hydromorphone Methadone Morphine Oxycodone Oxymorphone Propoxyphene Tramadol MNKOIv001 MNKOI0000800860 2021 October 21 zsnj0236 Mallinckrodt Litigation Documents mnk Synchrony public no restrictions O'Brien2011GoodmanGilman1.pdf /011/011/011.L01/FILES FROM SYNCHRONY MEDICAL/Project Folders/Methadone Educational Slides/12-COV-0253/Module 1/1 References/References-General produced document; Electronic File In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) AccessMedicine | Print: Drug Addiction: Introduction mkearney 2015 June 20 document 38 Buprenorphine Buprenorphine Hydrochloride Buprenorphine/Naloxone Fentanyl Hydromorphone Meperidine Methadone Morphine Oxycodone MNKOIv001 MNKOI0000849062 2021 October 21 fffk0236 Mallinckrodt Litigation Documents mnk Synchrony public no restrictions Butler2008PharmacoepidemiolDrugSaf.pdf /011/011/011.L01/FILES FROM SYNCHRONY MEDICAL/Project Folders/MNK-795 Manuscripts/13-COV-0060/4 References/1 Annotated produced document; Electronic File In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) National addictions vigilance intervention and prevention program (NAVIPPRO[trade]): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse 2015 June 20 document 13 Fentanyl Hydrocodone Hydrocodone Bitartrate Methadone Morphine Oxycodone Oxymorphone MNKOIv001 MNKOI0000861073 2021 October 21 qybg0236 Mallinckrodt Litigation Documents mnk public no restrictions 2016 August 02 /013/013-02/McDaniel, Neal/McDaniel emails 1 1 10 fwd_11/McDaniel emails 1 1 10 fwd_11.pst/Top of Personal Folders/Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) New Research: Opioid Addiction and Dependence After Surgery is Significantly Higher than Previously Known Nasdaq:PCRX 01:21:32 PM McDaniel, Neal 2016 August 02 01:21:32 PM FW: New Research: Opioid Addiction and Dependence After Surgery is Significantly Higher than Previously Known Nasdaq:PCRX FW: New Research: Opioid Addiction and Dependence After Surgery is Significantly Higher than Previously Known Nasdaq:PCRX "McDaniel, Neal O" <neal.mcdaniel@mallinckrodt.com> 2016 August 02 Document Email 1 "Basham, Jerry" <jerry.basham@mallinckrodt.com>, "Burton, Steve" <steve.burton@mallinckrodt.com>, "Druen, Todd" <todd.druen@mallinckrodt.com>, "Ferrara, Keith" <keith.ferrara@mallinckrodt.com>, "Quinn, Ted K." <ted.quinn@mallinckrodt.com>, "Rouser, Deborah" <deborah.rouser@mallinckrodt.com>, "Seida, Robert" <robert.seida@mallinckrodt.com>, "Thomas, Michelle" <michelle.thomas@mallinckrodt.com> opioids MNKOIv001 MNKOI0000728531 2021 October 21 fydk0235 Mallinckrodt Litigation Documents mnk public no restrictions 2014 December 13 /009/009/Falcone emails 14 - 16_15/Falcone emails 14 - 16_15.pst/Top of Personal Folders/Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Pain relief for vets doesn’t have to lead to deadly prescription drug addiction | The Sacramento Bee 02:16:12 PM Falcone, Melissa 2014 December 13 02:16:12 PM Pain relief for vets doesn’t have to lead to deadly prescription drug addiction | The Sacramento Bee Pain relief for vets doesn’t have to lead to deadly prescription drug addiction | The Sacramento Bee "Decker, John F" <john.decker@mallinckrodt.com> 2014 December 13 Document Email 1 "Falcone, Melissa M" <melissa.falcone@mallinckrodt.com>, "Kisinger, Connie" <connie.kisinger@mallinckrodt.com> opioids MNKOIv001 MNKOI0000465612 2021 October 21 ljgk0235 Mallinckrodt Litigation Documents mnk Falcone, Melissa public no restrictions Mallinckrodt_Epi-Program_Response to FDA Outlline.docx /009/009/Falcone emails 14 - 16_18/Falcone emails 14 - 16_18.pst/Top of Personal Folders/Archive/FW: EXALGO Epi Program SOW produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NATIONAL ADDICTIONS VIGILANCE Kimberly Lobo 2014 June 25 Document 4 Hydromorphone Morphine Oxycodone Oxymorphone Tramadol MNKOIv001 MNKOI0000468924 2021 October 21 lzgk0235 Mallinckrodt Litigation Documents mnk public no restrictions 2014 July 29 /009/009/Falcone emails 14 - 16_18/Falcone emails 14 - 16_18.pst/Top of Personal Folders/Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) 2015 AMCP Pain Management Substance Abuse Addiction Forum 09 09 14 (2).doc 01:30:42 PM Falcone, Melissa 2014 July 29 01:30:42 PM RE: 2015 AMCP Pain Management Substance Abuse Addiction Forum 09 09 14 (2).doc RE: 2015 AMCP Pain Management Substance Abuse Addiction Forum 09 09 14 (2).doc "Hasse, Debra C" <debra.hasse@mallinckrodt.com> 2014 July 29 Document Email 2 "Falcone, Melissa M" <melissa.falcone@mallinckrodt.com> opioids MNKOIv001 MNKOI0000469678 2021 October 21 xshk0235 Mallinckrodt Litigation Documents mnk Falcone, Melissa public no restrictions Mallinckrodt_Epi-Program_SOW_Additions_5 14 14 Final.pdf /009/009/Falcone emails 14 - 16_19/Falcone emails 14 - 16_19.pst/Top of Personal Folders/Archive/Exalgo AD labeling Inflexxion study produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NATIONAL ADDICTIONS VIGILANCE Kimberly Lobo 2014 May 15 Document 8 Hydromorphone Morphine Oxycodone Oxymorphone Tramadol MNKOIv001 MNKOI0000470629 2021 October 21 ysfh0235 Mallinckrodt Litigation Documents mnk MedLogix public no restrictions Porter and Jick. N Engl J Med. 1980;302(2)_123.pdf /004/004/004.L01/004/M_/Mallinckrodt/MNK Opioid Project Submission/2014/MA1437 - HAL Managed Care Manuscript/References/Not Used produced document; Electronic File In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) Addiction Rare in Patients Treated with Narcotics; N Engl J Med 1980.302:123-123 Apex CoVantage LLC. 2014 October 08 document 1 opioids MNKOIv001 MNKOI0000419634 2021 October 21 rlwx0235 Mallinckrodt Litigation Documents mnk public no restrictions 2014 February 02 /009/009/Chick emails 1 1 10 fwd_8/Chick emails 1 1 10 fwd_8.pst/Top of Personal Folders/Archive produced document; Email In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) PAIN ADDICTION AND THE LAW 09:38:09 PM Chick, Stacy 2014 February 02 09:38:09 PM RE: PAIN ADDICTION AND THE LAW RE: PAIN ADDICTION AND THE LAW "Novak, Rod P" <rod.novak@mallinckrodt.com> 2014 February 02 Document Email 2 "Jones, Paul C (Sales)" <paul.c.jones@mallinckrodt.com>, "Falcone, Melissa M" <melissa.falcone@mallinckrodt.com> "Chick, Stacy A" <stacy.chick@mallinckrodt.com> opioids MNKOIv001 MNKOI0000437477 2021 October 21 qllk0235 Mallinckrodt Litigation Documents mnk Falcone, Melissa public no restrictions Exalgo_EpiStudyProtocol_12 30 13 Revision hyperlinks_clean_LN_SK.pdf /009/009/Falcone emails 14 - 16_22/Falcone emails 14 - 16_22.pst/Top of Personal Folders/Archive/FW: EXALGO Epidemiological Study Protocol Submitted produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NATIONAL ADDICTIONS VIGILANCE Kimberly Lobo 2014 January 05 Document 49 Buprenorphine Hydromorphone Methadone Morphine Oxycodone Oxymorphone Tapentadol Tramadol MNKOIv001 MNKOI0000474510 2021 October 21 xnxk0235 Mallinckrodt Litigation Documents mnk Falcone, Melissa public no restrictions Exalgo_EpiStudy_Report_FINAL_02.24.14.pdf /009/009/Falcone emails 14 - 16_19/Falcone emails 14 - 16_19.pst/Top of Personal Folders/Archive/FW: Inflexxion Publication Recommendations for EXALGO produced document; Attachment In re: Mallinckrodt plc, Case No. 20-12522-JTD (Bankr. D. Del. 2020) NATIONAL ADDICTIONS VIGILANCE Kimberly Lobo 2014 June 12 Document 83 Hydromorphone Methadone Morphine Oxycodone Oxymorphone Tapentadol Tramadol MNKOIv001 MNKOI0000471175 2021 October 21